CHEMBL336100,AAADQEFQWNJHOZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,IC50,=,5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL336100,AAADQEFQWNJHOZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,KI,=,0.9,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL14144,AAEKULYONKUBOZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14971892,KI,=,242.29,NM,,"","","","","","",,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [3H]-nisoxatine radioligand,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL3323101,AAHLCKVWZXFMPB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,6,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3323101,AAHLCKVWZXFMPB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3.8,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323101,AAHLCKVWZXFMPB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,5.8,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323101,AAHLCKVWZXFMPB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,137,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323101,AAHLCKVWZXFMPB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,5.8,NM,314414,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL12,AAOVKJBEBIDNHE-UHFFFAOYSA-N,DIAZEPAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL12,AAOVKJBEBIDNHE-UHFFFAOYSA-N,DIAZEPAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3334773,AAXDLPLNFKHHPR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,IC50,=,425.7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL456654,ABAOWFCFAADMKA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,8,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL141741,ABARJWHHNCOEQT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,KI,=,110,NM,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2169900,ABCUTHOEKRCYIS-UHFFFAOYSA-N,AZETIDIN-3-YL(PHENYL)METHANOL HCL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,0.2,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL990,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,BUTENAFINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,3909.9,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL990,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,BUTENAFINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3877.5,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3577956,ABJWJGMTLYSISP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25893048,ACTIVITY,,,,Not Active,"","","","","","",,,,,,,,Binding affinity to human NET at 1 uM,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL551556,ABLMTRUAAOJKSC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,106,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205816,ABONQAUMSMWLEK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205816,ABONQAUMSMWLEK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL565844,ABPSWEJOHYDZDP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,900,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL565844,ABPSWEJOHYDZDP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,5100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL565844,ABPSWEJOHYDZDP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,2040,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL512472,ABWNRPAQIBGXIY-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,25,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL275212,ABXUYGWOEIXKBD-KTKRTIGZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14971892,KI,=,450,NM,,"","","","","","",,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [125I]-RTI-55 radioligand,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL553395,ABYFXYVIEFXQPH-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,"",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10755640,KI,=,240,NM,,"","","","","","",,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,"",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11082457,KI,=,1000,NM,,"","","","","","",,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,"",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12110997,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
,ABZSPJVXTTUFAA-UHFFFAOYSA-N,"",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12649361,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL7143,ACEHBQPPDDGCGZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10715164,KI,=,6380,NM,,"","","","","","",,,,,,,,Compound was evaluated for its binding affinity towards human NET (norepinephrine) transporter,2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.,J. Med. Chem.,PUBLICATION,
CHEMBL765,ACGDKVXYNVEAGU-UHFFFAOYSA-N,GUANETHIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL765,ACGDKVXYNVEAGU-UHFFFAOYSA-N,GUANETHIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL496,ACGUYXCXAPNIKK-UHFFFAOYSA-N,HEXACHLOROPHENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL496,ACGUYXCXAPNIKK-UHFFFAOYSA-N,HEXACHLOROPHENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL606809,ACGWDXHPVXMSNJ-KOQKOIQBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,380,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1069,ACWBQPMHZXGDFX-QFIPXVFZSA-N,VALSARTAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1069,ACWBQPMHZXGDFX-QFIPXVFZSA-N,VALSARTAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL404013,ACZMLOPMXAUHFP-QFBILLFUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,4.5,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL334577,ADCPRYKGPAHETD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213054,KI,=,5.3,NM,,"","","","","","",,,,,,,,Inhibition of [125I]- RTI -55 binding at the Norepinephrine transporter sites on HEK-hNET cells,Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL2030634,ADGIWWYGVBZYMC-UHFFFAOYSA-N,N-(CYCLOHEXYLMETHYL)PYRROLIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL115769,ADQZGIYHFQQPRB-UHFFFAOYSA-N,RWJ-68354,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1070,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL115769,ADQZGIYHFQQPRB-UHFFFAOYSA-N,RWJ-68354,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1061,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1702607,ADVPTQAUNPRNPO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12649361,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL499576,AEAWXYVKJBWNDY-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,7,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL220801,AEEJHYWVYVJIRH-OFVILXPXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,1820,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL313833,AELCINSCMGFISI-UHFFFAOYSA-N,TRANYLCYPROMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,5900,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL252557,AEMRFAOFKBGASW-UHFFFAOYSA-N,GLYCOLIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL252557,AEMRFAOFKBGASW-UHFFFAOYSA-N,GLYCOLIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL44884,AEUTYOVWOVBAKS-UWVGGRQHSA-N,ETHAMBUTOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL44884,AEUTYOVWOVBAKS-UWVGGRQHSA-N,ETHAMBUTOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3612831,AEWLCYATCHHWMP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,0.62,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL399147,AEWPIBYOYSOWAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,IC50,=,68000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL399147,AEWPIBYOYSOWAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,INHIBITION,=,2.3,%,,"","","","","","",,,,,,,,Inhibition of NET at 1 uM,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14257,AEYFRZGFXCIRPL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14971892,KI,=,5.6,NM,,"","","","","","",,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [125I]-RTI-55 radioligand,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL405728,AFBGSNRISAOHKD-FUHWJXTLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,160,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL596001,AFKZQXYPUGXQNH-SESHTJHWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,8.5,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1221,AFNXATANNDIXLG-UHFFFAOYSA-N,SULCONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2027,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1221,AFNXATANNDIXLG-UHFFFAOYSA-N,SULCONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2010,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1818467,AFOUVNVDHQZVBK-RTBURBONSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,19.95,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL530334,AFPFOKAYUJMERG-CABCVRRESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,5000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1204414,AFRJOWOPSIECIY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,11,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL121611,AFTYGKFAHDIZJA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,IC50,=,116,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL121611,AFTYGKFAHDIZJA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,KI,=,82,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL508112,AFZSMODLJJCVPP-UHFFFAOYSA-N,BENZOTHIAZYL DISULFIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL508112,AFZSMODLJJCVPP-UHFFFAOYSA-N,BENZOTHIAZYL DISULFIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL134342,AGBQKNBQESQNJD-SSDOTTSWSA-N,LIPOIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL134342,AGBQKNBQESQNJD-SSDOTTSWSA-N,LIPOIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL379536,AGCDRDCNYZHHKS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL267744,AGHANLSBXUWXTB-UHFFFAOYSA-N,TICRYNAFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL267744,AGHANLSBXUWXTB-UHFFFAOYSA-N,TICRYNAFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2207386,AGKMPGSBLMAGAX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23141912,INHIBITION,=,10.83,%,,"","","","","","",,,,,,,,Inhibition of NET at 1 uM by radioligand displacement assay,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1741,AGOYDEPGAOXOCK-KCBOHYOISA-N,CLARITHROMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1741,AGOYDEPGAOXOCK-KCBOHYOISA-N,CLARITHROMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL382768,AGRVUDWDZKZCAA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL596148,AHCAMFIUFHMBFK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,IC50,=,80,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL596148,AHCAMFIUFHMBFK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,45,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL216736,AHEMMEONOCHONP-DBUDALRPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17154506,KI,=,102.2,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 labeled 2beta-carbomethoxy-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL490,AHOUBRCZNHFOSL-YOEHRIQHSA-N,PAROXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,85,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL490,AHOUBRCZNHFOSL-YOEHRIQHSA-N,PAROXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,328,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL490,AHOUBRCZNHFOSL-YOEHRIQHSA-N,PAROXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,40,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL490,AHOUBRCZNHFOSL-YOEHRIQHSA-N,PAROXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,40,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL490,AHOUBRCZNHFOSL-YOEHRIQHSA-N,PAROXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12232544,KI,=,45,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL490,AHOUBRCZNHFOSL-YOEHRIQHSA-N,PAROXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12232544,KI,=,156,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL490,AHOUBRCZNHFOSL-YOEHRIQHSA-N,PAROXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,KI,=,90,NM,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL490,AHOUBRCZNHFOSL-YOEHRIQHSA-N,PAROXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,=,100,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL490,AHOUBRCZNHFOSL-YOEHRIQHSA-N,PAROXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,86,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL490,AHOUBRCZNHFOSL-YOEHRIQHSA-N,PAROXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,86,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1076395,AHRCLHZVCLENJC-KMFDXPJZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL449047,AHRDEWSZTRJWJB-BTXUNPJVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18434164,KI,=,75,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL407803,AHXRAUZDJFQCSL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,IC50,=,2258,NM,,"","","","","","",,,,,,,,Compound was tested for inhibition of [3H]NE binding to norepinephrine transporter HEK cells,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL407803,AHXRAUZDJFQCSL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,KI,=,2068,NM,,"","","","","","",,,,,,,,Compound was tested for inhibition of [125I]-RTI-55 binding to norepinephrine transporter HEK cells,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL407803,AHXRAUZDJFQCSL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,RATIO,=,1.09,,,"","","","","","",,,,,,,,Ratio of uptake inhibition to binding affinity to human NET (IC50/Ki),Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL273208,AIBJZSMLYKTKIK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,10,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL273208,AIBJZSMLYKTKIK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,10,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224241,AIGSBZFJFSQVPD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,7.94,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL565332,AIHZABOGLZWKHW-PMACEKPBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,INHIBITION,=,38,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL583,AIJTTZAVMXIJGM-UHFFFAOYSA-N,GREPAFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL583,AIJTTZAVMXIJGM-UHFFFAOYSA-N,GREPAFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL446281,AILKVNMCCFEAQT-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,>,322,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14,AIXAANGOTKPUOY-UHFFFAOYSA-N,CARBACHOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL14,AIXAANGOTKPUOY-UHFFFAOYSA-N,CARBACHOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1818463,AJFRCYMRJNJFPE-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,10,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3633757,AJIMVLSQIMXLNV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26475518,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Displacement of [3H]-Nisoxetine from recombinant human NET at 10 uM after 1.5 hrs by Microbeta scintillation counting analysis relative to control,Synthesis and evaluation of aporphine analogs containing C1 allyl isosteres at the h5-HT2A receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL54440,AJLFOPYRIVGYMJ-INTXDZFKSA-N,MEVASTATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL54440,AJLFOPYRIVGYMJ-INTXDZFKSA-N,MEVASTATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL559610,AJLUMLBNDXXSIW-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,11.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL559610,AJLUMLBNDXXSIW-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,13.8,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL1618305,AJPSBXJNFJCCBI-YOHUGVJRSA-N,NALOXONAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1618305,AJPSBXJNFJCCBI-YOHUGVJRSA-N,NALOXONAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1818546,AJRLLMMPWPRYOM-BPGUCPLFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,63.1,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL496298,AJRXGUDPNCWOIG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,4.79,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL3323187,AKCCORFIPGKYKO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,9100,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL67024,AKCNZFOHJFSRSN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,IC50,=,170,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL67024,AKCNZFOHJFSRSN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,KI,=,79,NM,,"","","","","","",,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL522296,AKCWJIPYUJCKIS-HOTGVXAUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,7,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL217928,AKEDNWBVXPATHJ-LVXARBLLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,,,,Not Determined,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL364713,AKNNEGZIBPJZJG-MSOLQXFVSA-N,NOSCAPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL364713,AKNNEGZIBPJZJG-MSOLQXFVSA-N,NOSCAPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL497492,AKOJURNFNIUCOV-AEFFLSMTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,45,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL497493,AKOJURNFNIUCOV-WMZOPIPTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,14,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL575131,AKRRCLREANRVLZ-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,84,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL203674,AKYOXKZSLULYCY-UGSOOPFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,920,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224470,ALCQDLGGOYWNLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,32,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2110816,ALELTFCQZDXAMQ-UHFFFAOYSA-N,BUTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,5100,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1255834,ALFGDCNSEBJYSP-UHFFFAOYSA-N,BW-723C86,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,3625.7,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1255834,ALFGDCNSEBJYSP-UHFFFAOYSA-N,BW-723C86,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3595.7,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL567945,ALLVIFFNCLDETM-SECBINFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL155359,AMAFHSJSCNHJAA-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,17000,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL476315,AMBALGQRTVWPRL-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,748,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1909080,AMGRXJSJSONEEG-UHFFFAOYSA-L,STRONTIUM CHLORIDE HEXAHYDRATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909080,AMGRXJSJSONEEG-UHFFFAOYSA-L,STRONTIUM CHLORIDE HEXAHYDRATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL42553,AMIHUYQKNJHXPT-XNSJETLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16302792,KI,=,5,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]dopamine from human NET expressed in COS7 cells,"Rhodamine-labeled 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)tropane analogues as high-affinity fluorescent probes for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL1818446,AMIXKESLNNOGEZ-HZPDHXFCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,39.81,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1170585,AMKBEJSLPSMHMK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,501.19,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL541226,AMLGZPQHVSFYSD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,16,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL598562,AMNKPXBJLVWEJK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,413,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL596775,AMOKJMKEFDPTPN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,>,100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1085233,AMRZCARGTNPWTE-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,57,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1085233,AMRZCARGTNPWTE-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,305,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1083741,AMRZCARGTNPWTE-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,441,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1083741,AMRZCARGTNPWTE-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,602,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL257738,ANDYBNKRXGVQGP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18060777,KI,=,140,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL496911,ANKBUMUPFQMGBF-SLWGAWGTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18434164,KI,=,430,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1813311,ANLYZSJGJNCZJB-WMLDXEAASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,5888.44,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL562476,ANOKEIWYHCYLAM-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,IC50,=,23,NM,,"",cell_based,"","","","",MDCK,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET expressed in MDCK cells,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL562476,ANOKEIWYHCYLAM-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,IC50,=,28,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL562476,ANOKEIWYHCYLAM-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,IC50,=,137,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL562476,ANOKEIWYHCYLAM-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,28,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL562476,ANOKEIWYHCYLAM-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,28,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL566816,ANOKEIWYHCYLAM-QZTJIDSGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,IC50,=,150,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL570856,ANOKEIWYHCYLAM-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,IC50,=,415,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL565309,ANOKEIWYHCYLAM-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,IC50,=,79,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1242950,ANTKBACNWQHQJE-UHFFFAOYSA-N,AC-42,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20684563,KI,>=,1000,NM,,"","","","","","",,,,,,,,Binding affinity to human NE transporter by radioligand displacement assay,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,PUBLICATION,
CHEMBL451,ANTSCNMPPGJYLG-UHFFFAOYSA-N,CHLORDIAZEPOXIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL451,ANTSCNMPPGJYLG-UHFFFAOYSA-N,CHLORDIAZEPOXIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL469222,ANVIRSRIYYSFBV-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,31,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL517424,ANZMQHLROXAIJU-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,19,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL521589,ANZXOIAKUNOVQU-UHFFFAOYSA-N,BAMBUTEROL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL521589,ANZXOIAKUNOVQU-UHFFFAOYSA-N,BAMBUTEROL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL460499,AOCCBINRVIKJHY-UHFFFAOYSA-N,CARMOFUR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL460499,AOCCBINRVIKJHY-UHFFFAOYSA-N,CARMOFUR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL573361,AOCFDQDGDIOFRW-CCRGXQTGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,=,1200,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,DOXORUBICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL53463,AOJJSUZBOXZQNB-TZSSRYMLSA-N,DOXORUBICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL417,AOJJSUZBOXZQNB-VTZDEGQISA-N,EPIRUBICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL417,AOJJSUZBOXZQNB-VTZDEGQISA-N,EPIRUBICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1087922,AOJOZQNALFJCNW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,1500,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173087,AOUKQWFJPNRGAH-FGJGXXMFSA-N,"6-(3,4-DICHLOROPHENYL)-1-[1-(METHYLOXY)-3-BUTEN-1-YL]-3-AZABICYCLO[4.1.0]HEPTANE (DIASTEREOMERIC MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,1,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173087,AOUKQWFJPNRGAH-FGJGXXMFSA-N,"6-(3,4-DICHLOROPHENYL)-1-[1-(METHYLOXY)-3-BUTEN-1-YL]-3-AZABICYCLO[4.1.0]HEPTANE (DIASTEREOMERIC MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,3.98,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1200623,AOXRBFRFYPMWLR-XGXHKTLJSA-N,ETHYLESTRENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2098,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200623,AOXRBFRFYPMWLR-XGXHKTLJSA-N,ETHYLESTRENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2080,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3287723,AOYJKNKRKBOUAP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24735492,INHIBITION,=,-4.8,%,,"","","","","","",,,,,,,,Binding affinity to human NET at 10 uM by radioligand displacement assay,Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence.,J. Med. Chem.,PUBLICATION,
CHEMBL1784685,APARPRRWRUIPGQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21570838,INHIBITION,<,50,%,Active,"","","","","","",,,,,,,,Inhibition of human recombinant NET at 10 uM by radioligand binding assay,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224317,APFRQKRCPYHTLD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,5.01,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1076586,APHXKHUFVKITGC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20137933,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL379205,APJFYUJBFNMVNI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,61,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL267345,APKFDSVGJQXUKY-INPOYWNPSA-N,AMPHOTERICIN B,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL267345,APKFDSVGJQXUKY-INPOYWNPSA-N,AMPHOTERICIN B,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL241646,APMCQNBYSJNSHZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18052090,KI,=,56,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,PUBLICATION,
CHEMBL3673134,APOHGRUBKIYISF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1209,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL2322001,APQGMQHBIOJWDO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,25,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2206509,APTVKHQLUJFYAC-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,7.1,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323088,APTVKHQLUJFYAC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,KI,=,7.6,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL404754,APWBVHFSBGGAAZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,38,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL249161,AQBBMDYZYWMBQN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,IC50,,,,Not Determined,"","","","","","",,,,,,,,Inhibition of NET,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL249161,AQBBMDYZYWMBQN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,INHIBITION,=,13,%,,"","","","","","",,,,,,,,Inhibition of NET at 1 uM,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL878,AQCHWTWZEMGIFD-UHFFFAOYSA-N,METOLAZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL878,AQCHWTWZEMGIFD-UHFFFAOYSA-N,METOLAZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3323107,AQEBNLPGUGBPPZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,19,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL1083706,AQGRUVIDIWOMIH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,25,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL452861,AQHHHDLHHXJYJD-AWEZNQCLSA-N,(-)-PROPANOLOL ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL452861,AQHHHDLHHXJYJD-AWEZNQCLSA-N,(-)-PROPANOLOL ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL275742,AQHHHDLHHXJYJD-CQSZACIVSA-N,DEXPROPRANOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL275742,AQHHHDLHHXJYJD-CQSZACIVSA-N,DEXPROPRANOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL27,AQHHHDLHHXJYJD-UHFFFAOYSA-N,PROPRANOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL27,AQHHHDLHHXJYJD-UHFFFAOYSA-N,PROPRANOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL257593,AQIDZODGJIWGLO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,47,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL30,AQIXAKUUQRKLND-UHFFFAOYSA-N,CIMETIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL30,AQIXAKUUQRKLND-UHFFFAOYSA-N,CIMETIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2407328,AQLYDOOFZXWOAC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,36,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL768,AQNDDEOPVVGCPG-UHFFFAOYSA-N,ESMOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL768,AQNDDEOPVVGCPG-UHFFFAOYSA-N,ESMOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL202518,AQQRGNNYEPRIIF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL428408,AQRRWNJTDQZWAN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,18000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673151,AQSSBDDIMZJNQJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,432,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL253182,AQWGYBOWCFEBRM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18085744,KI,=,618,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET t expressed in HEK293 cells,"Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.",J. Med. Chem.,PUBLICATION,
CHEMBL551443,AQWUGZUSQXSOTJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,404,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1204412,AQZJYBPKTZMMER-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3334784,ARIJCTMJQZWJNV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,68.9,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL498495,AROKURNCLIVVKP-KBXCAEBGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,200,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL498495,AROKURNCLIVVKP-KBXCAEBGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL497461,AROKURNCLIVVKP-KDOFPFPSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,420,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL498142,AROKURNCLIVVKP-KSSFIOAISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,370,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL445082,AROKURNCLIVVKP-RDTXWAMCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,26,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL445082,AROKURNCLIVVKP-RDTXWAMCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,40,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1614641,ARPYQKTVRGFPIS-VIFPVBQESA-N,FLUNOXAPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1614641,ARPYQKTVRGFPIS-VIFPVBQESA-N,FLUNOXAPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL378839,ARSOFBZWWWOBKV-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,175,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL232070,ARUHQVGRDPJNBG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,1100000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL232070,ARUHQVGRDPJNBG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL471211,ASCGGWXVCATSKL-YOEHRIQHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954038,IC50,=,21,NM,,"",cell_based,"","","","",HEK293,,,,,,,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter","Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL589179,ASGNFMOFCHAUOT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19926484,KI,=,406,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1076375,ASGUPSYAPIGYKQ-ATAGQQDESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL250689,ASRDPULQBHFPGU-WFIHMLKPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17418570,KI,=,950,NM,,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter,CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL659,ASUTZQLVASHGKV-JDFRZJQESA-N,GALANTAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL659,ASUTZQLVASHGKV-JDFRZJQESA-N,GALANTAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL446,ASWVTGNCAZCNNR-UHFFFAOYSA-N,SULFAMETHAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL446,ASWVTGNCAZCNNR-UHFFFAOYSA-N,SULFAMETHAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL444633,ATEBXHFBFRCZMA-VXTBVIBXSA-N,RIFABUTIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL444633,ATEBXHFBFRCZMA-VXTBVIBXSA-N,RIFABUTIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL461153,ATQOTXBBRYXYCL-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,44,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL598561,ATVZOYVGUWYSKX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,276,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2047572,ATXUZVSWVVGJPF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,IC50,=,800,NM,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL612232,AUIYTQCQFPAFCD-MLVZRXLZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10821718,KI,=,208,NM,,"",cell_based,"","","","",,,,,,,,Compound was evaluated for inhibition of [3H]NE uptake in HEK-hNET cells expressing Human norepinephrine transporter,Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL612232,AUIYTQCQFPAFCD-MLVZRXLZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10821718,KI,=,5440,NM,,"",cell_based,"","","","",,,,,,,,Compound was evaluated for binding affinity using [125I]RTI-55 as a radioligand in HEK-hNET cells expressing human norepinephrine transporter,Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL2113279,AUJWWBGAFLMMKB-SMTRIPRVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,>,6900,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL2113279,AUJWWBGAFLMMKB-SMTRIPRVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,1390,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL2206514,AUOGWJKRNSZLMZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,137,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1642902,AUOZLNRXVPELRP-ABAIWWIYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,28,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642905,AUOZLNRXVPELRP-IAQYHMDHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,371,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642904,AUOZLNRXVPELRP-NHYWBVRUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,92,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642903,AUOZLNRXVPELRP-XHDPSFHLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,257,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL50588,AUVVAXYIELKVAI-CKBKHPSWSA-N,EMETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL50588,AUVVAXYIELKVAI-CKBKHPSWSA-N,EMETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1079263,AUYQRPCINYAISL-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,10,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1544,AUYYCJSJGJYCDS-LBPRGKRZSA-N,LIOTHYRONINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1544,AUYYCJSJGJYCDS-LBPRGKRZSA-N,LIOTHYRONINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL964,AUZONCFQVSMFAP-UHFFFAOYSA-N,DISULFIRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,70370,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL964,AUZONCFQVSMFAP-UHFFFAOYSA-N,DISULFIRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,69812,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL611063,AVDNQARKBDHXAZ-UBNPUMAJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,0.501,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL595133,AVHPWUACYYPSMI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,IC50,=,146,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL595133,AVHPWUACYYPSMI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,78,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL174,AVKUERGKIZMTKX-NJBDSQKTSA-N,AMPICILLIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL174,AVKUERGKIZMTKX-NJBDSQKTSA-N,AMPICILLIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2205829,AVNYJOIRGGOFFW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205829,AVNYJOIRGGOFFW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL456,AVOLMBLBETYQHX-UHFFFAOYSA-N,ETHACRYNIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL456,AVOLMBLBETYQHX-UHFFFAOYSA-N,ETHACRYNIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL465515,AVSJNVNTDDYDEP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,10500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1085339,AVTQGGVDIQOXSO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,5,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1085339,AVTQGGVDIQOXSO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,72,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL3310488,AVYVBCVILBXGLV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,68.6,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310488,AVYVBCVILBXGLV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,87,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310488,AVYVBCVILBXGLV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310488,AVYVBCVILBXGLV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1202031,AVZJOJWZRMWFIR-OZIFAFRSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,1400,NM,,"","","","","","",,,,,,,,Binding affinity against human cloned norepinephrine transporter using 40-80 pM [125I]RTI.,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL1202031,AVZJOJWZRMWFIR-OZIFAFRSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,3200,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL123830,AWHFBFFVXKIBQI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,IC50,=,299,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL123830,AWHFBFFVXKIBQI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,KI,=,844,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL3321789,AWIYLVWAILOVMX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25070422,KI,=,1791,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1233879,AWNMAACWZSNOOV-UHFFFAOYSA-N,KURASOIN B,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23880542,KI,=,2757,NM,,"","","","","","",,,,,,,,Binding affinity to human norepinephrine transporter by ligand displacement assay,Neuroactive diol and acyloin metabolites from cone snail-associated bacteria.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3703730,AWYWUACFNBIOSL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,13,NM,302094,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL344110,AXJNQTWCGWGLCZ-LPHOPBHVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,650,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL344110,AXJNQTWCGWGLCZ-LPHOPBHVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,1800,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL356981,AXJNQTWCGWGLCZ-QFBILLFUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,260,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL356981,AXJNQTWCGWGLCZ-QFBILLFUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,420,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL2430698,AXKWQHHRWNPPGK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,5,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430698,AXKWQHHRWNPPGK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,62.1,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL18972,AXNGJCOYCMDPQG-UHFFFAOYSA-N,GLEMANSERIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15999145,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL2440659,AXVLPJHYYFHCHK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24074843,INHIBITION,>,35,%,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]-RTI-55 from human recombinant NET expressed in MDCK cells at 10 uM relative to control,Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL591514,AXVMBCUCHZMEOH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19926484,KI,=,667,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL133902,AYCFVKGYERYDRT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,IC50,=,2.8,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL133902,AYCFVKGYERYDRT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,KI,=,100,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL3310632,AYEJAYBDNXGSOD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,10,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL340281,AYESQVUVFADUMC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213054,KI,=,5.2,NM,,"","","","","","",,,,,,,,Inhibition of [125I]- RTI -55 binding at the Norepinephrine transporter sites on HEK-hNET cells,Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL478878,AYXSHRRPHCTQPJ-PMACEKPBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,49,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1084291,AZFGCYKKRIPXTL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,9,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL442843,AZMKBJHIXZCVNL-BXKDBHETSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL442843,AZMKBJHIXZCVNL-BXKDBHETSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,71990,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL457967,AZMKBJHIXZCVNL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL457967,AZMKBJHIXZCVNL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,57020,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL221903,AZOHUEDNMOIDOC-NVQXNPDNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,1230,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL578346,AZTPZTRJVCAAMX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,>,40000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3353960,AZXLOZLZVXIRFJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25017029,IC50,=,82,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3613151,BAMKKHHTCLKCOQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.04,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL373508,BAWNTPWIVXZYLH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17367122,ACTIVITY,,,,Not Active,"",cell_based,"","","","",CHO,,,,,,,Displacement of radiolabeled protriptyline from human recombinant NET expressed in CHO cells at 10 uM,Designing active template molecules by combining computational de novo design and human chemist's expertise.,J. Med. Chem.,PUBLICATION,
CHEMBL376952,BAYDYCDSOWCJTI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL206152,BBGHTDMYOQEIGR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,13.3,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256058,BBLALPDUHCRAKZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,70,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL549509,BBNHSIZBHGYEBG-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,37,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL141114,BBPHSCYBCPQBRH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,KI,=,36,NM,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL573898,BBYFZRZFESDGLZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,170,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL11,BCGWQEUPMDMJNV-UHFFFAOYSA-N,IMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,20,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL11,BCGWQEUPMDMJNV-UHFFFAOYSA-N,IMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,142,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL11,BCGWQEUPMDMJNV-UHFFFAOYSA-N,IMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,37,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL11,BCGWQEUPMDMJNV-UHFFFAOYSA-N,IMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10411589,KI,=,118,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL11,BCGWQEUPMDMJNV-UHFFFAOYSA-N,IMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12431845,KI,=,98,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL11,BCGWQEUPMDMJNV-UHFFFAOYSA-N,IMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15081025,KI,=,16,NM,,"","","","","","",,,,,,,,Binding affinity towards Norepinephrine transporter using [3H]nisoxitine as radioligand,"Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL11,BCGWQEUPMDMJNV-UHFFFAOYSA-N,IMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17846138,IC50,=,74,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,PUBLICATION,
CHEMBL372435,BCHCCPODJPHTTL-GKQVGWSZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15121762,KI,=,277,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL512044,BCZUZJIUZQQTDT-RBUKOAKNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,2,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL497666,BDCMARKCSKLIKU-SUMWQHHRSA-N,MDL-28618,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,880,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL497680,BDDVUVHPEHJEPJ-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,13,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL258449,BDGQOYDELXXRKV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,282,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323179,BDLAKWIEWPJWSY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,<,3,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3323179,BDLAKWIEWPJWSY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,<,3,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323179,BDLAKWIEWPJWSY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3.4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323179,BDLAKWIEWPJWSY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,4.4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323179,BDLAKWIEWPJWSY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,<,3,NM,314422,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL401417,BDOAHAJYARXKHW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,IC50,,,,Not Determined,"","","","","","",,,,,,,,Inhibition of NET,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL401417,BDOAHAJYARXKHW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,INHIBITION,=,82,%,,"","","","","","",,,,,,,,Inhibition of NET at 1 uM,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL514200,BDOFPOSOPQRCSW-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,=,175,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL208178,BDXVEVIJMYWTJE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,6.8,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2164389,BECROBIDPQYXRW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22770500,INHIBITION,,,,Not Active,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter at 10 uM by radioligand binding assay,"3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain models.",J. Med. Chem.,PUBLICATION,
CHEMBL495894,BEGCAIREKDZFRP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,4.9,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL388759,BEKJWERDBUYMAG-HIUFNZKISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,960,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL388759,BEKJWERDBUYMAG-HIUFNZKISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,3290,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL194781,BEKVIGOVWYQMOT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,5,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673142,BENAFAMTKPICCC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2929,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3703741,BEWPJYFILUTZHB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,214.8,NM,302105,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL42442,BEZZFPOZAYTVHN-UHFFFAOYSA-N,OXFENDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL42442,BEZZFPOZAYTVHN-UHFFFAOYSA-N,OXFENDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL588119,BFCDFTHTSVTWOG-YLJYHZDGSA-N,SULOCTIDIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1400.4,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL588119,BFCDFTHTSVTWOG-YLJYHZDGSA-N,SULOCTIDIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1388.8,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL691,BFPYWIDHMRZLRN-SLHNCBLASA-N,ETHINYL ESTRADIOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,959,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL691,BFPYWIDHMRZLRN-SLHNCBLASA-N,ETHINYL ESTRADIOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,951,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200604,BGDKAVGWHJFAGW-UHFFFAOYSA-N,TROPICAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200604,BGDKAVGWHJFAGW-UHFFFAOYSA-N,TROPICAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL231858,BGHABJXKIQKRJZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,339000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL231858,BGHABJXKIQKRJZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,871000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1084577,BGJYOLBNUMRPNE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,26,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL139513,BGNPKSJMUHXEOF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,INHIBITION,=,17,%,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL512665,BGQYUSCFJWWBHR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,40000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL267044,BGRJTUBHPOOWDU-NSHDSACASA-N,LEVOSULPIRIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL267044,BGRJTUBHPOOWDU-NSHDSACASA-N,LEVOSULPIRIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL26,BGRJTUBHPOOWDU-UHFFFAOYSA-N,SULPIRIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL26,BGRJTUBHPOOWDU-UHFFFAOYSA-N,SULPIRIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL395408,BGSBHLAICAANSC-GOSISDBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,144,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL247733,BGSBHLAICAANSC-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL247733,BGSBHLAICAANSC-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL247733,BGSBHLAICAANSC-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL247733,BGSBHLAICAANSC-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL407815,BGXIKTHXOUZBOU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,429,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL272744,BHAREOZDRRGSHA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,860,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1099212,BHCVJMVHWIDLDP-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,=,576,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1099212,BHCVJMVHWIDLDP-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,INHIBITION,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL205596,BHQCQFFYRZLCQQ-OELDTZBJSA-N,CHOLIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL205596,BHQCQFFYRZLCQQ-OELDTZBJSA-N,CHOLIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL525532,BHTUHPLMWNGSLY-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,1000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL524798,BHTUHPLMWNGSLY-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,95,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL524798,BHTUHPLMWNGSLY-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3622346,BIALXFMHWCNRAQ-OQIWPSSASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25801931,INHIBITION,=,8,%,,"","","","","","",,,,,,,,Inhibition of human NET at 10 uM relative to control,Pseudosaccharin amines as potent and selective KV1.5 blockers.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1813470,BIDMNSYJUSJTRE-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,537.03,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813313,BIDMNSYJUSJTRE-RBUKOAKNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,537.03,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813313,BIDMNSYJUSJTRE-RBUKOAKNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,724.44,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL3084803,BIDUPMYXGFNAEJ-APGVDKLISA-N,ASTROMICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3084803,BIDUPMYXGFNAEJ-APGVDKLISA-N,ASTROMICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL439423,BIHDNMFWZMAKEI-WCQYABFASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,110,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1629810,BIIFEDMBGOQTDO-USCPGHQQSA-N,2-HYDROXYPROPYL-BETA-CYCLODEXTRIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1270,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1629810,BIIFEDMBGOQTDO-USCPGHQQSA-N,2-HYDROXYPROPYL-BETA-CYCLODEXTRIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1260,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1224401,BINJCVHVYJSTMI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,10,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL540333,BISDZXSPECCJOM-MOGJOVFKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,1540,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL399228,BIXIBQFJRMFLKO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,9200,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL497337,BIXIWGCNVRAWEX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,0.68,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL467123,BJBCUOODXPAOKN-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,34,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL445206,BJIOGJUNALELMI-ARJAWSKDSA-N,ISOEUGENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL445206,BJIOGJUNALELMI-ARJAWSKDSA-N,ISOEUGENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL202811,BJJMXMMHXNEXRL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16337793,IC50,>,100,NM,,"","","","","","",,,,,,,,Inhibitory activity against NET,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL578612,BJLKZFUZNNATGZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL578612,BJLKZFUZNNATGZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL578612,BJLKZFUZNNATGZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,1570,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL401676,BJQGGALRPGCIFD-WCQYABFASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,49,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL402794,BJQHLKABXJIVAM-BGYRXZFFSA-N,BIS(2-ETHYLHEXYL)PHTHALATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL402794,BJQHLKABXJIVAM-BGYRXZFFSA-N,BIS(2-ETHYLHEXYL)PHTHALATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL256227,BJSPCVGBAKIYFP-MJGOQNOKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,3867,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL208232,BJSTYDNATGHOTI-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,2.2,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3612835,BJTGZJWWRAYVMS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,IC50,=,238,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3612835,BJTGZJWWRAYVMS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL408940,BJWRNMDFZRRXMB-QFBILLFUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,14,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL526825,BKCSCHQRSOSNPN-HKUYNNGSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,8,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL570593,BKMZXLKUUMOTKA-XMMPIXPASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821575,IC50,=,5.4,NM,,"","","","","","",,,,,,,,Inhibition of NET,Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,PUBLICATION,
CHEMBL198018,BKQSBMKFNNGLCD-NEPJUHHUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter; nt is not tested,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL157138,BKRGVLQUQGGVSM-KBXCAEBGSA-N,LISURIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL157138,BKRGVLQUQGGVSM-KBXCAEBGSA-N,LISURIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2430681,BKSQHIKAUPPMAY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,5176,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430681,BKSQHIKAUPPMAY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,56.6,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430681,BKSQHIKAUPPMAY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,75,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3704751,BKVALIDOPGIDPZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,2,NM,317705,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL3704751,BKVALIDOPGIDPZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,1924,NM,317693,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL463431,BKWWNLJWEVOUOL-DLBZAZTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,IC50,>,100000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL463431,BKWWNLJWEVOUOL-DLBZAZTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,KI,=,39119,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL463431,BKWWNLJWEVOUOL-DLBZAZTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740668,IC50,>,100000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]NE reuptake at human NET expressed in HEK cells,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL463431,BKWWNLJWEVOUOL-DLBZAZTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740668,KI,=,39119,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL480988,BKWWNLJWEVOUOL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19014888,IC50,>,100000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL480988,BKWWNLJWEVOUOL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19014888,KI,=,39119,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL600053,BKYSPAJPVPEZOE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19954972,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL479409,BKZBLBKUEHCXOL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL232068,BLAXQDSTBRMZPC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,10000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL232068,BLAXQDSTBRMZPC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,81000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1171975,BLEJWKMRQPRJHY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,25.12,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL278172,BLFLLBZGZJTVJG-UHFFFAOYSA-N,BENZOCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL278172,BLFLLBZGZJTVJG-UHFFFAOYSA-N,BENZOCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL15245,BLGXFZZNTVWLAY-SCYLSFHTSA-N,YOHIMBINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,>,20000,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL15245,BLGXFZZNTVWLAY-SCYLSFHTSA-N,YOHIMBINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL15245,BLGXFZZNTVWLAY-SCYLSFHTSA-N,YOHIMBINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL499,BLJRIMJGRPQVNF-JTQLQIEISA-N,TIMOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL499,BLJRIMJGRPQVNF-JTQLQIEISA-N,TIMOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL596714,BLKKGRNFYMEBJN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,330,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224490,BLKNUASSHDJVDJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,1.26,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224490,BLKNUASSHDJVDJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,2.51,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL506137,BLPFKCJJWVVUNI-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1306,BLSQLHNBWJLIBQ-OZXSUGGESA-N,TERCONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,25391,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1306,BLSQLHNBWJLIBQ-OZXSUGGESA-N,TERCONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,25182,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL567597,BLUAFEHZUWYNDE-DKGJTOOQSA-N,ARTEMISININ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL567597,BLUAFEHZUWYNDE-DKGJTOOQSA-N,ARTEMISININ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2047579,BLVOPMLJPLEJNF-QVKFZJNVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,36,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL2047580,BLVOPMLJPLEJNF-YCRPNKLZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,IC50,=,531,NM,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL461143,BLWMSZSENYHERE-RBUKOAKNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1070,BLXXJMDCKKHMKV-UHFFFAOYSA-N,NABUMETONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1868,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1070,BLXXJMDCKKHMKV-UHFFFAOYSA-N,NABUMETONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1853,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2203713,BLZNLOLTHDUEOL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22840695,INHIBITION,=,18,%,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells at 10 uM after 120 mins,"Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine.",Eur. J. Med. Chem.,PUBLICATION,
CHEMBL2338038,BMBZYVSLEAFRRW-KSSFIOAISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,5.01,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432063,BMHWWKPJPARTBN-RAOGCBAWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL101905,BMNNHOAPHMYHIH-NUWOQIAWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10698458,IC50,=,2.2,NM,,"",cell_based,"","","","",,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL377785,BMNNHOAPHMYHIH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16784855,IC50,=,2.2,NM,,"","","","","","",,,,,,,,Inhibition of (-)-[3H]NE uptake at NET,Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL377785,BMNNHOAPHMYHIH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16784855,KI,=,17.28,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET transfected in HEK293 cells,Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL219224,BMRJUXFHOOHDBF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,35,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219224,BMRJUXFHOOHDBF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,3200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219224,BMRJUXFHOOHDBF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,360,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219224,BMRJUXFHOOHDBF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,>,6300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL566207,BMWDQBTXNBGORC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,4100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566207,BMWDQBTXNBGORC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,6840,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566207,BMWDQBTXNBGORC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,2350,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL192,BNRNXUUZRGQAQC-UHFFFAOYSA-N,SILDENAFIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL192,BNRNXUUZRGQAQC-UHFFFAOYSA-N,SILDENAFIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3124968,BNSBTAITEDOQSS-GOSISDBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24410637,ACTIVITY,>,10,%,,"","","","","","",,,,,,,,Activity at NET (unknown origin) at 10 uM relative to control,Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition.,J. Med. Chem.,PUBLICATION,
CHEMBL211494,BNTIEMZWVNNNAF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,KI,>,2000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL595457,BNWDHFFDZARHMY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,IC50,=,51,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL595457,BNWDHFFDZARHMY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,25,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1200545,BOBLHFUVNSFZPJ-JOYXJVLSSA-N,DIFLORASONE DIACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200545,BOBLHFUVNSFZPJ-JOYXJVLSSA-N,DIFLORASONE DIACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL334923,BOHGZALGHLQJNA-QINSGFPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11229746,AFFINITY,=,6,%,,"","","","","","",,,,,,,,Compound was tested for binding affinity against noradrenergic uptake,First tricyclic oximino derivatives as 5-HT3 ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1076377,BOKVAQSTZQNOIA-UVWWSMGFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL2047578,BONBIWJAPUUALK-AVRWGWEMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,55,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL2047577,BONBIWJAPUUALK-IQGLISFBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,63,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL373233,BOPYYBXXVMRACX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,6,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL603417,BOQKMDDOTKOYRK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,IC50,=,116,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL603417,BOQKMDDOTKOYRK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,125,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL157971,BOUBQAHEWYSCCH-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,>,20000,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL427216,BOVGTQGAOIONJV-UHFFFAOYSA-N,GLICLAZIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL427216,BOVGTQGAOIONJV-UHFFFAOYSA-N,GLICLAZIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL133043,BPGNWJZOLVBWNC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,IC50,=,4.1,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL133043,BPGNWJZOLVBWNC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,KI,=,84,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL379699,BPGTUWPLEUDMHZ-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,6,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL482294,BPTUECTWLFZRON-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL539054,BPTVMTODGGFNIG-KUGOCAJQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,22500,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL395910,BQCMCDRDLYXGDO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,4900,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL395910,BQCMCDRDLYXGDO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,14000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL377498,BQKRARPXRCZXGV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL203640,BQLSUBYYRRZHRK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,171,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL203640,BQLSUBYYRRZHRK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,830,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL551991,BQUXAJWDRCSKFN-IBGZPJMESA-N,BMS-269223,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19541481,INHIBITION,,,,Not Active,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL497340,BQYHDNIHHQQZPU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18461921,KI,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,PUBLICATION,
CHEMBL367461,BRCFAGPWPWYSAX-QOCRQHEPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15012999,INHIBITION,=,13,%,,"","","","","","",,,,,,,,Inhibitory activity against human adrenergic norepinephrine transporter at 10 uM,Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL232104,BRIVIXLMMUIBJY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17606674,INHIBITION,,,,Not Active,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,"Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.",Antimicrob. Agents Chemother.,PUBLICATION,
CHEMBL270165,BRKDRAMGEIRGGU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18060777,KI,=,3700,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256817,BRMWMWORGPTOCB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,46,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL219335,BRQZSYKMAXVFLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,14,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219335,BRQZSYKMAXVFLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,73,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219335,BRQZSYKMAXVFLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,23,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219335,BRQZSYKMAXVFLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,340,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL385607,BRTWZDQCGNRNRK-LVXARBLLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,5007,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL186056,BRZFVBLWHJLYPD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15456270,KI,=,17,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity for Norepinephrine transporter (NET) expressed in LCK PK1 cells,2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.,J. Med. Chem.,PUBLICATION,
CHEMBL466963,BSMJJWYXCCOYNP-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,31,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL488638,BSMNRYCSBFHEMQ-GZMMTYOYSA-N,DOV-102677,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18539031,IC50,=,103,NM,,"","","","","","",,,,,,,,Inhibition of norepinephrine uptake at human cloned NET,Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL488638,BSMNRYCSBFHEMQ-GZMMTYOYSA-N,DOV-102677,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,794.33,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL488638,BSMNRYCSBFHEMQ-GZMMTYOYSA-N,DOV-102677,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,58.88,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL592374,BSMNRYCSBFHEMQ-KCJUWKMLSA-N,AMITIFADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18539031,IC50,=,22.8,NM,,"","","","","","",,,,,,,,Inhibition of norepinephrine uptake at human cloned NET,Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL592374,BSMNRYCSBFHEMQ-KCJUWKMLSA-N,AMITIFADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,63.1,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL592374,BSMNRYCSBFHEMQ-KCJUWKMLSA-N,AMITIFADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,147.91,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL592374,BSMNRYCSBFHEMQ-KCJUWKMLSA-N,AMITIFADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,IC50,=,71.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL528995,BSMNRYCSBFHEMQ-UHFFFAOYSA-N,DOV-216303,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18539031,IC50,=,20.3,NM,,"","","","","","",,,,,,,,Inhibition of norepinephrine uptake at human cloned NET,Studies on the structure-activity relationship of bicifadine analogs as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL528995,BSMNRYCSBFHEMQ-UHFFFAOYSA-N,DOV-216303,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,63,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL528995,BSMNRYCSBFHEMQ-UHFFFAOYSA-N,DOV-216303,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,IC50,=,72.4,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL528995,BSMNRYCSBFHEMQ-UHFFFAOYSA-N,DOV-216303,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,20,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL528995,BSMNRYCSBFHEMQ-UHFFFAOYSA-N,DOV-216303,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,23,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL528995,BSMNRYCSBFHEMQ-UHFFFAOYSA-N,DOV-216303,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,143,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL206608,BSUHUYQWXIGAFH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16337793,IC50,>,100,NM,,"","","","","","",,,,,,,,Inhibitory activity against NET,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1808426,BSUNLXLBVQPAFJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21724392,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 0.5 uM,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257424,BSYKAWMTFFQDNB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,82,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257424,BSYKAWMTFFQDNB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,50,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL25,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,ASPIRIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL25,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,ASPIRIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3310496,BSZJUUFTQGBZQN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,23,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL458080,BTBAPWWSVZCOSR-DXWGQUKGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,2200,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL467432,BTDIKAPSRZPGSC-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19067522,KI,=,1.02,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET receptor expressed in HEK293 cells,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL475937,BTDNKAUJHUIUPT-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,=,7,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1170211,BTDSNKFEFWKZPW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,6.31,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
,BTNXVMLCKOPOEP-UHFFFAOYSA-N,TRIAZOLEDIONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL3310636,BTQKCUGOWJLBQO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,10,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL566090,BTTZJAYHAIJMSO-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,16,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL603855,BTVODQSCRZBWKN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,INHIBITION,=,48,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1000 nM after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1762,BUJAGSGYPOAWEI-UHFFFAOYSA-N,TOCAINIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1762,BUJAGSGYPOAWEI-UHFFFAOYSA-N,TOCAINIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL477572,BUJVJHVEEOZSIE-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,86,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL378070,BUKUIUSQEZHUTR-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,1060,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1076368,BUUOITHKMQYTQY-ZWRUYHAFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL481280,BUZBVOKDNAZIIM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18588282,INHIBITION,<,10,%,,"","","","","","",,,,,,,,Inhibition of human NET at 1 uM,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,PUBLICATION,
CHEMBL504028,BVTKYAZPIRQNNS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,58,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL504028,BVTKYAZPIRQNNS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL460407,BWBCTVUBHWYIEP-UONOGXRCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,2934,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL460407,BWBCTVUBHWYIEP-UONOGXRCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,8541,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL459367,BWBCTVUBHWYIEP-ZIAGYGMSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,2857,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL459367,BWBCTVUBHWYIEP-ZIAGYGMSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,20180,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1076380,BWNPTZCMCUMGFU-IAMOBIESSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL668,BWPIARFWQZKAIA-UHFFFAOYSA-N,PROTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,1.41,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL668,BWPIARFWQZKAIA-UHFFFAOYSA-N,PROTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18588282,IC50,=,7.1,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,PUBLICATION,
CHEMBL668,BWPIARFWQZKAIA-UHFFFAOYSA-N,PROTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18983139,IC50,=,9.1,NM,,"","","","","","",,,,,,,,Displacement of radiolabeled protriptyline from human NET,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,PUBLICATION,
CHEMBL668,BWPIARFWQZKAIA-UHFFFAOYSA-N,PROTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18983139,KI,=,6.8,NM,,"","","","","","",,,,,,,,Displacement of radiolabeled protriptyline from human NET,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,PUBLICATION,
CHEMBL668,BWPIARFWQZKAIA-UHFFFAOYSA-N,PROTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20875743,IC50,=,17,NM,,"","","","","","",,,,,,,,Inhibition of human aorepinephrine transporter,"Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL668,BWPIARFWQZKAIA-UHFFFAOYSA-N,PROTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20945906,KD,=,1.4,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Diaryldiamines with dual inhibition of the histamine H(3) receptor and the norepinephrine transporter and the efficacy of 4-(3-(methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol in pain.,J. Med. Chem.,PUBLICATION,
CHEMBL668,BWPIARFWQZKAIA-UHFFFAOYSA-N,PROTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21726069,KI,=,2.3,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NE transporter,"Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.",J. Med. Chem.,PUBLICATION,
CHEMBL668,BWPIARFWQZKAIA-UHFFFAOYSA-N,PROTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,1.7,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL668,BWPIARFWQZKAIA-UHFFFAOYSA-N,PROTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,KI,=,2,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL668,BWPIARFWQZKAIA-UHFFFAOYSA-N,PROTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23466604,IC50,=,2.1,NM,,"","","","","","",,,,,,,,Binding affinity to human norepinephrine transporter by radioligand displacement assay,Synthesis and structure-activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL668,BWPIARFWQZKAIA-UHFFFAOYSA-N,PROTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23466604,KI,=,1.6,NM,,"","","","","","",,,,,,,,Binding affinity to human norepinephrine transporter by radioligand displacement assay,Synthesis and structure-activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL668,BWPIARFWQZKAIA-UHFFFAOYSA-N,PROTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23582449,IC50,=,2.5,NM,,"","","","","","",,,,,,,,Binding affinity to human nonepinephrine transporter by radioligand displacement assay,Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL668,BWPIARFWQZKAIA-UHFFFAOYSA-N,PROTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26988801,IC50,=,2.8,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxentine from human recombinant norepinephrine transporter expressed in CHO cells,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL597608,BWQFRVKQDHYVEW-HUBLWGQQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,3.98,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL232675,BWUZPMKOTOLHJN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,111000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL232675,BWUZPMKOTOLHJN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL592697,BWXOLUJTEOFJOY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19926484,KI,=,503,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3673147,BXKXPJPYACCXTA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,805.9,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL269538,BXNJHAXVSOCGBA-UHFFFAOYSA-N,HARMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643338,KI,=,3260,NM,,"","","","","","",,,,,,,,Binding affinity towards NET,Binding of beta-carbolines at 5-HT(2) serotonin receptors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3593399,BXQHWNKKHXHIDQ-HTKOBJQYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,0.77,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1083392,BXRBQSOCONPANY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,2,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1083392,BXRBQSOCONPANY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,5.1,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL203821,BXVHYBOSHLZFER-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16337793,IC50,>,100,NM,,"","","","","","",,,,,,,,Inhibitory activity against NET,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL584173,BXXRQIARNFYYBC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,21,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL192619,BXZSHOGOEKAIFQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15801845,KI,=,7552,NM,,"",cell_based,"","","","",HEK293,,,,,,,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,PUBLICATION,
CHEMBL1460,BXZVVICBKDXVGW-NKWVEPMBSA-N,DIDANOSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1460,BXZVVICBKDXVGW-NKWVEPMBSA-N,DIDANOSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL91,BYBLEWFAAKGYCD-UHFFFAOYSA-N,MICONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2939,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL91,BYBLEWFAAKGYCD-UHFFFAOYSA-N,MICONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2915,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3593404,BYHRMOSVXQWMGN-SLHAJLBXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,3.3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL11768,BYLRMZMKZKCWAA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9435902,INHIBITION,=,60,%,,"","","","","","",,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL628,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,PENTOXIFYLLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL628,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,PENTOXIFYLLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL575854,BYRGPNIGCQCEQB-INXRADFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,=,1170,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL496938,BYTXKMDEYAZNON-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18793858,KI,>,1900,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,"Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL476313,BYZZRTNQROTLCL-IBGZPJMESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL462384,BZEJZLOEKMOQPW-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,2,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL20,BZKPWHYZMXOIDC-UHFFFAOYSA-N,ACETAZOLAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL20,BZKPWHYZMXOIDC-UHFFFAOYSA-N,ACETAZOLAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1808437,BZMIEAZWZMSACC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21724392,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 0.5 uM,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1630579,BZRYYBWNOUALTQ-UHFFFAOYSA-N,MYRTECAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1630579,BZRYYBWNOUALTQ-UHFFFAOYSA-N,MYRTECAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL519819,BZXPKSLKLWOLEJ-BJUDXGSMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18487050,KI,=,1810,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL487869,CAAOEKZYPZJLCR-QAPCUYQASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,3000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL515988,CACJRDOFRVCXPK-WIOPOQQRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,2010,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL229381,CACJYDSRIOGEJW-GNXKAVGDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,1170,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL229381,CACJYDSRIOGEJW-GNXKAVGDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,2870,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL247933,CAISPEIKDAWTHS-LOSJGSFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17583504,KI,=,460,NM,,"","","","","","",,,,,,,,Binding affinity to NET,Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1159650,CBGUOGMQLZIXBE-XGQKBEPLSA-N,CLOBETASOL PROPIONATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1159650,CBGUOGMQLZIXBE-XGQKBEPLSA-N,CLOBETASOL PROPIONATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL395110,CBHCDHNUZWWAPP-UHFFFAOYSA-N,MEPAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1877,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL395110,CBHCDHNUZWWAPP-UHFFFAOYSA-N,MEPAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1861,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL497463,CBIWVBLPTDWHKB-APWZRJJASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL525375,CBIWVBLPTDWHKB-QFBILLFUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,40,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL525375,CBIWVBLPTDWHKB-QFBILLFUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL498686,CBIWVBLPTDWHKB-VQIMIIECSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,180,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL561599,CBKZFNTYOMFOLF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,1584.89,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL180101,CBQGYUDMJHNJBX-OALUTQOASA-N,ESREBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11454918,KI,=,15.8,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL180101,CBQGYUDMJHNJBX-OALUTQOASA-N,ESREBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12431845,KI,=,11,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL180101,CBQGYUDMJHNJBX-OALUTQOASA-N,ESREBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,3,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL180101,CBQGYUDMJHNJBX-OALUTQOASA-N,ESREBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19067522,KI,=,1.04,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET receptor expressed in HEK293 cells,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL180101,CBQGYUDMJHNJBX-OALUTQOASA-N,ESREBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,3.1,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL180101,CBQGYUDMJHNJBX-OALUTQOASA-N,ESREBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,0.3,NM,,"","","","","","",,,,,,,,Inhibition of norepinephrine reuptake at NET,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL180101,CBQGYUDMJHNJBX-OALUTQOASA-N,ESREBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,2,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14370,CBQGYUDMJHNJBX-UHFFFAOYSA-N,REBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12620070,RATIO,=,0.15,,,"","","","","","",,,,,,,,Ratio of binding affinity between human norepinephrine transporter (NET) and human serotonin transporter (SERT),Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.,J. Med. Chem.,PUBLICATION,
CHEMBL14370,CBQGYUDMJHNJBX-UHFFFAOYSA-N,REBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14971892,KI,=,1.1,NM,,"","","","","","",,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [3H]-nisoxatine radioligand,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL14370,CBQGYUDMJHNJBX-UHFFFAOYSA-N,REBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,11,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14370,CBQGYUDMJHNJBX-UHFFFAOYSA-N,REBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,11,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14370,CBQGYUDMJHNJBX-UHFFFAOYSA-N,REBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14370,CBQGYUDMJHNJBX-UHFFFAOYSA-N,REBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14370,CBQGYUDMJHNJBX-UHFFFAOYSA-N,REBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,=,3,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14370,CBQGYUDMJHNJBX-UHFFFAOYSA-N,REBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14370,CBQGYUDMJHNJBX-UHFFFAOYSA-N,REBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14370,CBQGYUDMJHNJBX-UHFFFAOYSA-N,REBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,3.2,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL14370,CBQGYUDMJHNJBX-UHFFFAOYSA-N,REBOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,3.2,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL445977,CBSIZHJYORKATA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18461921,KI,>,100000,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,PUBLICATION,
CHEMBL272790,CBSPAZYMJJLPIY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,570,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL115,CBVCZFGXHXORBI-PXQQMZJSSA-N,INDINAVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL115,CBVCZFGXHXORBI-PXQQMZJSSA-N,INDINAVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL202939,CCCKABNBMAAFTD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL374634,CCEQAXVCJWOVQY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,27,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL374634,CCEQAXVCJWOVQY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,63,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL374634,CCEQAXVCJWOVQY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,12,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL374634,CCEQAXVCJWOVQY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,31,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL576063,CCGVLNAUEKVICK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL576063,CCGVLNAUEKVICK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL576063,CCGVLNAUEKVICK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,6500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL479783,CCLDYFDEDOTWJF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,70,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL378319,CCVMCNVDASICFL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,75,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1077638,CCXVQWDBHGEOJC-NSHDSACASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,103,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL10,CDMGBJANTYXAIV-UHFFFAOYSA-N,SB-203580,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL10,CDMGBJANTYXAIV-UHFFFAOYSA-N,SB-203580,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL573897,CDVPUDLPRZVZHB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,34,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684044,CDXVXAPUCWBZKN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,890,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310621,CEILENYWVBYUHW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,52,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310621,CEILENYWVBYUHW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310621,CEILENYWVBYUHW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1644474,CEJARUPLPSANRD-PTEHBNRSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,19,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2107687,CEJGGHKJHDHLAZ-UHFFFAOYSA-M,VALETHAMATE BROMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2107687,CEJGGHKJHDHLAZ-UHFFFAOYSA-M,VALETHAMATE BROMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1684054,CELRKOSFIVSEBS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,4000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2112595,CEQQBJFDYJRGJS-FOCLMDBBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,IC50,>,10,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL2112595,CEQQBJFDYJRGJS-FOCLMDBBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,KI,=,1760,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL577283,CEUJKSVEPJAVKD-GOSISDBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,1200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL567932,CEUJKSVEPJAVKD-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,24,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1112,CEUORZQYGODEFX-UHFFFAOYSA-N,ARIPIPRAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12784105,KI,=,2090,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL396402,CFBLMCGUBGGURK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18052090,KI,=,11,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,PUBLICATION,
CHEMBL3639720,CFCQNYUGCHNQOU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1049,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL207023,CFFAIDBFDNPCHJ-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,5.1,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL133070,CFMJSXBSNWAVPU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14592523,KI,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL508102,CFOYWRHIYXMDOT-UHFFFAOYSA-N,CARBIMAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL508102,CFOYWRHIYXMDOT-UHFFFAOYSA-N,CARBIMAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL461152,CFRDDSRHIVKVRS-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,INHIBITION,=,51,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1 uM,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL27979,CFUHKRLMDNFZED-SFTDATJTSA-N,"A-349,821",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12657274,KI,=,9772.37,NM,,"","","","","","",,,,,,,,Binding affinity towards human UPTK-NE transporter,Synthesis and SAR of aminoalkoxy-biaryl-4-carboxamides: novel and selective histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323100,CFUHORQJAJFNTA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,7.8,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL605501,CFVHNYYHCCJXDK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,2850,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL139277,CGAIDLFOIWNVLO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,KI,=,40,NM,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL520869,CGANQTTYLGBMNA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,5,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL152362,CGFBQVYTBDDHBS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,>,20000,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL6,CGIGDMFJXJATDK-UHFFFAOYSA-N,INDOMETHACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL6,CGIGDMFJXJATDK-UHFFFAOYSA-N,INDOMETHACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3310479,CGKMHQPZZRFYHQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,13,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310479,CGKMHQPZZRFYHQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,99,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310479,CGKMHQPZZRFYHQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL524313,CGROONDICFFSDT-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,8,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL525714,CGVBIXZVEMXIQU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,1.7,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL245482,CHDGVSNCSOCUHK-IBGZPJMESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,12,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL392016,CHDGVSNCSOCUHK-LJQANCHMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,8,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2152070,CHEANNSDVJOIBS-MHZLTWQESA-N,AM-1638,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,INHIBITION,>,70,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter at 10 uM relative to control,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2037531,CHGXPKZHRZIZSQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22520153,KI,=,49,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET by liquid scintillation assay,Benzothiazoles as probes for the 5HT(1A) receptor and the serotonin transporter (SERT): A search for new dual-acting agents as potential antidepressants.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL278165,CHLYWPGOYPDIPF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9986702,KI,=,35,NM,,"",cell_based,"","","","",,,,,,,,In vitro binding affinity against monoamine transporter NET (norepinephrine transporter) in LLC-PK1 cell membranes.,"A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol.",J. Med. Chem.,PUBLICATION,
CHEMBL56337,CHNUOJQWGUIOLD-NFZZJPOKSA-N,EPALRESTAT,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL56337,CHNUOJQWGUIOLD-NFZZJPOKSA-N,EPALRESTAT,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL241694,CHNXZKVNWQUJIB-CEGNMAFCSA-N,ETHISTERONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL241694,CHNXZKVNWQUJIB-CEGNMAFCSA-N,ETHISTERONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2172192,CHVVPMVMKPMDFR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22664127,ACTIVITY,,,,Not Active,"","","","","","",,,,,,,,Binding affinity to NET at 1 uM by radioligand displacement assay,"Antagonists of 5-HT(6) receptors. Substituted 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[3,4-e]pyrimidines and 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[4,3-d]pyrimidines-Synthesis and 'structure-activity' relationship.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1813486,CHWUQEOFMAPDHN-BBRMVZONSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,4466.84,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813487,CHWUQEOFMAPDHN-CZUORRHYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,3801.89,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL2432039,CHZUEGVOEFMIJH-ZKRSMWHSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1572,CIDUJQMULVCIBT-MQDUPKMGSA-N,NETILMICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1572,CIDUJQMULVCIBT-MQDUPKMGSA-N,NETILMICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL207810,CIIUAPSLDQFRMB-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,42.1,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL569048,CIJDFRPQIGEUOQ-OALUTQOASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,IC50,=,230,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1644481,CIJDXZHBTVURGN-PTEHBNRSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,128,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1076399,CIKMPDFZQJOHQC-QLOTUHGJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL2021581,CIVPMJLKYXGWQT-KFWWJZLASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,1000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2021580,CIVPMJLKYXGWQT-KKUMJFAQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,IC50,=,0.398,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]noradrenalin reuptake at human NET expressed in LLCPK cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2021580,CIVPMJLKYXGWQT-KKUMJFAQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,1,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2021580,CIVPMJLKYXGWQT-KKUMJFAQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,3.16,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL196,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,ASCORBATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL196,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,ASCORBATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL507379,CJCQYKYOUMGRPX-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,300,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL459,CJCSPKMFHVPWAR-JTQLQIEISA-N,METHYLDOPA,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL459,CJCSPKMFHVPWAR-JTQLQIEISA-N,METHYLDOPA,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2105617,CJDRUOGAGYHKKD-FUIWMBJSSA-N,AJMALINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2105617,CJDRUOGAGYHKKD-FUIWMBJSSA-N,AJMALINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1172526,CJIGYBHHAXYYSY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,19.95,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3105243,CJJUYQAVCJRKRK-KOSPPIAVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24262882,KI,=,153,NM,,"","","","","","",,,,,,,,Displacement of [3H]Imipramin from human NET after 2 hrs by liquid scintillation counting analysis,"Synthesis, radiosynthesis and first in vitro evaluation of novel PET-tracers for the dopamine transporter: [(11)C]IPCIT and [(18)F]FE@IPCIT.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL814,CJOFXWAVKWHTFT-XSFVSMFZSA-N,FLUVOXAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,2950,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL814,CJOFXWAVKWHTFT-XSFVSMFZSA-N,FLUVOXAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,4743,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL814,CJOFXWAVKWHTFT-XSFVSMFZSA-N,FLUVOXAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,1300,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL814,CJOFXWAVKWHTFT-XSFVSMFZSA-N,FLUVOXAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12232544,KI,=,1119,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL814,CJOFXWAVKWHTFT-XSFVSMFZSA-N,FLUVOXAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12232544,KI,=,1427,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1172381,CJOKQBSVKKHHCD-COPLHBTASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,1995.26,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173342,CJOKQBSVKKHHCD-MISXGVKJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,316.23,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL234379,CJOTYXSOAIOWPI-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,94000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL376852,CJUVIUZOUUBMJB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,210,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL376852,CJUVIUZOUUBMJB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,1300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL376852,CJUVIUZOUUBMJB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,360,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL376852,CJUVIUZOUUBMJB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,>,9200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL198655,CJVNIBWRWXJTAF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,ACTIVITY,=,53,%,,"","","","","","",,,,,,,,Percentage displacement of [3H]nisoxetine radioligand from norepinephrine transporter at concentration of 1000 nM,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL198655,CJVNIBWRWXJTAF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,>,200,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432060,CKFQOWSPJPMWEK-IINHSQADSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1082723,CKLPLPZSUQEDRT-WPCRTTGESA-N,NITD609,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20813948,IC50,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity to human recombinant norepinephrine transporter,"Spiroindolones, a potent compound class for the treatment of malaria.",Science,PUBLICATION,
CHEMBL383081,CKPPJIQWWSHKBB-SJCJKPOMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,1100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL469151,CKTXYRYJADRLRV-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,61,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL572142,CLDXUDCHEILGJZ-GOTSBHOMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,INHIBITION,=,24,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200558,CLKOFPXJLQSYAH-ABRJDSQDSA-N,BACITRACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200558,CLKOFPXJLQSYAH-ABRJDSQDSA-N,BACITRACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1096001,CLLQMGVKRYVVFS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,93,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2047567,CLPXEXYSIPWDMI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,74,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1683882,CLQNHTVQVGGNMJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,63,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL456223,CLSUYIGLXGEXLU-CHWSQXEVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,4746,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL456223,CLSUYIGLXGEXLU-CHWSQXEVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,8520,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL511500,CLSUYIGLXGEXLU-QWHCGFSZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,628,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL511500,CLSUYIGLXGEXLU-QWHCGFSZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,5993,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1085959,CLUGYQSXBJPTPD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,97,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL397889,CLVQITJMWWKDJN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18052090,KI,=,279,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,PUBLICATION,
CHEMBL2171415,CLYPRUFOUBOJEJ-UHFFFAOYSA-N,"3-((3,4-DICHLOROPHENYL)(PROPOXY)METHYL)AZETIDINE HCL",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,IC50,=,10,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2171415,CLYPRUFOUBOJEJ-UHFFFAOYSA-N,"3-((3,4-DICHLOROPHENYL)(PROPOXY)METHYL)AZETIDINE HCL",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,87,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1515611,CMCCHHWTTBEZNM-UHFFFAOYSA-N,BROMISOVALUM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1515611,CMCCHHWTTBEZNM-UHFFFAOYSA-N,BROMISOVALUM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL577272,CMGOBJCRHLBLJP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL523416,CMINFVGCVRRRQQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,2.72,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL1275709,CMJSIPQFDNXSOL-QWHCGFSZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20949929,IC50,=,0.22,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1078743,CMNJEKBHBKVRME-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,135,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL88,CMSMOCZEIVJLDB-UHFFFAOYSA-N,CYCLOPHOSPHAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL88,CMSMOCZEIVJLDB-UHFFFAOYSA-N,CYCLOPHOSPHAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL402027,CMSMRUGCRICBLQ-WCQYABFASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,44,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL154,CMWTZPSULFXXJA-VIFPVBQESA-N,NAPROXEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL154,CMWTZPSULFXXJA-VIFPVBQESA-N,NAPROXEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2432047,CNPQMMDLXZBMLB-KPCGFGSOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL200473,CNTBONUVPQEEGZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16202585,IC50,=,66300,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL577138,CNZYWYSSMUKCGY-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,54,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL522097,COCNIWDSGPEBCT-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,2,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1744190,COGUASSENRQBTI-KMIIZFTKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL1744190,COGUASSENRQBTI-KMIIZFTKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,BUSULFAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24814532,DRUG UPTAKE,,,,Not Active,"",cell_based,"","","","",,,,,,,,Cellular uptake in human SK-N-SH cells assessed as noradrenaline transporter-mediated uptake at 1 x 10'-4 M after 15 mins by [3H]-noradrenaline uptake assay,Synthesis and biological effects of new hybrid compounds composed of benzylguanidines and the alkylating group of busulfan on neuroblastoma cells.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,BUSULFAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL820,COVZYZSDYWQREU-UHFFFAOYSA-N,BUSULFAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL421867,CPELCYRAOXWACY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,IC50,=,230,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL421867,CPELCYRAOXWACY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,KI,=,120,NM,,"","","","","","",,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL1454946,CPEUVMUXAHMANV-UHFFFAOYSA-N,FLUBENDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1454946,CPEUVMUXAHMANV-UHFFFAOYSA-N,FLUBENDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL516094,CPFZMZOYHKWMOT-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,53,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL16073,CPJSUEIXXCENMM-UHFFFAOYSA-N,PHENACETIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL16073,CPJSUEIXXCENMM-UHFFFAOYSA-N,PHENACETIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2432051,CPLYGLAQLNAQOI-SEDVZXITSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL404956,CPNTXNSOEZESIH-QZTJIDSGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,860,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL427563,CPNTXNSOEZESIH-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,18,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1784673,CPOQTXKWWFQYCF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21570838,INHIBITION,<,50,%,Not Active,"","","","","","",,,,,,,,Inhibition of human recombinant NET at 10 uM by radioligand binding assay,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1321,CPTBDICYNRMXFX-UHFFFAOYSA-N,PROCARBAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1321,CPTBDICYNRMXFX-UHFFFAOYSA-N,PROCARBAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL510139,CQIUKKVOEOPUDV-IYSWYEEDSA-N,CITRININ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL510139,CQIUKKVOEOPUDV-IYSWYEEDSA-N,CITRININ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL405462,CQJCAOGPWRQORA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL606150,CQNQTEGBNDNNMO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,IC50,=,302,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL606150,CQNQTEGBNDNNMO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,487,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL135982,CQSPEDPZNBMSKV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9435902,INHIBITION,=,29.4,%,,"","","","","","",,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL415244,CRAGVFOTRKKIFB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,KI,=,74,NM,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1169622,CREVKPZAPMYUJW-ZIAGYGMSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,3162.28,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL270791,CRLQFKMWDMUITC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,10,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL203741,CROGUKBPHFMYKB-UGSOOPFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,3200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL457931,CRTQNTKRJCYBET-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,9,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3127675,CRWYIZWOHXWIGZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24410637,ACTIVITY,>,10,%,,"","","","","","",,,,,,,,Activity at NET (unknown origin) at 10 uM relative to control,Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition.,J. Med. Chem.,PUBLICATION,
CHEMBL3673138,CSAJSGHGBPMKBX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,881.4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL198177,CSIVTULLSFNYFC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,ACTIVITY,=,18,%,,"","","","","","",,,,,,,,Percentage displacement of [3H]nisoxetine radioligand from norepinephrine transporter at concentration of 1000 nM,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL198177,CSIVTULLSFNYFC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,>,200,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1914697,CSQWTWVZSNGFRN-IAFLDTSXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21458259,KI,=,49.1,NM,,"",cell_based,"","","","",LLC-PK1,,,,,,,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL212763,CTAHXNUPBZTDFO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,130,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1289,CTETYYAZBPJBHE-UHFFFAOYSA-N,HALOPROGIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2770,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1289,CTETYYAZBPJBHE-UHFFFAOYSA-N,HALOPROGIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2747,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2047568,CTGKEWQPUSZCPT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,78,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL206598,CTGMREDPJFWWBJ-LIRRHRJNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,960,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL516933,CTNIUTSUTZHULD-JRTRGBLZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,2710,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL256970,CTPBZYGSXVZQMN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,26,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1068,CTRLABGOLIVAIY-UHFFFAOYSA-N,OXCARBAZEPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1068,CTRLABGOLIVAIY-UHFFFAOYSA-N,OXCARBAZEPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL560877,CTVFQEBCIXRGTI-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,4.1,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL560877,CTVFQEBCIXRGTI-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,10.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL257265,CUCYIEARHKRHHK-AEFFLSMTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323102,CUFCKDTWFRBJEK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,8.8,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3323102,CUFCKDTWFRBJEK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,6.7,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323102,CUFCKDTWFRBJEK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,13.9,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323102,CUFCKDTWFRBJEK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,19.8,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323102,CUFCKDTWFRBJEK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,6.7,NM,314424,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL1645600,CUHDMEXRHJPGHR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,EC50,=,28,NM,,"",cell_based,"","","","",HEK293,,,,,,,Agonist activity at human cloned NET expressed in HEK293 cells by FLIPR assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1645600,CUHDMEXRHJPGHR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,138,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205822,CUIQKJJPRAKRJM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207388,CULSPSVPJXBZMJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23141912,INHIBITION,=,10.16,%,,"","","","","","",,,,,,,,Inhibition of NET at 1 uM by radioligand displacement assay,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3334781,CUPOAMXQXTXPSU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,50.6,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL469887,CURALKDCIXHBQR-JTDONDQYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,454,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1123,CURUTKGFNZGFSE-UHFFFAOYSA-N,DICYCLOMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1123,CURUTKGFNZGFSE-UHFFFAOYSA-N,DICYCLOMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2313297,CUWBKAWUQFYRQI-RMKNXTFCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23281824,INHIBITION,=,57,%,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells at 10 uM after 120 mins by scintillation counting analysis,Synthesis of (E)-8-(3-chlorostyryl)caffeine analogues leading to 9-deazaxanthine derivatives as dual A(2A) antagonists/MAO-B inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL249134,CUZLSPYEHKUVQH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,IC50,=,560,NM,,"","","","","","",,,,,,,,Inhibition of NET,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL249134,CUZLSPYEHKUVQH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,INHIBITION,=,69,%,,"","","","","","",,,,,,,,Inhibition of NET at 1 uM,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL403441,CVFBVSUFNWOPLD-LJQANCHMSA-N,PF-526014,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,16,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL403441,CVFBVSUFNWOPLD-LJQANCHMSA-N,PF-526014,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,18,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL403441,CVFBVSUFNWOPLD-LJQANCHMSA-N,PF-526014,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,12,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL386224,CVFBVSUFNWOPLD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,16,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL386224,CVFBVSUFNWOPLD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,16,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL218581,CVHOPXZORYBSMH-UNMCSNQZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,39,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3335556,CVKXGRRJHJHUFY-LJQANCHMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25221667,ACTIVITY,=,68,%,,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter (unknown origin) at 10 uM by radioligand binding assay,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL1835782,CWDYYODRDVPEOW-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21906941,INHIBITION,=,60,%,,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter at 10 uM,"Synthesis and structure-activity relationships of 4,5-fused pyridazinones as histamine H3 receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2030631,CWEGCQIIDCZZED-UHFFFAOYSA-N,N-BENZYLPYRROLIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257264,CWHLGCRIEMGRGS-WBVHZDCISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,5948,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL295234,CWOYLIJQLSNRRN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643338,KI,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity towards NET,Binding of beta-carbolines at 5-HT(2) serotonin receptors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173701,CWQJTYANMLPKAM-IFXJQAMLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,10300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1231530,CWXYHOHYCJXYFQ-UHFFFAOYSA-N,BETAMIPRON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1231530,CWXYHOHYCJXYFQ-UHFFFAOYSA-N,BETAMIPRON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2326692,CWYBNSVSYKQGJB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,130,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL590615,CWYDYWFZPBTTIM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19954972,KI,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity to NET,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL577501,CXFKXPAAWKFBPJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL577501,CXFKXPAAWKFBPJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL596796,CXJYZDWEGFRWPU-PSOPSSQASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,10,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL16,CXOFVDLJLONNDW-UHFFFAOYSA-N,PHENYTOIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL16,CXOFVDLJLONNDW-UHFFFAOYSA-N,PHENYTOIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL575753,CXPIEWAMVILDLK-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,92,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL210578,CXQUOFVDYCOSEZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25070422,KI,,,,Not Determined,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201024,CXYRUNPLKGGUJF-XKTSLVMZSA-M,METHSCOPOLAMINE BROMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201024,CXYRUNPLKGGUJF-XKTSLVMZSA-M,METHSCOPOLAMINE BROMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL404520,CYDMQBQPVICBEU-XRNKAMNCSA-N,CHLORTETRACYCLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL404520,CYDMQBQPVICBEU-XRNKAMNCSA-N,CHLORTETRACYCLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL462410,CYHDCZGFQGQXJH-CLFYSBASSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053782,KI,=,67.5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET transfected in human HEK293 cells,"Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL3094318,CYPDLWIUOMSUJR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24238903,INHIBITION,=,76.1,%,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL365055,CYQHDGVGYUKXFU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15380202,INHIBITION,=,67,%,,"","","","","","",,,,,,,,Inhibitory activity against Norepinephrine transporter at 10 uM,4-Acylamino-and 4-ureidobenzamides as melanin-concentrating hormone (MCH) receptor 1 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL12227,CYUGXTVDOUZASH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9435902,KI,=,3520,NM,,"","","","","","",,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL75880,CYXKNKQEMFBLER-UHFFFAOYSA-N,PERHEXILINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,3294.2,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL75880,CYXKNKQEMFBLER-UHFFFAOYSA-N,PERHEXILINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3267,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL197669,CYYQMAWUIRPCNW-UHFFFAOYSA-N,ST1535,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16250647,INHIBITION,<,10,%,,"","","","","","",,,,,,,,Percent inhibition against Norepinephrine transporter at 1 uM nonselective,"2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.",J. Med. Chem.,PUBLICATION,
CHEMBL202565,CZICWAXMIHSKKP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL311469,CZIHNRWJTSTCEX-UHFFFAOYSA-N,2-ACETYLAMINOFLUORENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,8595,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL311469,CZIHNRWJTSTCEX-UHFFFAOYSA-N,2-ACETYLAMINOFLUORENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,8524,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL98350,CZQHHVNHHHRRDU-UHFFFAOYSA-N,LY-294002,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL98350,CZQHHVNHHHRRDU-UHFFFAOYSA-N,LY-294002,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3323093,CZRBQWFOPMBTQM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,22,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL1080735,CZUGKEKGXKWONC-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20137933,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL560673,CZVBECXOXXYCQD-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,60,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2419440,DAAWESBJYLHFAS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23837744,INHIBITION,,,,Active,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter (unknown origin) at 10 uM,"Atropisomeric 4-phenyl-4H-1,2,4-triazoles as selective glycine transporter 1 inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL380758,DACQOKGPDFDFGY-UGSOOPFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,1250,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430688,DARUNLRORREIKV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,509.5,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430688,DARUNLRORREIKV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,91.6,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430688,DARUNLRORREIKV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,99,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL556299,DASUUHWEMHDMII-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,10,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1914693,DAXFTWVNVGRVQC-AFNJWWOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21458259,KI,=,16211,NM,,"",cell_based,"","","","",LLC-PK1,,,,,,,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1094231,DAXGWLCLIPNRDH-UHFFFAOYSA-N,"1-(3-CHLORO-4-FLUOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (ENANTIOMERIC MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20427184,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter at 1 uM,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL897,DBABZHXKTCFAPX-UHFFFAOYSA-N,PROBENECID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL897,DBABZHXKTCFAPX-UHFFFAOYSA-N,PROBENECID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL472253,DBDIPFBJGDKNIO-FZMZJTMJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954038,IC50,=,19,NM,,"",cell_based,"","","","",HEK293,,,,,,,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter","Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL710,DBEPLOCGEIEOCV-WSBQPABSSA-N,FINASTERIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL710,DBEPLOCGEIEOCV-WSBQPABSSA-N,FINASTERIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL248702,DBGIVFWFUFKIQN-VIFPVBQESA-N,DEXFENFLURAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL248702,DBGIVFWFUFKIQN-VIFPVBQESA-N,DEXFENFLURAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL564445,DBNIRDAYCJINLF-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,36.7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL357322,DBOLXXRVIFGDTI-UHFFFAOYSA-N,4-BENZYLPYRIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12565962,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE uptake evaluated at the monoamine transporter (NET),Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2206518,DBOZEPCLJKANCL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,31.8,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL212328,DBPGONCPPLDYIH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,KI,>,2000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL1062,DBPWSSGDRRHUNT-CEGNMAFCSA-N,HYDROXYPROGESTERONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1062,DBPWSSGDRRHUNT-CEGNMAFCSA-N,HYDROXYPROGESTERONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL420900,DBQULVOZIKDPMG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,IC50,=,192,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL420900,DBQULVOZIKDPMG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,KI,=,477,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL871,DBVJJBKOTRCVKF-UHFFFAOYSA-N,ETIDRONIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL871,DBVJJBKOTRCVKF-UHFFFAOYSA-N,ETIDRONIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL574008,DBVKCFHUKVYYIQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,2,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2407331,DBZNPAHUGJSVMH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,70,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL498563,DCABXDIJRCWHAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,0.3,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL3186763,DCAMTBFFNOHDAW-DYTRJAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25244572,INHIBITION,=,91.1,%,,"","","","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET at 10 uM,"Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus.",J. Med. Chem.,PUBLICATION,
CHEMBL426659,DCBHDYASYVFKAM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16202585,IC50,=,41500,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205833,DCGVCGVBZDMLGR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding affinity to NET at 10 uM,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205833,DCGVCGVBZDMLGR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL139,DCOPUUMXTXDBNB-UHFFFAOYSA-N,DICLOFENAC,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL139,DCOPUUMXTXDBNB-UHFFFAOYSA-N,DICLOFENAC,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3310639,DCSFZFQYIIRZFM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,91,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1729,DCSUBABJRXZOMT-UHFFFAOYSA-N,CISAPRIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1729,DCSUBABJRXZOMT-UHFFFAOYSA-N,CISAPRIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL138031,DCTIZVFKPUZNEA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,KI,=,55,NM,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL40,DDBREPKUVSBGFI-UHFFFAOYSA-N,PHENOBARBITAL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL40,DDBREPKUVSBGFI-UHFFFAOYSA-N,PHENOBARBITAL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL194909,DDBXZYDSZVDTAS-ZJUUUORDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL598026,DDDMGCMKOCLAAT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,>,100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL147040,DDKXNVHSNBNSEK-MAUKXSAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,150,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL147040,DDKXNVHSNBNSEK-MAUKXSAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,250,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL513248,DDNDQTODRFYZEU-WFASDCNBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954038,IC50,=,6,NM,,"",cell_based,"","","","",HEK293,,,,,,,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter","Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL257280,DDPFMTCKLODLQM-GKBBYZSKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18243691,INHIBITION,=,12,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,"Potent, selective MCH-1 receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2367892,DDTDNCYHLGRFBM-YZEKDTGTSA-N,TEICOPLANIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2367892,DDTDNCYHLGRFBM-YZEKDTGTSA-N,TEICOPLANIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL562,DDUHZTYCFQRHIY-RBHXEPJQSA-N,GRISEOFULVIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL562,DDUHZTYCFQRHIY-RBHXEPJQSA-N,GRISEOFULVIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL242011,DDWGQGZPYDSYEL-LSDHHAIUSA-N,HINOKININ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24112084,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Activity at human NET expressed in african green monkey COS7 cells assessed as norepinephrine release at 0.5 to 500 uM after 10 mins using [3H]-norepinephrine pretreated for 1 hr before compound addition followed by wash out by reversed transport efflux assay,The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities.,J. Nat. Prod.,PUBLICATION,
CHEMBL242011,DDWGQGZPYDSYEL-LSDHHAIUSA-N,HINOKININ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24112084,IC50,=,8760,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK cells using [3H]-norepinephrine as substrate after 10 mins by scintillation counting,The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities.,J. Nat. Prod.,PUBLICATION,
CHEMBL242011,DDWGQGZPYDSYEL-LSDHHAIUSA-N,HINOKININ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24112084,INHIBITION,,,,Active,"",cell_based,"","","","",,,,,,,,Non-competitive inhibition of human NET expressed in MDCK cells using [3H]-norepinephrine as substrate,The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities.,J. Nat. Prod.,PUBLICATION,
CHEMBL3085023,DEBMLCCWWGKBJP-WKCHPHFGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16213721,KI,=,3550,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL470903,DECJIAJUQYVNQV-KHQMHLGISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,552,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3323174,DELHGKQNJWIBFE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,5,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL196468,DEMWBYUAYXJYOC-NEPJUHHUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL196468,DEMWBYUAYXJYOC-NEPJUHHUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,KI,=,4600,NM,,"","","","","","",,,,,,,,In vitro binding affinity towards human norepinephrine transporter,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL196468,DEMWBYUAYXJYOC-NEPJUHHUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560923,IC50,=,9200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]nisoxetine from human NET expressed in HEK293 cells,Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL196468,DEMWBYUAYXJYOC-NEPJUHHUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20034793,IC50,=,9200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]nisoxetine from human NET transfected in human HEK293 cells,Synthesis and hSERT activity of homotryptamine analogs. Part 6: [3+2] dipolar cycloaddition of 3-vinylindoles.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL195774,DEMWBYUAYXJYOC-NWDGAFQWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL194910,DEMWBYUAYXJYOC-RYUDHWBXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1162965,DEMWBYUAYXJYOC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL373211,DEMWBYUAYXJYOC-VXGBXAGGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2432053,DEOOAAFCKARVDM-CAUKCHDASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3350037,DEQANNDTNATYII-JDBXKHNRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3350037,DEQANNDTNATYII-JDBXKHNRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL595190,DEQWDXVSVPRQSI-PAASSLRSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,20,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL43064,DERZBLKQOCDDDZ-JLHYYAGUSA-N,CINNARIZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2832,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL43064,DERZBLKQOCDDDZ-JLHYYAGUSA-N,CINNARIZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2808,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2407337,DEYDFIXCTXWVHT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,28,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1873703,DFBKLUNHFCTMDC-PICURKEMSA-N,DIELDRIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1873703,DFBKLUNHFCTMDC-PICURKEMSA-N,DIELDRIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL513884,DFLDZWQBWUBYFS-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1140,DFPAKSUCGFBDDF-UHFFFAOYSA-N,NIACINAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1140,DFPAKSUCGFBDDF-UHFFFAOYSA-N,NIACINAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL198033,DFPNKBKLTJXKDT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,3,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL611990,DFPSUOZWGQDKPI-COPLHBTASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,31.62,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL154257,DFZMRCICMFOMSN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,3300,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL452,DGBIGWXXNGSACT-UHFFFAOYSA-N,CLONAZEPAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL452,DGBIGWXXNGSACT-UHFFFAOYSA-N,CLONAZEPAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1914694,DGHITSOFNGOFOI-AFNJWWOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21458259,KI,=,12090,NM,,"",cell_based,"","","","",LLC-PK1,,,,,,,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL478836,DGKNIGATLZIOSX-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,271,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL316561,DGMKFQYCZXERLX-UHFFFAOYSA-N,PROGLUMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL316561,DGMKFQYCZXERLX-UHFFFAOYSA-N,PROGLUMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2113055,DGOLMTSTXLHVKN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15974579,KI,=,37.52,NM,,"",cell_based,"","","","",,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,PUBLICATION,
CHEMBL603620,DGQVZUDAKWRJPY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,>,100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1172919,DGWDYSSUZQAJAQ-MISXGVKJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,63.1,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL583113,DGZJTKQIMNNTQO-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,304,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3613153,DHGQDGVOFHPDSG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,IC50,=,275,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3613153,DHGQDGVOFHPDSG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,0.53,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2338044,DHKBDZKBBAEQNU-LRDDRELGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,0.631,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL577988,DHLSZOUSVZEAKZ-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,INHIBITION,=,32,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL773,DHMQDGOQFOQNFH-UHFFFAOYSA-N,GLYCINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL773,DHMQDGOQFOQNFH-UHFFFAOYSA-N,GLYCINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2205821,DHQYUPWRESNGBC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL461571,DHUATBAZHILHIC-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18701276,IC50,=,2160,NM,,"","","","","","",,,,,,,,Displacement of radioligand from NET,Highly functionalized 7-azaindoles as selective PPAR gamma modulators.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173276,DHXSMGUKIICGAC-TVQRCGJNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,920,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1173276,DHXSMGUKIICGAC-TVQRCGJNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21319801,IC50,=,150,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,PUBLICATION,
CHEMBL208070,DHYMNQOPOAQKFE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,9.7,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL48449,DHZBEENLJMYSHQ-XCVPVQRUSA-N,CANTHARIDIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL48449,DHZBEENLJMYSHQ-XCVPVQRUSA-N,CANTHARIDIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL253597,DHZBNHMEIOBPAE-JVVVGQRLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18067245,ACTIVITY,<,50,%,,"","","","","","",,,,,,,,Binding affinity to NET receptor at 10 uM,Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo.,J. Med. Chem.,PUBLICATION,
CHEMBL451105,DIEUHEQWLCVFKO-DNVCBOLYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,700,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL472563,DIIRBUSHKZQLRI-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,INHIBITION,=,21,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1 uM,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL461148,DIIRBUSHKZQLRI-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,22,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL457866,DILAIXDPRRLKOQ-DXWGQUKGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,330,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL395609,DIMAAAZZSSXDEH-DFBJGRDBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17127059,KI,=,121,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]nisoxetine uptake in human NET expressed in MDCK cells,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL469068,DINOQTNPFRDVRK-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,39,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684055,DIOWQSMFSBKMCS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,21,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684055,DIOWQSMFSBKMCS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,61,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684055,DIOWQSMFSBKMCS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,470,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL580,DIWRORZWFLOCLC-UHFFFAOYSA-N,LORAZEPAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL580,DIWRORZWFLOCLC-UHFFFAOYSA-N,LORAZEPAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL399831,DIYWRNLYKJKHAM-MDOVXXIYSA-N,(-)-CUBEBIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24112084,IC50,>,200000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK cells using [3H]-norepinephrine as substrate after 10 mins by scintillation counting,The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities.,J. Nat. Prod.,PUBLICATION,
CHEMBL1224318,DJFCVWKVRXLZFF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,50.12,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL487894,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,DIPYRONE SODIUM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL487894,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,DIPYRONE SODIUM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL519240,DJKJVWJQAVGLHJ-YPMHNXCESA-N,A-987306,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18983139,ACTIVITY,=,88.6,%,,"","","","","","",,,,,,,,Binding affinity to human NET at 10 uM relative to control,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,PUBLICATION,
CHEMBL519240,DJKJVWJQAVGLHJ-YPMHNXCESA-N,A-987306,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18983139,INHIBITION,=,11,%,,"","","","","","",,,,,,,,Inhibition of human NET at 10 uM,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,PUBLICATION,
CHEMBL219116,DJLLHNLJLSEKHJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,11,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219116,DJLLHNLJLSEKHJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,1400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219116,DJLLHNLJLSEKHJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,110,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219116,DJLLHNLJLSEKHJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,>,6100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL469668,DJVJRXDBDBMWFD-JPKZNVRTSA-N,WAY-256805,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,82,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL469668,DJVJRXDBDBMWFD-JPKZNVRTSA-N,WAY-256805,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,50,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL511959,DJVJRXDBDBMWFD-NTEVMMBTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,3474,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL511959,DJVJRXDBDBMWFD-NTEVMMBTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,785,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL469667,DJVJRXDBDBMWFD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,147,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL469667,DJVJRXDBDBMWFD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,91,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1076393,DJWCABWSEAXBCU-BOTYWPRBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1830891,DKFCBQMDHKALKE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,120,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830891,DKFCBQMDHKALKE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,209,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1224227,DKLPATDCBOSBMT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,IC50,=,13.3,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224227,DKLPATDCBOSBMT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,84,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL498141,DKMITNDZRUDDGX-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,900,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL526270,DKMITNDZRUDDGX-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,6,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL526270,DKMITNDZRUDDGX-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,3,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL660,DKNWSYNQZKUICI-UHFFFAOYSA-N,AMANTADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL660,DKNWSYNQZKUICI-UHFFFAOYSA-N,AMANTADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL288826,DKXNWXXUHISEHY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.19,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL482295,DKXQXLBXXKLLSH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,6400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL75435,DKYWVDODHFEZIM-NSHDSACASA-N,DEXKETOPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL75435,DKYWVDODHFEZIM-NSHDSACASA-N,DEXKETOPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL571,DKYWVDODHFEZIM-UHFFFAOYSA-N,KETOPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL571,DKYWVDODHFEZIM-UHFFFAOYSA-N,KETOPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909050,DLDAZIVPAOLETE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909050,DLDAZIVPAOLETE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL513,DLGOEMSEDOSKAD-UHFFFAOYSA-N,CARMUSTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL513,DLGOEMSEDOSKAD-UHFFFAOYSA-N,CARMUSTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL61006,DLNKOYKMWOXYQA-UHFFFAOYSA-N,PHENYLPROPANOLAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12954796,KI,=,15,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL61006,DLNKOYKMWOXYQA-UHFFFAOYSA-N,PHENYLPROPANOLAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12954796,KI,=,30.1,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL61006,DLNKOYKMWOXYQA-UHFFFAOYSA-N,PHENYLPROPANOLAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12954796,KI,=,42.1,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL61006,DLNKOYKMWOXYQA-UHFFFAOYSA-N,PHENYLPROPANOLAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12954796,KI,=,137,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL403078,DLQIUZVQSULILG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,83,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL374769,DLVMQSXQUZPAKP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,520,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL374769,DLVMQSXQUZPAKP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,730,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL374769,DLVMQSXQUZPAKP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,1400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL374769,DLVMQSXQUZPAKP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,>,5500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL1173430,DLXDOKNGJXKCNQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,2440,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL232069,DMFIBBAULMICJR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,215000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL232069,DMFIBBAULMICJR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL217053,DMFOOUGJUFPBOG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17154491,INHIBITION,<,30,%,,"","","","","","",,,,,,,,Inhibition of human NE transporter at 10 uM,Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits.,J. Med. Chem.,PUBLICATION,
CHEMBL127,DMJNNHOOLUXYBV-PQTSNVLCSA-N,MEROPENEM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL127,DMJNNHOOLUXYBV-PQTSNVLCSA-N,MEROPENEM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL403377,DMKNBJGZUPGVEW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18060777,KI,=,5700,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2380979,DMOBQDGHIHODJN-QWHCGFSZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23578689,IC50,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2380979,DMOBQDGHIHODJN-QWHCGFSZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23578689,INHIBITION,=,25,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes at 1 uM,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1095523,DMULXMAWQFEZSA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,=,225,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1095523,DMULXMAWQFEZSA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,INH,=,94000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2181924,DNGYIBDXSUNKMV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22853801,ACTIVITY,<,50,%,,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter at 100 nM,New positron emission tomography (PET) radioligand for imaging s-1 receptors in living subjects.,J. Med. Chem.,PUBLICATION,
CHEMBL519910,DNHPSSPWARRIMM-FOYRJYEQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,1100,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL286398,DNIAPMSPPWPWGF-UHFFFAOYSA-N,PROPYLENE GLYCOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL286398,DNIAPMSPPWPWGF-UHFFFAOYSA-N,PROPYLENE GLYCOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL477782,DNSFFPXOVPKGCT-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,30,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200709,DNTGGZPQPQTDQF-XBXARRHUSA-N,CROTAMITON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200709,DNTGGZPQPQTDQF-XBXARRHUSA-N,CROTAMITON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL494624,DNTKPSJIKIXCOA-BPNKVWISSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18434164,KI,=,49,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL494626,DNTKPSJIKIXCOA-VZXSFKIWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18434164,KI,=,3.5,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2338054,DNTVXLSMTRVFMZ-MBSDFSHPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,5.01,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3612834,DNULEDAKWYIMHX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,IC50,=,885,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3612834,DNULEDAKWYIMHX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,0.94,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL599230,DNVMLFGJFSQQDE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,1180,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1405,DNXHEGUUPJUMQT-CBZIJGRNSA-N,ESTRONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1405,DNXHEGUUPJUMQT-CBZIJGRNSA-N,ESTRONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1466,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,DICUMAROL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1466,DOBMPNYZJYQDGZ-UHFFFAOYSA-N,DICUMAROL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL822,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,TERBINAFINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,4129.5,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL822,DOMXUEMWDBAQBQ-WEVVVXLNSA-N,TERBINAFINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,4095.4,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL551473,DONMCIZYEUHXSH-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,7.8,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL3310481,DOQJYOJZNNPBRY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,10,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310481,DOQJYOJZNNPBRY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,97,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310481,DOQJYOJZNNPBRY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1204411,DOQYJYPXUDTPLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,IMIQUIMOD,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1282,DOUYETYNHWVLEO-UHFFFAOYSA-N,IMIQUIMOD,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL589178,DOYLLHOWPJQFPA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19926484,KI,=,632,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL248824,DPGZNUSUOPLFNV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,>,100000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2338050,DPINDTNFGDXWLU-BLLLJJGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,3.98,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2338048,DPINDTNFGDXWLU-LRDDRELGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,0.316,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2338049,DPINDTNFGDXWLU-MLGOLLRUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,0.501,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2338051,DPINDTNFGDXWLU-WBMJQRKESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,3.98,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1076382,DPMFIKUKSRSTHR-STYDTVTQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL597968,DPNWJTQXCYFUOT-VOMIJIAVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,2.3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL19019,DQCKKXVULJGBQN-XFWGSAIBSA-N,NALTREXONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL19019,DQCKKXVULJGBQN-XFWGSAIBSA-N,NALTREXONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1198,DQKXQSGTHWVTAD-UHFFFAOYSA-N,PRAMOXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1198,DQKXQSGTHWVTAD-UHFFFAOYSA-N,PRAMOXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL486538,DQMQNSKBKIYETN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,41,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL487691,DQMYTSCZLQLEID-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,6000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL856,DQMZLTXERSFNPB-UHFFFAOYSA-N,PRIMIDONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL856,DQMZLTXERSFNPB-UHFFFAOYSA-N,PRIMIDONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2206529,DQNPRNKGUDQMJY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,19,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL577597,DQPHXSWTVKEOEO-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,22,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL512878,DQRDMGPCIADVBP-ZSFQTYJUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,>,2000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1097469,DRAQRLXEPIYYIE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,=,255,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1097469,DRAQRLXEPIYYIE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,INH,=,82000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL45,DRLFMBDRBRZALE-UHFFFAOYSA-N,MELATONIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL45,DRLFMBDRBRZALE-UHFFFAOYSA-N,MELATONIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL227231,DRLOWUSIOOIRRD-HIUFNZKISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,2300,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL227231,DRLOWUSIOOIRRD-HIUFNZKISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,2530,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL2337604,DRRQCYGCMNHHQK-GUYCJALGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,2,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL332097,DRRXQCXSBONKPD-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15177457,KI,=,97100,NM,,"","","","","","",,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter; Average of two experiments,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL514560,DRWJMJVERMOJBX-GOSISDBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,16,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL478834,DRWJMJVERMOJBX-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,8,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL478834,DRWJMJVERMOJBX-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,8,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL258013,DRYNWXRVJSBMFJ-CPFSXVBKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,270,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL204199,DSAPXKWYVMTXKI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16337793,IC50,>,100,NM,,"","","","","","",,,,,,,,Inhibitory activity against NET,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL399429,DSBUEYRGXKHYAZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,12000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL459391,DSDLGRNFGNGRFT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL459391,DSDLGRNFGNGRFT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL379679,DSIUMNNVBQZCEG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,317,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL379679,DSIUMNNVBQZCEG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,4000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1783889,DSNALXIKDKGHLJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25893048,ACTIVITY,,,,Not Active,"","","","","","",,,,,,,,Binding affinity to human NET at 1 uM,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2252949,DSSYKIVIOFKYAU-OIBJUYFYSA-N,(-)-CAMPHOR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2252949,DSSYKIVIOFKYAU-OIBJUYFYSA-N,(-)-CAMPHOR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL504760,DSSYKIVIOFKYAU-XCBNKYQSSA-N,CAMPHOR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL504760,DSSYKIVIOFKYAU-XCBNKYQSSA-N,CAMPHOR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL560999,DTBBOFHJHSCSAN-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,148,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2096877,DTGXSBMWMFLEGI-JRRMTSHWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,=,780,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL2096877,DTGXSBMWMFLEGI-JRRMTSHWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,KI,=,390,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL426178,DTGXSBMWMFLEGI-OEXSPLCWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,=,13000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL426178,DTGXSBMWMFLEGI-OEXSPLCWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,KI,=,7800,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL520735,DTIHRSKIBFPMSD-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,800,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL204759,DTNUPBSOODGRKW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,11.7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL204759,DTNUPBSOODGRKW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,136,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1683903,DTPYYGUOEBJVJL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,8733,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL324269,DTPZQRWLIAELHU-YHZLUUAOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,IC50,,,,Not Determined,"","","","","","",,,,,,,,In vitro ability of compound to inhibit NE re-uptake of radiolabeled [3H]-tritium transmitter into synaptosome; ND=not determined,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL324269,DTPZQRWLIAELHU-YHZLUUAOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,KI,=,385,NM,,"","","","","","",,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL514447,DUCJOVLKXCHFKO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,60,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL290634,DUGOZIWVEXMGBE-STQMWFEESA-N,(SS)-METHYL-PHENIDATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12431845,KI,=,339,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL796,DUGOZIWVEXMGBE-UHFFFAOYSA-N,METHYLPHENIDATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,61,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL796,DUGOZIWVEXMGBE-UHFFFAOYSA-N,METHYLPHENIDATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,660,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL796,DUGOZIWVEXMGBE-UHFFFAOYSA-N,METHYLPHENIDATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,KI,=,340,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL481526,DUKLUAWTTPYZNJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,1500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323106,DUMPPDQZUJJGKY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,6.8,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL410015,DUNLKPYMIRLCRM-IFXJQAMLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,9.4,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL608560,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19954972,INHIBITION,,,,Not Determined,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL608560,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL608560,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2432049,DUZKXKAAUHDBQA-CAUKCHDASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL550870,DVAFTUPEVMCRKD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,3.98,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL413562,DVAKZGWOGMMTDJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15974579,KI,=,108,NM,,"",cell_based,"","","","",,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,PUBLICATION,
CHEMBL334255,DVBJBNKEBPCGSY-UHFFFAOYSA-M,CETYLPYRIDINIUM BROMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2653,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL334255,DVBJBNKEBPCGSY-UHFFFAOYSA-M,CETYLPYRIDINIUM BROMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2631,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1642899,DVCQRBZBVYAGNZ-GDBMZVCRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,174,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642901,DVCQRBZBVYAGNZ-GOEBONIOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,98,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642898,DVCQRBZBVYAGNZ-HOCLYGCPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,167,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642900,DVCQRBZBVYAGNZ-ZBFHGGJFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,164,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1836644,DVDGHCLLWLHYLG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21863888,KI,=,6.8,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET receptor,Efficient Conversion of a Nonselective Norepinephrin Reuptake Inhibitor into a Dual Muscarinic Antagonist-ß(2)-Agonist for the Treatment of Chronic Obstructive Pulmonary Disease.,J. Med. Chem.,PUBLICATION,
CHEMBL493264,DVFKWYNNNBWGRC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,640,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673137,DVONUWHZWNLFQL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,92.4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3673137,DVONUWHZWNLFQL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,368.6,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3104091,DVSMVUMYJDOPJQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24365159,KI,>,10000,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL577497,DWBBFNBXAKCWFH-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,726,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2380971,DWEUBXIQNVYDHT-HIFRSBDPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23578689,IC50,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2380971,DWEUBXIQNVYDHT-HIFRSBDPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23578689,INHIBITION,=,68,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes at 1 uM,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2380980,DWEUBXIQNVYDHT-ZFWWWQNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23578689,IC50,=,8200,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2380980,DWEUBXIQNVYDHT-ZFWWWQNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23578689,INHIBITION,=,-1.7,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes at 1 uM,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323103,DWFQMVGSQLUODG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,INHIBITION,=,48,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells at 100 nM after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL1319362,DWSGTFTVBLXELC-RDYJJYPNSA-N,HOMATROPINE HYDROBROMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1319362,DWSGTFTVBLXELC-RDYJJYPNSA-N,HOMATROPINE HYDROBROMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3673150,DWTFUODFLDHIAT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,392.4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL475945,DWTJKIXZDHRVPT-FQEVSTJZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,>,3000,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL515614,DWTJKIXZDHRVPT-HXUWFJFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,=,26,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1651208,DWTYHCYVKJONSP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23009245,INHIBITION,=,4,%,,"","","","","","",,,,,,,,Inhibition of radioligand binding to human NET at 10 uM,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,PUBLICATION,
CHEMBL506098,DXFWUAWSMRONLI-RXGFHJPUSA-N,HYDROPEROXYCADIFORIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17618015,IC50,=,0.05,UG.ML-1,,"","","","","","",,,,,,,,Inhibition of noradrenaline transporter,Bioactive peroxides as potential therapeutic agents.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1096467,DXRCWRDHBIVBIS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20427184,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter at 1 uM,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL569025,DXTDNUFZTNALDJ-SFTDATJTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,INHIBITION,=,18,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
,DYIRSNMPIZZNBK-UHFFFAOYSA-N,EED226,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,28135235,IC50,=,30000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL482903,DYJBCVKMYPRGRR-BJUDXGSMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18487050,KI,=,1680,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3323105,DYQBWKPHLQJDJC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,13,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3323105,DYQBWKPHLQJDJC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,11.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323105,DYQBWKPHLQJDJC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,22.8,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323105,DYQBWKPHLQJDJC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,300,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323105,DYQBWKPHLQJDJC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,11.5,NM,314426,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3703738,DYQJFQKEXMXHKX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,194.9,NM,302102,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL236046,DYUSEVKSEDICGM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17616397,KI,=,290,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1914698,DZCYWZREDUKUMT-IAFLDTSXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21458259,KI,=,27.7,NM,,"",cell_based,"","","","",LLC-PK1,,,,,,,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL452429,DZEOBMAMUUMJNJ-SJCJKPOMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,230,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL497479,DZEOBMAMUUMJNJ-SJKOYZFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,36,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL497479,DZEOBMAMUUMJNJ-SJKOYZFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,26,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL152842,DZLHSFJMKLMKMN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,1000,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL346178,DZOJBGLFWINFBF-UMSFTDKQSA-N,OSANETANT,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25738882,INHIBITION,>=,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from recombinant human norepinephrine transporter expressed in CHO cells at 1 uM after 120 mins by scintillation counting analysis relative to control,Discovery and optimization of novel antagonists to the human neurokinin-3 receptor for the treatment of sex-hormone disorders (part I).,J. Med. Chem.,PUBLICATION,
CHEMBL103504,DZQDCXYKGIEDDJ-XBBDAYDNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10698458,IC50,=,18,NM,,"",cell_based,"","","","",,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673135,DZTZPWDKQRGFKW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,302.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL201978,DZULEPZTNHLZTO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,18.5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL201978,DZULEPZTNHLZTO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,262,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2036272,DZWCPJPFRNJGMB-DFQHDRSWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,2400,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL2036274,DZWCPJPFRNJGMB-IODNYQNNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,880,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL2036273,DZWCPJPFRNJGMB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,1000,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL2036273,DZWCPJPFRNJGMB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,5200,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL1258452,DZZIAERGLDKTBT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20812727,KI,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL850,DZZWHBIBMUVIIW-DTORHVGOSA-N,SPARFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL850,DZZWHBIBMUVIIW-DTORHVGOSA-N,SPARFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL211527,FABMPYBEKUUBIW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1560,FAKRSMQSSFJEIM-RQJHMYQMSA-N,CAPTOPRIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1560,FAKRSMQSSFJEIM-RQJHMYQMSA-N,CAPTOPRIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200600,FAOZLTXFLGPHNG-KNAQIMQKSA-N,FLUOROMETHOLONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200600,FAOZLTXFLGPHNG-KNAQIMQKSA-N,FLUOROMETHOLONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1173599,FAQPJNPOZWJWED-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,>,100000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL2171408,FAVINESADHRZRB-UHFFFAOYSA-N,"3-((3,4-DICHLOROPHENYL)(ETHOXY)METHYL)AZETIDINE HCL",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,49,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2171420,FBCBBHPWZDGQBH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,81,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL34259,FBOZXECLQNJBKD-ZDUSSCGKSA-N,METHOTREXATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL34259,FBOZXECLQNJBKD-ZDUSSCGKSA-N,METHOTREXATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL689,FBPFZTCFMRRESA-KVTDHHQDSA-N,MANNITOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL689,FBPFZTCFMRRESA-KVTDHHQDSA-N,MANNITOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3703725,FBUHCPMYBAXIMM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,150.1,NM,302089,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL3703725,FBUHCPMYBAXIMM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,360.4,NM,302088,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL270099,FBYDVYUKCVAEAU-WMZOPIPTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17983754,KI,=,1.35,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL199054,FBYZEHXPWUZCPM-KGLIPLIRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1084309,FCEXIPULXFOGIW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,46,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL213035,FCHUPCOGZXEFDS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,73,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL204538,FCINLQHPPAWABH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,19.3,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL204538,FCINLQHPPAWABH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,69.8,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1762476,FCJZJQBLFVEPPT-UNTBIKODSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21398123,IC50,=,12000,NM,,"","","","","","",,,,,,,,Inhibition of NET,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1813306,FCMFWPCHZOKPLR-NHYWBVRUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,912.01,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL410055,FCURKYXBYVWDLH-FXAWDEMLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,80,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256137,FCUSICKWCXJXBW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,51,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL470080,FCVFHVSYVLGVRV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,ACTIVITY,=,34,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells at 1000 nM,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL470080,FCVFHVSYVLGVRV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,INHIBITION,=,19,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells at 1000 nM,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL479410,FCXKPNHKJPFYSO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,700,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL479410,FCXKPNHKJPFYSO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18782666,IC50,=,770,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. Part 3: Site-directed metabolism as a strategy to avoid active circulating metabolites: structure-activity relationships of (thioalkyl)phenoxy benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256819,FCZCOULCVQEFCA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,21,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL453062,FDBFTQAPQQWDDD-CRAIPNDOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,190,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL486045,FDBFTQAPQQWDDD-MAUKXSAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,8,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL520736,FDBFTQAPQQWDDD-QAPCUYQASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL525249,FDBFTQAPQQWDDD-YJBOKZPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,160,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL203562,FDCLNKXJEZCPEW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,12.4,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL203562,FDCLNKXJEZCPEW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,150,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL21,FDDDEECHVMSUSB-UHFFFAOYSA-N,SULFANILAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL21,FDDDEECHVMSUSB-UHFFFAOYSA-N,SULFANILAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3593397,FDKMWPCRMXOEIV-NINOIYOQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,52,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL476,FDKXTQMXEQVLRF-ZHACJKMWSA-N,DACARBAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL476,FDKXTQMXEQVLRF-ZHACJKMWSA-N,DACARBAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL446481,FDNFLRXXOIWCQA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,630,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL67078,FDTFUBJUWHYSGU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,IC50,=,48,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL67078,FDTFUBJUWHYSGU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,KI,=,41,NM,,"","","","","","",,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL232299,FDYWMYJFNNYCEI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,3900,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL232299,FDYWMYJFNNYCEI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,13000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2337597,FDZMWAFQMOJQFO-RHSMWYFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,5.01,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337596,FDZMWAFQMOJQFO-YOEHRIQHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,31.62,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL989,FEBLZLNTKCEFIT-VSXGLTOVSA-N,FLUOCINOLONE ACETONIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL989,FEBLZLNTKCEFIT-VSXGLTOVSA-N,FLUOCINOLONE ACETONIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL417035,FECMCOWJDSNXAS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,IC50,=,190,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL417035,FECMCOWJDSNXAS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,KI,=,190,NM,,"","","","","","",,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL2371930,FEENACCUUASIIK-OPQDNGBESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17064074,EC50,=,1380.38,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET in COS7 cells,Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL1224239,FEFGXICFKQBCRL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,3.16,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1808432,FEJYXUSNDZMQOV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21724392,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 0.5 uM,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL46,FELGMEQIXOGIFQ-UHFFFAOYSA-N,ONDANSETRON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL46,FELGMEQIXOGIFQ-UHFFFAOYSA-N,ONDANSETRON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1813314,FEYNATNTSNGKKO-DOMZBBRYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,56.23,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813315,FEYNATNTSNGKKO-SWLSCSKDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,141.25,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL274119,FFEARJCKVFRZRR-UHFFFAOYSA-N,RACEMETHIONINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12649361,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL310604,FFFHZYDWPBMWHY-UHFFFAOYSA-N,HOMOCYSTEINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12649361,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL108,FFGPTBGBLSHEPO-UHFFFAOYSA-N,CARBAMAZEPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL108,FFGPTBGBLSHEPO-UHFFFAOYSA-N,CARBAMAZEPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL481306,FFJCCOLDJHZNND-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,130,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL516730,FFJNDOUWRPDJJX-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,46,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL576542,FFMLDCYSPNMTJA-GOSISDBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,91,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683888,FFPZKPBDKMJMOH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,26,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3334794,FFTJRFHZXXMTTK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,IC50,=,495,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL218997,FFTNCZSASXDDKK-FPOVZHCZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,37,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL218997,FFTNCZSASXDDKK-FPOVZHCZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,46,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL477374,FFWMVMYKTQEBAE-NSHDSACASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,16,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL122452,FFZXXMKWEGRDRF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,IC50,=,210,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL122452,FFZXXMKWEGRDRF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,KI,=,194,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL1085567,FGLZNYXYSDQEEU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683889,FGMVBSZPVPCFKQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,10,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1940403,FGTGRXMIFIZGBG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25070422,KI,=,2249,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL550402,FGTRDYXFZBKEJR-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,18,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL219916,FGXWKSZFVQUSTL-UHFFFAOYSA-N,DOMPERIDONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2614,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL219916,FGXWKSZFVQUSTL-UHFFFAOYSA-N,DOMPERIDONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2593,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL267648,FHFYDNQZQSQIAI-UHFFFAOYSA-N,PEFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL267648,FHFYDNQZQSQIAI-UHFFFAOYSA-N,PEFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL513618,FHGGWRRIFBYBAE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,700,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL526669,FHNHVNKWEHYJDJ-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,100,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL526669,FHNHVNKWEHYJDJ-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,30,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL504606,FHNHVNKWEHYJDJ-QZTJIDSGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,1300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL505433,FHNHVNKWEHYJDJ-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,18,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL505433,FHNHVNKWEHYJDJ-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL443952,FHNHVNKWEHYJDJ-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,1000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL381754,FHRNDZQBSORXCR-LIRRHRJNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,540,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3663917,FHVZRKFXAWGVLU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1.4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663917,FHVZRKFXAWGVLU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2.2,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663917,FHVZRKFXAWGVLU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,8.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663917,FHVZRKFXAWGVLU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,1.4,NM,314420,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL147983,FIGPOABEAKIBCL-WMLDXEAASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,28,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL147983,FIGPOABEAKIBCL-WMLDXEAASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,48,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL356552,FIGPOABEAKIBCL-YOEHRIQHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,170,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL463585,FIIZGBLPZZYXCS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,9,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL458019,FIKAKWIAUPDISJ-UHFFFAOYSA-L,PARAQUAT DICHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL458019,FIKAKWIAUPDISJ-UHFFFAOYSA-L,PARAQUAT DICHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL564285,FJFCTBPGJGVZBJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,1000,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL342716,FJIWMGGJQBHZKG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,KI,=,42,NM,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL934,FJLBFSROUSIWMA-UHFFFAOYSA-N,METYRAPONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL934,FJLBFSROUSIWMA-UHFFFAOYSA-N,METYRAPONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2220442,FJLGEFLZQAZZCD-VAWYXSNFSA-N,FLUVASTATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2220442,FJLGEFLZQAZZCD-VAWYXSNFSA-N,FLUVASTATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3310633,FJRHKFCLJYAKFM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,10,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323090,FKCXCDFQELSYLK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,5.2,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3323090,FKCXCDFQELSYLK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,5.2,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323090,FKCXCDFQELSYLK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,7.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323090,FKCXCDFQELSYLK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,254,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323090,FKCXCDFQELSYLK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,5.2,NM,314411,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL568096,FKDKUDMUXGCBLI-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,IC50,=,118,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL403,FKENQMMABCRJMK-RITPCOANSA-N,SULBACTAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL403,FKENQMMABCRJMK-RITPCOANSA-N,SULBACTAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL567482,FKPMMRLETAKLGP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL567482,FKPMMRLETAKLGP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL198176,FKPQTOXELNJTMQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,9,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683890,FLAQOJMPRHHQFA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,137,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL213030,FLCMZOWXDMNREV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,45,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1242923,FLGSUSWMWSZVMP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20684563,KI,>=,1000,NM,,"","","","","","",,,,,,,,Binding affinity to human NE transporter by radioligand displacement assay,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,PUBLICATION,
CHEMBL597134,FLHCVNZEHIWJGJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,EC50,=,9,NM,,"","","","","","",,,,,,,,Agonist activity at NET,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL597134,FLHCVNZEHIWJGJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,33,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL597134,FLHCVNZEHIWJGJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,33,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL557660,FLOGKESFYXJKPK-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,19,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3593405,FMBFPKABXNIGRK-SLHAJLBXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,3.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL311617,FMGYKKMPNATWHP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10411589,KI,=,507,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1475,FMHHVULEAZTJMA-UHFFFAOYSA-N,TRIOXSALEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1475,FMHHVULEAZTJMA-UHFFFAOYSA-N,TRIOXSALEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3115074,FMJSLPJYTAKVLJ-CQVJSGDESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26091726,INHIBITION,=,7,%,,"","","","","","",,,,,,,,Inhibition of human NE transporter at 10 uM relative to control,Discovery and characterization of a potent and selective EP4 receptor antagonist.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673149,FMMKJZJKDJFMKF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,5332,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL31184,FMMWHPNWAFZXNH-UHFFFAOYSA-N,BENZO[DEF]CHRYSENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL31184,FMMWHPNWAFZXNH-UHFFFAOYSA-N,BENZO[DEF]CHRYSENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL478661,FMOPBZKBYNKBBB-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,114,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL381373,FMVNGPGSZIETQV-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,255,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL598168,FNQZKQRJZBPGQR-URBRKQAFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,7.6,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1086275,FNRNKAMBXVROAU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,58,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171414,FNYDYQPDDZMXFQ-UHFFFAOYSA-N,"3-((BENZYLOXY)(3,4-DICHLOROPHENYL)METHYL)AZETIDINE HCL",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,30,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL585,FNYLWPVRPXGIIP-UHFFFAOYSA-N,TRIAMTERENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL585,FNYLWPVRPXGIIP-UHFFFAOYSA-N,TRIAMTERENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL464422,FOEJRTWJHDIANT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,IC50,=,481,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL464422,FOEJRTWJHDIANT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,KI,=,2440,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL462311,FOEJRTWJHDIANT-UONOGXRCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,481,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL462311,FOEJRTWJHDIANT-UONOGXRCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,2440,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL460406,FOEJRTWJHDIANT-ZIAGYGMSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,3101,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL460406,FOEJRTWJHDIANT-ZIAGYGMSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,12100,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1945251,FOGCUXYHCCUINS-UNSMHXHVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24262882,KI,=,20,NM,,"","","","","","",,,,,,,,Displacement of [3H]Imipramin from human NET after 2 hrs by liquid scintillation counting analysis,"Synthesis, radiosynthesis and first in vitro evaluation of novel PET-tracers for the dopamine transporter: [(11)C]IPCIT and [(18)F]FE@IPCIT.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1173429,FOKYJAFKMXEAJL-ISVAXAHUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,151,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL376113,FOMAEAAMXSBAJG-LANGDILFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,4000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL376113,FOMAEAAMXSBAJG-LANGDILFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,>,6100,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL257551,FOMBUMQDBKFBLB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205813,FOTUXOOYRRRHFQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding affinity to NET at 10 uM,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL351760,FOWTXXOWJKWIGY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,12800,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL1173607,FOZZHOLQHJQMRY-SWLSCSKDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,3.98,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173607,FOZZHOLQHJQMRY-SWLSCSKDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,3.98,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL232663,FPDIGUTXTUXSEH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,62000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL232663,FPDIGUTXTUXSEH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2205835,FPHVMMXTLGSYHV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205835,FPHVMMXTLGSYHV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1085905,FPJZMICPDWNXEV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,490,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL439337,FPQRVMRURWGBHW-LIRRHRJNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,650,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL496913,FPXGGQHHZZOHQY-GAPKJMMISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18434164,KI,=,50,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL394585,FPYUHFVUAJRFHA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,178000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL394585,FPYUHFVUAJRFHA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,420000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL582894,FQEQHKRYLKAFDD-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,111,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2024087,FQIJPHXWIONJLF-JKOKRWQUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22171543,INHIBITION,=,-10.6,%,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from NET at 10 uM,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,PUBLICATION,
CHEMBL1370561,FQPFAHBPWDRTLU-UHFFFAOYSA-N,AMINOPHYLLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1370561,FQPFAHBPWDRTLU-UHFFFAOYSA-N,AMINOPHYLLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1094514,FQPJRGDRIOAJCS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20427184,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter at 1 uM,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310487,FQRVPUNOHDAYPI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,30.8,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310487,FQRVPUNOHDAYPI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310487,FQRVPUNOHDAYPI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310487,FQRVPUNOHDAYPI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3311308,FQUAFMNPXPXOJE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24881566,IC50,>,100000,NM,,"","","","","","",,,,,,,,Inhibition of human NET by BacMam bind SPA/summary (Abse5) assay,Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL196368,FQUMMDVLHAIHNA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,18,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL387117,FRKGVKAPAMAQSO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,28,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL387117,FRKGVKAPAMAQSO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL387117,FRKGVKAPAMAQSO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,190,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL387117,FRKGVKAPAMAQSO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,660,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL478623,FRXKHOISTFCGOP-IBGZPJMESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,466,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1909049,FSIWGHXVLYRBFQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909049,FSIWGHXVLYRBFQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1076211,FSKFPVLPFLJRQB-UHFFFAOYSA-N,TOLPERISONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1076211,FSKFPVLPFLJRQB-UHFFFAOYSA-N,TOLPERISONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL596806,FSLROBKNJCTZIC-PYZFKAKLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,3.98,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL189171,FSQKKOOTNAMONP-UHFFFAOYSA-N,ACEMETACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL189171,FSQKKOOTNAMONP-UHFFFAOYSA-N,ACEMETACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL146042,FSUVEHUIVCMLNZ-MAUKXSAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,55,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL146042,FSUVEHUIVCMLNZ-MAUKXSAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,130,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL146615,FSUVEHUIVCMLNZ-YJBOKZPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,540,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL146615,FSUVEHUIVCMLNZ-YJBOKZPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,630,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL976,FSVJFNAIGNNGKK-UHFFFAOYSA-N,PRAZIQUANTEL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL976,FSVJFNAIGNNGKK-UHFFFAOYSA-N,PRAZIQUANTEL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1683880,FSYUMFOIUHBSHI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,39,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL744,FTALBRSUTCGOEG-UHFFFAOYSA-N,RILUZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1733,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL744,FTALBRSUTCGOEG-UHFFFAOYSA-N,RILUZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1718,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1076396,FTMPAENPBHVAOJ-QLOTUHGJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1224092,FTQBIVFBXYAAQX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,12.59,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1818452,FTQFUQZSKDXZNW-ZYMOGRSISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,1.58,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1818452,FTQFUQZSKDXZNW-ZYMOGRSISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,316.23,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL496285,FTQUSRCNRLUCRK-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,240,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL497846,FTTNLGGOMYVLOP-WMZOPIPTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL497846,FTTNLGGOMYVLOP-WMZOPIPTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,4,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL376737,FTVCCHUPUJEUIW-FIPFOOKPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,381,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673161,FUDKVBNOVUMNRU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,53.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL257481,FUFMKPBBSWMURG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,78,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL263373,FUHOKNRCOVAKDB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,275,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL263373,FUHOKNRCOVAKDB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,1490,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL382248,FULUQLAFMOKDPE-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,8.3,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL202907,FUNFIWMUTFWLPO-GTNSWQLSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,2100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL515613,FUONWQQDHNHFGH-WMZOPIPTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,1360,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL83668,FUSNMLFNXJSCDI-UHFFFAOYSA-N,TOLNAFTATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL83668,FUSNMLFNXJSCDI-UHFFFAOYSA-N,TOLNAFTATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL214021,FVFURMJFTAJXRH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17234405,INHIBITION,=,48,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter receptor at 10uM,"An evaluation of 3,4-methylenedioxy phenyl replacements in the aminopiperidine chromone class of MCHr1 antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683904,FVJRSFJCTCDWPN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,9217,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL213229,FVLUAITUNFZGCJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,15,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL12948,FVLVBPDQNARYJU-UHFFFAOYSA-N,SEMUSTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL12948,FVLVBPDQNARYJU-UHFFFAOYSA-N,SEMUSTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL377678,FVLVLFVHHIGOFZ-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,9.8,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683894,FVPYKEUHDWGTTO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,206,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL145994,FVVRXOHRSYEMTM-SIKLNZKXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,460,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL145994,FVVRXOHRSYEMTM-SIKLNZKXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,2600,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL147544,FVVRXOHRSYEMTM-UGKGYDQZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,4800,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL147544,FVVRXOHRSYEMTM-UGKGYDQZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL220766,FVWTYUWMRRCCPG-CPJSRVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,388,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL237512,FWJKAQILVAFVQQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17616397,KI,=,250,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL593821,FWMIXTKPPHIFDD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,IC50,=,29,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL593821,FWMIXTKPPHIFDD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,21,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL562108,FWQBSLOVNYWJFZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1645612,FWSGCKKLRWEEEX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,1020,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1086274,FWSGTPZWDAUURJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,27,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL207860,FXACQNXCWARQOA-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,2,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1214007,FXIKVFNIIRHKBX-PMWAWBRWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20597489,KI,=,87,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL409546,FXNBCHXTTZIOEI-OALUTQOASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,210,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL186962,FXPKVPDERQMXMV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15456270,KI,=,286,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity for Norepinephrine transporter (NET) expressed in LCK PK1 cells,2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.,J. Med. Chem.,PUBLICATION,
CHEMBL451460,FXQBHPKGRGPIKE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,1400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL469233,FXQFRAJLWAPPQJ-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,94,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL478032,FYCRQILFHXYKKL-WCQYABFASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,19,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL476527,FYDXJUSDGLWNFV-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,63,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL402089,FYGDANPUVIMKMO-SUMWQHHRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,12,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL602850,FYGREZKTJIXWIH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19954972,INHIBITION,,,,Not Determined,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL602850,FYGREZKTJIXWIH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL602850,FYGREZKTJIXWIH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL608,FYPMFJGVHOHGLL-UHFFFAOYSA-N,PROBUCOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL608,FYPMFJGVHOHGLL-UHFFFAOYSA-N,PROBUCOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL264430,FYRQVFPRGMKFAC-LAUBAEHRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,6.5,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL232870,FYXXKYRAPMHRTN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,314000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL232870,FYXXKYRAPMHRTN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,993000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1818455,FYXXTOJUMHTXEW-QRWMCTBCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,1,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1818455,FYXXTOJUMHTXEW-QRWMCTBCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,501.19,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1818454,FYXXTOJUMHTXEW-QZTJIDSGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,1.58,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL441864,FZAYBHQQLZFDLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL441864,FZAYBHQQLZFDLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,1700,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL441864,FZAYBHQQLZFDLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,490,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL441864,FZAYBHQQLZFDLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,1500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL3673140,FZFWHCGLHYASKK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,264.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL1643900,FZIIBLBHXXRTMG-RAOGCBAWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21146989,KI,=,3623,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK cells,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643900,FZIIBLBHXXRTMG-RAOGCBAWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,KI,=,3623,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2206525,FZJAPDJONFNIEV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,7.2,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173770,FZKVHQCDVIXSMY-QMHKHESXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,411,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1258722,FZPKLZHGBRKKCP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20727749,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of norepinephrine receptor at 10 uM,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL448912,FZRYLYZNENTFJM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,347,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL448912,FZRYLYZNENTFJM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1085907,FZUUUZNHPYGRAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,3550,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL260440,GAARSROYUMPZLY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,4.4,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL260440,GAARSROYUMPZLY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,4.4,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643901,GACBJAOXQGFNDL-RAOGCBAWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21146989,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK cells,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643901,GACBJAOXQGFNDL-RAOGCBAWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL116463,GALCSZPFCCZIBC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11585444,IC50,=,1140,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine transporter,From hit to lead. Analyzing structure-profile relationships.,J. Med. Chem.,PUBLICATION,
CHEMBL380383,GAMXLCNZCZEZGS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16784855,KI,=,5.87,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET transfected in HEK293 cells,Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1080069,GAOZHRLCFIUCBN-JTQLQIEISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,36,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL436673,GAWWNBHCOINKBY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,27,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3704749,GAWYDFHTJQSNCE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,5.7,NM,317703,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL3704749,GAWYDFHTJQSNCE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,2340,NM,317691,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL432394,GAZPWELASOLBPG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10956218,KI,=,230,NM,,"","","","","","",,,,,,,,In vitro binding affinity on cloned Norepinephrine transporter,"Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines.",J. Med. Chem.,PUBLICATION,
CHEMBL553025,GBABOYUKABKIAF-IELIFDKJSA-N,VINORELBINE BASE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL553025,GBABOYUKABKIAF-IELIFDKJSA-N,VINORELBINE BASE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL575199,GBDCEJWZYYZILX-CCRGXQTGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,=,960,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL248825,GBLKVAKAYJPCCZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,61000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224238,GBLULAKVGYVWTB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,2.51,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL475527,GBPYXOBRYGPNKY-CQSZACIVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,121,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL401596,GBSPTFCPJIXLFF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,36,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL380191,GBWQTSFXTHVNTA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,69,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL578,GBXSMTUPTTWBMN-XIRDDKMYSA-N,ENALAPRIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL578,GBXSMTUPTTWBMN-XIRDDKMYSA-N,ENALAPRIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1395,GCKMFJBGXUYNAG-HLXURNFRSA-N,METHYLTESTOSTERONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1395,GCKMFJBGXUYNAG-HLXURNFRSA-N,METHYLTESTOSTERONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2047563,GCQYUVJKJNRUBX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,50,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL323678,GDIDBVDYSJUGMI-NGKMOHNRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,IC50,,,,Not Determined,"","","","","","",,,,,,,,In vitro ability of compound to inhibit NE re-uptake of radiolabeled [3H]-tritium transmitter into synaptosome; ND=not determined,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL323678,GDIDBVDYSJUGMI-NGKMOHNRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,KI,=,68,NM,,"","","","","","",,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL181,GDLBFKVLRPITMI-UHFFFAOYSA-N,DIAZOXIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL181,GDLBFKVLRPITMI-UHFFFAOYSA-N,DIAZOXIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL415,GDLIGKIOYRNHDA-UHFFFAOYSA-N,CLOMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,38,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL415,GDLIGKIOYRNHDA-UHFFFAOYSA-N,CLOMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11454918,KI,=,53.7,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL415,GDLIGKIOYRNHDA-UHFFFAOYSA-N,CLOMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14573386,KI,=,38,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL415,GDLIGKIOYRNHDA-UHFFFAOYSA-N,CLOMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,64.6,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL415,GDLIGKIOYRNHDA-UHFFFAOYSA-N,CLOMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26372073,INHIBITION,=,5,%,,"","","","","","",,,,,,,,Displacement of [3H]-nisoxetine from norepinephrine transporter (unknown origin) at 0.1 mM relative to control,Reengineered tricyclic anti-cancer agents.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL415,GDLIGKIOYRNHDA-UHFFFAOYSA-N,CLOMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26372073,INHIBITION,=,76,%,,"","","","","","",,,,,,,,Displacement of [3H]-nisoxetine from norepinephrine transporter (unknown origin) at 1 mM relative to control,Reengineered tricyclic anti-cancer agents.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL415,GDLIGKIOYRNHDA-UHFFFAOYSA-N,CLOMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26372073,INHIBITION,=,100,%,,"","","","","","",,,,,,,,Displacement of [3H]-nisoxetine from norepinephrine transporter (unknown origin) at 10 mM relative to control,Reengineered tricyclic anti-cancer agents.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL415,GDLIGKIOYRNHDA-UHFFFAOYSA-N,CLOMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,71,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL415,GDLIGKIOYRNHDA-UHFFFAOYSA-N,CLOMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,70,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL471696,GDSLVFLGCFUFPN-KHQMHLGISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,>,2000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL294733,GDTWDHOANPFJQI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15080991,KI,=,1360,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity to norepinephrine (NE) transporter in membranes of cells selectively expressing the human genes for NET,Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1956115,GDYIQUFNICPYHF-GOSISDBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22175825,IC50,=,340,NM,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter,Potent inhibitors of LpxC for the treatment of Gram-negative infections.,J. Med. Chem.,PUBLICATION,
CHEMBL1956115,GDYIQUFNICPYHF-GOSISDBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22175825,INHIBITION,>,50,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,Potent inhibitors of LpxC for the treatment of Gram-negative infections.,J. Med. Chem.,PUBLICATION,
CHEMBL1956115,GDYIQUFNICPYHF-GOSISDBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22175825,KI,=,250,NM,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter,Potent inhibitors of LpxC for the treatment of Gram-negative infections.,J. Med. Chem.,PUBLICATION,
CHEMBL205005,GEBDYHRDARRAJZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,43,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL492438,GEFDXUZHLNJUMR-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18800760,IC50,=,500,NM,,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter,Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL47482,GEICAQNIOJFRQN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18847250,KI,>,10000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxitine from NET,"Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.",J. Med. Chem.,PUBLICATION,
CHEMBL1084934,GESKFXJTJLLILS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,1400,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2338035,GFBHUZKPXOPMMX-GUYCJALGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,2,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310497,GFGPKOBHHRPKSF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,74,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310497,GFGPKOBHHRPKSF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310497,GFGPKOBHHRPKSF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1451,GFNANZIMVAIWHM-OBYCQNJPSA-N,TRIAMCINOLONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1451,GFNANZIMVAIWHM-OBYCQNJPSA-N,TRIAMCINOLONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL451071,GFNCCLBUKZBTIA-LOPIXSETSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18434164,KI,=,150,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL234928,GFNMZMSNUJYADM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17391962,INHIBITION,=,34,%,,"","","","","","",,,,,,,,Inhibition of human NET at 1 uM,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205817,GFQHCUYWLHSGJR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL380056,GFWKSCDPOYKBDG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,IC50,=,2130,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL380056,GFWKSCDPOYKBDG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,KI,=,1060,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL258063,GGDZOYZQDNYTKY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL416409,GGGXMDDQIHPMRC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213078,IC50,=,93,NM,,"","","","","","",,,,,,,,Compound was tested for the inhibition of norepinephrine (NE) reuptake,Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL416409,GGGXMDDQIHPMRC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213078,RATIO,=,13,,,"","","","","","",,,,,,,,Ratio of IC50 value against Norepinephrine transporter (NE) to that of Dopamine transporter (DA),Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL326713,GGNUKUMOMWBKFX-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15177457,KI,=,554000,NM,,"","","","","","",,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL326713,GGNUKUMOMWBKFX-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15177457,KI,=,695000,NM,,"","","","","","",,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1082211,GGUUYQBMWBFCFQ-IBGZPJMESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20137933,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL880,GGXKWVWZWMLJEH-UHFFFAOYSA-N,FAMCICLOVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL880,GGXKWVWZWMLJEH-UHFFFAOYSA-N,FAMCICLOVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,FLUOROURACIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL185,GHASVSINZRGABV-UHFFFAOYSA-N,FLUOROURACIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL565396,GIDJZDYNVHMFAH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,6500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL565396,GIDJZDYNVHMFAH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,>,7140,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL565396,GIDJZDYNVHMFAH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,5600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL438257,GIENPXSUZALJHK-SJCJKPOMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,410,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201203,GIJXKZJWITVLHI-PMOLBWCYSA-N,BENZTROPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1391,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201203,GIJXKZJWITVLHI-PMOLBWCYSA-N,BENZTROPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1379,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2338036,GIKANUDLIOICAL-KSSFIOAISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,0.501,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2338037,GIKANUDLIOICAL-RDTXWAMCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,31.62,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL563518,GISYFCKSYSNKHX-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,10.8,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL563518,GISYFCKSYSNKHX-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,13.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL3310631,GIXNXFPSTUDIAY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,18,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201082,GIYXAJPCNFJEHY-UHFFFAOYSA-N,FLUOXETINE HYDROCHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,IC50,=,4410,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1201082,GIYXAJPCNFJEHY-UHFFFAOYSA-N,FLUOXETINE HYDROCHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,4.7,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL447183,GIZYIOOBBUHOBS-UHFFFAOYSA-N,AR-C102222,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21398123,IC50,,,,Not Active,"","","","","","",,,,,,,,Inhibition of NET,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL99946,GJJFMKBJSRMPLA-DZGCQCFKSA-N,LEVOMILNACIPRAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,40,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL99946,GJJFMKBJSRMPLA-DZGCQCFKSA-N,LEVOMILNACIPRAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,40,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL252923,GJJFMKBJSRMPLA-HIFRSBDPSA-N,"1R,2S-MILNACIPRAN",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14573386,KI,=,200,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL252923,GJJFMKBJSRMPLA-HIFRSBDPSA-N,"1R,2S-MILNACIPRAN",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14744476,KI,=,22,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL252923,GJJFMKBJSRMPLA-HIFRSBDPSA-N,"1R,2S-MILNACIPRAN",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14744476,KI,=,68,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL252923,GJJFMKBJSRMPLA-HIFRSBDPSA-N,"1R,2S-MILNACIPRAN",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,5500,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL252923,GJJFMKBJSRMPLA-HIFRSBDPSA-N,"1R,2S-MILNACIPRAN",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,5500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL252923,GJJFMKBJSRMPLA-HIFRSBDPSA-N,"1R,2S-MILNACIPRAN",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,41,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL252923,GJJFMKBJSRMPLA-HIFRSBDPSA-N,"1R,2S-MILNACIPRAN",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,85,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL259209,GJJFMKBJSRMPLA-UHFFFAOYSA-N,MILNACIPRAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,77,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL259209,GJJFMKBJSRMPLA-UHFFFAOYSA-N,MILNACIPRAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,77,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL259209,GJJFMKBJSRMPLA-UHFFFAOYSA-N,MILNACIPRAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954038,IC50,=,77,NM,,"",cell_based,"","","","",HEK293,,,,,,,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter","Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL259209,GJJFMKBJSRMPLA-UHFFFAOYSA-N,MILNACIPRAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,0.794,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL471001,GJJFMKBJSRMPLA-ZFWWWQNUSA-N,"1S,2R-MILNACIPRAN",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954038,IC50,=,40,NM,,"",cell_based,"","","","",HEK293,,,,,,,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter","Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL493056,GJORZJNPTHLFPB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,6000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL152748,GJPNFSRZAKZIAJ-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,6900,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL134,GJSURZIOUXUGAL-UHFFFAOYSA-N,CLONIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,>,20000,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL134,GJSURZIOUXUGAL-UHFFFAOYSA-N,CLONIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11082457,KI,=,1000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL134,GJSURZIOUXUGAL-UHFFFAOYSA-N,CLONIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL134,GJSURZIOUXUGAL-UHFFFAOYSA-N,CLONIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3317694,GJZAPYUNMABLBD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25017029,IC50,=,13,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1744173,GJZWWIMXGJBWFD-HAEFCHRDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,2400,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL1744173,GJZWWIMXGJBWFD-HAEFCHRDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,4400,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL698,GKCBAIGFKIBETG-UHFFFAOYSA-N,TETRACAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL698,GKCBAIGFKIBETG-UHFFFAOYSA-N,TETRACAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL243141,GKCCZGXUGNBNGL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,2500,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL954,GKIRPKYJQBWNGO-OCEACIFDSA-N,ENCLOMIPHENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,862,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL954,GKIRPKYJQBWNGO-OCEACIFDSA-N,ENCLOMIPHENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,855,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL598767,GKIYCLAZFANGKD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,143,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL592696,GKNLPWOESJYQTF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19926484,KI,=,1203,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL460291,GKQPCPXONLDCMU-CCEZHUSRSA-N,LACIDIPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,5735,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL460291,GKQPCPXONLDCMU-CCEZHUSRSA-N,LACIDIPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,5687,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL199824,GKTQBPYMIGXPKG-JVVVGQRLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16392798,KI,=,6980,NM,,"","","","","","",,,,,,,,Binding affinity to NET,"Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand.",J. Med. Chem.,PUBLICATION,
CHEMBL1771,GKTWGGQPFAXNFI-HNNXBMFYSA-N,CLOPIDOGREL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1771,GKTWGGQPFAXNFI-HNNXBMFYSA-N,CLOPIDOGREL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL608708,GKZNLBBTTXPNLH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,INHIBITION,=,12,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1000 nM after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3334787,GLFCAUWDGGEFFN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,83.2,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL511466,GLLHCTWOTAUGQC-ZSFQTYJUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,553,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL570781,GLMKIAAMEYVAIS-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,43,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,MERCAPTOPURINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,MERCAPTOPURINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL25719,GLZPCOQZEFWAFX-JXMROGBWSA-N,GERANIOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL25719,GLZPCOQZEFWAFX-JXMROGBWSA-N,GERANIOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL256818,GLZVSWBABDDJJM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,78,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL438490,GMAJNYRLILNPJN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17412583,ACTIVITY,=,73,%,,"","","","","","",,,,,,,,Binding affinity at noradrenaline transporter at 1 uM,Synthesis and biological evaluation of diamine-based histamine H3 antagonists with serotonin reuptake inhibitor activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL438490,GMAJNYRLILNPJN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17412583,KI,=,201,NM,,"","","","","","",,,,,,,,Binding affinity at human noradrenaline transporter,Synthesis and biological evaluation of diamine-based histamine H3 antagonists with serotonin reuptake inhibitor activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL142028,GMHDOCXPDYDKOR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,KI,=,21,NM,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3703731,GMTDFEZUDHTSAN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,18.8,NM,302095,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL202409,GMWFVXBLHOYMAG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,18,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL202409,GMWFVXBLHOYMAG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,259,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL36715,GMZVRMREEHBGGF-UHFFFAOYSA-N,PIRACETAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL36715,GMZVRMREEHBGGF-UHFFFAOYSA-N,PIRACETAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL451837,GNCUMPKNBKWCMB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL451837,GNCUMPKNBKWCMB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL599813,GNEJBSYNDIMJCO-BGUVMLPUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,8.5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL599609,GNEJBSYNDIMJCO-MAOIFBLLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,6.2,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL592167,GNEJBSYNDIMJCO-WKXZFPGYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,3.7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL574081,GNESBMMZVPTREH-UHDQLFAASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,=,1110,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL260439,GNGXSMDBVKAQSC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,14,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL260439,GNGXSMDBVKAQSC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,14,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201117,GNXFOGHNGIVQEH-UHFFFAOYSA-N,METHOCARBAMOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201117,GNXFOGHNGIVQEH-UHFFFAOYSA-N,METHOCARBAMOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL563404,GNYXJFDSZWNBKT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,33,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL642,GOEMGAFJFRBGGG-UHFFFAOYSA-N,ACEBUTOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL642,GOEMGAFJFRBGGG-UHFFFAOYSA-N,ACEBUTOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2205819,GOYQRMVWIWPDFU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL337822,GOZODOHXYHQNFU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,KI,=,20,NM,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL207407,GOZTZBHGDRHFET-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,42,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL458282,GPDDTDCIQUPUIA-MKRRPMGHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,4100,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL2430691,GPFOQDAZAVIYMI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,12.1,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430691,GPFOQDAZAVIYMI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,33,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL206007,GPHQCFPKKILZDC-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16413778,KI,=,54.4,NM,,"","","","","","",,,,,,,,Binding affinity to NET,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL7568,GPKJTRJOBQGKQK-UHFFFAOYSA-N,QUINACRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2896,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL7568,GPKJTRJOBQGKQK-UHFFFAOYSA-N,QUINACRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2872,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1730,GPRBEKHLDVQUJE-QSWIMTSFSA-N,CEFOTAXIME,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1730,GPRBEKHLDVQUJE-QSWIMTSFSA-N,CEFOTAXIME,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL66068,GPTFOAJWBIXTMY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15080991,KI,=,118,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity to norepinephrine (NE) transporter in membranes of cells selectively expressing the human genes for NET,Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL450710,GPVPGABIUWQWLB-GXTWGEPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,18,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL450710,GPVPGABIUWQWLB-GXTWGEPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,19,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL492215,GPVPGABIUWQWLB-JSGCOSHPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,6940,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2031737,GPZMWOXSIRVXQW-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22313227,KI,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity to human recombinant NET,Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.,J. Med. Chem.,PUBLICATION,
CHEMBL3334780,GPZZVYRXCADSAJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,5.3,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL514,GQYIWUVLTXOXAJ-UHFFFAOYSA-N,LOMUSTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL514,GQYIWUVLTXOXAJ-UHFFFAOYSA-N,LOMUSTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL606144,GRBCPJNRLNFZRM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,IC50,=,128,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL606144,GRBCPJNRLNFZRM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,73,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL607546,GRBWDTDDMWUOBH-DDZGMJBXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,3300,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1818441,GRCVTMNCDBAKJY-GFOWMXPYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,50.12,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1830888,GRFGQBNGPFNYCF-CQSZACIVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,143,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830888,GRFGQBNGPFNYCF-CQSZACIVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,199,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL402441,GRFLLIUZAGYUSO-HNAYVOBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,1.7,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171213,GRGFMFALKDYCBN-UHFFFAOYSA-N,3-((4-CHLOROPHENYL)(ETHOXY)METHYL)AZETIDINE HCL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,10,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL381914,GRHZPOKPBBOJOD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16337793,IC50,>,100,NM,,"","","","","","",,,,,,,,Inhibitory activity against NET,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2029052,GRIXJAFEBWYBJE-ANUWOGMRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15177457,KI,=,5454000,NM,,"","","","","","",,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL600854,GRMXPWKSNKSJGL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,25,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL539564,GRNINAGHVYRWAO-HLRBRJAUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,21,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL520760,GRQBTYJVQQSMFR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173428,GRQDILLJMSLURW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,114,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL469888,GRQJWLQCSDAJSU-MFYZWQBTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,455,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1099179,GRUIIAQNNWQJPW-GOSISDBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,=,30,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1099179,GRUIIAQNNWQJPW-GOSISDBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,INH,=,92000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1096495,GRUIIAQNNWQJPW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,=,56,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL567289,GSCMKUDZZALNHS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,1200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL81977,GSCPDZHWVNUUFI-UHFFFAOYSA-N,3-AMINOBENZAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL81977,GSCPDZHWVNUUFI-UHFFFAOYSA-N,3-AMINOBENZAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL33,GSDSWSVVBLHKDQ-JTQLQIEISA-N,LEVOFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL33,GSDSWSVVBLHKDQ-JTQLQIEISA-N,LEVOFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL4,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,OFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL4,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,OFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL392394,GSGVDKOCBKBMGG-UHFFFAOYSA-N,GS-39783,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12954796,KI,=,224,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1644607,GSHCBUDNKQJONH-OPVJXMOQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,31,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL608704,GSKKFMDTLUPADS-PHBSMUBBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,5400,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1080790,GSMFLJBANXQXTM-NSHDSACASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,13,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257338,GSMNVIUCCXHOLS-GUYCJALGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,65,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL207915,GSQLCOBXOUVYQV-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,145,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1204413,GSXGGZMCFSEFOR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,26,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL372318,GTKJFGPZQFGMLW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,1430,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1818450,GTRIRKWLHVGYGS-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,25.12,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL491408,GUEUKMXCMIUBEX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18782666,IC50,>,10,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. Part 3: Site-directed metabolism as a strategy to avoid active circulating metabolites: structure-activity relationships of (thioalkyl)phenoxy benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL17157,GUGOEEXESWIERI-UHFFFAOYSA-N,TERFENADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1928,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL17157,GUGOEEXESWIERI-UHFFFAOYSA-N,TERFENADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1912,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1818464,GUIDCAHCXPHFSP-QZTJIDSGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,39.81,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3310623,GUVSOKCRWWGAEF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,23,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310623,GUVSOKCRWWGAEF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310623,GUVSOKCRWWGAEF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL492841,GVAGNJNCGNKLIE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,7300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL517305,GVFNSRVEVUSCRN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,5,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310484,GVIKXRIOBFGDFP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,15.9,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310484,GVIKXRIOBFGDFP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310484,GVIKXRIOBFGDFP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310484,GVIKXRIOBFGDFP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310484,GVIKXRIOBFGDFP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,RATIO IC50,>,7,,,"",cell_based,"","","","",,,,,,,,Ratio of duloxetine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310484,GVIKXRIOBFGDFP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,RATIO IC50,>,7,,,"",cell_based,"","","","",,,,,,,,Ratio of venlafaxine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL47,GVJHHUAWPYXKBD-IEOSBIPESA-N,VITAMIN E,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL47,GVJHHUAWPYXKBD-IEOSBIPESA-N,VITAMIN E,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3310486,GVURCJXFYIMVMG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,32.5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310486,GVURCJXFYIMVMG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310486,GVURCJXFYIMVMG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310486,GVURCJXFYIMVMG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310486,GVURCJXFYIMVMG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,RATIO IC50,>,7,,,"",cell_based,"","","","",,,,,,,,Ratio of duloxetine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310486,GVURCJXFYIMVMG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,RATIO IC50,>,7,,,"",cell_based,"","","","",,,,,,,,Ratio of venlafaxine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1813310,GVWVNROHWPGGAQ-GOEBONIOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,14125.38,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL3673127,GWMUISILSXOPNB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,675.1,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL199093,GWNCELRRXGHFMX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,47,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL205505,GWNPJZXWVMSYBY-LIRRHRJNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,11500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256902,GWOOARVSRFHYAH-MJGOQNOKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,3861,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL13341,GWUSZQUVEVMBPI-UHFFFAOYSA-N,NIMETAZEPAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL13341,GWUSZQUVEVMBPI-UHFFFAOYSA-N,NIMETAZEPAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1762480,GXBAVPWCNHSDRH-WMQZXYHMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21398123,IC50,=,7400,NM,,"","","","","","",,,,,,,,Inhibition of NET,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL296419,GXDALQBWZGODGZ-UHFFFAOYSA-N,ASTEMIZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1375,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL296419,GXDALQBWZGODGZ-UHFFFAOYSA-N,ASTEMIZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1364,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1684050,GXDMUUDAPHURSU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,330,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684050,GXDMUUDAPHURSU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,530,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684050,GXDMUUDAPHURSU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,780,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL408,GXPHKUHSUJUWKP-UHFFFAOYSA-N,TROGLITAZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL408,GXPHKUHSUJUWKP-UHFFFAOYSA-N,TROGLITAZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL598825,GXWUVPPXUBCALT-JMSVASOKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,0.631,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL599845,GXWUVPPXUBCALT-SLEUVZQESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,0.501,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL599845,GXWUVPPXUBCALT-SLEUVZQESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,31.62,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL877,GYDJEQRTZSCIOI-LJGSYFOKSA-N,TRANEXAMIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL877,GYDJEQRTZSCIOI-LJGSYFOKSA-N,TRANEXAMIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL138958,GYIQQYDOLSGVHC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,INHIBITION,=,17,%,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL498774,GYJUQRIRWMPONQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18461921,KI,=,58100,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,PUBLICATION,
CHEMBL2205825,GYKFQDQFKGGVKD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1644602,GYNVBZHVGBAXPA-IZZQQSIFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,30,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL133646,GYTGCOARTYXPAX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213054,KI,=,33.4,NM,,"","","","","","",,,,,,,,Inhibition of [125I]- RTI -55 binding at the Norepinephrine transporter sites on HEK-hNET cells,Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL451165,GYURBKTVOWBCTD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,50,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL375131,GYZLMHZBYPNULH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,38,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL375131,GYZLMHZBYPNULH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,77,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL422931,GZAMCYJCPQMIHJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23477943,IC50,>,1000,NM,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin),Discovery of disubstituted piperidines and homopiperidines as potent dual NK1 receptor antagonists-serotonin reuptake transporter inhibitors for the treatment of depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL422931,GZAMCYJCPQMIHJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23477943,INHIBITION,,,,Active,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) at 10 uM,Discovery of disubstituted piperidines and homopiperidines as potent dual NK1 receptor antagonists-serotonin reuptake transporter inhibitors for the treatment of depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1080789,GZAWVIWERRSMCS-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,24,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1078076,GZJJRCVIVJXCPO-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,263,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL597531,GZJLFOYGSNAXDK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,292,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224163,GZMVATBMIADACI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,251.19,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL425010,GZRLZFDDKKLOGM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15801845,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,PUBLICATION,
CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,RALOXIFENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,282,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL81,GZUITABIAKMVPG-UHFFFAOYSA-N,RALOXIFENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,280,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL103701,GZWGAKOZADNOEU-NPHMYQBISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10698458,IC50,=,109,NM,,"",cell_based,"","","","",,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL428706,GZWPHROGQGOESZ-HJWRWDBZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14971892,KI,=,24,NM,,"","","","","","",,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line using [125I]RTI-55 as radioligand,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL428706,GZWPHROGQGOESZ-HJWRWDBZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16451060,KI,=,15,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Evaluation of carbon-11-labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-iodoethenyl)phenyl]nortropane as a potential radioligand for imaging the serotonin transporter by PET.,J. Med. Chem.,PUBLICATION,
CHEMBL173427,GZWPHROGQGOESZ-PHHAAFCNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12620070,KI,=,32,NM,,"",cell_based,"","","","",,,,,,,,In vitro competitive binding versus [3H]- nisoxatine in murine kidney cells transfected with cDNA for human norepinephrine transporter (NET),Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.,J. Med. Chem.,PUBLICATION,
CHEMBL173427,GZWPHROGQGOESZ-PHHAAFCNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12620070,RATIO,=,19.6,,,"","","","","","",,,,,,,,Ratio of binding affinity between human norepinephrine transporter (NET) and human serotonin transporter (SERT),Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.,J. Med. Chem.,PUBLICATION,
CHEMBL174088,GZWPHROGQGOESZ-SYEBVZJNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12620070,KI,=,24,NM,,"",cell_based,"","","","",,,,,,,,In vitro competitive binding versus [3H]- nisoxatine in murine kidney cells transfected with cDNA for human norepinephrine transporter (NET),Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.,J. Med. Chem.,PUBLICATION,
CHEMBL174088,GZWPHROGQGOESZ-SYEBVZJNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12620070,RATIO,=,474,,,"","","","","","",,,,,,,,Ratio of binding affinity between human norepinephrine transporter (NET) and human serotonin transporter (SERT),Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.,J. Med. Chem.,PUBLICATION,
CHEMBL481124,HACMDNQQWHUHKC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,2700,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL348716,HAJXHZRMFWRJQH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,>,20000,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL574543,HAPMRZPBVFBVGL-UHDQLFAASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,>,10000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL696,HAPOVYFOVVWLRS-UHFFFAOYSA-N,ETHOSUXIMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL696,HAPOVYFOVVWLRS-UHFFFAOYSA-N,ETHOSUXIMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3663913,HAQQTPCJCLWUMT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,33,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663913,HAQQTPCJCLWUMT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,73,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663913,HAQQTPCJCLWUMT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,93,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663913,HAQQTPCJCLWUMT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,73,NM,314416,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL257221,HASNZFFRDSPBMJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18060777,KI,=,3300,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430693,HAUQQZNNDHTKIA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,3825,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430693,HAUQQZNNDHTKIA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,72,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430693,HAUQQZNNDHTKIA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,75.4,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL433257,HAVJATCHLFRDHY-KSZYUSJVSA-N,HARRINGTONINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL433257,HAVJATCHLFRDHY-KSZYUSJVSA-N,HARRINGTONINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3084927,HBOJXELDXYNVMR-YNVWKDRESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9435902,KI,=,577,NM,,"","","","","","",,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL129,HBOMLICNUCNMMY-XLPZGREQSA-N,ZIDOVUDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL129,HBOMLICNUCNMMY-XLPZGREQSA-N,ZIDOVUDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL555280,HBOXPGCKZVUQOF-ZVWHLABXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,47900,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL409877,HBSKTTXZUZBHRU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18060777,KI,=,4800,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1568,HBUBKKRHXORPQB-FJFJXFQQSA-N,FLUDARABINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1568,HBUBKKRHXORPQB-FJFJXFQQSA-N,FLUDARABINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1818465,HBZMBTZPNQEKHQ-QRWMCTBCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,31.62,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL249951,HCOYSMZXQIWWOK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,IC50,=,8700,NM,,"","","","","","",,,,,,,,Inhibition of NET,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL249951,HCOYSMZXQIWWOK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,INHIBITION,=,18,%,,"","","","","","",,,,,,,,Inhibition of NET at 1 uM,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8496700,ACTIVITY,=,87,%,,"","","","","","",,,,,,,,Displacement of [3H]DMI from norepinephrine transporter assessed as specific binding relative to total binding,The role of receptor binding in drug discovery.,J. Nat. Prod.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8496700,KI,=,580,NM,,"","","","","","",,,,,,,,Displacement of [3H]DMI from norepinephrine transporter,The role of receptor binding in drug discovery.,J. Nat. Prod.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,0.63,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,3.5,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,0.83,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10411589,KI,=,8.54,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12431845,KI,=,3.8,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14573386,KI,=,3.8,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16675639,KI,=,2.1,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16675639,KI,=,3.9,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16675639,KI,=,4.1,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16989524,IC50,=,0.93,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in MDCK cell membrane,Antidepressant principles of the roots of Polygala tenuifolia.,J. Nat. Prod.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17123820,KI,=,1,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17428804,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]NE uptake at human wild type NET expressed in african green monkey COS1 cells after 48 hrs,chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.,J. Biol. Chem.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17846138,IC50,=,4.2,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,3.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,2.1,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,=,3.9,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,3.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,3.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,IC50,=,3.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,3.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,3.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,KI,=,2.1,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19791802,KI,=,5.11,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.",J. Med. Chem.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,0.6,NM,,"","","","","","",,,,,,,,Inhibition of norepinephrine reuptake at NET,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,3.3,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,3.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,=,3.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,KI,=,2.1,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,KI,=,3.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20945906,KD,=,0.83,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Diaryldiamines with dual inhibition of the histamine H(3) receptor and the norepinephrine transporter and the efficacy of 4-(3-(methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol in pain.,J. Med. Chem.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,3.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,KI,=,2.1,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23403082,IC50,=,0.93,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells after 3 hrs,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23403082,INHIBITION,=,49,%,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells at 10 uM after 3 hrs relative to control,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23403082,KI,=,0.92,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells after 3 hrs,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,1.5,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24365159,KI,=,1.1,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24365159,KI,=,1.15,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL72,HCYAFALTSJYZDH-UHFFFAOYSA-N,DESIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1168,HDACQVRGBOVJII-JBDAPHQKSA-N,RAMIPRIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1168,HDACQVRGBOVJII-JBDAPHQKSA-N,RAMIPRIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL37161,HDDSHPAODJUKPD-UHFFFAOYSA-N,FENBENDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL37161,HDDSHPAODJUKPD-UHFFFAOYSA-N,FENBENDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1762474,HDHLQBIWVMHJAZ-WMQZXYHMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21398123,IC50,=,17000,NM,,"","","","","","",,,,,,,,Inhibition of NET,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3612836,HDKHKSGEUQDNGB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL456638,HDLNQDARKJUPIY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,210,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL456638,HDLNQDARKJUPIY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,1494,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3287654,HDOQLXMDBHVEMJ-SMWREMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24944746,INHIBITION,,,,Not Active,"",cell_based,"","","","",,,,,,,,"Inhibition of 2,5,6-[3H]-dopamine uptake at human NET expressed in African green monkey COS7 cells at 10 uM incubated for 10 mins prior to radioligand addition measured after 5 mins by scintillation counting analysis",Novel and high affinity fluorescent ligands for the serotonin transporter based on (s)-citalopram.,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL1349,HDOVUKNUBWVHOX-QMMMGPOBSA-N,VALACYCLOVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1349,HDOVUKNUBWVHOX-QMMMGPOBSA-N,VALACYCLOVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1077202,HDTINEVDGKNACJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,910,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL562533,HDXRSCIIKGHXQP-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,28,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205820,HDZWTAJVYGVJEQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205820,HDZWTAJVYGVJEQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL258271,HEBFKAQNVHADTH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,84,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL572927,HEBFYRLCWBRALV-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,21,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL44618,HEDRZPFGACZZDS-UHFFFAOYSA-N,CHLOROFORM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL44618,HEDRZPFGACZZDS-UHFFFAOYSA-N,CHLOROFORM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL369997,HEFDYDISPNHKAM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,263,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL369997,HEFDYDISPNHKAM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,370,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL175,HEFNNWSXXWATRW-JTQLQIEISA-N,DEXIBUPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL175,HEFNNWSXXWATRW-JTQLQIEISA-N,DEXIBUPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL427526,HEFNNWSXXWATRW-SNVBAGLBSA-N,(R)-IBUPROPHEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL427526,HEFNNWSXXWATRW-SNVBAGLBSA-N,(R)-IBUPROPHEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL521,HEFNNWSXXWATRW-UHFFFAOYSA-N,IBUPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL521,HEFNNWSXXWATRW-UHFFFAOYSA-N,IBUPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2206516,HEKXQZYFIMYCKA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,35,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL457,HEMJJKBWTPKOJG-UHFFFAOYSA-N,GEMFIBROZIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL457,HEMJJKBWTPKOJG-UHFFFAOYSA-N,GEMFIBROZIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1172525,HESFIOJTTFAYOC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,79.43,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3663907,HFAXMKVVLFVHBE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2450,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663907,HFAXMKVVLFVHBE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3060,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663907,HFAXMKVVLFVHBE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,5990,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663907,HFAXMKVVLFVHBE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,3060,NM,314400,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL256020,HFDKMRZLKAZCKK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,170,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL34139,HFGZFHCWKKQGIS-NOZJJQNGSA-N,GENACONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL34139,HFGZFHCWKKQGIS-NOZJJQNGSA-N,GENACONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1230813,HFHDHCJBZVLPGP-RWMJIURBSA-N,ALFADEX,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1230813,HFHDHCJBZVLPGP-RWMJIURBSA-N,ALFADEX,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL239301,HFHWEFNEZUUCLY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18052090,KI,=,95,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,PUBLICATION,
CHEMBL493384,HFIXKYCVEYCJOY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18461921,KI,=,19687,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,PUBLICATION,
CHEMBL1224091,HFJPQKBQGCFBQI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,2.51,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3334783,HFKOIMHFPUBUFE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,IC50,=,327.9,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1323615,HFXCUJLZEIBVQQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3943,NM,Active,"","","","","","",,,,,,,,"PUBCHEM_BIOASSAY: Late-stage radioligand binding dose response assay to identify inhibitors of NADPH oxidase 1 (NOX1): PDSP screen Ki. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1792, AID1796, AID1823, AID2532, AID2538, AID2539, AID2541, AID2545, AID2556, AID2664, AID2752, AID2773, AID434992, AID434993, AID434997, AID435002, AID435009, AID435013, AID463255, AID488778, AID504381, AID504410] Panel member name: Biogenic amine transporter NET",PUBCHEM BIOASSAY DATA SET,,DATASET,
CHEMBL550401,HGAHRPAUWSBEBM-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,32,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL382673,HGBGXSPIBLZGHS-PXAZEXFGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,11,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL383706,HGBGXSPIBLZGHS-SJCJKPOMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,770,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL383706,HGBGXSPIBLZGHS-SJCJKPOMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,770,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL203331,HGBGXSPIBLZGHS-SJKOYZFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,310,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL204323,HGBGXSPIBLZGHS-YVEFUNNKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,310,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1076398,HGJXQBURQUDARU-YNBFDDPPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL2391541,HGRHWEAUHXYNNP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,IC50,=,42657.95,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2391541,HGRHWEAUHXYNNP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,KI,=,12008,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2391541,HGRHWEAUHXYNNP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]Nisoxetine from human recombinant norepinephrine transporter expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting analysis,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2391541,HGRHWEAUHXYNNP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26739781,Ki,<,10000,NM,,"","","","","","",,,,,,,,Binding affinity to NET (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2024089,HGSHFGWWOPXUPH-WHOFXGATSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22171543,INHIBITION,=,69.6,%,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from NET at 10 uM,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,PUBLICATION,
CHEMBL3323092,HGTGGWUXBQZEBH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,15,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL202644,HGUDCSBIBQSBGQ-BQAIUKQQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,160,NM,,"","","","","","",,,,,,,,Inhibition of [3H]NE uptake,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL202644,HGUDCSBIBQSBGQ-BQAIUKQQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,380,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL444540,HGUDCSBIBQSBGQ-GNAFDRTKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,103,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL30327,HGUFODBRKLSHSI-UHFFFAOYSA-N,"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL30327,HGUFODBRKLSHSI-UHFFFAOYSA-N,"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL149246,HGVLJGHVYCBNBB-UHFFFAOYSA-N,3-BENZHYDRYL-PYRIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12565962,KI,=,7320,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE uptake evaluated at the monoamine transporter (NET),Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1956107,HGVUTNMCDMGTOE-WOVMCDHWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22175766,IC50,=,4400,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells after 120 mins,"Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities.",J. Med. Chem.,PUBLICATION,
CHEMBL1956107,HGVUTNMCDMGTOE-WOVMCDHWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22175766,INHIBITION,=,86,%,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells at 10 uM after 120 mins,"Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities.",J. Med. Chem.,PUBLICATION,
CHEMBL429759,HGZVDXQCKWQIFI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,179,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL219146,HHJUWIANJFBDHT-KOTLKJBCSA-N,VINDESINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL219146,HHJUWIANJFBDHT-KOTLKJBCSA-N,VINDESINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1818443,HHRJGTNXMGSJLB-HZPDHXFCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,6.31,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL204254,HHSYAWUBPBEDMP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,9.4,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL204254,HHSYAWUBPBEDMP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,216,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL565593,HHZNTCLXZVSLGW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,4890,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL565593,HHZNTCLXZVSLGW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,2580,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL370110,HIBUHKNMTZCDMF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16219465,ACTIVITY,,,,Not Active,"","","","","","",,,,,,,,Inhibitory activity against NET upto 10 uM,Synthesis and SAR of highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drugs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL748,HIGSLXSBYYMVKI-UHFFFAOYSA-N,PRALIDOXIME CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL748,HIGSLXSBYYMVKI-UHFFFAOYSA-N,PRALIDOXIME CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2338042,HIKRIVCRSDESKA-LRDDRELGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,0.501,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2338043,HIKRIVCRSDESKA-MLGOLLRUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,1.26,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1645599,HJCOGULOEUQZGT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,198,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2407329,HJKCBQAEYYPLHW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,98,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1779058,HJKLOGARPBXZTP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1220,HJLSLZFTEKNLFI-UHFFFAOYSA-N,TINIDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1220,HJLSLZFTEKNLFI-UHFFFAOYSA-N,TINIDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2030623,HJOLMLNXMCFYQQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL427904,HKERIGVYOINJIO-KBXCAEBGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,2.9,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL594171,HKILKCVBPMXBMC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,INHIBITION,<,10,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1000 nM after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL520301,HKMJCOCCPVLYPB-BJUDXGSMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18487050,KI,=,2880,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL551935,HKMZTVMDWMICAE-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,72,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL456807,HKOOXMFOFWEVGF-UHFFFAOYSA-N,PHENYLHYDRAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL456807,HKOOXMFOFWEVGF-UHFFFAOYSA-N,PHENYLHYDRAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL566418,HKOVZQZDXNHYOJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,86,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566418,HKOVZQZDXNHYOJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,1800,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL3085027,HKWYFLNOIRZTIH-BWTSREIZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16213721,KI,=,997,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1454,HLFSDGLLUJUHTE-SNVBAGLBSA-N,LEVAMISOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1454,HLFSDGLLUJUHTE-SNVBAGLBSA-N,LEVAMISOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL513367,HLQQIEZMTRFYMO-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,5600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL115444,HLZHNRNWOPIWCL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11585444,IC50,=,3020,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine transporter,From hit to lead. Analyzing structure-profile relationships.,J. Med. Chem.,PUBLICATION,
CHEMBL338115,HMBHRMFLDKKSCT-UHFFFAOYSA-N,6-METHOXY-HARMALAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643338,KI,>,4100,NM,,"","","","","","",,,,,,,,Binding affinity towards NET,Binding of beta-carbolines at 5-HT(2) serotonin receptors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL602550,HMQMRPICUDGPQP-NSLUPJTDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,39,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL598560,HMSJPIAQQVBQMP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,247,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1830892,HMXOXSKENXHTKZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830892,HMXOXSKENXHTKZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,13,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL307314,HNCXDNKKOJCVCN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,IC50,=,487,NM,,"","","","","","",,,,,,,,Compound was tested for inhibition of [3H]NE binding to norepinephrine transporter HEK cells,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL307314,HNCXDNKKOJCVCN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,KI,=,830,NM,,"","","","","","",,,,,,,,Compound was tested for inhibition of [125I]-RTI-55 binding to norepinephrine transporter HEK cells,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL307314,HNCXDNKKOJCVCN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,RATIO,=,5.6,,,"","","","","","",,,,,,,,Selectivity ratio determined of Ki human Norepinephrine transporter to Ki human Serotonin transporter,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL307314,HNCXDNKKOJCVCN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,RATIO,=,10.99,,,"","","","","","",,,,,,,,Ratio of uptake inhibition to binding affinity to human NET (IC50/Ki),Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1411979,HNJJXZKZRAWDPF-UHFFFAOYSA-N,METHAPYRILENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1391,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1411979,HNJJXZKZRAWDPF-UHFFFAOYSA-N,METHAPYRILENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1380,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL283899,HNOKHIURIJOQKM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17391962,INHIBITION,=,15,%,,"","","","","","",,,,,,,,Inhibition of human NET at 1 uM,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2096859,HNVGNUVAMRLMSG-HXSCFSKGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,272,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL2096859,HNVGNUVAMRLMSG-HXSCFSKGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,136,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL218082,HNVGNUVAMRLMSG-JYVUQVBGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,37.4,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL218082,HNVGNUVAMRLMSG-JYVUQVBGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,23,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL224819,HNVGNUVAMRLMSG-SHWKFHJASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,32.4,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL224819,HNVGNUVAMRLMSG-SHWKFHJASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,16.2,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL557868,HNVLFSMNTLSQDR-RTWAWAEBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,91.9,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL402000,HNYCNSONMUNSQM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,18,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,IFOSFAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1024,HOMGKSMUEGBAAB-UHFFFAOYSA-N,IFOSFAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1094209,HOMRLSWXGFQYGM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20427184,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter at 1 uM,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683885,HOXBFDRIDWJAEN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,326,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL583676,HOYMQTQKCIHRHI-OALUTQOASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,INHIBITION,=,25,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL347336,HPHYXLXHERUQOH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,6200,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,LETROZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,LETROZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1076378,HPLIJTVQBQSTDD-ZWRUYHAFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL10316,HPMRFMKYPGXPEP-UHFFFAOYSA-N,IDAZOXAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,>,20000,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL866,HPNSFSBZBAHARI-RUDMXATFSA-N,MYCOPHENOLIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL866,HPNSFSBZBAHARI-RUDMXATFSA-N,MYCOPHENOLIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL558651,HPPVWRRONLIBLV-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,8,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643896,HPQILAIJSLHQQC-MLHJIOFPSA-N,RTI-229,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21146989,IC50,=,1728,NM,,"","","","","","",,,,,,,,Inhibition of NET,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310628,HQCGHDLCHPAWBG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,37,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL603920,HQJTZVWELLEYIW-VOMIJIAVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,17,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL420644,HQVQWOHDTVRIMI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,120,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL420644,HQVQWOHDTVRIMI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,249,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1644471,HQWOOKZKFBMBCD-PTEHBNRSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,54,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL155460,HQWVGYBVUZNQFB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,1900,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL1818547,HRCVSENKVJEEJB-GFOWMXPYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,50.12,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL385173,HRJQWACHSNEZEE-DBUDALRPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17154506,KI,=,31.7,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 labeled 2beta-carbomethoxy-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL258336,HRKLUXSFAYPUIK-CVEARBPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,1518,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL258336,HRKLUXSFAYPUIK-CVEARBPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,3789,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL258338,HRKLUXSFAYPUIK-JKSUJKDBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,1565,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1830883,HRZCVADZOIJDCK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,2304,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830883,HRZCVADZOIJDCK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,4310,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL432022,HSALZIQGHGTBLM-RYTUYPIVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,IC50,,,,Not Determined,"","","","","","",,,,,,,,In vitro ability of compound to inhibit NE re-uptake of radiolabeled [3H]-tritium transmitter into synaptosome; ND=not determined,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL432022,HSALZIQGHGTBLM-RYTUYPIVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,KI,=,316,NM,,"","","","","","",,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1085066,HSMMZWQHSZFBQK-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,22,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1085066,HSMMZWQHSZFBQK-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,64,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1082292,HSMMZWQHSZFBQK-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,155,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1082292,HSMMZWQHSZFBQK-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,294,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL425961,HSPJWADLPHSZQN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL980,HSRJKNPTNIJEKV-UHFFFAOYSA-N,GUAIFENESIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL980,HSRJKNPTNIJEKV-UHFFFAOYSA-N,GUAIFENESIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1083405,HSRUEFWMMBYMIL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,22,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL23,HSUGRBWQSSZJOP-RTWAWAEBSA-N,DILTIAZEM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL23,HSUGRBWQSSZJOP-RTWAWAEBSA-N,DILTIAZEM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL403571,HTBZTZYEMXZZLC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,42000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL605309,HTHJJCBRKUSTFT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,IC50,=,460,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL605309,HTHJJCBRKUSTFT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,428,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1491,HTIQEAQVCYTUBX-UHFFFAOYSA-N,AMLODIPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1491,HTIQEAQVCYTUBX-UHFFFAOYSA-N,AMLODIPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL504544,HTJVDZSETPCPGD-HKUYNNGSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,28,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430685,HTKNCQZCINRNGM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,1900,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430685,HTKNCQZCINRNGM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,56.9,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430685,HTKNCQZCINRNGM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,92,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1016,HTQMVQVXFRQIKW-UHFFFAOYSA-N,CANDESARTAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,3065.2,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1016,HTQMVQVXFRQIKW-UHFFFAOYSA-N,CANDESARTAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3039.8,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1939222,HTSQRRQNKJNSLH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22191331,INHIBITION,=,-10,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter at 10 uM by radioligand displacement assay,ADME-guided design and synthesis of aryloxanyl pyrazolone derivatives to block mutant superoxide dismutase 1 (SOD1) cytotoxicity and protein aggregation: potential application for the treatment of amyotrophic lateral sclerosis.,J. Med. Chem.,PUBLICATION,
CHEMBL1830882,HTXNJLFLQDPRHG-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,199,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830882,HTXNJLFLQDPRHG-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830881,HTXNJLFLQDPRHG-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,207,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830881,HTXNJLFLQDPRHG-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830880,HTXNJLFLQDPRHG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,74,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830880,HTXNJLFLQDPRHG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,147,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL232866,HTZRCXHILRRXTC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,2884000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL232866,HTZRCXHILRRXTC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL476312,HUGQKIWTNMQGCP-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL478622,HUGQKIWTNMQGCP-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,29,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684052,HULJRWTYZFVYPA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,5000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1521,HUNXMJYCHXQEGX-UHFFFAOYSA-N,ZALEPLON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1521,HUNXMJYCHXQEGX-UHFFFAOYSA-N,ZALEPLON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL342055,HUOXUHKHSINJFL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12565962,KI,=,393,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE uptake evaluated at the monoamine transporter (NET),Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL898,HUPFGZXOMWLGNK-UHFFFAOYSA-N,DIFLUNISAL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL898,HUPFGZXOMWLGNK-UHFFFAOYSA-N,DIFLUNISAL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1490,HWHLPVGTWGOCJO-UHFFFAOYSA-N,TRIHEXYPHENIDYL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1490,HWHLPVGTWGOCJO-UHFFFAOYSA-N,TRIHEXYPHENIDYL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1224025,HWJCHTVVHUINLQ-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,158.49,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224024,HWJCHTVVHUINLQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,12.59,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224024,HWJCHTVVHUINLQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,19.95,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL383422,HWLVSITUDAPLNE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16337793,IC50,>,100,NM,,"","","","","","",,,,,,,,Inhibitory activity against NET,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL198706,HWOCKNMBFVXGDK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,165,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL218894,HWQHDSKQNMHWMT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,410,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218894,HWQHDSKQNMHWMT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,1600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218894,HWQHDSKQNMHWMT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,3100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218894,HWQHDSKQNMHWMT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,16000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL1527608,HWXIGFIVGWUZAO-UHFFFAOYSA-N,DOXOFYLLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1527608,HWXIGFIVGWUZAO-UHFFFAOYSA-N,DOXOFYLLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL381127,HWYVHRCKBXGZLV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,235,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL381127,HWYVHRCKBXGZLV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,2600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL3355575,HXCSDXBLCTUKEB-BXWFABGCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25155913,INHIBITION,=,52,%,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) at 30 uM,Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1483,HXHWSAZORRCQMX-UHFFFAOYSA-N,ALBENDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1483,HXHWSAZORRCQMX-UHFFFAOYSA-N,ALBENDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3323091,HXJTYROTEDEIBT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,<,1,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3323091,HXJTYROTEDEIBT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,13.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323091,HXJTYROTEDEIBT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,20,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323091,HXJTYROTEDEIBT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,92.3,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323091,HXJTYROTEDEIBT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,20,NM,314406,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323091,HXJTYROTEDEIBT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,20,NM,314408,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL1824784,HXOMGUPFBWZKBK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21788137,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET transporter by NIMH PDSP,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1830884,HXPJUTFPDVBIKT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,30,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830884,HXPJUTFPDVBIKT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,54,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
,HXTGXYRHXAGCFP-UHFFFAOYSA-N,MDL 100907,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15999145,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1224093,HXVMFBSINMZKRO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,7.94,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL595,HYAFETHFCAUJAY-UHFFFAOYSA-N,PIOGLITAZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL595,HYAFETHFCAUJAY-UHFFFAOYSA-N,PIOGLITAZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL193,HYIMSNHJOBLJNT-UHFFFAOYSA-N,NIFEDIPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL193,HYIMSNHJOBLJNT-UHFFFAOYSA-N,NIFEDIPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL205028,HYMIOQDNASQILW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,2520,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL205028,HYMIOQDNASQILW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,4200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL107077,HYOCZQPMJUZYKD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10956218,KI,=,1992,NM,,"","","","","","",,,,,,,,In vitro binding affinity on cloned Norepinephrine transporter,"Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines.",J. Med. Chem.,PUBLICATION,
CHEMBL56367,HYWYRSMBCFDLJT-UHFFFAOYSA-N,NIMESULIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL56367,HYWYRSMBCFDLJT-UHFFFAOYSA-N,NIMESULIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2206533,HYXFPJJRAOYSTI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,16.5,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL487763,HYXMIUGYZHSSJS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,89,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL449235,HYXUARRYTJMRKQ-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,118,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL686,HYYBABOKPJLUIN-UHFFFAOYSA-N,MEFENAMIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL686,HYYBABOKPJLUIN-UHFFFAOYSA-N,MEFENAMIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL377057,HYYSFPWXVUOONL-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,26,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL11493,HZEVDVGPBUFIAW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9435902,KI,=,1330,NM,,"","","","","","",,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL1082459,HZFCYBLDOJMSFO-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,48,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1082459,HZFCYBLDOJMSFO-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,61,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1086035,HZFCYBLDOJMSFO-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,8,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1086035,HZFCYBLDOJMSFO-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,28,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL260131,HZHJKYFUXCEIEP-KBXCAEBGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,5.9,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3703745,HZPNLSFQNAKABD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1015,NM,302109,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL568350,HZPZVEJWTPAYPU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,2500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL270625,HZRDBNNJLUYHJA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18060777,KI,=,530,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673129,HZUHEVWACVPCEV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,443,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3673129,HZUHEVWACVPCEV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,816.6,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL190937,IAGCXXVAWFKIDP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15801845,KI,=,787.4,NM,,"",cell_based,"","","","",HEK293,,,,,,,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,PUBLICATION,
CHEMBL190937,IAGCXXVAWFKIDP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15974579,KI,=,303,NM,,"",cell_based,"","","","",,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,PUBLICATION,
CHEMBL190937,IAGCXXVAWFKIDP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18085744,KI,=,303,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET t expressed in HEK293 cells,"Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.",J. Med. Chem.,PUBLICATION,
CHEMBL458639,IAIACGGIZWXQIK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,23,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL458639,IAIACGGIZWXQIK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,2767,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL107,IAKHMKGGTNLKSZ-INIZCTEOSA-N,COLCHICINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL107,IAKHMKGGTNLKSZ-INIZCTEOSA-N,COLCHICINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1083425,IAMMWWXBTYJBCX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,40,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1079264,IAPNVLHDPZOUSQ-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,11,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257991,IASPBORHOMBZMY-UHFFFAOYSA-N,SRT-1720,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19199480,IC50,=,2470,NM,,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter,"Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators.",J. Med. Chem.,PUBLICATION,
CHEMBL344513,IAXQDXIYZZJWKO-MAUKXSAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,150,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL344513,IAXQDXIYZZJWKO-MAUKXSAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,310,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL145940,IAXQDXIYZZJWKO-YJBOKZPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,1100,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL145940,IAXQDXIYZZJWKO-YJBOKZPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,1800,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL504,IAZDPXIOMUYVGZ-UHFFFAOYSA-N,DIMETHYL SULFOXIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL504,IAZDPXIOMUYVGZ-UHFFFAOYSA-N,DIMETHYL SULFOXIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3310494,IBFDSAQZQXGCJT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,30,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL379496,IBJQKBDBQJHDOQ-KOXSSGOCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16821765,IC50,>,1000000,NM,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of rat NET-mediated norepinephrine uptake in CHO cells,Development of peptidic dopamine transporter inhibitors via aromatic modification-mediated conformational restriction.,J. Med. Chem.,PUBLICATION,
CHEMBL137020,IBKOZXQELVZJBY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213078,IC50,=,260,NM,,"","","","","","",,,,,,,,Compound was tested for the inhibition of norepinephrine (NE) reuptake,Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL137020,IBKOZXQELVZJBY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213078,RATIO,=,22,,,"","","","","","",,,,,,,,Ratio of IC50 value against Norepinephrine transporter (NE) to that of Dopamine transporter (DA),Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL452928,IBMMANZZPBFJNC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,1541,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL452928,IBMMANZZPBFJNC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,634,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3612825,IBNJJBGOQUDBKY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,IC50,=,267,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3612825,IBNJJBGOQUDBKY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.12,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL398370,IBOZZWGMZPMXBO-RQJABVFESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446069,KI,=,1.98,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"Synthesis and biological evaluation of 2beta,3alpha-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14613,IBOZZWGMZPMXBO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14971892,KI,=,7.5,NM,,"","","","","","",,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [3H]-nisoxatine radioligand,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL3215298,IBSREHMXUMOFBB-JFUDTMANSA-N,ABAMECTIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3215298,IBSREHMXUMOFBB-JFUDTMANSA-N,ABAMECTIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL534942,IBUZSMCHAASZTO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,19,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL534942,IBUZSMCHAASZTO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,50,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL608151,IBZJKEOJOGAMGJ-COPLHBTASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,IC50,=,0.158,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]noradrenalin reuptake at human NET expressed in LLCPK cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL608151,IBZJKEOJOGAMGJ-COPLHBTASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,0.501,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL608151,IBZJKEOJOGAMGJ-COPLHBTASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,1.58,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL608151,IBZJKEOJOGAMGJ-COPLHBTASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,0.501,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL608151,IBZJKEOJOGAMGJ-COPLHBTASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,0.501,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2164371,ICGMZCVSHDKQTE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22770500,INHIBITION,,,,Not Active,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter at 10 uM by radioligand binding assay,"3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain models.",J. Med. Chem.,PUBLICATION,
CHEMBL1200585,ICMWWNHDUZJFDW-DHODBPELSA-N,OXYMETHOLONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200585,ICMWWNHDUZJFDW-DHODBPELSA-N,OXYMETHOLONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2386917,ICTBPKWPCGSFPZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23622982,ACTIVITY,,,,Not Active,"","","","","","",,,,,,,,Binding affinity to human norepinephrine transporter by radioligand binding assay,"Discovery of 2-((1H-benzo[d]imidazol-1-yl)methyl)-4H-pyrido[1,2-a]pyrimidin-4-ones as novel PKM2 activators.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL579254,ICUSSYNHQDIHBC-CCRGXQTGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,=,129,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1173532,ICXJGCSEMJXNQF-ZIAGYGMSSA-N,"1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,IC50,=,2,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]noradrenalin reuptake at human NET expressed in pig LLCPK cells after 1 hr,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173532,ICXJGCSEMJXNQF-ZIAGYGMSSA-N,"1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,7.94,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173532,ICXJGCSEMJXNQF-ZIAGYGMSSA-N,"1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,12.02,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by SPA,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173532,ICXJGCSEMJXNQF-ZIAGYGMSSA-N,"1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,12.59,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173532,ICXJGCSEMJXNQF-ZIAGYGMSSA-N,"1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,125.89,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173532,ICXJGCSEMJXNQF-ZIAGYGMSSA-N,"1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,7.94,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL589086,ICYDUOWTRYFBOY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19926484,KI,=,8854,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL560050,ICZPNJDXXLLJEO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2047575,IDGXKCMPBMPCQQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,88,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1079265,IDJLHSSQHKZAPT-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,37,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL403090,IDPUQOWVIAMLNB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,11,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL139245,IDWDPGNSPWMIDM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,KI,=,78,NM,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432044,IDXFKHDXIHNWAI-RAOGCBAWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL826,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,ENOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL826,IDYZIJYBMGIQMJ-UHFFFAOYSA-N,ENOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL590472,IDZYJTXHWNKKBY-VIKVFOODSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,2.51,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL556888,IEAAUYDUGMCSHI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1078741,IECZTWNGAWLQAQ-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,43,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3663906,IEHDEVXKWOALDJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1400,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663906,IEHDEVXKWOALDJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,41400,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663906,IEHDEVXKWOALDJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,128000,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663906,IEHDEVXKWOALDJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,41400,NM,314399,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL566000,IELBAACIVCODPI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566000,IELBAACIVCODPI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566000,IELBAACIVCODPI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,2070,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL2106399,IEMDOFXTVAPVLX-YWQHLDGFSA-N,KITASAMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2106399,IEMDOFXTVAPVLX-YWQHLDGFSA-N,KITASAMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL337791,IEMZWXPJSYEEOM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,KI,=,81,NM,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2,IENZQIKPVFGBNW-UHFFFAOYSA-N,PRAZOSIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2,IENZQIKPVFGBNW-UHFFFAOYSA-N,PRAZOSIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1097470,IFCHBQFBWRMERT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,=,550,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1097470,IFCHBQFBWRMERT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,INH,=,73000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL446260,IFOBTLHRUXGTFC-RBUKOAKNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL475965,IFWGJAXMPXZADJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19146417,INHIBITION,<,10,%,,"","","","","","",,,,,,,,Inhibition of human NET at 1 uM,"The discovery of a selective, small molecule agonist for the MAS-related gene X1 receptor.",J. Med. Chem.,PUBLICATION,
CHEMBL1204009,IFWPZKFWNGLFCD-UFTMZEDQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821575,IC50,=,0.037,NM,,"","","","","","",,,,,,,,Inhibition of NET,Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,PUBLICATION,
CHEMBL153062,IGFHQQFPSIBGKE-UHFFFAOYSA-N,4-NONYLPHENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1254,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL153062,IGFHQQFPSIBGKE-UHFFFAOYSA-N,4-NONYLPHENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1244,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3309704,IGFZSDUARCFCFB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,39,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309704,IGFZSDUARCFCFB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309704,IGFZSDUARCFCFB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2326687,IGHNBPCIIFLLHN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,250,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL520970,IGIFNSQJPOGUFY-BJUDXGSMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18487050,KI,=,712,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL575700,IGKKFJKUWPDJDR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,104,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL563117,IGKPIVYFTICMLH-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256511,IGNDYXSKELQDJB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,246,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL210514,IGTBNUVMBDYPQG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16722655,KI,=,5090,NM,,"","","","","","",,,,,,,,Binding affinity to human NE transporter,"Discovery of a novel, orally active, small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.",J. Med. Chem.,PUBLICATION,
CHEMBL404317,IHBJHLUWGRKAPP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,26,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL219653,IHBJHYKTBCSULK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,310,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219653,IHBJHYKTBCSULK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,730,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219653,IHBJHYKTBCSULK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,1700,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219653,IHBJHYKTBCSULK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,2600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL196751,IHBSSBISPQPZFN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,17,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2326690,IHFKHNCURWJDHC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,46,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL471345,IHFKYJNUXPYFQN-GOSISDBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,INHIBITION,=,27,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1 uM,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL270642,IHHOPZQJPZTOOA-ZBFHGGJFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,525,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL179166,IHIXIJGXTJIKRB-UHFFFAOYSA-N,SODIUM ORTHOVANAD,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL179166,IHIXIJGXTJIKRB-UHFFFAOYSA-N,SODIUM ORTHOVANAD,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL264374,IIBYAHWJQTYFKB-UHFFFAOYSA-N,BEZAFIBRATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL264374,IIBYAHWJQTYFKB-UHFFFAOYSA-N,BEZAFIBRATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL923,IIDJRNMFWXDHID-UHFFFAOYSA-N,RISEDRONIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL923,IIDJRNMFWXDHID-UHFFFAOYSA-N,RISEDRONIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL401071,IIHVGQJVNJHAMA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,85000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL418971,IISBACLAFKSPIT-UHFFFAOYSA-N,BISPHENOL A,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,16620,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL418971,IISBACLAFKSPIT-UHFFFAOYSA-N,BISPHENOL A,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,16483,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1808425,IISCUUOMDCMADJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21724392,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 0.5 uM,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL513206,IIVGYQYUSCHDRA-LIAHKDQHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,>,2000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL479383,IJHSPFFWIXGDBB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18588282,INHIBITION,<,10,%,,"","","","","","",,,,,,,,Inhibition of human NET at 1 uM,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,PUBLICATION,
CHEMBL264418,IJMPFBJUROFOGZ-NVXWUHKLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,130,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL264680,IJMPFBJUROFOGZ-RDJZCZTQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,10,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2338046,IJNSXDVGJQEXPC-BDJLRTHQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,1,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2338045,IJNSXDVGJQEXPC-ZBEGNZNMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,0.794,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430680,IJNVPBUKXATNNR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,2033,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430680,IJNVPBUKXATNNR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,83,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430680,IJNVPBUKXATNNR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,89.2,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL446809,IJZRPGINHKPXPE-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,=,6,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL226335,IKGXIBQEEMLURG-NVPNHPEKSA-N,RUTIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12110997,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL2036270,IKMZLQWBQYJRNA-KBGJBQQCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,380,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL2036271,IKMZLQWBQYJRNA-ZGTDKVADSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,2800,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL1949930,IKXSPLZKOZXPFB-RQBPZYBGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22226656,IC50,=,4400,NM,,"","","","","","",,,,,,,,Inhibition of NA transporter,"Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: identification of a potent and selective 5-HT6 receptor antagonist showing activity in rat social recognition test.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1949930,IKXSPLZKOZXPFB-RQBPZYBGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22226656,INHIBITION,>,50,%,,"","","","","","",,,,,,,,Inhibition of NA transporter at 10 uM,"Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: identification of a potent and selective 5-HT6 receptor antagonist showing activity in rat social recognition test.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL258292,IKZQDEYILGZICZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,438,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL514515,ILKQBHSHNTVIIC-FQEVSTJZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,>,3000,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL476154,ILKQBHSHNTVIIC-HXUWFJFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,=,53,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL411677,ILKYNXUJXDGZRH-QFBILLFUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,17,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL274525,ILLGYRJAYAAAEW-QMMMGPOBSA-N,ABT-418,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,7518514,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL562854,ILOAMTJMRVQTSL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,42,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL595449,ILPANLYEJQKXKY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19646882,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3703726,ILPGXQBGCYEMTR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,47.3,NM,302090,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL451500,ILYANWOXFYOOPX-TUUXNKATSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,IC50,=,7441,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL451500,ILYANWOXFYOOPX-TUUXNKATSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,KI,=,7441,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL487874,ILZIENIHITYFQQ-AEPIDVSQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,347,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL233530,IMAGBMSOGGYLDK-CHWSQXEVSA-N,METHYL 2-PHENYLCYCLOHEXANECARBOXYLATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,1360000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL471035,IMESNXOOQNBNMN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,827,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL568372,IMHRUEORWKDPGA-GOSISDBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,6000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256557,IMHXBNROFRDAND-HNAYVOBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,3.5,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3334785,IMMKHFZNCWNBOD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,74.2,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1201146,IMONTRJLAWHYGT-ZCPXKWAGSA-N,NORETHINDRONE ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201146,IMONTRJLAWHYGT-ZCPXKWAGSA-N,NORETHINDRONE ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201151,IMSSROKUHAOUJS-MJCUULBUSA-N,MESTRANOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1382,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201151,IMSSROKUHAOUJS-MJCUULBUSA-N,MESTRANOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1371,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL574004,IMXJQWVQVSZOKO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,EC50,=,28,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL574004,IMXJQWVQVSZOKO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,18,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL428880,IMZMKUWMOSJXDT-UHFFFAOYSA-N,CROMOLYN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL428880,IMZMKUWMOSJXDT-UHFFFAOYSA-N,CROMOLYN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3310491,INAKZKQNNCSLRZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,37,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310491,INAKZKQNNCSLRZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310491,INAKZKQNNCSLRZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL506,INDBQLZJXZLFIT-UHFFFAOYSA-N,PRIMAQUINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL506,INDBQLZJXZLFIT-UHFFFAOYSA-N,PRIMAQUINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL567288,INDDCTQFCFNYFA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,1300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224492,INEHYFAMZQPYDY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,1,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224492,INEHYFAMZQPYDY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,2.51,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1642893,INFXKGQBKNZHOQ-GXTWGEPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,174,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642890,INFXKGQBKNZHOQ-JSGCOSHPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,124,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642892,INFXKGQBKNZHOQ-OCCSQVGLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,855,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642891,INFXKGQBKNZHOQ-TZMCWYRMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,731,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1076373,INIVRKBZJAJTGE-UUPYPVMGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL862,INJOMKTZOLKMBF-UHFFFAOYSA-N,GUANFACINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL862,INJOMKTZOLKMBF-UHFFFAOYSA-N,GUANFACINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2442940,INPPXFAIFVJMMD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24050790,INHIBITION,,,,Not Active,"","","","","","",,,,,,,,Binding affinity to human norepinephrine transporter at 10 uM by radioligand binding assay,"Identification of a novel benzoxazolone derivative as a selective, orally active 18 kDa translocator protein (TSPO) ligand.",J. Med. Chem.,PUBLICATION,
CHEMBL1087,INWLQCZOYSRPNW-UHFFFAOYSA-N,MEPIVACAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1087,INWLQCZOYSRPNW-UHFFFAOYSA-N,MEPIVACAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1830889,IODCZMRTDNJNCT-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,80,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830889,IODCZMRTDNJNCT-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,91,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL495210,IODDIRNVZLCLED-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,36.1,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL451620,IOEFEBQWPLLQHN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,30,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL378483,IOLBHHBTJKDZMF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,IC50,=,980,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL378483,IOLBHHBTJKDZMF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,KI,=,490,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL567467,IPBRKYZIBYMQNY-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,IC50,=,49,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL401069,IPCUDCIZXKOOCV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,26000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL614,IPEHBUMCGVEMRF-UHFFFAOYSA-N,PYRAZINAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL614,IPEHBUMCGVEMRF-UHFFFAOYSA-N,PYRAZINAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL214268,IPKZCLGGYKRDES-ZDUSSCGKSA-N,PHA-543613,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16821801,INHIBITION,<,10,%,,"","","","","","",,,,,,,,Inhibition of human NE transporter at 1 uM,"Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship.",J. Med. Chem.,PUBLICATION,
CHEMBL1201346,IPOKCKJONYRRHP-FMQUCBEESA-N,BALSALAZID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201346,IPOKCKJONYRRHP-FMQUCBEESA-N,BALSALAZID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2029821,IPTWXMISVLTMAV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22364337,ACTIVITY,>,50,%,,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter at 10 uM,"Discovery of 1,4-disubstituted 3-cyano-2-pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor.",J. Med. Chem.,PUBLICATION,
CHEMBL257603,IQIONMXYTYNILR-WCQYABFASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1644482,IQNGYWRUWKYNSE-GNXNZQSNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,222,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1502,IQPSEEYGBUAQFF-UHFFFAOYSA-N,PANTOPRAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1502,IQPSEEYGBUAQFF-UHFFFAOYSA-N,PANTOPRAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL67203,IQRFNUMAKGJEQR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,IC50,=,97,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL67203,IQRFNUMAKGJEQR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,KI,=,23,NM,,"","","","","","",,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL563060,IQUFPTOFVDDVOF-UXHICEINSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,>,1000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL603109,IQUWBNFDLZZVRR-VOMIJIAVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,19,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL445794,IQZVBBALTJFFCB-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,2900,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL469809,IQZVBBALTJFFCB-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,1200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL520035,IRDYKJUJFKVPBO-LIAHKDQHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,677,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2338047,IRFOFLZPBFIIGA-LRDDRELGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,1,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL493263,IRKCYPUGOBXCFU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,50,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310641,IRQADABOPVURIK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,65,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL182,IRSCQMHQWWYFCW-UHFFFAOYSA-N,GANCICLOVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL182,IRSCQMHQWWYFCW-UHFFFAOYSA-N,GANCICLOVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL214209,IRVGZJHWMUWHKA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,IC50,=,40,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL214209,IRVGZJHWMUWHKA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,KI,=,20,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL695,IRYJRGCIQBGHIV-UHFFFAOYSA-N,TRIMETHADIONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL695,IRYJRGCIQBGHIV-UHFFFAOYSA-N,TRIMETHADIONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL257809,ISKVOQJXBREYEF-ZANVPECISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,29,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL219334,ISSWMAXVWUPHQN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,330,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219334,ISSWMAXVWUPHQN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,3800,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219334,ISSWMAXVWUPHQN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,970,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219334,ISSWMAXVWUPHQN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,4300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL1762478,ISUTYHCEBNDJBQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21398123,IC50,=,7100,NM,,"","","","","","",,,,,,,,Inhibition of NET,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL333465,ISVBJSRQEBWKPB-SZPZYZBQSA-N,LOBELANE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15121762,KI,=,1800,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL14060,ISWSIDIOOBJBQZ-UHFFFAOYSA-N,PHENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL14060,ISWSIDIOOBJBQZ-UHFFFAOYSA-N,PHENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL526849,ISXTVMLLUKKPCR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18461921,KI,>,100000,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,PUBLICATION,
CHEMBL560536,ISYQRUPHFNFRMZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,63.1,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3593400,ITALTGDRMWXEDY-UOUQJYNVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,0.33,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL303494,ITEKLFIKJBIAEP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15080991,KI,=,3024,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity to norepinephrine (NE) transporter in membranes of cells selectively expressing the human genes for NET,Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL396540,ITHSRMGXDMLBTP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17391962,INHIBITION,=,99,%,,"","","","","","",,,,,,,,Inhibition of human NET at 1 uM,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1628648,ITJNARMNRKSWTA-RLXJOQACSA-N,[3H]NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17428804,BMAX,=,129.5,PMOL,,"",cell_based,"","","","",,,,,,,,Activity at human wild type NET expressed in african green monkey COS1 cells assessed per mg protein,chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.,J. Biol. Chem.,PUBLICATION,
CHEMBL1628648,ITJNARMNRKSWTA-RLXJOQACSA-N,[3H]NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17428804,KD,=,5.1,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity to human wild type NET expressed in african green monkey COS1 cells,chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.,J. Biol. Chem.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10411589,KI,=,4.21,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12620070,RATIO,=,0.05,,,"","","","","","",,,,,,,,Ratio of binding affinity between human norepinephrine transporter (NET) and human serotonin transporter (SERT),Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.,J. Med. Chem.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15456270,KI,=,1.6,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity for Norepinephrine transporter (NET) expressed in LCK PK1 cells,2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.,J. Med. Chem.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,83.7,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,15,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,15,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,=,6,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,6,NM,,"","","","","","",,,,,,,,Inhibition of norepinephrine reuptake at NET,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,LOGEC50,=,-8.99,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in COS7 cells assessed as inhibition of [3H]norepinephrine uptake,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,8.3,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,7.94,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,7.94,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,IC50,=,18,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,78,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,100,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,20,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,78,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL295467,ITJNARMNRKSWTA-UHFFFAOYSA-N,NISOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,92,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2407322,ITKQJLPIARUDPX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,18,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1813479,ITPUGBSWGNTRDI-SMDDNHRTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,6456.54,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1650,ITRJWOMZKQRYTA-RFZYENFJSA-N,CORTISONE ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1650,ITRJWOMZKQRYTA-RFZYENFJSA-N,CORTISONE ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2030622,ITUMTGGIBOPIJQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1836646,ITXRGZRPRZJEGV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21863888,KI,=,2900,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET receptor,Efficient Conversion of a Nonselective Norepinephrin Reuptake Inhibitor into a Dual Muscarinic Antagonist-ß(2)-Agonist for the Treatment of Chronic Obstructive Pulmonary Disease.,J. Med. Chem.,PUBLICATION,
CHEMBL467324,ITZFVZTXKPPHPP-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,110,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL378498,IUAVOMFUIPYCBG-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,6.1,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL13,IUBSYMUCCVWXPE-UHFFFAOYSA-N,METOPROLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL13,IUBSYMUCCVWXPE-UHFFFAOYSA-N,METOPROLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL499815,IUCNQFHEWLYECJ-CXCSZTQTSA-L,ATRACTYLOSIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL499815,IUCNQFHEWLYECJ-CXCSZTQTSA-L,ATRACTYLOSIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1258614,IUEKKZWRWOFGRT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20727749,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of norepinephrine receptor at 10 uM,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL141681,IUSCPVMMEKQANO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,KI,=,20,NM,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1836645,IUTQZHKFJYKMRH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21863888,KI,,,,Not Determined,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET receptor,Efficient Conversion of a Nonselective Norepinephrin Reuptake Inhibitor into a Dual Muscarinic Antagonist-ß(2)-Agonist for the Treatment of Chronic Obstructive Pulmonary Disease.,J. Med. Chem.,PUBLICATION,
CHEMBL1080788,IUTSKNRONKMGOS-QMMMGPOBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,95,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL127516,IUWVALYLNVXWKX-UHFFFAOYSA-N,BUTAMBEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL127516,IUWVALYLNVXWKX-UHFFFAOYSA-N,BUTAMBEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL702,IVBHGBMCVLDMKU-GXNBUGAJSA-N,PIPERACILLIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL702,IVBHGBMCVLDMKU-GXNBUGAJSA-N,PIPERACILLIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1076403,IVKLSMVTZWVITC-GLNHKFLLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL247538,IVMHSWRHRXAZNE-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,11,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310625,IWAFLTUMYXUBBH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,21,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173341,IWEJGKHITDGZSV-CABZTGNLSA-N,1-PHENYL-3-AZABICYCLO[4.1.0]HEPTANE (STRUCTURAL MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,63.1,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173341,IWEJGKHITDGZSV-CABZTGNLSA-N,1-PHENYL-3-AZABICYCLO[4.1.0]HEPTANE (STRUCTURAL MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,158.49,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173341,IWEJGKHITDGZSV-CABZTGNLSA-N,1-PHENYL-3-AZABICYCLO[4.1.0]HEPTANE (STRUCTURAL MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,398.11,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1087923,IWHDPHKISOJDMA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,200,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL229699,IWJUZLMNKAYNPQ-GNXKAVGDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,4870,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL229699,IWJUZLMNKAYNPQ-GNXKAVGDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,1630,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL1643,IWUCXVSUMQZMFG-AFCXAGJDSA-N,RIBAVIRIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1643,IWUCXVSUMQZMFG-AFCXAGJDSA-N,RIBAVIRIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL258451,IWUJCJJESBVFNA-HNAYVOBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,4,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1517,IWVCMVBTMGNXQD-PXOLEDIWSA-N,OXYTETRACYCLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1517,IWVCMVBTMGNXQD-PXOLEDIWSA-N,OXYTETRACYCLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL539716,IWVPGLLZAJONSB-UXHICEINSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,42.5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL539716,IWVPGLLZAJONSB-UXHICEINSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,90,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL3287653,IWWHJVANFFIWSJ-GNFJTHHVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24944746,INHIBITION,,,,Not Active,"",cell_based,"","","","",,,,,,,,"Inhibition of 2,5,6-[3H]-dopamine uptake at human NET expressed in African green monkey COS7 cells at 10 uM incubated for 10 mins prior to radioligand addition measured after 5 mins by scintillation counting analysis",Novel and high affinity fluorescent ligands for the serotonin transporter based on (s)-citalopram.,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL383734,IWWHZPZRJFBBJV-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,86,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1097146,IWXNUOQJTVYMHH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1097146,IWXNUOQJTVYMHH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,INH,=,54000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL470078,IWYMWKSOTYKSEE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,1452,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL470078,IWYMWKSOTYKSEE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,1376,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL258140,IXAZZNONZSLTKY-QUCCMNQESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,6688,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL272063,IXBHAYXQNHDHST-WBVHZDCISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,3776,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201237,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,LEVOBUNOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201237,IXHBTMCLRNMKHZ-LBPRGKRZSA-N,LEVOBUNOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL198463,IXHFUNSVBJAYHP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16219465,ACTIVITY,,,,Not Active,"","","","","","",,,,,,,,Inhibitory activity against NET upto 10 uM,Synthesis and SAR of highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drugs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL234128,IXOXSNBFVBNEKC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,2110000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL234128,IXOXSNBFVBNEKC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL206521,IXXMPCPWTWLRBY-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16413778,KI,=,11.9,NM,,"","","","","","",,,,,,,,Binding affinity to NET,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224400,IYHIZUCENFBTJG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,3.16,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224400,IYHIZUCENFBTJG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,6.31,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL633,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,AMIODARONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2271,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL633,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,AMIODARONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2252,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL219540,IYNBYQDXVFMDGE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,220,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219540,IYNBYQDXVFMDGE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,2700,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL559147,IYOZTVGMEWJPKR-IJLUTSLNSA-N,Y-27632,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL559147,IYOZTVGMEWJPKR-IJLUTSLNSA-N,Y-27632,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3317699,IYQPFLICRCNMTK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25017029,IC50,=,3200,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224225,IYTKIEQZFQYQAC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,12,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL504231,IYTYICIRVUHWDC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,16,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1818544,IYUTUTQAPBTSKQ-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,398.11,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL603495,IYXFYMMSRUEOGZ-BHDTVMLSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,150,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1743259,IZBNNCFOBMGTQX-UHFFFAOYSA-N,ETOPERIDONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL932,IZEKFCXSFNUWAM-UHFFFAOYSA-N,DIPYRIDAMOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL932,IZEKFCXSFNUWAM-UHFFFAOYSA-N,DIPYRIDAMOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL562767,IZHREGYJHUWQHR-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,56,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL486042,IZIPWOZWZWBTMH-FOYRJYEQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,840,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL470690,IZMZEMAKFSYLMD-KHQMHLGISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,1030,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL604685,IZXAGSUHTCPYKG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,IC50,=,707,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL604685,IZXAGSUHTCPYKG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,1030,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL466670,IZYQNPOIOLPIRC-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,156,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310485,JAJZURBQJLCEQE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,14.6,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310485,JAJZURBQJLCEQE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310485,JAJZURBQJLCEQE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310485,JAJZURBQJLCEQE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310485,JAJZURBQJLCEQE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,RATIO IC50,>,7,,,"",cell_based,"","","","",,,,,,,,Ratio of duloxetine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310485,JAJZURBQJLCEQE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,RATIO IC50,>,7,,,"",cell_based,"","","","",,,,,,,,Ratio of venlafaxine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL559081,JAKBXJLCBFHUQX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,14,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL559081,JAKBXJLCBFHUQX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,17,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL559081,JAKBXJLCBFHUQX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,220,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2397268,JAKRIQWSQWQJHM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23627311,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter (unknown origin) at 5 uM by psychoactive drug screening programme assay,Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-methyl-D-aspartate receptors.,J. Med. Chem.,PUBLICATION,
CHEMBL204005,JAPHVUWBEYMUCG-ZBEGNZNMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,880,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL611960,JAUMZHMWXNWFKB-PYNNCUBPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,180,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1172,JAUOIFJMECXRGI-UHFFFAOYSA-N,DESLORATADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1116,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1172,JAUOIFJMECXRGI-UHFFFAOYSA-N,DESLORATADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1107,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL565386,JBABGZDZOMSKLX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL565386,JBABGZDZOMSKLX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL565386,JBABGZDZOMSKLX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,>,100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL153479,JBDGDEWWOUBZPM-XYPYZODXSA-N,AMBROXOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL153479,JBDGDEWWOUBZPM-XYPYZODXSA-N,AMBROXOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1381098,JBDOSUUXMYMWQH-UHFFFAOYSA-N,1-NAPHTHYLISOTHIOCYANATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1381098,JBDOSUUXMYMWQH-UHFFFAOYSA-N,1-NAPHTHYLISOTHIOCYANATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1433,JBIWCJUYHHGXTC-AKNGSSGZSA-N,DOXYCYCLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1433,JBIWCJUYHHGXTC-AKNGSSGZSA-N,DOXYCYCLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL605089,JBNMIXNIEIEPSS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,IC50,=,1092,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL605089,JBNMIXNIEIEPSS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,1130,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL477573,JBTZQUNHYUVAIK-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,96,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL998,JCCNYMKQOSZNPW-UHFFFAOYSA-N,LORATADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL998,JCCNYMKQOSZNPW-UHFFFAOYSA-N,LORATADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL154945,JCEBKNUYKMFQGZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,1100,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL233088,JCGZOWXIYHYCOD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,4720,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL233088,JCGZOWXIYHYCOD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,15000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,CHLORAMBUCIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL515,JCKYGMPEJWAADB-UHFFFAOYSA-N,CHLORAMBUCIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL101168,JCXKHYLLVKZPKE-UHFFFAOYSA-N,1-AMINOBENZOTRIAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL101168,JCXKHYLLVKZPKE-UHFFFAOYSA-N,1-AMINOBENZOTRIAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL138195,JCYQFYGFKORSIY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,INHIBITION,=,25.5,%,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1812545,JDBSZVDIUIRSDG-DAFODLJHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21726069,INHIBITION,<,10,%,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NE transporter at 10 uM relative to control,"Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.",J. Med. Chem.,PUBLICATION,
CHEMBL3703748,JDEHEODNVULATB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,51,NM,302112,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL1643899,JDFBBZLNLYXHDC-CAUKCHDASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21146989,KI,=,5883,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK cells,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643899,JDFBBZLNLYXHDC-CAUKCHDASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,KI,=,5883,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL463000,JDGKZYSACWLQKT-RBRZPYPVSA-N,POLYGALATENOSIDE A,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16989524,IC50,=,30000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in MDCK cell membrane,Antidepressant principles of the roots of Polygala tenuifolia.,J. Nat. Prod.,PUBLICATION,
CHEMBL3334798,JDOZNEHOYKLUQH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,IC50,=,633.5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL194960,JDYWZWHJMGYGFK-SKDRFNHKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1078074,JEEXCFPOFSQJAA-NSHDSACASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,26,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1455766,JEJWQCTZDAJWOX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24690494,KI,<,1000,NM,,"","","","","","",,,,,,,,Binding affinity to NET (unknown origin),Antagonists of the kappa opioid receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL229436,JERGWFJDGWCPDJ-GNXKAVGDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,1550,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL229436,JERGWFJDGWCPDJ-GNXKAVGDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,1970,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL552341,JEUQNCNSWGGZRH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,79.43,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL403251,JEYCKWDBZTXTRQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,74,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL403251,JEYCKWDBZTXTRQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,22,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1808433,JEZVWAQXXDFILV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21724392,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 0.5 uM,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1170213,JFCGNEFWNWVNQD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,316.23,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430700,JFHFWAQIJRRGSM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,1187,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430700,JFHFWAQIJRRGSM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,49.6,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430700,JFHFWAQIJRRGSM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,91,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL290106,JFIOVJDNOJYLKP-UHFFFAOYSA-N,BITHIONOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1235,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL290106,JFIOVJDNOJYLKP-UHFFFAOYSA-N,BITHIONOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1225,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3613156,JFNSLRXMKOYKGO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,0.83,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL350692,JFXXREWKFGYUCE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,1300,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL3309701,JFZWFXQVYNCLJA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,33.5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309701,JFZWFXQVYNCLJA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,90,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309701,JFZWFXQVYNCLJA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309701,JFZWFXQVYNCLJA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309701,JFZWFXQVYNCLJA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,RATIO IC50,>,7,,,"",cell_based,"","","","",,,,,,,,Ratio of duloxetine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309701,JFZWFXQVYNCLJA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,RATIO IC50,>,7,,,"",cell_based,"","","","",,,,,,,,Ratio of venlafaxine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL252556,JGPMMRGNQUBGND-UHFFFAOYSA-N,IDEBENONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL252556,JGPMMRGNQUBGND-UHFFFAOYSA-N,IDEBENONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1644608,JGPRTHDFGZBWFN-IZZQQSIFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,5,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL29,JGSARLDLIJGVTE-MBNYWOFBSA-N,BENZYLPENICILLIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL29,JGSARLDLIJGVTE-MBNYWOFBSA-N,BENZYLPENICILLIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL419728,JGWXNVMXDBFNMX-KRCSLNALSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10698458,IC50,=,23,NM,,"",cell_based,"","","","",,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL542746,JGYZGTZUFGVWMT-YYLIZZNMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,12500,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2047564,JGZNMAIDTSSPBU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,83,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1224161,JHBXYVBNWXENQD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,25.12,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432056,JHFKLSFCMAHSDK-LLOIJXFCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL469459,JHIFTPLQHSGJLO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,600,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL469459,JHIFTPLQHSGJLO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,514,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL255957,JHJNQSMDFYVXBO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,157,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL576758,JHNQGHUWSOJCOC-UXHICEINSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,10,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200679,JIAARYAFYJHUJI-UHFFFAOYSA-L,ZINC CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,7008.3,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200679,JIAARYAFYJHUJI-UHFFFAOYSA-L,ZINC CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,6950.4,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL493027,JIIHYINDBVZYIB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,9200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL325669,JIMSUICOCSIKLE-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15177457,KI,=,235500,NM,,"","","","","","",,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter; Average of two experiments,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL396318,JINIYXOBIKXUET-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,85000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL396318,JINIYXOBIKXUET-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL512551,JIQNPRNQHOWEMG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,19,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL336940,JIVIBEFNFXNPFI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,IC50,=,4.7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL336940,JIVIBEFNFXNPFI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,KI,=,6.8,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL1055,JIVPVXMEBJLZRO-UHFFFAOYSA-N,CHLORTHALIDONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1055,JIVPVXMEBJLZRO-UHFFFAOYSA-N,CHLORTHALIDONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL104673,JJAUMTXFZLAGOI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10956218,KI,=,1205,NM,,"","","","","","",,,,,,,,In vitro binding affinity on cloned Norepinephrine transporter,"Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines.",J. Med. Chem.,PUBLICATION,
CHEMBL516,JJCFRYNCJDLXIK-UHFFFAOYSA-N,CYPROHEPTADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15081025,KI,=,290,NM,,"","","","","","",,,,,,,,Binding affinity towards Norepinephrine transporter using [3H]nisoxitine as radioligand,"Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL516,JJCFRYNCJDLXIK-UHFFFAOYSA-N,CYPROHEPTADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,564,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL516,JJCFRYNCJDLXIK-UHFFFAOYSA-N,CYPROHEPTADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,559,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL378379,JJMNVQSTRSYLOB-UGSOOPFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,440,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2030627,JJTSIVODPMDGBG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3593398,JJVNHIVTHFANPP-KATIXKQHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,12,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL406156,JJVUOKFSHYKOJS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,150,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL493476,JKBJIWKBKAEYBB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,3100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1006,JKOQGQFVAUAYPM-UHFFFAOYSA-N,AMIFOSTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1006,JKOQGQFVAUAYPM-UHFFFAOYSA-N,AMIFOSTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1684043,JKRXUDRMEIXFBV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,120,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1083211,JLHRDEJKVFNGBV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,30,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL443,JLKIGFTWXXRPMT-UHFFFAOYSA-N,SULFAMETHOXAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL443,JLKIGFTWXXRPMT-UHFFFAOYSA-N,SULFAMETHOXAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL470082,JLLXWYHRIUISMQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,94,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL470082,JLLXWYHRIUISMQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,58,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1083707,JLTIELDULXFJCW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,340,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL599608,JLWSMMAHZFKYJR-URBRKQAFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,9.7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL194205,JMCFSRJDUZTPRD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,44,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL522707,JMKKUONSGMKXDD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,12.6,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL411033,JMLINUIVZHMJBT-GCZMORHFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,20,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1076372,JMMANJJHPYIIKO-WBFXVXKESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL500629,JMOZPPPEEGAIOO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL12131,JMPFSEBWVLAJKM-UHFFFAOYSA-N,CLOSANTEL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL12131,JMPFSEBWVLAJKM-UHFFFAOYSA-N,CLOSANTEL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1076400,JMXYLTXGYKFHEY-AFYXJIINSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL498482,JMYADEOPJFRDDM-OALUTQOASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,39,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL498120,JMYADEOPJFRDDM-RTBURBONSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,27,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL478833,JNLWAWMHYQYRKA-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,34,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL605209,JNLXUEPMJIMNHM-JMSVASOKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,0.251,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL602235,JNLXUEPMJIMNHM-SLEUVZQESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,0.398,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL602235,JNLXUEPMJIMNHM-SLEUVZQESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,199.53,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL437,JNMRHUJNCSQMMB-UHFFFAOYSA-N,SULFATHIAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL437,JNMRHUJNCSQMMB-UHFFFAOYSA-N,SULFATHIAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1540,JNTOCHDNEULJHD-UHFFFAOYSA-N,PENCICLOVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1540,JNTOCHDNEULJHD-UHFFFAOYSA-N,PENCICLOVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL205025,JNVMCWLQXGNYMA-JCOPYZAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,440,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL383682,JNVMCWLQXGNYMA-LNLSOMNWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,330,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL132955,JOBHARMVZDXCRY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,IC50,=,10,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL132955,JOBHARMVZDXCRY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,KI,=,40,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL507806,JOHKRZVJVWMMNT-LRDDRELGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954038,IC50,=,13,NM,,"",cell_based,"","","","",HEK293,,,,,,,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter","Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL2204360,JOJYHYRCIYAVHN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21486038,INHIBITION,=,88,%,,"","","","","","",,,,,,,,Inhibition of human NET at 1 uM,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,PUBLICATION,
CHEMBL322067,JOQQHMGSIKNGAF-HLFYOVGASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,IC50,=,22,NM,,"","","","","","",,,,,,,,In vitro inhibition of [3H]NE re-uptake into synaptosome,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL322067,JOQQHMGSIKNGAF-HLFYOVGASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,KI,=,44,NM,,"","","","","","",,,,,,,,Compound was tested for its ability to displace [3H]citalopram from norepinephrine transporter,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL173861,JOQQHMGSIKNGAF-NXDIHJKXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21146989,KI,=,44,NM,,"","","","","","",,,,,,,,Inhibition of NET,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL523146,JOQTYFCRRMFQJX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18782666,IC50,>,10,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. Part 3: Site-directed metabolism as a strategy to avoid active circulating metabolites: structure-activity relationships of (thioalkyl)phenoxy benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224468,JORAUIMOUGISHQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,20,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL462547,JOYRKODLDBILNP-UHFFFAOYSA-N,URETHANE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL462547,JOYRKODLDBILNP-UHFFFAOYSA-N,URETHANE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL270366,JPMSOQZFFUMLIX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,951,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL457655,JPRQFPVEGGQSSX-CLDCJMNLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,1460,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL1940404,JPTSMZMSIACDAD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25070422,KI,=,3959,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL560049,JPUDXOCAZQSFHB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,215,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1076384,JQMZORXHAOQOMZ-HVHKLXTMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL569699,JQNSRSIGKZYQAA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,8700,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL569699,JQNSRSIGKZYQAA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,5700,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL386223,JQQRBSOAFDAWGZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1818462,JQQXRQMPNKINQO-WOJBJXKFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,50.12,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1885748,JQSJAVBMIMDUFO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23642479,INHIBITION,=,59,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter at 10 uM relative to control,Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3334793,JQUXSYNGQWDWDG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,IC50,=,1456.3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL374478,JQXXHWHPUNPDRT-WLSIYKJHSA-N,RIFAMPICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL374478,JQXXHWHPUNPDRT-WLSIYKJHSA-N,RIFAMPICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL202410,JREHJCKVQXOMFL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,88,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL202410,JREHJCKVQXOMFL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,1400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL3663915,JRMIJYKTHQCXEO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,4.3,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663915,JRMIJYKTHQCXEO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,24.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663915,JRMIJYKTHQCXEO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,>,1000,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663915,JRMIJYKTHQCXEO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,24.5,NM,314418,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL260039,JRNAGNLSMXSNPN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL578610,JRPWUGPYWRJACU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL578610,JRPWUGPYWRJACU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL578610,JRPWUGPYWRJACU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,6480,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL3323104,JRUNWUCFSINWFW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,11,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3323104,JRUNWUCFSINWFW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,11.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323104,JRUNWUCFSINWFW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,29.4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323104,JRUNWUCFSINWFW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,180,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323104,JRUNWUCFSINWFW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,11.5,NM,314425,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL926,JRWZLRBJNMZMFE-UHFFFAOYSA-N,DOBUTAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,383,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL926,JRWZLRBJNMZMFE-UHFFFAOYSA-N,DOBUTAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,380,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1592,JSDRRTOADPPCHY-HSQYWUDLSA-N,QUINAPRIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1592,JSDRRTOADPPCHY-HSQYWUDLSA-N,QUINAPRIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL566586,JSKNQLMFNCOKRW-PMACEKPBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,INHIBITION,=,13,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL206211,JSMCJJAIEPJIIJ-UGSOOPFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,2100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3085033,JSMMTOCSBNIMIR-AERCQKQUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16213721,KI,=,8410,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1110,JSWZEAMFRNKZNL-UHFFFAOYSA-N,ALOSETRON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1110,JSWZEAMFRNKZNL-UHFFFAOYSA-N,ALOSETRON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1078312,JSYQQBKBYKJHAO-VIFPVBQESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,217,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL198215,JTBUWXHKRDNJAX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,43,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL411921,JTCQOAITNDJYSA-HKUYNNGSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,12,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL258930,JTCQOAITNDJYSA-IEBWSBKVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,350,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL545557,JTDIXQXYTWHVIP-IDVLALEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,55,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL260036,JTDKALUSBWIJPG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,25,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL141,JTEGQNOMFQHVDC-NKWVEPMBSA-N,LAMIVUDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL141,JTEGQNOMFQHVDC-NKWVEPMBSA-N,LAMIVUDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL515936,JTFGLXWULCGHRY-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL505431,JTGBYRRUQUQVJF-UFADHCMUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,IC50,=,957,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL505431,JTGBYRRUQUQVJF-UFADHCMUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,KI,=,1748,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL411263,JTLPJEXKDFZLAY-HKUYNNGSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17983754,KI,=,1,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1683871,JTOBXLVKTKGLSL-UHFFFAOYSA-N,"(1-(3,4-DICHLOROPHENYL)CYCLOHEXYL)METHANAMINE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,273,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL517978,JTVKAFWSBOMWKU-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,18,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL84158,JTVPZMFULRWINT-UHFFFAOYSA-N,TIAPRIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL84158,JTVPZMFULRWINT-UHFFFAOYSA-N,TIAPRIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1537,JTWOMNBEOCYFNV-NFFDBFGFSA-N,AZLOCILLIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1537,JTWOMNBEOCYFNV-NFFDBFGFSA-N,AZLOCILLIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL611367,JTZODQOWHKXAGE-HALDLXJZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,3.98,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL257130,JUESHDJIQYYBKK-SJCJKPOMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,150,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL512189,JUFVWXGWKDEQTH-RRIHMMEISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,466,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1813312,JUHGVUXNNZSORA-LPHOPBHVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,416.87,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813312,JUHGVUXNNZSORA-LPHOPBHVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,>,10000,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813318,JUHGVUXNNZSORA-VQIMIIECSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,204.17,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL220195,JUKMAYKVHWKRKY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,10,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL220195,JUKMAYKVHWKRKY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,190,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL220195,JUKMAYKVHWKRKY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,14,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL220195,JUKMAYKVHWKRKY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,4200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL1722,JUMYIBMBTDDLNG-UHFFFAOYSA-N,METHYLPHENIDATE HYDROCHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15828826,IC50,=,51,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake in HEK293 cells expressing human norepinephrine transporter,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,PUBLICATION,
CHEMBL1722,JUMYIBMBTDDLNG-UHFFFAOYSA-N,METHYLPHENIDATE HYDROCHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15828826,IC50,=,788,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK293 cells,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,PUBLICATION,
CHEMBL429023,JUVIOZPCNVVQFO-HBGVWJBISA-N,ROTENONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL429023,JUVIOZPCNVVQFO-HBGVWJBISA-N,ROTENONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2203551,JUWUZLUBIRHYMM-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,EFFICACY,=,95.9,%,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET at 10 uM after 1.5 hrs by microbeta scintillation counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2203551,JUWUZLUBIRHYMM-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,203,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET after 1.5 hrs by microbeta scintillation counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL1095367,JVDABEHLVBLHMY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,170,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1645602,JVFNBOUZKYZEJE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,482,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2030625,JVHYCBRRZUMPEJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673175,JVICAIHCMVKYNI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,540.9,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL566240,JVIKPFIJPCEZJS-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,357,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200559,JVTAAEKCZFNVCJ-UHFFFAOYSA-N,LACTIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200559,JVTAAEKCZFNVCJ-UHFFFAOYSA-N,LACTIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL459332,JVTAHMMQYMBPEN-IYIFBUTFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,2040,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL2036265,JVVOHDBHFSMSNA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,1300,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL1670,JWBOIMRXGHLCPP-UHFFFAOYSA-N,MITOTANE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,819,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1670,JWBOIMRXGHLCPP-UHFFFAOYSA-N,MITOTANE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,812,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2047565,JWEVRDWOVZZPKU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,82,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL631,JWHAUXFOSRPERK-UHFFFAOYSA-N,PROPAFENONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,3016,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL631,JWHAUXFOSRPERK-UHFFFAOYSA-N,PROPAFENONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2991,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL345442,JWHRWJZJTWFYRA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,750,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL2171416,JWNKMCJAUXMBAD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,IC50,=,12,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2171416,JWNKMCJAUXMBAD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,87,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL596795,JWSCWFWSMYRJBE-PSOPSSQASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,19.95,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1084311,JWVNRZQALLUPMN-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,100,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1084311,JWVNRZQALLUPMN-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,109,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1084312,JWVNRZQALLUPMN-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,18,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1084312,JWVNRZQALLUPMN-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,19,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL434,JWZZKOKVBUJMES-UHFFFAOYSA-N,ISOPROTERENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL434,JWZZKOKVBUJMES-UHFFFAOYSA-N,ISOPROTERENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1224319,JXIHZLYRWFFHPQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,6.31,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL159,JXLYSJRDGCGARV-CFWMRBGOSA-N,VINBLASTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL159,JXLYSJRDGCGARV-CFWMRBGOSA-N,VINBLASTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL457635,JXMNHUDMPQBBLE-BAEQUSMLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,1230,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL566208,JYBXLCIZWPNCMU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,135,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566208,JYBXLCIZWPNCMU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,2240,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566208,JYBXLCIZWPNCMU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,389,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL389621,JYGXADMDTFJGBT-VWUMJDOOSA-N,HYDROCORTISONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL389621,JYGXADMDTFJGBT-VWUMJDOOSA-N,HYDROCORTISONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2047571,JYIMWQCCVNSNJW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,IC50,=,420,NM,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL258291,JZCIRLJPOBBVMR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,159,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL448897,JZFGPXKITYCBJZ-CVEARBPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,550,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL63323,JZFPYUNJRRFVQU-UHFFFAOYSA-N,NIFLUMIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL63323,JZFPYUNJRRFVQU-UHFFFAOYSA-N,NIFLUMIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2047573,JZHYJRPFUZJBQH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,IC50,=,265,NM,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL454770,JZKRUQHCKJXZSS-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310627,JZLLVPLMTCNSLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,13,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL117405,JZQKKSLKJUAGIC-NSHDSACASA-N,S(-)-PINDOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL117405,JZQKKSLKJUAGIC-NSHDSACASA-N,S(-)-PINDOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL500,JZQKKSLKJUAGIC-UHFFFAOYSA-N,PINDOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL500,JZQKKSLKJUAGIC-UHFFFAOYSA-N,PINDOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL435,JZUFKLXOESDKRF-UHFFFAOYSA-N,HYDROCHLOROTHIAZIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL435,JZUFKLXOESDKRF-UHFFFAOYSA-N,HYDROCHLOROTHIAZIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1812741,JZWBQZKHNDUSFQ-XFKSJGNHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21058665,IC50,=,11,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,PUBLICATION,
CHEMBL197643,JZXQQBOUEFCSBP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,21,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1818442,KAGBHVBIOJBGBD-NINOIYOQSA-N,AMITIFADINE HYDROCHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,63.1,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1818442,KAGBHVBIOJBGBD-NINOIYOQSA-N,AMITIFADINE HYDROCHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,IC50,=,71,NM,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL589177,KARYRXNBSOIGJH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19926484,KI,>,500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL443090,KATOUFNMRLTTPE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,8400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL245687,KAVHHDMCLXFYPS-NRFANRHFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,12,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL245687,KAVHHDMCLXFYPS-NRFANRHFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,IC50,=,12,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432048,KBAKPEFQDPCCTP-RAOGCBAWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL611970,KBCFUZMHKDDBCJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,INHIBITION,<,10,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1000 nM after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL270151,KBHALIJUSMYPCR-AFWDCEBSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18243691,INHIBITION,=,64,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,"Potent, selective MCH-1 receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337593,KBLODNDMWLXBEK-RHSMWYFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,10,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337592,KBLODNDMWLXBEK-YOEHRIQHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,3.98,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL504479,KCCUCFUQSYGPBH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19492813,IC50,=,300,NM,,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter,Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,PUBLICATION,
CHEMBL467512,KCFUXTYNOWCQBR-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,400,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1645619,KCIORJWXNLIEPL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,73,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL187093,KCKIWWYHRZPHRB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15380202,INHIBITION,=,68,%,,"","","","","","",,,,,,,,Inhibitory activity against Norepinephrine transporter at 10 uM,4-Acylamino-and 4-ureidobenzamides as melanin-concentrating hormone (MCH) receptor 1 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1196,KCLANYCVBBTKTO-UHFFFAOYSA-N,PROPARACAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1196,KCLANYCVBBTKTO-UHFFFAOYSA-N,PROPARACAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL539050,KCLIFHPTVWHVGF-GUTACTQSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,44,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1083428,KCQQWPYAESYXHU-GFCCVEGCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,6,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1083428,KCQQWPYAESYXHU-GFCCVEGCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,9,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1083429,KCQQWPYAESYXHU-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,2,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1083429,KCQQWPYAESYXHU-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1642897,KDERKEZKMQCRPQ-DZGCQCFKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,73,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642897,KDERKEZKMQCRPQ-DZGCQCFKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21095126,IC50,=,73,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant norepinephrine transporter,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1642896,KDERKEZKMQCRPQ-HIFRSBDPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,45,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642895,KDERKEZKMQCRPQ-UKRRQHHQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,117,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642894,KDERKEZKMQCRPQ-ZFWWWQNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,27,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL577612,KDLATVNCFJVLBE-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,527,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1753,KDLRVYVGXIQJDK-AWPVFWJPSA-N,CLINDAMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1753,KDLRVYVGXIQJDK-AWPVFWJPSA-N,CLINDAMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1215761,KDRRURQANSXWJL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23168018,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine uptake at human NET expressed in COS7 cells after 5 mins by beta-counting,A rhodamine-labeled citalopram analogue as a high-affinity fluorescent probe for the serotonin transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430689,KECBOARJOOAZSP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,3570,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430689,KECBOARJOOAZSP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,74,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430689,KECBOARJOOAZSP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,82.3,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3334797,KEGBICCDHKITSP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,IC50,=,477.5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL3334797,KEGBICCDHKITSP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,96.7,%,,"","","","","","",,,,,,,,Displacement of [3H]Imipramin from human NET at 10 uM relative to control,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1813308,KEIRMFURGIUOGY-SWLSCSKDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,2344.23,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL3334789,KEQMEADCNMBAIF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,29.3,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1086220,KEQORMMUOMSYLY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,481,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL3640036,KESMMXPCOOCEDA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,25,NM,317707,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL3640036,KESMMXPCOOCEDA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,4728,NM,317695,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL575714,KETAEAPLSWORIE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,80,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3593274,KETAPAGKHJIKAN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,2.1,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL132683,KFDFKTMFADMFFP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14592523,IC50,=,122,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake in HEK cells expressing human NET,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL132683,KFDFKTMFADMFFP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14592523,IC50,=,173,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake in HEK cells expressing human NET,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL132683,KFDFKTMFADMFFP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14592523,KI,=,2960,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL132683,KFDFKTMFADMFFP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14592523,KI,=,3060,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL450907,KFFYQORCJDVDTB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,1930,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL450907,KFFYQORCJDVDTB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,5133,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL450907,KFFYQORCJDVDTB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,10600,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL450907,KFFYQORCJDVDTB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,30430,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL450907,KFFYQORCJDVDTB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,IC50,=,1930,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL450907,KFFYQORCJDVDTB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,KI,=,10600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL1080926,KFUNLUIORXHBPH-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20137933,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256021,KGCAQBRBCVWBSF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,960,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL401878,KGLPNVVDPAVWHX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL381256,KGRXCESVCIYMSX-IMMIMJPRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,947,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL206128,KGRXCESVCIYMSX-OVWBULDYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,359,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL3310635,KHACQPYREOXZTB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,7,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL258180,KHDOKCLXCQAKEX-MAUKXSAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,18,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL491753,KHFAFXFRTUHQNO-UHFFFAOYSA-N,KF-A3,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17846138,IC50,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,PUBLICATION,
CHEMBL154228,KHGNFQVPPCBUSI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,2100,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL218568,KHIUUVSTTUGPRZ-CUNXSJBXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,1390,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL447825,KHKLNHSDQIKVSU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,61,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL447825,KHKLNHSDQIKVSU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,1106,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL942,KHOITXIGCFIULA-UHFFFAOYSA-N,BISACODYL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL942,KHOITXIGCFIULA-UHFFFAOYSA-N,BISACODYL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1171260,KHVUFWSEOLNUFN-IINYFYTJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,415,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1171260,KHVUFWSEOLNUFN-IINYFYTJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21319801,IC50,=,170,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,PUBLICATION,
CHEMBL394157,KHYFCJWXLVZFLY-QXSJWSMHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446069,KI,=,4.67,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"Synthesis and biological evaluation of 2beta,3alpha-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1099178,KHYNNQYNYMSTIB-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,=,18000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1099178,KHYNNQYNYMSTIB-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,INH,=,0,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1095850,KHYNNQYNYMSTIB-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,=,57,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1095850,KHYNNQYNYMSTIB-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,INH,=,91000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1097148,KHYNNQYNYMSTIB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,=,95,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1097148,KHYNNQYNYMSTIB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,INH,=,88000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL516507,KIAUBZBIKKPZNR-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL196365,KIDMMWCQWSLXGQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,8,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL196365,KIDMMWCQWSLXGQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,10,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL196365,KIDMMWCQWSLXGQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,190,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323173,KILGJUZHPOSPFN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,1.3,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3703736,KILSXJAEWHCKLW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,131.5,NM,302100,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL1224320,KIMRUTAJTDBFHO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,0.501,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224320,KIMRUTAJTDBFHO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,0.794,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1085198,KINFMOXIYLIVMO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,52,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3663912,KIRDSTWSOYAHOS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2.2,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663912,KIRDSTWSOYAHOS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,8.1,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663912,KIRDSTWSOYAHOS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,119,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663912,KIRDSTWSOYAHOS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,8.1,NM,314415,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
,KIWQWJKWBHZMDT-GSVOUGTGSA-N,D-HOMOCYSTEINE THIOLACTONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12649361,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL427215,KIXBFSFRCBHKLN-INIZCTEOSA-N,(R)-SILA-VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16513343,IC50,=,200,NM,,"","","","","","",,,,,,,,Inhibition of noradrenaline reuptake at human recombinant noradrenaline transporter,(R)-sila-venlafaxine: a selective noradrenaline reuptake inhibitor for the treatment of emesis.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL427215,KIXBFSFRCBHKLN-INIZCTEOSA-N,(R)-SILA-VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21413808,IC50,=,251,NM,,"","","","","","",,,,,,,,Inhibition of NET,Synopsis of some recent tactical application of bioisosteres in drug design.,J. Med. Chem.,PUBLICATION,
CHEMBL427215,KIXBFSFRCBHKLN-INIZCTEOSA-N,(R)-SILA-VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23061607,IC50,=,251,NM,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) assessed as noradrenaline reuptake,Organosilicon molecules with medicinal applications.,J. Med. Chem.,PUBLICATION,
CHEMBL2204342,KIXBFSFRCBHKLN-MRXNPFEDSA-N,(S)-SILA-VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21413808,IC50,=,4715,NM,,"","","","","","",,,,,,,,Inhibition of NET,Synopsis of some recent tactical application of bioisosteres in drug design.,J. Med. Chem.,PUBLICATION,
CHEMBL2204341,KIXBFSFRCBHKLN-UHFFFAOYSA-N,RAC-SILA-VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21413808,IC50,=,109,NM,,"","","","","","",,,,,,,,Inhibition of NET,Synopsis of some recent tactical application of bioisosteres in drug design.,J. Med. Chem.,PUBLICATION,
CHEMBL2204341,KIXBFSFRCBHKLN-UHFFFAOYSA-N,RAC-SILA-VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23061607,IC50,=,109,NM,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) assessed as noradrenaline reuptake,Organosilicon molecules with medicinal applications.,J. Med. Chem.,PUBLICATION,
CHEMBL486235,KJKJGUOGZBYCCJ-AEFFLSMTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,3000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL13209,KJONHKAYOJNZEC-UHFFFAOYSA-N,NITRAZEPAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL13209,KJONHKAYOJNZEC-UHFFFAOYSA-N,NITRAZEPAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL293492,KJPRLNWUNMBNBZ-QPJJXVBHSA-N,CINNAMALDEHYDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL293492,KJPRLNWUNMBNBZ-QPJJXVBHSA-N,CINNAMALDEHYDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL460204,KJRMGZKFHBXRRA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,8530,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL460204,KJRMGZKFHBXRRA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,4064,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL207867,KJSYAMNHDJSTMY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,135,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL493058,KKCKVAFKRSKQRE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1830887,KKELNYPZMKZDOL-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,283,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830887,KKELNYPZMKZDOL-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,611,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1078164,KKHPGFXTXRPZGB-NSHDSACASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,67,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14192,KKKDZZRICRFGSD-UHFFFAOYSA-N,BENZYLIMIDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL14192,KKKDZZRICRFGSD-UHFFFAOYSA-N,BENZYLIMIDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL597967,KKLRTSAUACDUNQ-GTKSSXFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,14,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL202846,KKTUFJIEHNEGDF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,7.6,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL202846,KKTUFJIEHNEGDF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,219,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL3094312,KKYAPAJUTFYVRD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24238903,INHIBITION,=,29.3,%,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,MITOXANTRONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,4989.8,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL58,KKZJGLLVHKMTCM-UHFFFAOYSA-N,MITOXANTRONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,4948.5,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL402090,KLAPRIKTPASOCO-GXTWGEPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL398009,KLBBBQNCHMPXRI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,20000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL398009,KLBBBQNCHMPXRI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,84000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL479,KLBQZWRITKRQQV-UHFFFAOYSA-N,THIORIDAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1551,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL479,KLBQZWRITKRQQV-UHFFFAOYSA-N,THIORIDAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1538,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1669669,KLFVWQCQUXXLOU-UHFFFAOYSA-N,RO-5212773,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21237643,INHIBITION,=,44,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): discovery of EPPTB (RO5212773).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL511695,KLRJYPAUNJPVOA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,INHIBITION,=,7,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells at 1000 nM,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL511695,KLRJYPAUNJPVOA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,1220,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL337020,KLRMDPMJYLBCKY-IJXZTRCJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213054,KI,=,690,NM,,"","","","","","",,,,,,,,Inhibition of [125I]- RTI -55 binding at the Norepinephrine transporter sites on HEK-hNET cells,Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL2030635,KLUCWWVQVUXBSE-UHFFFAOYSA-N,N-(2-PHENYLETHYL)PYRROLIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL448648,KLWUNOLDNDXUMO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,ACTIVITY,=,38,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells at 1000 nM,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL448648,KLWUNOLDNDXUMO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,INHIBITION,=,31,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells at 1000 nM,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL486237,KMLPWAMYQIJTNH-QUCCMNQESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,1100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1818448,KMNJYBBPXRFSBY-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,0.631,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1518,KNAHARQHSZJURB-UHFFFAOYSA-N,PROPYLTHIOURACIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1518,KNAHARQHSZJURB-UHFFFAOYSA-N,PROPYLTHIOURACIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2206531,KNAQCUBNCHCAPI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,9,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432046,KNBHNNRMMAKKFI-SEDVZXITSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3092631,KNECEHLDOUTFJU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24269480,INHIBITION,>,50,%,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin),Potent P2Y1 urea antagonists bearing various cyclic amine scaffolds.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2047566,KNEXRPBWIYIHRH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,63,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL565,KNHUKKLJHYUCFP-UHFFFAOYSA-N,CLOFIBRATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL565,KNHUKKLJHYUCFP-UHFFFAOYSA-N,CLOFIBRATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL445747,KNMQSIXWQIRNCP-NDXYWBNTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19284718,KI,>,10000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.,J. Med. Chem.,PUBLICATION,
CHEMBL461330,KNRWBQQXTOGVJT-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,463,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL370063,KNTQYVICAJIRLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,146,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL199053,KOGVQIODXLTVAN-OLZOCXBDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1813307,KOMUTRYSVZSJSV-LSDHHAIUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,562.34,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1082534,KOMVBLAWAGFCNI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,1030,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1171391,KOPIUBJLSUXFHC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,7.94,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3613642,KORKKQLDGMHNKO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26235950,INHIBITION,=,4,%,,"","","","","","",,,,,,,,Binding affinity to human NE transporter assessed as inhibition of control specific binding at 10 uM,Identification of orally-bioavailable antagonists of the TRPV4 ion-channel.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3613155,KPCRSRJGGIXJEI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.27,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL150932,KPDJDJHGSVDTMY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,120,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL425589,KPESCGPEZLRTMM-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,690,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1065,KPJZHOPZRAFDTN-ZRGWGRIASA-N,METHYSERGIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1065,KPJZHOPZRAFDTN-ZRGWGRIASA-N,METHYSERGIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL23034,KPKLDBBNSFWOFA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15456270,KI,=,699,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity for Norepinephrine transporter (NET) expressed in LCK PK1 cells,2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.,J. Med. Chem.,PUBLICATION,
CHEMBL23034,KPKLDBBNSFWOFA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15801845,KI,=,1352,NM,,"",cell_based,"","","","",HEK293,,,,,,,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,PUBLICATION,
CHEMBL23034,KPKLDBBNSFWOFA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15974579,KI,=,699,NM,,"",cell_based,"","","","",,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,PUBLICATION,
CHEMBL565638,KPOGSLKDEJXGPM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,>,40000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL498847,KPQZUUQMTUIKBP-UHFFFAOYSA-N,SECNIDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL498847,KPQZUUQMTUIKBP-UHFFFAOYSA-N,SECNIDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL557555,KPSRODZRAIWAKH-UHFFFAOYSA-N,CIPROFIBRATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL557555,KPSRODZRAIWAKH-UHFFFAOYSA-N,CIPROFIBRATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3613152,KPTPOXGMWXQMFV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.54,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1099373,KPUDPAXPYHVNAD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,25,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL701,KPYSYYIEGFHWSV-UHFFFAOYSA-N,BACLOFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL701,KPYSYYIEGFHWSV-UHFFFAOYSA-N,BACLOFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL141343,KPZQRBACZSLMPH-UHFFFAOYSA-N,U-78517F,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL141343,KPZQRBACZSLMPH-UHFFFAOYSA-N,U-78517F,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL259694,KQAWRUCRTMUOJJ-KBXCAEBGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,7,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL556167,KQHYJWANORXMTF-GRTNUQQKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16413778,KI,=,156,NM,,"","","","","","",,,,,,,,Binding affinity to NET,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL128,KQKPFRSPSRPDEB-UHFFFAOYSA-N,SUMATRIPTAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL128,KQKPFRSPSRPDEB-UHFFFAOYSA-N,SUMATRIPTAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL391806,KQOBDZDVQFUADH-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,3,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL440230,KQOBDZDVQFUADH-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL447,KQPKPCNLIDLUMF-UHFFFAOYSA-N,SECOBARBITAL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL447,KQPKPCNLIDLUMF-UHFFFAOYSA-N,SECOBARBITAL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1208572,KQXDHUJYNAXLNZ-XQSDOZFQSA-N,SALINOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1208572,KQXDHUJYNAXLNZ-XQSDOZFQSA-N,SALINOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2326501,KRCLPAGVJVBLJR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23237837,INHIBITION,=,52,%,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human recombinant NE transporter expressed in CHO cells at 1 uM,Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL401550,KRJLGYVCEZYCEV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,131,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1261,KRKNYBCHXYNGOX-UHFFFAOYSA-N,CITRIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1261,KRKNYBCHXYNGOX-UHFFFAOYSA-N,CITRIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL629,KRMDCWKBEZIMAB-UHFFFAOYSA-N,AMITRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,19,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL629,KRMDCWKBEZIMAB-UHFFFAOYSA-N,AMITRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,102,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL629,KRMDCWKBEZIMAB-UHFFFAOYSA-N,AMITRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,35,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL629,KRMDCWKBEZIMAB-UHFFFAOYSA-N,AMITRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14744476,KI,=,13.3,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL629,KRMDCWKBEZIMAB-UHFFFAOYSA-N,AMITRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14744476,KI,=,63,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL629,KRMDCWKBEZIMAB-UHFFFAOYSA-N,AMITRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,IC50,=,2041.74,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL629,KRMDCWKBEZIMAB-UHFFFAOYSA-N,AMITRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,KI,=,333,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL629,KRMDCWKBEZIMAB-UHFFFAOYSA-N,AMITRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,23,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL629,KRMDCWKBEZIMAB-UHFFFAOYSA-N,AMITRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,22,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2326685,KRNOLRHDBBTXOP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,170,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL234127,KRQBCJRFWIYJDK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,2500000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL234127,KRQBCJRFWIYJDK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2414911,KRSNVUPLMVRORR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23880542,KI,=,867,NM,,"","","","","","",,,,,,,,Binding affinity to human norepinephrine transporter by ligand displacement assay,Neuroactive diol and acyloin metabolites from cone snail-associated bacteria.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1752,KSCFJBIXMNOVSH-UHFFFAOYSA-N,DYPHYLLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1752,KSCFJBIXMNOVSH-UHFFFAOYSA-N,DYPHYLLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL32749,KSEBMYQBYZTDHS-HWKANZROSA-N,FERULIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL32749,KSEBMYQBYZTDHS-HWKANZROSA-N,FERULIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1224090,KSKOKUBPUSATCC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,2.51,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL512967,KSQKTWNQJCTCMA-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,60,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL560535,KSQOUNJPKDJKKL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,7.94,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL560535,KSQOUNJPKDJKKL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,7.94,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL124222,KSRAFZQYEJWAQE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,IC50,>,10,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL124222,KSRAFZQYEJWAQE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,KI,=,5850,NM,,"",cell_based,"","","","",,,,,,,,Compound was tested for its affinity by the inhibition of [125I]RTI-55 binding at norepinephrine transporter (NET) transfected in HEK cells,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL566173,KSVISHYLWAYQCI-OALUTQOASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,IC50,=,1200,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL540445,KTEXNACQROZXEV-SLXBATTESA-N,PARTHENOLIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL540445,KTEXNACQROZXEV-SLXBATTESA-N,PARTHENOLIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL192824,KTFFRYZZEFRULN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15801845,KI,=,7036,NM,,"",cell_based,"","","","",HEK293,,,,,,,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,PUBLICATION,
CHEMBL1200322,KTGRHKOEFSJQNS-BDQAORGHSA-N,ESCITALOPRAM OXALATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20597489,KI,,,,Not Determined,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL1172744,KTJHVHZJTXJNIH-QZTJIDSGSA-N,1-(METHOXYMETHYL)-6-(NAPHTHALEN-2-YL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,10,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1172744,KTJHVHZJTXJNIH-QZTJIDSGSA-N,1-(METHOXYMETHYL)-6-(NAPHTHALEN-2-YL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,12.59,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1172744,KTJHVHZJTXJNIH-QZTJIDSGSA-N,1-(METHOXYMETHYL)-6-(NAPHTHALEN-2-YL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,39.81,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,IMATINIB,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,IMATINIB,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL348034,KUBLGYWISNGZNK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,680,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL382810,KUDFJDYXEMEWNB-OAUVRVJYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,2000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1087924,KUHFOMDKXOTLGD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,29,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1818445,KUJKCGJIUCGPED-AAFJCEBUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,0.398,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1818445,KUJKCGJIUCGPED-AAFJCEBUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,31.62,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1818444,KUJKCGJIUCGPED-HZPDHXFCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,0.398,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL435034,KUKSICQKSBGDSV-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,2400,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL2205814,KULMFBVVFDTVNX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL210116,KURNFMGUSYWHLC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,340,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1645614,KUTIVIKNDVNVAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,328,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL391947,KUYNMYBNRQCGCC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17616397,KI,=,240,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL578219,KVHCMVHVGGEFGG-CCRGXQTGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,=,2000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL212452,KVHKGSIWONIENO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16784855,KI,=,2.94,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET transfected in HEK293 cells,Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL537196,KVIXRWQLEHRFLW-DPSPSOFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16413778,KI,=,56,NM,,"","","","","","",,,,,,,,Binding affinity to NET,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL378418,KVNXQYJMNFSXRE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,35,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL511525,KVRIVKGFVFCJEI-JPKZNVRTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,29,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL511525,KVRIVKGFVFCJEI-JPKZNVRTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,14,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL459852,KVRIVKGFVFCJEI-NTEVMMBTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,577,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL459852,KVRIVKGFVFCJEI-NTEVMMBTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,187,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL511347,KVRIVKGFVFCJEI-UHFFFAOYSA-N,WY-46824,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,58,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL511347,KVRIVKGFVFCJEI-UHFFFAOYSA-N,WY-46824,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,46,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL24944,KVSKGMLNBAPGKH-UHFFFAOYSA-N,TRIBROMSALAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL24944,KVSKGMLNBAPGKH-UHFFFAOYSA-N,TRIBROMSALAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1813316,KVTPLEPXMVVCIZ-CJNGLKHVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,26.92,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813317,KVTPLEPXMVVCIZ-XJKSGUPXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,38.02,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL2430686,KVVQAOOISUGMSL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,2745,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430686,KVVQAOOISUGMSL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,44.5,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430686,KVVQAOOISUGMSL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,78,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL715,KVWDHTXUZHCGIO-UHFFFAOYSA-N,OLANZAPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL715,KVWDHTXUZHCGIO-UHFFFAOYSA-N,OLANZAPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL509228,KWAYIPPRBHZSBU-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,1100,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL504971,KWAYIPPRBHZSBU-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,30,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2036267,KWGNEMHDJWLIGQ-JPWYFDBFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,160,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL2034995,KWGNEMHDJWLIGQ-SWQINVOKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,2200,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL3673145,KWGNNADVFYRCOK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1020,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL279157,KWGRBVOPPLSCSI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12954796,KI,=,43.1,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL279157,KWGRBVOPPLSCSI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12954796,KI,=,218,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL279157,KWGRBVOPPLSCSI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12954796,KI,=,4092,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1818468,KWIJNWQXQHEXSP-RTBURBONSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,19.95,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL612,KWTSXDURSIMDCE-QMMMGPOBSA-N,DEXTROAMPHETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22037049,EC50,=,7.1,NM,,"",tissue,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET cloned in rat brain synaptosome by scintillation counting,Trace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine class.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL612,KWTSXDURSIMDCE-QMMMGPOBSA-N,DEXTROAMPHETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,IC50,=,630.96,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL612,KWTSXDURSIMDCE-QMMMGPOBSA-N,DEXTROAMPHETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,KI,=,101,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL405,KWTSXDURSIMDCE-UHFFFAOYSA-N,AMPHETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12954796,KI,=,7.1,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL563495,KWWVMVUZZJMGRZ-CHPOKUKFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,14,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL563495,KWWVMVUZZJMGRZ-CHPOKUKFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,43,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL551573,KWWVMVUZZJMGRZ-ZVDHGWRTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL551573,KWWVMVUZZJMGRZ-ZVDHGWRTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,44,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL505439,KXCIACPDRWQKBQ-KBXCAEBGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,8000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173415,KXJGGCUESGCVLH-ZIAGYGMSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,125.89,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL458488,KXLFAQOYCLVWOS-LJPFFJIGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,1690,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL596805,KXLJVOFBGQNGTJ-VIKVFOODSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,1.58,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1813482,KXQVOLBRJCPHMW-HZMBPMFUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,4265.8,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL2338031,KXRRNOJECCYJIA-GUYCJALGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,7.94,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL137769,KXVANVFVPHMDSA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9435902,INHIBITION,=,8.5,%,,"","","","","","",,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL335423,KXYMHOPZXNZJHG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14592523,IC50,=,1452,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake in HEK cells expressing human NET,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL335423,KXYMHOPZXNZJHG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14592523,KI,=,4500,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309702,KYHMFLOOKCBLDX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,37.2,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309702,KYHMFLOOKCBLDX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,86,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309702,KYHMFLOOKCBLDX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309702,KYHMFLOOKCBLDX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309702,KYHMFLOOKCBLDX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,RATIO IC50,>,7,,,"",cell_based,"","","","",,,,,,,,Ratio of duloxetine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309702,KYHMFLOOKCBLDX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,RATIO IC50,>,7,,,"",cell_based,"","","","",,,,,,,,Ratio of venlafaxine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL561598,KYMPTONVLFUIMS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,15.85,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL9514,KYRVNWMVYQXFEU-UHFFFAOYSA-N,NOCODAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL9514,KYRVNWMVYQXFEU-UHFFFAOYSA-N,NOCODAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL466006,KYTHDBXSBSSRTI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19445453,KI,>,6000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK293 cells,Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL466006,KYTHDBXSBSSRTI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19445453,KI,>,6000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL2206532,KYUYTLMYZDCTDV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,7.3,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1118,KYYIDSXMWOZKMP-UHFFFAOYSA-N,DESVENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,2753,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1118,KYYIDSXMWOZKMP-UHFFFAOYSA-N,DESVENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,3152,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1118,KYYIDSXMWOZKMP-UHFFFAOYSA-N,DESVENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16675639,KI,=,531.3,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1118,KYYIDSXMWOZKMP-UHFFFAOYSA-N,DESVENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16675639,KI,=,558.4,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1118,KYYIDSXMWOZKMP-UHFFFAOYSA-N,DESVENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16675639,KI,=,3385.1,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1118,KYYIDSXMWOZKMP-UHFFFAOYSA-N,DESVENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL1118,KYYIDSXMWOZKMP-UHFFFAOYSA-N,DESVENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,>,650,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL1257555,KYYMUHCVQBBYFP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20833036,ACTIVITY,=,88,%,,"","","","","","",,,,,,,,Binding affinity to human norepinephrine transporter at 10 uM by radioligand displacement assay,Thienopyrimidines as ß3-adrenoceptor agonists: hit-to-lead optimization.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1813476,KZCROLYCBADBTI-DLBZAZTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,14.13,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813477,KZCROLYCBADBTI-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,60.26,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL469810,KZMOSMDAUNHNBH-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,6800,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2165447,KZONDTNPVHWVKU-NSHDSACASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,EFFICACY,=,97.2,%,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET at 10 uM after 1.5 hrs by microbeta scintillation counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2165447,KZONDTNPVHWVKU-NSHDSACASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,191,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET after 1.5 hrs by microbeta scintillation counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL249213,KZTLVKCVXWWSHF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,250000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL379755,KZXIQLJNAIYPLZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,IC50,=,2320,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL379755,KZXIQLJNAIYPLZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,KI,=,1160,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL153847,LACNYBMZWJBWCU-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,>,20000,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL1080907,LADSERODBYZUAW-FQEVSTJZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20137933,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL262357,LAMKUIMKGNOGQJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,921,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL226933,LAVPLSGMUSPWHO-BQUSRXHISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,1810,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL226933,LAVPLSGMUSPWHO-BQUSRXHISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,3630,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL202913,LBFUCVLJJXYYQF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16337793,IC50,>,100,NM,,"","","","","","",,,,,,,,Inhibitory activity against NET,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1812740,LBLVIDUIWXYVNG-AITUJVMLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21058665,IC50,=,122,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,PUBLICATION,
CHEMBL2326689,LBMMBEDCUJAMIZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,120,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL383745,LBZCFIOVPDHQQT-JCOPYZAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,210,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL204060,LBZCFIOVPDHQQT-LNLSOMNWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,>,5600,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL2030630,LCBQDWKMNGEPLD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL574126,LCJMOOYZLAZDBK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL347666,LCPXLRHRFOEFHQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,13000,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL508678,LCUQDUYHYRSPMJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL508678,LCUQDUYHYRSPMJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,8517,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL132082,LCWPWPFSABPKJM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,IC50,=,1.46,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL132082,LCWPWPFSABPKJM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,KI,=,23,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL498775,LCYYZQNDLDWZLI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18461921,KI,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,PUBLICATION,
CHEMBL121460,LDCWRCFCYHTIGC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,IC50,=,2600,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL121460,LDCWRCFCYHTIGC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,KI,=,261,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL207837,LDELVNUHOAVIQP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,91,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3703728,LDGGSTOTUUPJPO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,132.7,NM,302092,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL256816,LDPRCWPXDFHEJU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,42,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201193,LEBVLXFERQHONN-INIZCTEOSA-N,LEVOBUPIVACAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201193,LEBVLXFERQHONN-INIZCTEOSA-N,LEVOBUPIVACAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1099284,LEEDRVGVQYVFHX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19939513,ACTIVITY,=,15,%,,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter at 1 uM by radioligand displacement assay,"8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists.",Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1914692,LEESYDIUWLXOSV-DXCLHELWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21458259,KI,=,3855,NM,,"",cell_based,"","","","",LLC-PK1,,,,,,,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL332098,LEIFDHLVPBJTIV-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15177457,KI,=,4720,NM,,"","","","","","",,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter; Average of two experiments,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200391,LENZDBCJOHFCAS-UHFFFAOYSA-N,TROMETHAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200391,LENZDBCJOHFCAS-UHFFFAOYSA-N,TROMETHAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL437002,LEVTWCPGXIVKEH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL437002,LEVTWCPGXIVKEH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL366563,LEVWYRKDKASIDU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12649361,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL808,LEZWWPYKPKIXLL-UHFFFAOYSA-N,ECONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2435,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL808,LEZWWPYKPKIXLL-UHFFFAOYSA-N,ECONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2415,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1076374,LFFZPLJZCPCTRA-WIRYOQIKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1095274,LFLUHLCPXQWQKW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19939513,ACTIVITY,,,,Active,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter at 10 uM by radioligand displacement assay,"8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists.",Eur. J. Med. Chem.,PUBLICATION,
CHEMBL545,LFQSCWFLJHTTHZ-UHFFFAOYSA-N,ALCOHOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL545,LFQSCWFLJHTTHZ-UHFFFAOYSA-N,ALCOHOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1830875,LFTRJEGVGRCFEP-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,103,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830875,LFTRJEGVGRCFEP-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,151,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830876,LFTRJEGVGRCFEP-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,13,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830876,LFTRJEGVGRCFEP-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,27,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL18797,LFWHFZJPXXOYNR-MFOYZWKCSA-N,SULINDAC SULFIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL18797,LFWHFZJPXXOYNR-MFOYZWKCSA-N,SULINDAC SULFIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1224162,LGCPITGZBZPIIE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,100,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3703749,LGHFQLREBMQWRS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,174.2,NM,198867,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL1082210,LGKIWGDJKNJYMG-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20137933,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673156,LGOLCLAISOMHIH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,429.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL232867,LGPCFMYKDFHTOT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,240000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL232867,LGPCFMYKDFHTOT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,646000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1645608,LGPYPLZSWZJHBL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,218,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL573766,LGSKMJOUAMVJKK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,1940,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL156455,LGXVIGDEPROXKC-UHFFFAOYSA-N,"1,1-DICHLOROETHENE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL156455,LGXVIGDEPROXKC-UHFFFAOYSA-N,"1,1-DICHLOROETHENE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1643902,LGZPNSXZRKGUES-DKSPCFMDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21146989,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK cells,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643902,LGZPNSXZRKGUES-DKSPCFMDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3310626,LHDXSWGNSMXQLB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,68,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256841,LHEVFGSJGDXFCO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL573831,LHOOAMLZVNHXAN-IOXAMRCBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,>,2000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL264158,LHOSACAWSLTLQJ-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,22,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL551818,LHPQIFURGZJMMZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,251.19,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173427,LHPUYZQFWLLHPT-ISVAXAHUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,740,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1258723,LHSWZGXDIPQNGE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20727749,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of norepinephrine receptor at 10 uM,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205824,LIKZWSUAMNZHAE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673164,LINSRJQQGQTFBQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,155.1,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3673158,LITXWCJWLOYNDV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,62.3,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL1683872,LJALDWYVBOLBGW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,19,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL299233,LJBBMCNHIUJBDU-UHFFFAOYSA-N,TALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,66.1,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL600674,LJCOZBDBGBEZNJ-ZFNKBKEPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,170,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2206535,LJEZBJASWTZZEM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,15,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323098,LJLKXARFBFJHOY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,INHIBITION,=,58,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells at 100 nM after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL497339,LJNOQGHESDETDR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,19.6,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL251576,LJOGQAFQXBMQQW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,IC50,>,100000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL251576,LJOGQAFQXBMQQW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,INHIBITION,=,-4.9,%,,"","","","","","",,,,,,,,Inhibition of NET at 1 uM,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL203013,LJRLAJVWAFFRLV-IAQYHMDHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16361098,KI,>,1000,NM,,"","","","","","",,,,,,,,Binding affinity to NA transporter,"Synthesis and biological evaluation of novel hexahydro-pyrido[3',2':4,5]pyrrolo[1,2-a]pyrazines as potent and selective 5-HT(2C) receptor agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2079587,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,STANOZOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2079587,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,STANOZOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL177,LKCWBDHBTVXHDL-RMDFUYIESA-N,AMIKACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL177,LKCWBDHBTVXHDL-RMDFUYIESA-N,AMIKACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2432043,LKFSLMWAVKMONG-KPCGFGSOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL63560,LKJPYSCBVHEWIU-KRWDZBQOSA-N,(R)-BICALUTAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL63560,LKJPYSCBVHEWIU-KRWDZBQOSA-N,(R)-BICALUTAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3673152,LKORPZALGOFFBL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,355.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL307956,LKSUTFUZSGZMOS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15081025,KI,=,10000,NM,,"","","","","","",,,,,,,,Binding affinity towards Norepinephrine transporter using [3H]nisoxitine as radioligand,"Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL456639,LKTJWDXCFJJUGY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,360,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL456639,LKTJWDXCFJJUGY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,2736,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL608148,LKVOLTSPLLAMPJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,2440,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL356922,LKXCLZURUSBJKI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,9900,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL257810,LLAFUUNOXYVHHL-ZANVPECISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,40,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1241348,LLGDPTDZOVKFDU-XUHJSTDZSA-N,FALDAPREVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20823284,INHIBITION,=,20,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,"Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease.",Antimicrob. Agents Chemother.,PUBLICATION,
CHEMBL595638,LLOHGZFZQFVZTC-JLZXWRJPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,120,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL493667,LLTVABOFFOVVKQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL556093,LLXDSNCKQBRHMZ-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,10,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL559319,LLXDSNCKQBRHMZ-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,825,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL380406,LMAWVKHKZVLUQO-JCOPYZAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,361,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL204530,LMAWVKHKZVLUQO-LNLSOMNWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,143,NM,,"","","","","","",,,,,,,,Inhibition of [3H]NE uptake,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL204530,LMAWVKHKZVLUQO-LNLSOMNWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,1221,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL1542,LMEKQMALGUDUQG-UHFFFAOYSA-N,AZATHIOPRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1542,LMEKQMALGUDUQG-UHFFFAOYSA-N,AZATHIOPRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL469811,LMGLVWVNPWWAAK-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,10600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1054,LMJSLTNSBFUCMU-UHFFFAOYSA-N,TRICHLORMETHIAZIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1054,LMJSLTNSBFUCMU-UHFFFAOYSA-N,TRICHLORMETHIAZIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1214006,LMVDJMCDHZLBFE-PMWAWBRWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20597489,KI,=,142,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL54,LNEPOXFFQSENCJ-UHFFFAOYSA-N,HALOPERIDOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25070422,KI,=,5500,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL54,LNEPOXFFQSENCJ-UHFFFAOYSA-N,HALOPERIDOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1836,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL54,LNEPOXFFQSENCJ-UHFFFAOYSA-N,HALOPERIDOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1820,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL576821,LNIDNIKEDAQTOW-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,735,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL865,LNPDTQAFDNKSHK-UHFFFAOYSA-N,VALDECOXIB,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2927,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL865,LNPDTQAFDNKSHK-UHFFFAOYSA-N,VALDECOXIB,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2903,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2432042,LNTMHZZRTAQEJQ-CPVTZQMHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1170233,LNWGBLPMTUFHJM-HUUCEWRRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,794.33,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL54465,LOEPSYRVNXADMM-TYKWCNGQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18644726,KI,=,1430,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: chemical synthesis, evaluation in vitro and radiofluorination.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL55505,LOEPSYRVNXADMM-XUTJKUGGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18644726,KI,=,184,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: chemical synthesis, evaluation in vitro and radiofluorination.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3613148,LOGKFOZAEYYIAV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.09,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1744448,LOLFAJUUOFBGSF-KYIYJVAASA-N,BLEOMYCIN A2,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1744448,LOLFAJUUOFBGSF-KYIYJVAASA-N,BLEOMYCIN A2,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL188964,LOONKLFFRKQSJD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15801845,KI,=,946.2,NM,,"",cell_based,"","","","",HEK293,,,,,,,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,PUBLICATION,
CHEMBL188964,LOONKLFFRKQSJD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15974579,KI,>,5000,NM,,"",cell_based,"","","","",,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,PUBLICATION,
CHEMBL566420,LOWDJVQAZMFOLZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,4798,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566420,LOWDJVQAZMFOLZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,4760,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566420,LOWDJVQAZMFOLZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,2520,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1824778,LPAMOYXJLQSGRI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21788137,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET transporter by NIMH PDSP,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323172,LPEVXVVSNBJGCU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,INHIBITION,=,32,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells at 100 nM after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL1224160,LPLLJFFJYKVRLO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,7.94,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
,LPLLVINFLBSFRP-UHFFFAOYSA-N,EPHEDRONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12954796,KI,=,13.1,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL441687,LPLVUJXQOOQHMX-QWBHMCJMSA-N,GLYCYRRHIZIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL441687,LPLVUJXQOOQHMX-QWBHMCJMSA-N,GLYCYRRHIZIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL222863,LPMXVESGRSUGHW-HBYQJFLCSA-N,OUABAIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL222863,LPMXVESGRSUGHW-HBYQJFLCSA-N,OUABAIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL493130,LPQAVKPTKBXDEY-GHXDPTCOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19284718,KI,=,6780,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.,J. Med. Chem.,PUBLICATION,
CHEMBL404,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,TAZOBACTAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL404,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,TAZOBACTAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL111861,LPYXTAPPNYMYOP-XDBTXSBWSA-N,CORTISONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL111861,LPYXTAPPNYMYOP-XDBTXSBWSA-N,CORTISONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3673128,LQAFCQOIRLFSLX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,384.6,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL397787,LQAVUHFNJFDFLC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL397787,LQAVUHFNJFDFLC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL487875,LQBFAZFBAPGPPM-PHGOYLPISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,357,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL222787,LQDARHFLRKPAMM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17367122,INHIBITION,=,80,%,,"",cell_based,"","","","",CHO,,,,,,,Displacement of radiolabeled protriptyline from human recombinant NET expressed in CHO cells at 10 uM,Designing active template molecules by combining computational de novo design and human chemist's expertise.,J. Med. Chem.,PUBLICATION,
CHEMBL891,LQOLIRLGBULYKD-JKIFEVAISA-N,CLOXACILLIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL891,LQOLIRLGBULYKD-JKIFEVAISA-N,CLOXACILLIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL198960,LQONCZWYZLNINV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,7,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL457865,LQPCABVKUZFZCC-GNQYJHKCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,21.8,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL566376,LQXLMIBCEDZZFC-SFTDATJTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,INHIBITION,=,34,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL475936,LQYWRHPJMNCEEY-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,=,14,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL232879,LQZNMKWOFOJVOS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,121000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL232879,LQZNMKWOFOJVOS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL180630,LRAFIWLBFGAPRJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL180630,LRAFIWLBFGAPRJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20034793,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]nisoxetine from human NET transfected in human HEK293 cells,Synthesis and hSERT activity of homotryptamine analogs. Part 6: [3+2] dipolar cycloaddition of 3-vinylindoles.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL506247,LRBQNJMCXXYXIU-PPKXGCFTSA-N,TANNIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL506247,LRBQNJMCXXYXIU-PPKXGCFTSA-N,TANNIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL455937,LRISBEQMFXITND-HEHWQVRWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,>,3000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL1083427,LRKGVRWKYSKWQW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,30,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL204449,LRQBXHMVEXEFBO-GFCCVEGCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16263279,ACTIVITY,=,14,%,,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter at 10 uM,A new chemical tool for exploring the role of the PDE4D isozyme in leukocyte function.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL269799,LRQFAGSCSIOKKB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,1400,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1275791,LRSVJJWABVMKRA-PWSUYJOCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20949929,IC50,=,0.63,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL257964,LRXREOMAEUNNPU-GWCFXTLKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,76,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL207755,LSDAXRLUBRBZQK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,5.4,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1566249,LSNWBKACGXCGAJ-UHFFFAOYSA-N,AMPIROXICAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1566249,LSNWBKACGXCGAJ-UHFFFAOYSA-N,AMPIROXICAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1173414,LSPLQALBHLTUIH-ZIAGYGMSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,199.53,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1082,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,AMOXICILLIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1082,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,AMOXICILLIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL497140,LTDVATHIGODXNC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18793858,KI,>,1200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,"Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2386163,LTFSJEXVJFCDEL-SLHAJLBXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1.2,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2386163,LTFSJEXVJFCDEL-SLHAJLBXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1.5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL517423,LTGCAGJRXIORIR-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL494786,LTKIILYBJZQLLW-PEVLCXCCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18434164,KI,=,556,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1790051,LTKIILYBJZQLLW-QNIIYNMLSA-N,WIN-35065-2,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,IC50,=,920,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL1790051,LTKIILYBJZQLLW-QNIIYNMLSA-N,WIN-35065-2,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,KI,=,550,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL1790051,LTKIILYBJZQLLW-QNIIYNMLSA-N,WIN-35065-2,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,556,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL214240,LTKQGPSHVUGDKE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,54,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL599233,LTLFRBMKBHQUTH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,4100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1751,LTMHDMANZUZIPE-PUGKRICDSA-N,DIGOXIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1751,LTMHDMANZUZIPE-PUGKRICDSA-N,DIGOXIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2430695,LTOCWIOHTZQZEL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,865.7,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430695,LTOCWIOHTZQZEL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,87,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430695,LTOCWIOHTZQZEL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,91.6,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2012728,LTQWNQOQFFXHAJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22342142,INHIBITION,,,,Not Active,"","","","","","",,,,,,,,Inhibition of norepinephrine channel at 10 uM by radioligand displacement assay,Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310478,LTRGRJOIAIYRCQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,33.7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310478,LTRGRJOIAIYRCQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310478,LTRGRJOIAIYRCQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310478,LTRGRJOIAIYRCQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310478,LTRGRJOIAIYRCQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,RATIO IC50,>,7,,,"",cell_based,"","","","",,,,,,,,Ratio of duloxetine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310478,LTRGRJOIAIYRCQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,RATIO IC50,>,7,,,"",cell_based,"","","","",,,,,,,,Ratio of venlafaxine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3113642,LUDBNRIKUAJOOY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24393810,INHIBITION,=,1,%,,"","","","","","",,,,,,,,Displacement of [3H]-nisoxetin from human norepinephrine transporter at 1 uM relative to control,A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1909051,LUHHARLTABWBTO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909051,LUHHARLTABWBTO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL346021,LUHJZDCSPPPIDT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,>,20000,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL567041,LUIWHKVXZYFQLW-CJRXIRLBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,IC50,=,104,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257909,LUJLISGGFLGFKZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18060777,KI,=,112,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL165,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,RESVERATROL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2312,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL165,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,RESVERATROL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2293,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL54126,LULNWZDBKTWDGK-UHFFFAOYSA-M,NEOSTIGMINE BROMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL54126,LULNWZDBKTWDGK-UHFFFAOYSA-M,NEOSTIGMINE BROMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2206530,LULUPYXXDWTNNO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,29,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430684,LUQRHZHXLQQJTM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,990.3,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430684,LUQRHZHXLQQJTM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,40.4,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430684,LUQRHZHXLQQJTM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,90,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1084292,LUSQFJUMCWATFQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,853,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL3317698,LUYDHJNQCRADNJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25017029,IC50,=,1700,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1732,LUZRJRNZXALNLM-JGRZULCMSA-N,DIHYDROERGOTAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1732,LUZRJRNZXALNLM-JGRZULCMSA-N,DIHYDROERGOTAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL601880,LVFOKOCPQCOYER-VOMIJIAVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,2.6,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL601880,LVFOKOCPQCOYER-VOMIJIAVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,6.3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1231107,LVQDKIWDGQRHTE-UHFFFAOYSA-N,CYROMAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1231107,LVQDKIWDGQRHTE-UHFFFAOYSA-N,CYROMAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL599593,LVSZWRFDLAUNPF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,747,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL85882,LVTUDYZTQRSARZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18847250,KI,=,4490,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxitine from NET,"Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.",J. Med. Chem.,PUBLICATION,
CHEMBL2337600,LVUBCLOONUNZAC-WMLDXEAASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,10,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1672288,LVXAMCKZCLWWTF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21207959,KI,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity to NET,Syntheses of 2-amino and 2-halothiazole derivatives as high-affinity metabotropic glutamate receptor subtype 5 ligands and potential radioligands for in vivo imaging.,J. Med. Chem.,PUBLICATION,
CHEMBL1818456,LWFZPUPJSMFIKP-HZPDHXFCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,10,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3310482,LWGULHIUMBMSRR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,10.6,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310482,LWGULHIUMBMSRR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310482,LWGULHIUMBMSRR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310482,LWGULHIUMBMSRR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224562,LWIZTBGDAFNFMW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,19.95,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL154319,LWXMYCZRAJRIND-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,2300,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL325372,LXCFILQKKLGQFO-UHFFFAOYSA-N,METHYLPARABEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL325372,LXCFILQKKLGQFO-UHFFFAOYSA-N,METHYLPARABEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL378243,LXDSBNMMECZLMT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,IC50,=,990,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL378243,LXDSBNMMECZLMT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,KI,=,500,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL406789,LXFLYTRXPWVMTB-SUMWQHHRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,7.1,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1908355,LXIKEPCNDFVJKC-QXMHVHEDSA-N,TENIDAP,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1908355,LXIKEPCNDFVJKC-QXMHVHEDSA-N,TENIDAP,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1644477,LXIOTZOSBNBEKN-PTEHBNRSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,12,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL475528,LXKDYSGDYBBTJV-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,INHIBITION,=,25,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1 uM,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL461322,LXKDYSGDYBBTJV-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,166,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1393,LXMSZDCAJNLERA-ZHYRCANASA-N,SPIRONOLACTONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1393,LXMSZDCAJNLERA-ZHYRCANASA-N,SPIRONOLACTONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL204285,LXNRWPBVYRKZDQ-SJCJKPOMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,2100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673130,LXQRBRXJAMSDSI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,70.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL509446,LXXOMHAIVSCBSY-DLBZAZTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,77,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL509373,LXXOMHAIVSCBSY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,75,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL512677,LYBIOYSWEAGQEQ-FQEVSTJZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,215,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL471519,LYBIOYSWEAGQEQ-HXUWFJFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,9,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL457299,LYCAIKOWRPUZTN-UHFFFAOYSA-N,ETHYLENE GLYCOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL457299,LYCAIKOWRPUZTN-UHFFFAOYSA-N,ETHYLENE GLYCOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1173772,LYDZRRKPDGFEON-JSGCOSHPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,43.4,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1173772,LYDZRRKPDGFEON-JSGCOSHPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21319801,IC50,=,19,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,PUBLICATION,
CHEMBL401677,LYVNVEXOLQKXSZ-SUMWQHHRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,2.9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1076392,LYZSYRVZMDTIKX-QLYQYUPWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL258260,LZBZURMZSQMQEB-KPGYKUMBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18243691,INHIBITION,=,1,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,"Potent, selective MCH-1 receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL302795,LZNWYQJJBLGYLT-UHFFFAOYSA-N,TENOXICAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL302795,LZNWYQJJBLGYLT-UHFFFAOYSA-N,TENOXICAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL403956,LZPBAUCREIASQQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,232,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2112594,LZTYLQCFLVOYDH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,IC50,=,205,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL2112594,LZTYLQCFLVOYDH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,KI,=,545,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL2206526,LZYIBOJIMRPXNJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,4.4,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3317703,MASFTFKGBFXWJC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25017029,IC50,=,9.2,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL313493,MBABOKRGFJTBAE-UHFFFAOYSA-N,METHANESULFONIC ACID METHYL ESTER,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL313493,MBABOKRGFJTBAE-UHFFFAOYSA-N,METHANESULFONIC ACID METHYL ESTER,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL516825,MBCIBUXZJAIISR-SOFGYWHQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053782,KI,=,1180,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET transfected in human HEK293 cells,"Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL462431,MBCIBUXZJAIISR-VURMDHGXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053782,KI,=,109.9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET transfected in human HEK293 cells,"Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL2207382,MBFLODNVCSXSKE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23141912,INHIBITION,=,6.78,%,,"","","","","","",,,,,,,,Inhibition of NET at 1 uM by radioligand displacement assay,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL832,MBGGBVCUIVRRBF-UHFFFAOYSA-N,SULFINPYRAZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL832,MBGGBVCUIVRRBF-UHFFFAOYSA-N,SULFINPYRAZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL324967,MBVKPOXXMWDHKB-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15177457,KI,=,18400,NM,,"","","","","","",,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter; Average of two experiments,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337603,MCHVXQNUHBOZIA-CXAGYDPISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,0.794,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337602,MCHVXQNUHBOZIA-GUYCJALGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,1.58,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL310555,MCJGNVYPOGVAJF-UHFFFAOYSA-N,OXYQUINOLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL310555,MCJGNVYPOGVAJF-UHFFFAOYSA-N,OXYQUINOLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL466187,MCNALKIPDZCJNZ-OALUTQOASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19067522,KI,=,3.14,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET receptor expressed in HEK293 cells,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL593614,MCPOSCCUUUPTRR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,IC50,=,221,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL593614,MCPOSCCUUUPTRR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,208,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1224095,MDLYPVGOCJZPGM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,158.49,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL395931,MDQSOSLERPCADB-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,15,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL246920,MDQSOSLERPCADB-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL513090,MDTSUTPVPDPVGP-CHKHYCHESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,160,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL476144,MDXPOQYVXORXBP-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,18,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1813489,MEAWOAPXKTVYPU-IUODEOHRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,2951.21,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813488,MEAWOAPXKTVYPU-WFASDCNBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,5370.32,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1650844,MEBYDATXPNEUSM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20875743,INHIBITION,<,10,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter at 1 uM relative to control,"Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1536,MECHNRXZTMCUDQ-RKHKHRCZSA-N,ERGOCALCIFEROL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1536,MECHNRXZTMCUDQ-RKHKHRCZSA-N,ERGOCALCIFEROL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL201977,MEMCHWOZQTXCNY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2430683,MEPVQYBSRCKVHV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,7619,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430683,MEPVQYBSRCKVHV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,15,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430683,MEPVQYBSRCKVHV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,60,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2029054,MERKGGYYOYLGCB-ROPJLGIWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15177457,KI,>,10000000,NM,,"","","","","","",,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1080389,MESZSUFNQDICOD-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20137933,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL24,METKIMKYRPQLGS-UHFFFAOYSA-N,ATENOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL24,METKIMKYRPQLGS-UHFFFAOYSA-N,ATENOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL972,MEZLKOACVSPNER-GFCCVEGCSA-N,SELEGILINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL972,MEZLKOACVSPNER-GFCCVEGCSA-N,SELEGILINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL381071,MFCNYVIQGJNQQJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16337793,IC50,>,100,NM,,"","","","","","",,,,,,,,Inhibitory activity against NET,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL569,MFDFERRIHVXMIY-UHFFFAOYSA-N,PROCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL569,MFDFERRIHVXMIY-UHFFFAOYSA-N,PROCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3703734,MFFCMNOKOQHLPH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,13,NM,302098,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL1173354,MFHSHFDIBPWOJA-TVQRCGJNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,830,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL269939,MFKHVNDQMBWBBI-PISWEHOVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18243691,INHIBITION,=,69,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,"Potent, selective MCH-1 receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2030624,MFKYGKXYJBKSQN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL206599,MFRFEHWQLFFQLQ-UGSOOPFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,5000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1085338,MFTRIVHFDLRKDH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,1,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1085338,MFTRIVHFDLRKDH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,2.7,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL289469,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,GRANISETRON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL289469,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,GRANISETRON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL208251,MFXWGMNUZKYAND-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,1.4,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1097660,MGCWVDDXPPKNQT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1097660,MGCWVDDXPPKNQT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,INH,=,19000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL493568,MGEYXYRIODCARZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19445453,KI,>,6000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK293 cells,Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL493568,MGEYXYRIODCARZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19445453,KI,>,6000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL374492,MGKWXTIOHURCAH-LZDYDXGASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16821765,IC50,=,90000,NM,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of rat NET-mediated norepinephrine uptake in CHO cells,Development of peptidic dopamine transporter inhibitors via aromatic modification-mediated conformational restriction.,J. Med. Chem.,PUBLICATION,
CHEMBL469946,MGQRODBGBVCRHA-FZMZJTMJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954038,IC50,=,4.4,NM,,"",cell_based,"","","","",HEK293,,,,,,,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter","Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL209969,MGQYROXWDORYIL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224301,MGURNBDIUXGJTO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,39,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL550779,MGXQLLRKRSAUPY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,8,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205827,MGYAQEPRQTVZOM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205827,MGYAQEPRQTVZOM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,KI,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3323095,MHFUBIDIXOMIAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,3.4,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3323095,MHFUBIDIXOMIAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,350,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3323095,MHFUBIDIXOMIAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1.2,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323095,MHFUBIDIXOMIAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3.8,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323095,MHFUBIDIXOMIAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323095,MHFUBIDIXOMIAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,1.2,NM,314405,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323095,MHFUBIDIXOMIAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,1.2,NM,314413,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL381331,MHJZXDDQSMFDMW-ZBEGNZNMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL317757,MHNSOBBJZCWUGS-UHFFFAOYSA-N,DIFLUOROBENZTROPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9435902,KI,>,8500,NM,,"","","","","","",,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL317757,MHNSOBBJZCWUGS-UHFFFAOYSA-N,DIFLUOROBENZTROPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16213721,KI,=,844,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL404474,MHSMLXPGKSUMMH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,63,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL119605,MHWRJCBZOCBFBD-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15177457,KI,=,920000,NM,,"","","","","","",,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1687,MHXYWXHKLBMJKL-QBYKQQEBSA-N,TUBOCURARINE CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1687,MHXYWXHKLBMJKL-QBYKQQEBSA-N,TUBOCURARINE CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL543876,MIBSKSYCRFWIRU-UHFFFAOYSA-N,GBR-12909,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,IC50,=,1460,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL543876,MIBSKSYCRFWIRU-UHFFFAOYSA-N,GBR-12909,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,-5.9,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL543876,MIBSKSYCRFWIRU-UHFFFAOYSA-N,GBR-12909,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,85,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL543876,MIBSKSYCRFWIRU-UHFFFAOYSA-N,GBR-12909,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,1460,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL543876,MIBSKSYCRFWIRU-UHFFFAOYSA-N,GBR-12909,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,-6,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL543876,MIBSKSYCRFWIRU-UHFFFAOYSA-N,GBR-12909,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,20,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL543876,MIBSKSYCRFWIRU-UHFFFAOYSA-N,GBR-12909,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,85,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL407030,MIFVTYPADKEWAV-HGRQBIKSSA-N,GAMMA-CYCLODEXTRIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL407030,MIFVTYPADKEWAV-HGRQBIKSSA-N,GAMMA-CYCLODEXTRIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1080755,MIJPHKXHAZCAQK-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20137933,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL340978,MITFXPHMIHQXPI-UHFFFAOYSA-N,BENOXAPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL340978,MITFXPHMIHQXPI-UHFFFAOYSA-N,BENOXAPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2030633,MIZXZRHARATZMK-UHFFFAOYSA-N,"N-(3,4-DIMETHOXYBENZYL)PYRROLIDINE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224321,MJCKYDPFUPMINT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,1.26,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL480,MJIHNNLFOKEZEW-UHFFFAOYSA-N,LANSOPRAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL480,MJIHNNLFOKEZEW-UHFFFAOYSA-N,LANSOPRAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL305660,MJJALKDDGIKVBE-UHFFFAOYSA-N,EBASTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,460.3,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL305660,MJJALKDDGIKVBE-UHFFFAOYSA-N,EBASTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,456.4,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL471036,MJJDYOLPMGIWND-UHFFFAOYSA-N,LITOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,6500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL471036,MJJDYOLPMGIWND-UHFFFAOYSA-N,LITOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,1400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337608,MJNJOFYBUSUCSO-CXAGYDPISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,3.16,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337607,MJNJOFYBUSUCSO-GUYCJALGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,5.01,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432058,MJOVYQVAQIHDSE-DKSPCFMDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1644475,MJWXDPDEDHUUJV-JGPRNRPPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,188,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL409715,MJXIPRPHBIFHJC-MGPUTAFESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,4.2,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL551471,MJXRIUSTMWJDCG-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,22,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2207376,MJYQMQCVUXOIFY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23141912,INHIBITION,=,13.5,%,,"","","","","","",,,,,,,,Inhibition of NET at 1 uM by radioligand displacement assay,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683883,MKEIWZZHDFWQBD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,22,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL396083,MKGVCSJCNPSLPB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,789000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL396083,MKGVCSJCNPSLPB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1645596,MKIMQSUJTXVNED-UHFFFAOYSA-N,3-(2-PHENOXYPHENOXY)AZETIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,1640,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL247341,MKNCFIMZZSMFIK-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL184,MKUXAQIIEYXACX-UHFFFAOYSA-N,ACYCLOVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL184,MKUXAQIIEYXACX-UHFFFAOYSA-N,ACYCLOVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL806,MKXKFYHWDHIYRV-UHFFFAOYSA-N,FLUTAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL806,MKXKFYHWDHIYRV-UHFFFAOYSA-N,FLUTAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL52440,MKXZASYAUGDDCJ-NJAFHUGGSA-N,DEXTROMETHORPHAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL52440,MKXZASYAUGDDCJ-NJAFHUGGSA-N,DEXTROMETHORPHAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3334772,MLGACOKYDQJTGD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,IC50,=,635.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL15770,MLKXDPUZXIRXEP-MFOYZWKCSA-N,SULINDAC,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL15770,MLKXDPUZXIRXEP-MFOYZWKCSA-N,SULINDAC,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2430682,MLLKPBZCMWKIND-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,1662,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430682,MLLKPBZCMWKIND-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,66.9,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430682,MLLKPBZCMWKIND-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,87,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL503461,MLQKNFBXQZTRNM-AMVDFXKXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17428804,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]NE uptake at human wild type NET expressed in african green monkey COS1 cells after 48 hrs,chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.,J. Biol. Chem.,PUBLICATION,
CHEMBL2371931,MLQKNFBXQZTRNM-HEZRXYLWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17064074,EC50,=,1819.7,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET in COS7 cells,Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL202810,MLTWEZLEOAHOAA-SMWAQBJTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,450,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL506789,MLXZSGRSLJXYNT-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,5400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL469607,MLXZSGRSLJXYNT-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,3000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2326684,MMBDWDAKDCKUAX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,130,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL373385,MMKZDDDDODERSJ-GRAKBVBRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,270,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL373385,MMKZDDDDODERSJ-GRAKBVBRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,160,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL312037,MMKZDDDDODERSJ-GXRBRPDZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,60,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL312037,MMKZDDDDODERSJ-GXRBRPDZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,36,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL312037,MMKZDDDDODERSJ-GXRBRPDZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,=,60,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL312037,MMKZDDDDODERSJ-GXRBRPDZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,=,3850,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL312037,MMKZDDDDODERSJ-GXRBRPDZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,KI,=,36,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL312037,MMKZDDDDODERSJ-GXRBRPDZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,KI,=,1930,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL2096861,MMKZDDDDODERSJ-GYTBAZASSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,2230,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL2096861,MMKZDDDDODERSJ-GYTBAZASSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,1120,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL221993,MMKZDDDDODERSJ-JAAVRUMLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,3850,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL221993,MMKZDDDDODERSJ-JAAVRUMLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,1930,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL256646,MMSNYIQZTXLKBV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,200,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL347772,MMXYNKLYVRNTCK-UHFFFAOYSA-N,2-BENZHYDRYL-PYRIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12565962,KI,=,5530,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE uptake evaluated at the monoamine transporter (NET),Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL525559,MNHPKYUTSKOFJZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,8.43,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL93645,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,ACECLOFENAC,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL93645,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,ACECLOFENAC,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL599592,MNKYSXOLQYNYNU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,27,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673144,MNVQGSYZEJNUAT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,925.2,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL559654,MNXBENJELVJIHN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,84,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL494807,MNZCWNRZRKZOCQ-PQEADEMYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18434164,KI,=,31,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL567943,MOEMPBAHOJKXBG-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,370,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL566576,MOEMPBAHOJKXBG-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,7000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL481695,MOEZDBSMUWWXGO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,4200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL220765,MOOPIJCZPWGNKW-FIPFOOKPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,524,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL512795,MOQOVFQXRKZPCT-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,INHIBITION,=,31,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1 uM,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL215236,MOULTCTZAHHVRO-WQLSENKSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16784855,KI,=,13.03,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET transfected in HEK293 cells,Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432040,MPBJQDFYALBXED-CAUKCHDASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL223058,MPEVJCKYRIDFRP-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17123820,KI,=,8.29,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL578841,MPFXFPLOFFDVSF-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,232,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1080968,MPGDFMOXIHFZSL-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,11,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL259136,MPTXQMSURVDICU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,159,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3321790,MPWWGTFDWDZHRM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25070422,KI,=,1409,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL205837,MQFDETILCHDOAZ-ZBEGNZNMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,1150,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL564059,MQFMYYCALRUDSV-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,8,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL562802,MQFMYYCALRUDSV-CQSZACIVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,572,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL388612,MQFVMWBVJNBDJG-CIBWYJFOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,6500,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL388612,MQFVMWBVJNBDJG-CIBWYJFOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,2300,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL210027,MQGLAASXHMCXDS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,31,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL404885,MQNROJMRVKETEZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,194,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3703729,MQRPDUHCJZKKNO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,549,NM,302093,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL529,MQTOSJVFKKJCRP-BICOPXKESA-N,AZITHROMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL529,MQTOSJVFKKJCRP-BICOPXKESA-N,AZITHROMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL597,MRBDMNSDAVCSSF-UHFFFAOYSA-N,PHENTOLAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL597,MRBDMNSDAVCSSF-UHFFFAOYSA-N,PHENTOLAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL440878,MRBFFQVXMIGKST-NWDGAFQWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740668,IC50,>,100000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]NE reuptake at human NET expressed in HEK cells,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL440878,MRBFFQVXMIGKST-NWDGAFQWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740668,KI,>,100000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL313041,MRBFFQVXMIGKST-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19014888,IC50,>,100000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL313041,MRBFFQVXMIGKST-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19014888,KI,>,100000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL313041,MRBFFQVXMIGKST-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,IC50,>,100000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL313041,MRBFFQVXMIGKST-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,KI,>,100000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL3612829,MRCYIBGVKYPKAF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,IC50,=,153,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3612829,MRCYIBGVKYPKAF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.59,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL388832,MRPLQNITIUKVEG-SMOZNVCYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,4210,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL388832,MRPLQNITIUKVEG-SMOZNVCYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,1910,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL3577957,MRTJHEDYFUFHHQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25893048,ACTIVITY,,,,Not Active,"","","","","","",,,,,,,,Binding affinity to human NET at 1 uM,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL207067,MRYGKPHUQVMAJC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,6.5,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2036275,MRZYSDFMLQKBFH-LIOBNPLQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,1700,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL2036276,MRZYSDFMLQKBFH-YYLIZZNMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,760,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL359025,MSLSPRSRIMVUAY-MAUKXSAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,75,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL359025,MSLSPRSRIMVUAY-MAUKXSAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,110,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL424496,MSLSPRSRIMVUAY-YJBOKZPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,1500,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL424496,MSLSPRSRIMVUAY-YJBOKZPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,3500,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL1683874,MSRLFKAAHSYYJT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,4,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL451232,MSSKZLHARRXFKT-VNUWRVCDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19284718,KI,>,10000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.,J. Med. Chem.,PUBLICATION,
CHEMBL2432041,MSTPNDDVMWUDFF-CAUKCHDASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3215892,MTATYSOUXXNXHF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23141912,INHIBITION,=,6.28,%,,"","","","","","",,,,,,,,Inhibition of NET at 1 uM by radioligand displacement assay,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL484952,MTEFLXYKMHWTNG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19338356,ACTIVITY,<,50,%,Active,"","","","","","",,,,,,,,Binding affinity to NET,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL408329,MTFGWQIUGWXBJK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,461,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173280,MTLOYHNBLPYTSE-TVQRCGJNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,1210,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL211396,MTTQVAJJGOFFBH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,KI,>,2000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL3317695,MTYNQRLUWCXWLL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25017029,IC50,=,260,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224237,MUCOWQIQUFKAFL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,2.51,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL402924,MUJXFBPLIVKRBF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,50000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL386630,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,TESTOSTERONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL386630,MUMGGOZAMZWBJJ-DYKIIFRCSA-N,TESTOSTERONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL453996,MUOXAGUZMVATIC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,1800,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL574347,MUPPOMFFBLBAKT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,115,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200845,MUQNGPZZQDCDFT-JNQJZLCISA-N,HALCINONIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200845,MUQNGPZZQDCDFT-JNQJZLCISA-N,HALCINONIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3218985,MUQXFOQLDSJMCX-YADHBBJMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,INHIBITION,=,50,%,,"","","","","","",,,,,,,,Binding affinity to NE transporter (unknown origin) at 10 uM by displacement assay relative to control,,MedChemComm,PUBLICATION,
CHEMBL1812742,MUVQRHMVRFZUGP-IKJKNFHUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21058665,IC50,=,310,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,PUBLICATION,
CHEMBL189367,MUWHGPWUJGZMPM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15974579,KI,=,370,NM,,"",cell_based,"","","","",,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,PUBLICATION,
CHEMBL595766,MVCBKJMODFGYDE-LOKCHCMISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,2200,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL211412,MVELXQAMQGKSIK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,130,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1194,MVFGUOIZUNYYSO-UHFFFAOYSA-N,PRILOCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1194,MVFGUOIZUNYYSO-UHFFFAOYSA-N,PRILOCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL488025,MVGSNCBCUWPVDA-MFOYZWKCSA-N,EXISULIND,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL488025,MVGSNCBCUWPVDA-MFOYZWKCSA-N,EXISULIND,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL362783,MVOUTMRHQVFORJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15974579,KI,=,483.55,NM,,"",cell_based,"","","","",,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,PUBLICATION,
CHEMBL549965,MVRJFCQZNCIBPF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,23,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL523475,MVYOBBWPCHPRSG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19492813,IC50,=,1000,NM,,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter,Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,PUBLICATION,
CHEMBL283416,MWJUXAHARLFJAN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17391962,INHIBITION,=,27,%,,"","","","","","",,,,,,,,Inhibition of human NET at 1 uM,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL93,MWLSOWXNZPKENC-UHFFFAOYSA-N,ZILEUTON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL93,MWLSOWXNZPKENC-UHFFFAOYSA-N,ZILEUTON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL218999,MXBQNIQYUCTYND-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218999,MXBQNIQYUCTYND-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,19,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218999,MXBQNIQYUCTYND-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,25,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218999,MXBQNIQYUCTYND-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,120,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL215988,MXCAKGCIGZRYGJ-CHWSQXEVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,855,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL242920,MXCAKGCIGZRYGJ-QWHCGFSZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,2300,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL503234,MXNHEKIHSVXJPG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL595540,MXPYLJDZHAVWJM-DKOHEDPJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,440,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL568140,MXUDEADPGZWZCH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,2100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL568140,MXUDEADPGZWZCH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,5400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL568140,MXUDEADPGZWZCH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,1670,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL15476,MXYUKLILVYORSK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15121762,KI,=,1870,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL566958,MYBQVBFITHURNS-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,60,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL496297,MYDTUCJNFHJOAN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,0.2,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL600325,MYEJFUXQJGHEQK-ALRJYLEOSA-N,PROSCILLARIDIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL600325,MYEJFUXQJGHEQK-ALRJYLEOSA-N,PROSCILLARIDIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL345439,MYHWCLVILIUBBP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,4700,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL405349,MYIGEQURFWGOFU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,15,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL405349,MYIGEQURFWGOFU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,390,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2158704,MYJQZBNYMUUXQI-HXUWFJFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22386241,INHIBITION,,,,Not Active,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter at 10 uM,Synthesis and pharmacological evaluation of carbamic acid 1-phenyl-3-(4-phenyl-piperazine-1-yl)-propyl ester derivatives as new analgesic agents.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL262777,MYPYJXKWCTUITO-LYRMYLQWSA-N,VANCOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL262777,MYPYJXKWCTUITO-LYRMYLQWSA-N,VANCOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL8,MYSWGUAQZAJSOK-UHFFFAOYSA-N,CIPROFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL8,MYSWGUAQZAJSOK-UHFFFAOYSA-N,CIPROFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL454798,MYUDLLKSAURVGJ-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,240,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL598644,MYVJXQAAFVJXRY-VIKVFOODSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,7.94,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
,MYWUZJCMWCOHBA-UHFFFAOYSA-N,DL-METHAMPHETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12954796,KI,=,12.3,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1082209,MYYHPWVXRPLYMD-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20137933,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205815,MYZBXDLMEOAPIJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1812743,MZBDCJWEXVZTQQ-AYEZKCMBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21058665,IC50,=,26,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,PUBLICATION,
CHEMBL138354,MZEULCTZLPBZKJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,INHIBITION,=,39,%,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL223166,MZGJHBJKODTIQM-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17123820,KI,=,7.93,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL223166,MZGJHBJKODTIQM-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17983754,KI,=,0.95,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL223166,MZGJHBJKODTIQM-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19067522,KI,=,0.95,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET receptor expressed in HEK293 cells,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL1224399,MZGJPVOTOHUEGK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,3.98,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL552938,MZIGEEZFAITPCB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,25.12,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1828653,MZTLLFJYLUUPPP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,5,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1828653,MZTLLFJYLUUPPP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,22,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1095699,MZZGOOYMKKIOOX-VKHMYHEASA-N,AZASERINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1095699,MZZGOOYMKKIOOX-VKHMYHEASA-N,AZASERINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL379446,NAHZCGQMXZCULW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,531,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL379446,NAHZCGQMXZCULW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,2690,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL281594,NAUWTFJOPJWYOT-UHFFFAOYSA-N,VANOXERINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213078,IC50,=,79,NM,,"","","","","","",,,,,,,,Compound was tested for the inhibition of norepinephrine (NE) reuptake,Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL281594,NAUWTFJOPJWYOT-UHFFFAOYSA-N,VANOXERINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213078,RATIO,=,18,,,"","","","","","",,,,,,,,Ratio of IC50 value against Norepinephrine transporter (NE) to that of Dopamine transporter (DA),Piperidine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909): high affinity ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL1644600,NAZAMXVJDAUZNQ-IZZQQSIFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,891,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2047561,NBIWTPBSAFCSRX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,IC50,=,327,NM,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1813309,NBIXVIPZQQXWBM-GOEBONIOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,2454.71,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL521392,NBLMTDPDGYITGF-AEFFLSMTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,150,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL520201,NBLMTDPDGYITGF-WMZOPIPTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,150,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1586,NBMKJKDGKREAPL-DVTGEIKXSA-N,BECLOMETHASONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1586,NBMKJKDGKREAPL-DVTGEIKXSA-N,BECLOMETHASONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL205313,NBVSCHGTCFRUCS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16337793,IC50,>,100,NM,,"","","","","","",,,,,,,,Inhibitory activity against NET,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL208420,NCBUFRZNBFLCMW-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,2.7,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337598,NCBYCBRHLYXVNZ-RHSMWYFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,3.98,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL163,NCDNCNXCDXHOMX-XGKFQTDJSA-N,RITONAVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL163,NCDNCNXCDXHOMX-XGKFQTDJSA-N,RITONAVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL421,NCEXYHBECQHGNR-QZQOTICOSA-N,SULFASALAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL421,NCEXYHBECQHGNR-QZQOTICOSA-N,SULFASALAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2430677,NCPFSSICYASJEG-KBAYOESNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,10,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256408,NCRFMJNGTNNKEE-UHFFFAOYSA-N,N-(2-OXAZOLEMETHYL)MILNACIPRAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,450,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200656,NCXMLFZGDNKEPB-FFPOYIOWSA-N,NATAMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200656,NCXMLFZGDNKEPB-FFPOYIOWSA-N,NATAMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL714,NDAUXUAQIAJITI-UHFFFAOYSA-N,ALBUTEROL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL714,NDAUXUAQIAJITI-UHFFFAOYSA-N,ALBUTEROL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1642909,NDCNHLIWHOBKGK-BLLLJJGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,372,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642906,NDCNHLIWHOBKGK-LRDDRELGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,72,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642907,NDCNHLIWHOBKGK-MLGOLLRUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,126,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642908,NDCNHLIWHOBKGK-WBMJQRKESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,210,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL406,NDDAHWYSQHTHNT-UHFFFAOYSA-N,INDAPAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL406,NDDAHWYSQHTHNT-UHFFFAOYSA-N,INDAPAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL488049,NDHNYVIKBFYSGN-QFBILLFUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,430,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1970071,NDKGACIWVAOUQH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24135724,INHIBITION,>=,50,%,,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter (unknown origin) at 30 uM,"Discovery, design and synthesis of a selective S1P(3) receptor allosteric agonist.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683870,NDMODESSMWGHBK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,85,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683870,NDMODESSMWGHBK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,85,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL383611,NEDZBDOBZLQEFI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,21,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673168,NEPZBEGINWEWDI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,140.3,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL461706,NESUISGAACOCQG-RMRYJAPISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,540,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL461706,NESUISGAACOCQG-RMRYJAPISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,214,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL461705,NESUISGAACOCQG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,38,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL461705,NESUISGAACOCQG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,18,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL461707,NESUISGAACOCQG-ZEECNFPPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,25,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL461707,NESUISGAACOCQG-ZEECNFPPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,17,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL895,NETZHAKZCGBWSS-CEDHKZHLSA-N,NALBUPHINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL895,NETZHAKZCGBWSS-CEDHKZHLSA-N,NALBUPHINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3287656,NEVFWHLXCFNVPG-DTSDQNDWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24944746,INHIBITION,,,,Not Active,"",cell_based,"","","","",,,,,,,,"Inhibition of 2,5,6-[3H]-dopamine uptake at human NET expressed in African green monkey COS7 cells at 10 uM incubated for 10 mins prior to radioligand addition measured after 5 mins by scintillation counting analysis",Novel and high affinity fluorescent ligands for the serotonin transporter based on (s)-citalopram.,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL569014,NEVVQGBYHRTAEI-ZEQRLZLVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,INHIBITION,=,41,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL711,NFBAXHOPROOJAW-UHFFFAOYSA-N,PHENINDIONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL711,NFBAXHOPROOJAW-UHFFFAOYSA-N,PHENINDIONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2321991,NFEQUCGNNCYRCD-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3.3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2321992,NFEQUCGNNCYRCD-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,250,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2012737,NFEVAAXMHCVVQF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22342142,INHIBITION,,,,Not Active,"","","","","","",,,,,,,,Inhibition of norepinephrine channel at 10 uM by radioligand displacement assay,Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200406,NFLLKCVHYJRNRH-UHFFFAOYSA-N,DIMENHYDRINATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2037,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200406,NFLLKCVHYJRNRH-UHFFFAOYSA-N,DIMENHYDRINATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2020,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL130668,NFNRNOMETYDQMI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,IC50,=,1.9,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL130668,NFNRNOMETYDQMI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,KI,=,380,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL1078163,NFOLOYSQMPQIMO-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,69,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2036264,NFVFEGNKXDEQPE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,550,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL2036264,NFVFEGNKXDEQPE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,960,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL2036264,NFVFEGNKXDEQPE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,1100,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL3310490,NFVMXEOTEJTNLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,33.1,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310490,NFVMXEOTEJTNLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310490,NFVMXEOTEJTNLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310490,NFVMXEOTEJTNLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL518276,NFXSKGKGQACNCS-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,65,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL6731,NGBBVGZWCFBOGO-UHFFFAOYSA-N,TENAMFETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19717215,IC50,=,266,NM,,"","","","","","",,,,,,,,Inhibition of human noradrenaline transporter,Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL6731,NGBBVGZWCFBOGO-UHFFFAOYSA-N,TENAMFETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20466553,IC50,=,266,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,"Synthesis and in vitro toxicity of 4-MTA, its characteristic clandestine synthesis byproducts and related sulfur substituted alpha-alkylthioamphetamines.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL6731,NGBBVGZWCFBOGO-UHFFFAOYSA-N,TENAMFETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,IC50,=,3162.28,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL6731,NGBBVGZWCFBOGO-UHFFFAOYSA-N,TENAMFETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,KI,=,704,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1148,NGBFQHCMQULJNZ-UHFFFAOYSA-N,TORSEMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1148,NGBFQHCMQULJNZ-UHFFFAOYSA-N,TORSEMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1173274,NGHJSSNVKXEBAB-GXFFZTMASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,550,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL260336,NGJYHUYANNRTCI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL609023,NGRIUVQYFBDXMT-JYAVWHMHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,7.94,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL579056,NGSZLOCYHZRIMB-UHDQLFAASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,=,220,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1200862,NHTGHBARYWONDQ-JTQLQIEISA-N,METYROSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200862,NHTGHBARYWONDQ-JTQLQIEISA-N,METYROSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL453,NHUHCSRWZMLRLA-UHFFFAOYSA-N,SULFISOXAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL453,NHUHCSRWZMLRLA-UHFFFAOYSA-N,SULFISOXAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3094311,NHUZHVAPAIJQRS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24238903,INHIBITION,=,64.7,%,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL511827,NIAVVXCRSHJORD-LJQANCHMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,6,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL214237,NIBIYLDNVMUKNB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,39,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL109,NIJJYAXOARWZEE-UHFFFAOYSA-N,VALPROIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL109,NIJJYAXOARWZEE-UHFFFAOYSA-N,VALPROIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2206397,NIRASHDWADNQJU-UHFFFAOYSA-N,RO-4992479,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22795332,INHIBITION,=,-1,%,,"","","","","","",,,,,,,,Inhibition of human NE transporter at 10 uM by CEREP assay,Optimisation of imidazole compounds as selective TAAR1 agonists: discovery of RO5073012.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3703740,NIXMEJRSHLSZKN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,34.1,NM,302104,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL3085025,NIYGPRSVPKAIKA-CWNQJQRUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16213721,KI,=,3170,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL214159,NJCGBANIMWAYHY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,28,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1087921,NJGYZOMKDMARER-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,970,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL202055,NJZIWQLWRVISOP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL3673173,NJZNVVTVUJDMET-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,206.1,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL83,NKANXQFJJICGDU-QPLCGJKRSA-N,TAMOXIFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1472,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL83,NKANXQFJJICGDU-QPLCGJKRSA-N,TAMOXIFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1459,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL600424,NKULKNQOSDDCTA-VOMIJIAVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,4.1,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL600424,NKULKNQOSDDCTA-VOMIJIAVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,6.5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL3094314,NLGKYLSBSOGION-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24238903,INHIBITION,=,60.1,%,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL477783,NLRQPOSSIBJNGG-IBGZPJMESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,14,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1747,NLVFBUXFDBBNBW-PBSUHMDJSA-N,TOBRAMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1747,NLVFBUXFDBBNBW-PBSUHMDJSA-N,TOBRAMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1683881,NMFAKPRDDDKVBP-UHFFFAOYSA-N,"(1-(3,4-DICHLOROPHENYL)CYCLOHEPTYL)METHANAMINE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,2783,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL402371,NMHWBLJSIIETCI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,38,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2024094,NMIIKXFGCKOYRV-WHOFXGATSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22171543,INHIBITION,=,-0.2,%,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from NET at 10 uM,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,PUBLICATION,
CHEMBL257048,NMRSWXVEITZBIQ-UHFFFAOYSA-N,"N,N-DIMETHYL MILNACIPRAN",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1489,NMUSYJAQQFHJEW-KVTDHHQDSA-N,AZACITIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1489,NMUSYJAQQFHJEW-KVTDHHQDSA-N,AZACITIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL257906,NNGIOOYYOUWXAP-PISWEHOVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18243691,INHIBITION,=,77,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,"Potent, selective MCH-1 receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL79,NNJVILVZKWQKPM-UHFFFAOYSA-N,LIDOCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL79,NNJVILVZKWQKPM-UHFFFAOYSA-N,LIDOCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL145810,NNNDXILSDZTFTR-LPHOPBHVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,540,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL145810,NNNDXILSDZTFTR-LPHOPBHVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,2000,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL344116,NNNDXILSDZTFTR-QFBILLFUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,400,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL344116,NNNDXILSDZTFTR-QFBILLFUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,640,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL386073,NNOWQHZNUGOGEV-FIPFOOKPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,1480,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL487690,NNOXYEGAVKKWOL-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,1600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2206510,NNPFARQTHIIRJL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,47,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL578419,NNQDGWJXUJCRBF-MENKECLHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,=,121,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1173275,NNTJAYKRPQPBCZ-TVQRCGJNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,740,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1173275,NNTJAYKRPQPBCZ-TVQRCGJNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21319801,IC50,=,32,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,PUBLICATION,
CHEMBL2206515,NNVATDBGKYTMIL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,238,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL622,NNYBQONXHNTVIJ-UHFFFAOYSA-N,ETODOLAC,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL622,NNYBQONXHNTVIJ-UHFFFAOYSA-N,ETODOLAC,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL257047,NOZPULFYDFZTCM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL757,NPAGDVCDWIYMMC-IZPLOLCNSA-N,NANDROLONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL757,NPAGDVCDWIYMMC-IZPLOLCNSA-N,NANDROLONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL514759,NPBACWUTGOBPGG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,11,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1169733,NPBFISOTLZPTLN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,199.53,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3039597,NPEFREDMMVQEPL-RWPARATISA-N,GENTAMICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3039597,NPEFREDMMVQEPL-RWPARATISA-N,GENTAMICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3663909,NPFSYWQNMCUQFC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1640,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663909,NPFSYWQNMCUQFC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,5640,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663909,NPFSYWQNMCUQFC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,7530,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663909,NPFSYWQNMCUQFC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,1640,NM,314402,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL1644603,NPRIIPJXYKFSOJ-IZZQQSIFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,85,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL383220,NQBLHHIYFYAVRB-RBUKOAKNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16413778,INHIBITION,=,19.8,%,,"","","","","","",,,,,,,,Binding affinity to NET at 100 nM,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL550289,NQBQXWBCVCHJSE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,91,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL57,NQDJXKOVJZTUJA-UHFFFAOYSA-N,NEVIRAPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL57,NQDJXKOVJZTUJA-UHFFFAOYSA-N,NEVIRAPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL594068,NQKROFWTWKENTC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,INHIBITION,=,43,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1000 nM after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL559802,NQUQUDJZIDCEFJ-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,30,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL207914,NQWIZKWCQGEVLT-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,7.1,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2047574,NQXSFBZVBLPNCG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,IC50,=,178,NM,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL3673133,NQZVQAKLVZGMOR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,102.8,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3673133,NQZVQAKLVZGMOR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,674.4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL141974,NRBVOOUZUSJEKA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,KI,=,70,NM,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL577565,NREAZRDUCYUONQ-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,124,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL551135,NRIPPOKFEABEPU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,10,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1644605,NRKLSKYRBUUDLU-BJWYYQGGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,90,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL247340,NRMWWURWZRGVIQ-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,4,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1177,NRNCYVBFPDDJNE-UHFFFAOYSA-N,PEMOLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1177,NRNCYVBFPDDJNE-UHFFFAOYSA-N,PEMOLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3703743,NRTIHDQHAKWSTG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,26.4,NM,302107,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL598228,NRTIMMZNHIFNOB-IJOPVONJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,2,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL3310630,NRVOSXXQMRKXOI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,56,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL232672,NRWFUCFNIMDFPX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,550000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL232672,NRWFUCFNIMDFPX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,1390000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL202755,NSIMWGJISYLRDI-SJCJKPOMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL574629,NSKFLKQWPVFAAE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,6,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL374967,NSKKXDBWURWAOW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17367122,INHIBITION,=,77,%,,"",cell_based,"","","","",CHO,,,,,,,Displacement of radiolabeled protriptyline from human recombinant NET expressed in CHO cells at 10 uM,Designing active template molecules by combining computational de novo design and human chemist's expertise.,J. Med. Chem.,PUBLICATION,
CHEMBL1224300,NSQVIEVBUSYQLK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,25,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2407326,NSTTWNJKAWCIFK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,28,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1083705,NSVJPFSJIISEIG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,22,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL559456,NTBRVAZZXJHBGJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,6,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL559456,NTBRVAZZXJHBGJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL559456,NTBRVAZZXJHBGJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,128,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL195437,NTDQQZYCCIDJRK-UHFFFAOYSA-N,4-OCTYLPHENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,61647,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL195437,NTDQQZYCCIDJRK-UHFFFAOYSA-N,4-OCTYLPHENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,61138,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL243712,NTJOBXMMWNYJFB-UHFFFAOYSA-N,AMISULPRIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19337725,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL445743,NTKCCYPDVMIZQP-AEFFLSMTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,300,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL538053,NTMVOPDZLWZAQO-APTPAJQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,1800,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL258060,NTOHKBIOUPYUFZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,25,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205830,NTRDOPDLDNCOHJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205830,NTRDOPDLDNCOHJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3334801,NTSASDUHAQEZEA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,IC50,=,373.5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL2321997,NTSBDQLGAZMMFC-LLVKDONJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,54,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2321996,NTSBDQLGAZMMFC-NSHDSACASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,12,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2321995,NTSBDQLGAZMMFC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,57,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL473966,NTTIJAHCUAQKMW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,IC50,=,20370,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL473966,NTTIJAHCUAQKMW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,KI,=,19332,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL442272,NUAORYLXEWKQRZ-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL415098,NUAPUMDPHIFPBC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,21,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL263920,NUGRPPXOWJFLKG-OALUTQOASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,16,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3663920,NUMHOXGZNHJTHF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,10.4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663920,NUMHOXGZNHJTHF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,38.6,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663920,NUMHOXGZNHJTHF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,79.4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663920,NUMHOXGZNHJTHF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,38.6,NM,314428,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL207635,NUNBGFOIBBDTEC-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,95.9,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL404345,NUQCHJVIHOGEMV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,4900,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1644473,NUQHQIXAXZDZPW-PTEHBNRSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,347,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1784671,NVCJMYLJSSPEKR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21570838,INHIBITION,<,50,%,Not Active,"","","","","","",,,,,,,,Inhibition of human recombinant NET at 10 uM by radioligand binding assay,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673153,NVDYVZGABKJWFJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,5461,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL1224402,NVHLQOKZIFFNOX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,2.51,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224402,NVHLQOKZIFFNOX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,6.31,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL440584,NVIWIEFWADBWQX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,255,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL121027,NVIYCTHUJATAOR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,IC50,=,279,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL121027,NVIYCTHUJATAOR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,KI,=,370,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL476356,NVJYGIYRPBUKCC-PMACEKPBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,2,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL478876,NVJYGIYRPBUKCC-UXHICEINSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,35,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL27769,NVKAWKQGWWIWPM-ABEVXSGRSA-N,STANOLONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL27769,NVKAWKQGWWIWPM-ABEVXSGRSA-N,STANOLONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL14924,NVNZDUXXKQYTHC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14971892,KI,=,161,NM,,"","","","","","",,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [125I]-RTI-55 radioligand,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL109517,NWCPOGFPLUASJD-PEVDHWGLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,IC50,=,34,NM,,"","","","","","",,,,,,,,In vitro inhibition of [3H]NE re-uptake into synaptosome,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL109517,NWCPOGFPLUASJD-PEVDHWGLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,KI,=,149,NM,,"","","","","","",,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL326466,NWCPOGFPLUASJD-QUDVFMAMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,IC50,=,25,NM,,"","","","","","",,,,,,,,In vitro inhibition of [3H]NE re-uptake into synaptosome,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL326466,NWCPOGFPLUASJD-QUDVFMAMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,KI,=,152,NM,,"","","","","","",,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL326466,NWCPOGFPLUASJD-QUDVFMAMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16220969,IC50,=,25,NM,,"","","","","","",,,,,,,,Inhibition constant against norepinephrine transporter,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL109571,NWCPOGFPLUASJD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,IC50,=,45,NM,,"","","","","","",,,,,,,,In vitro inhibition of [3H]NE re-uptake into synaptosome,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL109571,NWCPOGFPLUASJD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,KI,=,111,NM,,"","","","","","",,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL105,NWIBSHFKIJFRCO-WUDYKRTCSA-N,MITOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL105,NWIBSHFKIJFRCO-WUDYKRTCSA-N,MITOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL270607,NWKCIVHGGAEYQL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18060777,KI,=,2000,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL102018,NWRMTPHQJUHLJH-NOZYUVCASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10698458,IC50,=,110,NM,,"",cell_based,"","","","",,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2326688,NWTJKIVXQLVNCQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,430,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL394089,NWZPRTYDJDHZJI-HZPDHXFCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,675000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL404475,NXELRJXDBIVZKB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,8400,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL572,NXFQHRVNIOXGAQ-YCRREMRBSA-N,NITROFURANTOIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL572,NXFQHRVNIOXGAQ-YCRREMRBSA-N,NITROFURANTOIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2113054,NXQVAVZAULOMGQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15974579,KI,=,191,NM,,"",cell_based,"","","","",,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,PUBLICATION,
CHEMBL214056,NXRPSLBPUSCIJD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL208069,NXRRKZLGAMZHCY-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,61,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2326691,NYADKXRJISYHGA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,74,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL216773,NYBAGOILAMMUMR-NCHKHCDFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16302792,KI,=,627,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]dopamine from human NET expressed in COS7 cells,"Rhodamine-labeled 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)tropane analogues as high-affinity fluorescent probes for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL3334802,NYBUFVNFJIAWTL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,IC50,=,136.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL207894,NYDRNGXEWTVMOM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,51,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL426304,NYDUTEZMPZHSRY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,81,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL426304,NYDUTEZMPZHSRY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,670,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL70586,NYKCGQQJNVPOLU-ONTIZHBOSA-N,SPIRADOLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL70586,NYKCGQQJNVPOLU-ONTIZHBOSA-N,SPIRADOLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL92401,NYMGNSNKLVNMIA-UHFFFAOYSA-N,IPRONIAZID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL92401,NYMGNSNKLVNMIA-UHFFFAOYSA-N,IPRONIAZID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL92401,NYMGNSNKLVNMIA-UHFFFAOYSA-N,IPRONIAZID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL257602,NYOJDMQJBPXCHG-GXTWGEPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,5.6,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1645618,NYOUEYCHUPCVGU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,1140,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171209,NYTOPNHZBPMVJZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,3.5,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL440554,NYXHSNJGOQCTBS-MQMFKJKRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15012999,INHIBITION,=,42,%,,"","","","","","",,,,,,,,Inhibitory activity against human adrenergic norepinephrine transporter at 10 uM,Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL408206,NZBRXUBKIJFZOJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18060777,KI,=,82,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL461268,NZCDMSTWUUULEH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,59,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL461268,NZCDMSTWUUULEH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL415324,NZHGWWWHIYHZNX-CSKARUKUSA-N,TRANILAST,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL415324,NZHGWWWHIYHZNX-CSKARUKUSA-N,TRANILAST,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL201223,OAASRUWEEIXAQF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16202585,IC50,=,82700,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323097,OADBNBUTUOPDJD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,130,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3323097,OADBNBUTUOPDJD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,8.8,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323097,OADBNBUTUOPDJD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,11.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323097,OADBNBUTUOPDJD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,14.3,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323097,OADBNBUTUOPDJD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,28.4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323097,OADBNBUTUOPDJD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,37.9,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323097,OADBNBUTUOPDJD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,128,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323097,OADBNBUTUOPDJD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,28.4,NM,314412,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323097,OADBNBUTUOPDJD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,37.9,NM,314404,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL1237174,OAKJQQAXSVQMHS-UHFFFAOYSA-N,HYDRAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1237174,OAKJQQAXSVQMHS-UHFFFAOYSA-N,HYDRAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL512685,OAUPYPVBPTVZBM-CQMVAQQKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,>,2000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2206513,OBCHZURPAABPDI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,136,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2029053,OBIZFSZXDHWUJZ-ANUWOGMRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15177457,KI,>,10000000,NM,,"","","","","","",,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643512,OBKCQTGBMZHBFE-CQSZACIVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21095126,IC50,=,138,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant norepinephrine transporter,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643509,OBKCQTGBMZHBFE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21095126,IC50,=,926,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant norepinephrine transporter,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL233532,OBKUWTMFPMVPNX-RTBURBONSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,658000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2206527,OBNBMYWZKYYXNS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,13.5,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL522065,OBPAJKUDOWNRDR-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,36,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL498687,OBPAJKUDOWNRDR-OALUTQOASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,15,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684047,OBWKCACUZGJXHN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684047,OBWKCACUZGJXHN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,10,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684047,OBWKCACUZGJXHN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,570,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684047,OBWKCACUZGJXHN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26935940,IC50,=,10,NM,,"","","","","","",,,,,,,,Inhibition of recombinant human norepinephrine transporter assessed as reduction in [3H]-NA reuptake,Emerging targets and new small molecule therapies in Parkinson's disease treatment.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3673148,OCDDZWTUNAXZEY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,175.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL403370,OCFADYHICWCDMN-ZBEGNZNMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,2200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL155603,OCTRGLRMRCYOEE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,2200,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL561739,OCXCCNYHGSRYEK-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,29,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL583411,OCYLDAPFNOMBGQ-MJGOQNOKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,18,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL402365,OCYYUEJRVUGFGH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,6500,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2326693,ODFLDWCDMOARBM-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,12,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL917,ODKNJVUHOIMIIZ-RRKCRQDMSA-N,FLOXURIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL917,ODKNJVUHOIMIIZ-RRKCRQDMSA-N,FLOXURIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1075627,ODLHCKMRHURGDZ-MIBBOOFZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL101740,ODQWQRRAPPTVAG-BOPFTXTBSA-N,CIDOXEPIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,29.5,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1628227,ODQWQRRAPPTVAG-UHFFFAOYSA-N,DOXEPIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,29,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1628227,ODQWQRRAPPTVAG-UHFFFAOYSA-N,DOXEPIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,29,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL399430,ODQZUOPUJDCECI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,130000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3334774,ODTKQPAQIAKYDZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,74,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL208535,ODVLOSXWFXUKAY-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,5.5,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL190860,ODXYYPIOITXURW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15801845,KI,=,141.7,NM,,"",cell_based,"","","","",HEK293,,,,,,,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,PUBLICATION,
CHEMBL167911,OEBRKCOSUFCWJD-UHFFFAOYSA-N,DICHLORVOS,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL167911,OEBRKCOSUFCWJD-UHFFFAOYSA-N,DICHLORVOS,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL303232,OECDZVROWVHNGS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15080991,KI,>,20000,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity to norepinephrine (NE) transporter in membranes of cells selectively expressing the human genes for NET,Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL197913,OECITYWBFXTMBT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16202585,IC50,=,23000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL783,OELFLUMRDSZNSF-BRWVUGGUSA-N,NATEGLINIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL783,OELFLUMRDSZNSF-BRWVUGGUSA-N,NATEGLINIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL209094,OEPVPUNMOOHWKG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,4.2,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL407,OFBIFZUFASYYRE-UHFFFAOYSA-N,FLUMAZENIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL407,OFBIFZUFASYYRE-UHFFFAOYSA-N,FLUMAZENIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,ALLOPURINOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1467,OFCNXPDARWKPPY-UHFFFAOYSA-N,ALLOPURINOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL187935,OFFZXSBVSKRSFL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15974579,KI,=,194,NM,,"",cell_based,"","","","",,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,PUBLICATION,
CHEMBL1601669,OFHCOWSQAMBJIW-AVJTYSNKSA-N,ALFACALCIDOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1009,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1601669,OFHCOWSQAMBJIW-AVJTYSNKSA-N,ALFACALCIDOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1000,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3262896,OFHXXBRBGWUOHR-NYYWCZLTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24678947,ACTIVITY,,,,Not Active,"","","","","","",,,,,,,,Binding affinity to NET (unknown origin) at 10 uM,Identification and characterization of small molecule modulators of the Epstein-Barr virus-induced gene 2 (EBI2) receptor.,J. Med. Chem.,PUBLICATION,
CHEMBL1071,OFPXSFXSNFPTHF-UHFFFAOYSA-N,OXAPROZIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1071,OFPXSFXSNFPTHF-UHFFFAOYSA-N,OXAPROZIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1440,OFVLGDICTFRJMM-WESIUVDSSA-N,TETRACYCLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1440,OFVLGDICTFRJMM-WESIUVDSSA-N,TETRACYCLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2407324,OFVYRZBLIGHUKA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,120,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL936,OGAKLTJNUQRZJU-UHFFFAOYSA-N,DIPHENIDOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL936,OGAKLTJNUQRZJU-UHFFFAOYSA-N,DIPHENIDOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL323447,OGDCBGGLUZRVAG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,IC50,=,297,NM,,"","","","","","",,,,,,,,In vitro inhibition of [3H]NE re-uptake into synaptosome,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL323447,OGDCBGGLUZRVAG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,KI,=,183,NM,,"","","","","","",,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL384687,OGFNNMZMCOBWPR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,48,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL723,OGHNVEJMJSYVRP-UHFFFAOYSA-N,CARVEDILOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,538,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL723,OGHNVEJMJSYVRP-UHFFFAOYSA-N,CARVEDILOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,533,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL9,OGJPXUAPXNRGGI-UHFFFAOYSA-N,NORFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL9,OGJPXUAPXNRGGI-UHFFFAOYSA-N,NORFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL609883,OGJYXTXOUOYPDQ-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,9,NM,,"","","","","","",,,,,,,,Inhibition of norepinephrine reuptake at NET,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL585708,OGJYXTXOUOYPDQ-OALUTQOASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,IC50,=,42,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1644483,OGKOSOTXSHSDIP-DABQJJPHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,126,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL870,OGSPWJRAVKPPFI-UHFFFAOYSA-N,ALENDRONIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL870,OGSPWJRAVKPPFI-UHFFFAOYSA-N,ALENDRONIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL409277,OGUCJMOATTVEME-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,29,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL192528,OGVZXKWRLUGGKA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15801845,KI,=,3910,NM,,"",cell_based,"","","","",HEK293,,,,,,,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,PUBLICATION,
CHEMBL90555,OGWKCGZFUXNPDA-XQKSVPLYSA-N,VINCRISTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL90555,OGWKCGZFUXNPDA-XQKSVPLYSA-N,VINCRISTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL520349,OHOQFGDSEWQDAX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19338356,ACTIVITY,<,50,%,Active,"","","","","","",,,,,,,,Binding affinity to NET,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL524188,OHTMMULBWQHGBT-AAPAXJHYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18434164,KI,=,55,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL495464,OHTMMULBWQHGBT-JRJWNBDDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18434164,KI,=,3.4,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL218847,OICPVJMMZDEJMO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,50,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218847,OICPVJMMZDEJMO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218847,OICPVJMMZDEJMO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218847,OICPVJMMZDEJMO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,1400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL1083409,OIFBYCGNUDQJBL-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,2,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1083409,OIFBYCGNUDQJBL-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1083408,OIFBYCGNUDQJBL-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1083408,OIFBYCGNUDQJBL-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,9,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1083393,OIFBYCGNUDQJBL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,2,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL131,OIGNJSKKLXVSLS-VWUMJDOOSA-N,PREDNISOLONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL131,OIGNJSKKLXVSLS-VWUMJDOOSA-N,PREDNISOLONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL334929,OIHBSJFKSKENBL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,INHIBITION,=,38,%,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1084042,OIHGHECQZMOUEI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,2,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1084042,OIHGHECQZMOUEI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL477587,OIJZGDHTGREJNF-JKIUYZKVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18644726,KI,=,102,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: chemical synthesis, evaluation in vitro and radiofluorination.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL449277,OIJZGDHTGREJNF-UHGJSFDGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18644726,KI,=,772,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: chemical synthesis, evaluation in vitro and radiofluorination.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2338040,OIMUKKZXUMOQAB-SJCJKPOMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,50.12,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2338041,OIMUKKZXUMOQAB-SJKOYZFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,10,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1237064,OIRCMLIIRQJBKA-CABZTGNLSA-N,"RAC-1-(3,4-DICHLO ROPHENYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERS)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,100,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1237064,OIRCMLIIRQJBKA-CABZTGNLSA-N,"RAC-1-(3,4-DICHLO ROPHENYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERS)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,251.19,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL575289,OIRUCIGVEPJTON-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,192,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3085030,OIYSCQVQNFKYTO-PKQPGRETSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16213721,KI,=,1630,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL204490,OIZUHURZTLEFGZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL231684,OJEXZTOASHOTIX-WOJBJXKFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,51000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL253376,OJGDCBLYJGHCIH-UHFFFAOYSA-N,BROMHEXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL253376,OJGDCBLYJGHCIH-UHFFFAOYSA-N,BROMHEXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3673169,OJMJJCYLOPIDKJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,112.4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL1447,OJMMVQQUTAEWLP-KIDUDLJLSA-N,LINCOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1447,OJMMVQQUTAEWLP-KIDUDLJLSA-N,LINCOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3085032,OJNGNVWCSYYTTM-MUJYYYPQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16213721,KI,=,259,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL94739,OJSFTALXCYKKFQ-YLJYHZDGSA-N,FEMOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,760,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL206580,OJTUQCJDORIBOX-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,300,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL471518,OJWLQAQJTIVAQB-HXUWFJFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,311,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432038,OKCSFONJDXUZOU-CAUKCHDASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL408384,OKJDGNKVEJTMBB-KBXCAEBGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,7.6,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL386281,OKJKIOJUDZFVDL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17234405,INHIBITION,=,45,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter receptor at 10uM,"An evaluation of 3,4-methylenedioxy phenyl replacements in the aminopiperidine chromone class of MCHr1 antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1644601,OKLKBYAVPPRKEG-IZZQQSIFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,132,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL138343,OKTHWSZPNZAXGL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,INHIBITION,=,23,%,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL526,OLBCVFGFOZPWHH-UHFFFAOYSA-N,PROPOFOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,9393,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL526,OLBCVFGFOZPWHH-UHFFFAOYSA-N,PROPOFOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,9316,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL231809,OLBSGDZXLHSPOR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17391962,INHIBITION,=,70,%,,"","","","","","",,,,,,,,Inhibition of human NET at 1 uM,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL609904,OLCRHPXGKWMFIP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,74,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL6467,OLEWMKVPSUCNLG-UHFFFAOYSA-N,4-METHYLTHIOAMPHETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19717215,EC50,=,34673.69,NM,,"",cell_based,"","","","",HEK293,,,,,,,Induction of human NET-dependent cytotoxicity in NET expressing HEK293 cells after 48 hrs by neutral red assay,Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL6467,OLEWMKVPSUCNLG-UHFFFAOYSA-N,4-METHYLTHIOAMPHETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19717215,IC50,=,2375,NM,,"","","","","","",,,,,,,,Inhibition of human noradrenaline transporter,Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL478835,OLINBEUJWKQKCV-IBGZPJMESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,10,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL260863,OLIZEOZRLLYHDY-HNAYVOBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,15,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL479683,OLLHYYCQHNBTQC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24582985,INHIBITION,=,34.6,%,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) at 10 uM by radioligand binding assay relative to control,5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC): a novel non-nitrogenous ligand for 5-HT2B receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL348865,OLLIUPXULGNHBZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,>,20000,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL1684053,OLMZNNJAFQDNIY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL367169,OLUONKODHNDKJM-HQRWHSCBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15012999,INHIBITION,=,23,%,,"","","","","","",,,,,,,,Inhibitory activity against human adrenergic norepinephrine transporter at 10 uM,Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3703750,OLXVUIIXACCIHX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,63,NM,198870,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL452376,OLYZEORLRJZNQC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,760,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2096856,OMBOXYLBBHNWHL-HXSCFSKGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,>,10000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL376899,OMBOXYLBBHNWHL-SHWKFHJASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,541,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL376899,OMBOXYLBBHNWHL-SHWKFHJASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,271,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL83729,OMBOXYLBBHNWHL-VOFREWHGSA-N,WIN-35066-2,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,920,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL83729,OMBOXYLBBHNWHL-VOFREWHGSA-N,WIN-35066-2,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,550,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL83729,OMBOXYLBBHNWHL-VOFREWHGSA-N,WIN-35066-2,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,=,920,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL83729,OMBOXYLBBHNWHL-VOFREWHGSA-N,WIN-35066-2,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,KI,=,550,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL3612832,OMKGHFXHPUBOFJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.32,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL198011,OMMZYEKKLHJLJY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,77,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL574020,OMORUWMYPOOINH-YNYQRCFRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,=,690,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL255450,OMTGXKFSSPIPRK-DZGCQCFKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,2.8,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200624,ONKUMRGIYFNPJW-KIEAKMPYSA-N,ETHYNODIOL DIACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200624,ONKUMRGIYFNPJW-KIEAKMPYSA-N,ETHYNODIOL DIACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3334792,ONLLHTKWUBCLOO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,19.4,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL583750,ONPYWJJNTLFDAR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL596989,ONSLZFSSJGOMSK-CPUCHLNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,12.59,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL596987,ONSLZFSSJGOMSK-GRDNDAEWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,0.158,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL596987,ONSLZFSSJGOMSK-GRDNDAEWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,0.794,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL510855,ONSNNWXLUHKPDE-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,29,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL602305,ONWOFJCPRAZRKC-BOPFTXTBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20020710,ACTIVITY,=,43,%,,"","","","","","",,,,,,,,Binding affinity to NET at 10 uM by displacement assay,Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain.,J. Med. Chem.,PUBLICATION,
CHEMBL564935,OOCIRVSPZDCFHT-IBGZPJMESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,3,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1382,OOGJQPCLVADCPB-HXUWFJFHSA-N,TOLTERODINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21863888,ACTIVITY,=,15,%,,"","","","","","",,,,,,,,Binding affinity at human NET receptor at 10 uM,Efficient Conversion of a Nonselective Norepinephrin Reuptake Inhibitor into a Dual Muscarinic Antagonist-ß(2)-Agonist for the Treatment of Chronic Obstructive Pulmonary Disease.,J. Med. Chem.,PUBLICATION,
CHEMBL378447,OOJWGIFGXZKDHN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,38,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3634745,OOOKPENMJKOYJM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26421921,IC50,>,1200,NM,,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter (unknown origin),"Design, Synthesis, and Pharmacological Evaluation of 5,6-Disubstituted Pyridin-2(1H)-one Derivatives as Phosphodiesterase 10A (PDE10A) Antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL450184,OORQAYQYEWAQJS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18793858,KI,>,1000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,"Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL198842,OOXDSSIGOMBXFF-WKIMUTGTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16302792,KI,=,308,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]dopamine from human NET expressed in COS7 cells,"Rhodamine-labeled 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)tropane analogues as high-affinity fluorescent probes for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL502379,OOXPOUDWMPWCQG-RBUKOAKNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,1.5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1170373,OOXRIQOVBUMMQG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,79.43,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL447750,OOZOQFAQHUVOAM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,2322,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL447750,OOZOQFAQHUVOAM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,4543,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL470488,OPHKAGKHRDCCTP-DPYJAVKESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,>,2000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3593275,OPTPKUISFYHAGF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,17,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3593392,OPTPKUISFYHAGF-UTONKHPSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,5.6,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3593391,OPTPKUISFYHAGF-YDALLXLXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,700,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL685,OPXLLQIJSORQAM-UHFFFAOYSA-N,MEBENDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL685,OPXLLQIJSORQAM-UHFFFAOYSA-N,MEBENDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL446321,OPZIFOOJYWJNSE-DLBZAZTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1371770,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,PIRIBEDIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11356907,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL3287655,OQGUIOWSTCLFME-GNFJTHHVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24944746,INHIBITION,,,,Not Active,"",cell_based,"","","","",,,,,,,,"Inhibition of 2,5,6-[3H]-dopamine uptake at human NET expressed in African green monkey COS7 cells at 10 uM incubated for 10 mins prior to radioligand addition measured after 5 mins by scintillation counting analysis",Novel and high affinity fluorescent ligands for the serotonin transporter based on (s)-citalopram.,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL459730,OQIBXTHHXDTIBJ-OAQYLSRUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18754613,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human cloned NET,"Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors.",J. Med. Chem.,PUBLICATION,
CHEMBL1697694,OQIQSTLJSLGHID-WNWIJWBNSA-N,AFLATOXIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1697694,OQIQSTLJSLGHID-WNWIJWBNSA-N,AFLATOXIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1813480,OQMBCBJEQWFPSN-DZGCQCFKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,>,10000,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL200906,OQMLSKSSPKAKJQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16275071,ACTIVITY,=,12,%,,"","","","","","",,,,,,,,Activity against norepinephrine uptake at 10 uM,A new chemical tool for exploring the physiological function of the PDE2 isozyme.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL207480,OQNFDJJNTQSMQQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,3.1,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL396537,OQPMHMPOPMZPGV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17391962,INHIBITION,=,81,%,,"","","","","","",,,,,,,,Inhibition of human NET at 1 uM,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL497665,OQRZMLVFIJAOKO-CRAIPNDOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,35,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL455447,OQRZMLVFIJAOKO-MAUKXSAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,10,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL455447,OQRZMLVFIJAOKO-MAUKXSAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL521179,OQWZIAVXCYIZNN-UHFFFAOYSA-N,SR-3677,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18834107,INHIBITION,=,16,%,,"","","","","","",,,,,,,,Inhibition of human NET at 3 uM,Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL467124,OQXFVNHXQYQZBS-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,INHIBITION,=,32,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1 uM,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3113644,ORDPXOCNLOPGLX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24393810,INHIBITION,=,-2,%,,"","","","","","",,,,,,,,Displacement of [3H]-nisoxetin from human norepinephrine transporter at 1 uM relative to control,A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL565382,OROOSQVGDDDAFY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,2000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL565382,OROOSQVGDDDAFY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,4300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL562244,ORQNDGDHUCGODU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,2,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL599639,ORUPHFRKUPILCN-HEHGZKQESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,1.95,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL599639,ORUPHFRKUPILCN-HEHGZKQESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,15.85,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL610795,ORUPHFRKUPILCN-IOASZLSFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,0.631,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL607871,ORUPHFRKUPILCN-WOSRLPQWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,125.89,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL457930,OSAULANLOUKVQI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,10,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL398440,OSDLLIBGSJNGJE-UHFFFAOYSA-N,CHLOROXYLENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL398440,OSDLLIBGSJNGJE-UHFFFAOYSA-N,CHLOROXYLENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL469458,OSFVTFVGHYSFBU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,INHIBITION,=,34,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells at 1000 nM,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL469458,OSFVTFVGHYSFBU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,519,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL567712,OSHSXYCWEWJREH-LJQANCHMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,677,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL407563,OSJBPKOZISTQCO-DZGCQCFKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,8999,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL402116,OSJBPKOZISTQCO-HIFRSBDPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,2250,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL402116,OSJBPKOZISTQCO-HIFRSBDPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1909072,OSJJYEUEJRVVOD-UHFFFAOYSA-N,PIPAMAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,450,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909072,OSJJYEUEJRVVOD-UHFFFAOYSA-N,PIPAMAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,446,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL577598,OSJVAFCFAQCABQ-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,92,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL155109,OSRPQIAWURAKDF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,430,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL108545,OSWPMRLSEDHDFF-UHFFFAOYSA-N,METHYL SALICYLATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL108545,OSWPMRLSEDHDFF-UHFFFAOYSA-N,METHYL SALICYLATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL459176,OSXVIZKTSFAUPG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,1,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL143707,OTCJLGGVKHCDCO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15801845,KI,=,663.8,NM,,"",cell_based,"","","","",HEK293,,,,,,,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,PUBLICATION,
CHEMBL3317696,OTPNPTZDWITNTA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25017029,IC50,=,2000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL29835,OTPPJICEBWOCKD-UHFFFAOYSA-N,BESIPIRDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,430,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL597530,OTTUCFBNHXCUBH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,536,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1236282,OTVAEFIXJLOWRX-NXEZZACHSA-N,THIAMPHENICOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1236282,OTVAEFIXJLOWRX-NXEZZACHSA-N,THIAMPHENICOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1644470,OTYQXOHDRTWMJY-MUJYYYPQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,26,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL817,OUDSBRTVNLOZBN-UHFFFAOYSA-N,TOLAZAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL817,OUDSBRTVNLOZBN-UHFFFAOYSA-N,TOLAZAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL26260,OUGIDAPQYNCXRA-UHFFFAOYSA-N,BETA-NAPHTHOFLAVONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL26260,OUGIDAPQYNCXRA-UHFFFAOYSA-N,BETA-NAPHTHOFLAVONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL410286,OULZYJCJGXXRLZ-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,160,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL248932,OUMLAORSIFDYJV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,IC50,=,710,NM,,"","","","","","",,,,,,,,Inhibition of NET,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL248932,OUMLAORSIFDYJV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,INHIBITION,=,68,%,,"","","","","","",,,,,,,,Inhibition of NET at 1 uM,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL571443,OUQIHZQQYQPARR-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,31,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL203776,OUQMYOZRLIWPPV-UGSOOPFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,1250,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL204288,OVEGFFRUJIZDSI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,800,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL204288,OVEGFFRUJIZDSI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,2350,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1076379,OVMNIKGRTOYPDR-JATJWMBJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL316862,OVSAXOVRTVDPOU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,205,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL316862,OVSAXOVRTVDPOU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,125,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL251254,OVSQVDMCBVZWGM-DTGCRPNFSA-N,HYPEROSIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12110997,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL250450,OVSQVDMCBVZWGM-QSOFNFLRSA-N,ISOQUERCETIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12110997,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1818447,OVVOKUDGMQGUQG-HUUCEWRRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,31.62,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL391143,OVZCYWBNBLGMMB-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,20,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL498680,OWDDBNVCYYHRPW-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,140,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1084933,OWEYOMCWVMSOQF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,38,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL611962,OWLDNNYJJFSQJU-LOKCHCMISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,1900,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL595674,OWRBWLIVQNSHAQ-DDZGMJBXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,1700,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL77675,OWRCNXZUPFZXOS-UHFFFAOYSA-N,"N,N'-DIPHENYL-GUANIDINE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1152,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL77675,OWRCNXZUPFZXOS-UHFFFAOYSA-N,"N,N'-DIPHENYL-GUANIDINE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1143,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1173751,OWTIWTHXBDWNDV-HUUCEWRRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,7.94,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL556268,OWUWJHDPUJMAGB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,48,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL188921,OWYLAEYXIQKAOL-UHFFFAOYSA-N,BUFLOMEDIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL188921,OWYLAEYXIQKAOL-UHFFFAOYSA-N,BUFLOMEDIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3612826,OXADJUSYVLITBP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,IC50,=,268,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3612826,OXADJUSYVLITBP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.72,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL250000,OXDQCMPUWXORTN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,300000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL270595,OXEFHEYEQUISKC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3663911,OXERSMRQMIRNOS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,22,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663911,OXERSMRQMIRNOS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,26.8,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663911,OXERSMRQMIRNOS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,>,300,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663911,OXERSMRQMIRNOS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,22,NM,314409,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL457415,OXWLQFOLXMGQTM-CHKHYCHESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,180,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL403949,OXXNPMVLHAHIKP-WMLDXEAASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,160,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL502707,OXYQNDFARIFPMG-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,89,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL404729,OYNDMWYYCBLSSM-HNAYVOBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,3.2,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL37744,OYPPVKRFBIWMSX-SXGWCWSVSA-N,ZIMELDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,9400,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL218193,OYPZJIHQZRPSNC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,7100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218193,OYPZJIHQZRPSNC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,>,8700,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218193,OYPZJIHQZRPSNC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,2500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218193,OYPZJIHQZRPSNC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,3200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL1077209,OYUQXAOEDHJVKK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,88,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL203488,OYYFMZJTKZIRQM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,21,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL203488,OYYFMZJTKZIRQM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,37.8,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL256136,OZGYIQFKTKLWDA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,26,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430694,OZKUXEIZXWPRFX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,59,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430694,OZKUXEIZXWPRFX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,65.7,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3704754,OZLLUGNMXJLQIE-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,2.3,NM,317709,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL3704754,OZLLUGNMXJLQIE-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,30.3,NM,317697,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL3704755,OZLLUGNMXJLQIE-CQSZACIVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,299.7,NM,317710,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL3704755,OZLLUGNMXJLQIE-CQSZACIVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,3415,NM,317698,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL3704753,OZLLUGNMXJLQIE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,8.1,NM,317708,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL3704753,OZLLUGNMXJLQIE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,50.1,NM,317696,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL469947,OZOIMHBDGJFSOJ-NHYWBVRUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954038,IC50,=,17,NM,,"",cell_based,"","","","",HEK293,,,,,,,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter","Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL471855,OZOVADGYFYTOAE-LJQANCHMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,80,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL139106,OZRCVSKLTROWSZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,INHIBITION,=,56,%,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL294481,OZUHPVAODZNQKI-RVWIWJKTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18644726,KI,=,1020,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: chemical synthesis, evaluation in vitro and radiofluorination.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL293583,OZUHPVAODZNQKI-XGAFWQRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18644726,KI,=,96.7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"3-(4-(6-Fluoroalkoxy-3,4-dihydroisoquinoline-2(1H)-yl)cyclohexyl)-1H-indole-5-carbonitriles for SERT imaging: chemical synthesis, evaluation in vitro and radiofluorination.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL493,OZVBMTJYIDMWIL-AYFBDAFISA-N,BROMOCRIPTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL493,OZVBMTJYIDMWIL-AYFBDAFISA-N,BROMOCRIPTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL469,OZWKMVRBQXNZKK-UHFFFAOYSA-N,KETOROLAC,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL469,OZWKMVRBQXNZKK-UHFFFAOYSA-N,KETOROLAC,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1762479,PAHRBTYOMQPLOY-XFULWGLBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21398123,IC50,=,16000,NM,,"","","","","","",,,,,,,,Inhibition of NET,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL526670,PATATAHKRVWCHN-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,75,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL264678,PAYGGRIFYBKVNJ-SUMWQHHRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,6.3,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL219703,PAZWPXLTYQROKI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,49,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219703,PAZWPXLTYQROKI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,860,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219703,PAZWPXLTYQROKI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,160,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219703,PAZWPXLTYQROKI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,1500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL2171210,PBCQYBZENRQFON-UHFFFAOYSA-N,3-(METHOXY(PHENYL)METHYL)AZETIDINE HCL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,1.5,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1243,PBCZLFBEBARBBI-UHFFFAOYSA-N,SULFABENZAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1243,PBCZLFBEBARBBI-UHFFFAOYSA-N,SULFABENZAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL486278,PBDMWGSHTOZGOM-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19492813,IC50,=,600,NM,,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter,Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,PUBLICATION,
CHEMBL486278,PBDMWGSHTOZGOM-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821575,IC50,=,0.6,NM,,"","","","","","",,,,,,,,Inhibition of NET,Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,PUBLICATION,
CHEMBL256168,PBERLNCGGCSXEK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL462805,PBKBHCJPMCMBCZ-GDLYOHBGSA-N,POLYGALATENOSIDE B,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16989524,IC50,=,6040,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in MDCK cell membrane,Antidepressant principles of the roots of Polygala tenuifolia.,J. Nat. Prod.,PUBLICATION,
CHEMBL544633,PBPZAEYGFWGLBT-VKLKMBQZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,35800,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1076369,PBRMKXYKEKJWTD-CISKXPIPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL3310637,PCSGUMGUIACOPL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,18,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL375685,PCXXVJSJWKSKBZ-GNXKAVGDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,1820,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL375685,PCXXVJSJWKSKBZ-GNXKAVGDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,4240,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL1224385,PCXZFUGPNRGVAN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,70,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL272493,PCZHCTVLCPQAAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,17,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1923307,PCZMXCGDABFVFX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22078214,INHIBITION,>,80,%,,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter at 10 uM,Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL503,PCZOHLXUXFIOCF-BXMDZJJMSA-N,LOVASTATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,8753,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL503,PCZOHLXUXFIOCF-BXMDZJJMSA-N,LOVASTATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,8680,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL255303,PDGMXEUBNYMTST-WMLDXEAASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,47,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL18701,PDMUULPVBYQBBK-UHFFFAOYSA-N,RO-201724,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL18701,PDMUULPVBYQBBK-UHFFFAOYSA-N,RO-201724,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
,PDNJLMZEGXHSCU-GSVOUGTGSA-N,D-HOMOCYSTEINE SULFINIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12649361,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1516176,PDNJLMZEGXHSCU-VKHMYHEASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12649361,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL2349533,PDUYPEOJRTWPFT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23434029,INHIBITION,=,63,%,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) at 10 uM,Discovery of biological evaluation of pyrazole/imidazole amides as mGlu5 receptor negative allosteric modulators.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1645616,PDVOMSJUMYNNBT-JTQLQIEISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,1010,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1645617,PDVOMSJUMYNNBT-SNVBAGLBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,110,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1645615,PDVOMSJUMYNNBT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,EC50,=,97,NM,,"",cell_based,"","","","",HEK293,,,,,,,Agonist activity at human cloned NET expressed in HEK293 cells by FLIPR assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1645615,PDVOMSJUMYNNBT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,226,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL818,PDWUPXJEEYOOTR-UHFFFAOYSA-N,IOBENGUANE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24814532,DRUG UPTAKE,,,,Active,"",cell_based,"","","","",,,,,,,,Cellular uptake in human SK-N-SH cells assessed as noradrenaline transporter-mediated uptake at 1 x 10'-4 M after 15 mins by [3H]-noradrenaline uptake assay,Synthesis and biological effects of new hybrid compounds composed of benzylguanidines and the alkylating group of busulfan on neuroblastoma cells.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL366170,PEFLMXJNQRODSP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15801845,KI,=,4440,NM,,"",cell_based,"","","","",HEK293,,,,,,,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,PUBLICATION,
CHEMBL255196,PEFNNJLMNBFNNG-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,4495,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL446230,PEOZAOHZZSCNEV-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,2600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14531,PETAHELMBJGYJY-HJWRWDBZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14971892,KI,=,2.5,NM,,"","","","","","",,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [125I]-RTI-55 radioligand,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL471899,PEUIEZIOUGCTOJ-RRIHMMEISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,788,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL565845,PFEJBPNFLAFPKN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,1623,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL565845,PFEJBPNFLAFPKN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,4600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL565845,PFEJBPNFLAFPKN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,7250,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL2407327,PFPDWJWOZCMTIS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,22,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL214335,PFTJCYRHNKTTTO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,22,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL214335,PFTJCYRHNKTTTO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,12,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL214335,PFTJCYRHNKTTTO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,18,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL214335,PFTJCYRHNKTTTO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,83,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL184618,PGBHMTALBVVCIT-VCIWKGPPSA-N,NEOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL184618,PGBHMTALBVVCIT-VCIWKGPPSA-N,NEOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1762470,PGBKVMPEZANYQB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21398123,IC50,,,,Not Active,"","","","","","",,,,,,,,Inhibition of NET,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL426317,PGGCRGAETLNAJC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16458504,KI,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity to NET by radioligand binding assay,"Synthesis, in vitro and in vivo evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3,5-dione: a novel agonist 5-HT1A receptor PET ligand.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL207214,PGIUKOCTZQBZIO-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,6.1,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171411,PGJNAAAPLQPFLU-UHFFFAOYSA-N,"3-((3,4-DICHLOROPHENYL)(PHENOXY)METHYL)AZETIDINE HCL",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,89,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1221512,PGOKBMWPBDRDGN-IBXSQZDTSA-N,L-744832,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1221512,PGOKBMWPBDRDGN-IBXSQZDTSA-N,L-744832,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL272286,PGQYZXSMJFWTHI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,2900,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL566886,PGTPXIBBHIHMQS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,969,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566886,PGTPXIBBHIHMQS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,3195,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566886,PGTPXIBBHIHMQS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,607,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL214273,PGYQPHBCJVVZFQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1149,PHIQHXFUZVPYII-ZCFIWIBFSA-N,LEVOCARNITINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1149,PHIQHXFUZVPYII-ZCFIWIBFSA-N,LEVOCARNITINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1105,PHJFLPMVEFKEPL-UHFFFAOYSA-N,6-METHOXY-2-NAPHTHYLACETIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1105,PHJFLPMVEFKEPL-UHFFFAOYSA-N,6-METHOXY-2-NAPHTHYLACETIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL621,PHLBKPHSAVXXEF-UHFFFAOYSA-N,TRAZODONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL621,PHLBKPHSAVXXEF-UHFFFAOYSA-N,TRAZODONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,8500,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL621,PHLBKPHSAVXXEF-UHFFFAOYSA-N,TRAZODONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL621,PHLBKPHSAVXXEF-UHFFFAOYSA-N,TRAZODONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL574920,PHMNKJGYIDQICY-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,14,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL41543,PHNLCHMJDSSPDQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL41543,PHNLCHMJDSSPDQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1644479,PHOVKMVBVOKTKB-DABQJJPHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,92,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1818545,PHRHUWNKARHRNO-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,398.11,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL383128,PHROHJIYKYCBCW-UGSOOPFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL552046,PHRPRBMCXLFXOY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,23,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1083410,PHSDSMUCNUCJGQ-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1083410,PHSDSMUCNUCJGQ-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,4,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1083410,PHSDSMUCNUCJGQ-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1083410,PHSDSMUCNUCJGQ-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,9,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1083083,PHSDSMUCNUCJGQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,2,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1083083,PHSDSMUCNUCJGQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,10,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1082458,PHSDSMUCNUCJGQ-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,1,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1082458,PHSDSMUCNUCJGQ-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,6,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1082458,PHSDSMUCNUCJGQ-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,2,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1082458,PHSDSMUCNUCJGQ-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1762477,PHTBVQOXRLNFDB-RWKFXIDCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21398123,IC50,,,,Not Active,"","","","","","",,,,,,,,Inhibition of NET,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL108947,PHTUQLWOUWZIMZ-BOPFTXTBSA-N,DOTHIEPIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,46,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL445,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,NORTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,1.8,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL445,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,NORTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,21,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL445,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,NORTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,4.37,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL445,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,NORTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10715164,KI,=,6.3,NM,,"","","","","","",,,,,,,,Compound was evaluated for its binding affinity towards human NET (norepinephrine) transporter,2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.,J. Med. Chem.,PUBLICATION,
CHEMBL445,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,NORTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14744476,KI,=,1.49,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL445,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,NORTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14744476,KI,=,8.3,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL445,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,NORTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,3.21,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL445,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,NORTRIPTYLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3.18,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL833,PHWBOXQYWZNQIN-UHFFFAOYSA-N,TICLOPIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL833,PHWBOXQYWZNQIN-UHFFFAOYSA-N,TICLOPIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL438450,PHZZSZDDGUPIKS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,150,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2036268,PIAOYGXDXCCGEO-KAECKJJSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,400,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL2036269,PIAOYGXDXCCGEO-SKKCDYJJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,2000,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL3334779,PIBFRRUEZPEANJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,37.8,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1644476,PICCBNDESXQSTL-PTEHBNRSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,13,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL94,PIJVFDBKTWXHHD-HIFRSBDPSA-N,PHYSOSTIGMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL94,PIJVFDBKTWXHHD-HIFRSBDPSA-N,PHYSOSTIGMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1078170,PIKCALBGLDBAKK-LLVKDONJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,169,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1080787,PIKCALBGLDBAKK-NSHDSACASA-N,PF-184298,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,21,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1080787,PIKCALBGLDBAKK-NSHDSACASA-N,PF-184298,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,21,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3703735,PILUFBWYZBSMTQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,421.3,NM,302099,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL245880,PIMIZGGCAMLEJJ-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL245880,PIMIZGGCAMLEJJ-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,IC50,=,5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL47244,PIMZUZSSNYHVCU-YKWPQBAZSA-N,PICROTOXININ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL47244,PIMZUZSSNYHVCU-YKWPQBAZSA-N,PICROTOXININ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL529437,PIQVDUKEQYOJNR-VZXSFKIWSA-N,COCAINE HYDROCHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,1990,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL529437,PIQVDUKEQYOJNR-VZXSFKIWSA-N,COCAINE HYDROCHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,1990,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL529437,PIQVDUKEQYOJNR-VZXSFKIWSA-N,COCAINE HYDROCHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20597489,KI,,,,Not Determined,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL1083210,PITDIXLZXHYFAC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,120,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3355573,PIVJTBXDGKAQQI-BPUTZDHNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25155913,INHIBITION,=,9,%,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) at 30 uM,Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL401867,PIVRFBAMCBQCDZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18060777,KI,=,760,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL456222,PJDWTDSVCNJUGD-CHWSQXEVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,1774,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL456222,PJDWTDSVCNJUGD-CHWSQXEVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,1782,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL450769,PJDWTDSVCNJUGD-OLZOCXBDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,1864,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL450769,PJDWTDSVCNJUGD-OLZOCXBDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,455,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1224240,PJIMUTYPWDGKIC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,0.631,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1233878,PJJNUMKZYDTVRG-UHFFFAOYSA-N,KURASOIN A,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23880542,INHIBITION,,,,Not Active,"","","","","","",,,,,,,,Binding affinity to human norepinephrine transporter by ligand displacement assay,Neuroactive diol and acyloin metabolites from cone snail-associated bacteria.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1712923,PJLVTVAIERNDEQ-BTJKTKAUSA-N,IRSOGLADINE MALEATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1712923,PJLVTVAIERNDEQ-BTJKTKAUSA-N,IRSOGLADINE MALEATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1539,PJSFRIWCGOHTNF-UHFFFAOYSA-N,SULFADOXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1539,PJSFRIWCGOHTNF-UHFFFAOYSA-N,SULFADOXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL567480,PJSOCXYIJJIWHO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL567480,PJSOCXYIJJIWHO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL1464,PJVWKTKQMONHTI-UHFFFAOYSA-N,WARFARIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1464,PJVWKTKQMONHTI-UHFFFAOYSA-N,WARFARIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3334770,PJXULSBRZWCAJP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,52.7,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL569364,PJZPOQITFNSOGK-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,92,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673180,PKEMWWJRFYCMFJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,8295,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL1224491,PKEWUQPHEKJOIK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,19.95,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684048,PKNHHRUELROULR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1085323,PKVDODLSCSUTRW-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,19,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1085323,PKVDODLSCSUTRW-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,25,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1085322,PKVDODLSCSUTRW-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,80,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1085322,PKVDODLSCSUTRW-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,143,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL207719,PKVYOVHKHCWTDE-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,78,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2407336,PLAKLZGCXGCZCY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,14,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2407333,PLAKLZGCXGCZCY-UTONKHPSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,21,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2407332,PLAKLZGCXGCZCY-YDALLXLXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,15,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL726,PLDUPXSUYLZYBN-UHFFFAOYSA-N,FLUPHENAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1962,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL726,PLDUPXSUYLZYBN-UHFFFAOYSA-N,FLUPHENAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1946,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1103,PLHJDBGFXBMTGZ-WEVVVXLNSA-N,FURAZOLIDONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1103,PLHJDBGFXBMTGZ-WEVVVXLNSA-N,FURAZOLIDONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL126224,PLIGPBGDXASWPX-UHFFFAOYSA-N,IPRINDOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,1262,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1170441,PLVMDZQEFNUCOF-SMDDNHRTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,1680,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL232498,PLVZUCHZVZCSGX-GORDUTHDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,255000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL232498,PLVZUCHZVZCSGX-GORDUTHDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL160,PMATZTZNYRCHOR-CGLBZJNRSA-N,CYCLOSPORINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL160,PMATZTZNYRCHOR-CGLBZJNRSA-N,CYCLOSPORINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL440272,PMCPPYXVCCGLLE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9435902,KI,=,4790,NM,,"","","","","","",,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL3310489,PMFYWAOJTSDFLF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,14.7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310489,PMFYWAOJTSDFLF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310489,PMFYWAOJTSDFLF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310489,PMFYWAOJTSDFLF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2321999,PMLBVCPRUZMORG-JTQLQIEISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,17,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2322000,PMLBVCPRUZMORG-SNVBAGLBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,24,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2321998,PMLBVCPRUZMORG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,66,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL477148,PMNGGGSGAMTCOG-FQEVSTJZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,27,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1515,PMRYVIKBURPHAH-UHFFFAOYSA-N,METHIMAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1515,PMRYVIKBURPHAH-UHFFFAOYSA-N,METHIMAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1729417,PMTIWRPLQBVEMR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24690494,KI,<,1000,NM,,"","","","","","",,,,,,,,Binding affinity to NET (unknown origin),Antagonists of the kappa opioid receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL208121,PMVYNXPSCGXPRM-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,6.5,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224164,PMWJXJVDUJHXHT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,3.16,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL517963,PMWLMRLBVALWMX-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,114,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1080969,PMZYRKGBQBCWOA-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,37,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL463389,PNEAEOHMGHCGPC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,71,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL272530,PNHQUTMNPCBPOX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,8000,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
,PNMYJIOQIAEYQL-UHFFFAOYSA-N,TH588,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24695224,% INHIBITION,=,99,,,inhibition,"",functional,"","","",,10000,NM,,,,,,,,,
CHEMBL251694,PNVNVHUZROJLTJ-INIZCTEOSA-N,(R)-VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21413808,IC50,=,61,NM,,"","","","","","",,,,,,,,Inhibition of NET,Synopsis of some recent tactical application of bioisosteres in drug design.,J. Med. Chem.,PUBLICATION,
CHEMBL252720,PNVNVHUZROJLTJ-MRXNPFEDSA-N,(S)-VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21413808,IC50,=,754,NM,,"","","","","","",,,,,,,,Inhibition of NET,Synopsis of some recent tactical application of bioisosteres in drug design.,J. Med. Chem.,PUBLICATION,
CHEMBL252720,PNVNVHUZROJLTJ-MRXNPFEDSA-N,(S)-VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23061607,IC50,=,149,NM,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) assessed as noradrenaline reuptake,Organosilicon molecules with medicinal applications.,J. Med. Chem.,PUBLICATION,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,1644,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,2269,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,1060,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,1060,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11454918,KI,=,6310,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11750180,KI,=,2480,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14573386,KI,=,2483,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14744476,KI,=,1420,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14744476,KI,=,1920,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,535,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,385,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,=,535,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,IC50,=,581,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21413808,IC50,=,149,NM,,"","","","","","",,,,,,,,Inhibition of NET,Synopsis of some recent tactical application of bioisosteres in drug design.,J. Med. Chem.,PUBLICATION,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,IC50,=,7943.28,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,KI,=,1623,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,5722,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,9,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,37,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,81,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,680,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2708,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2685,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL637,PNVNVHUZROJLTJ-UHFFFAOYSA-N,VENLAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,>,553,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL255663,POGCTVQQHWBYLG-DZGCQCFKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,2.7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684046,POKCWLLPLOIIOW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,960,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201012,POPFMWWJOGLOIF-XWCQMRHXSA-N,FLURANDRENOLIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201012,POPFMWWJOGLOIF-XWCQMRHXSA-N,FLURANDRENOLIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL111128,PORDAYLSLHLTRQ-FYOYPEGLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,IC50,=,28,NM,,"","","","","","",,,,,,,,In vitro inhibition of [3H]NE re-uptake into synaptosome,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL111128,PORDAYLSLHLTRQ-FYOYPEGLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,KI,=,99,NM,,"","","","","","",,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL331799,PORDAYLSLHLTRQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,IC50,=,45,NM,,"","","","","","",,,,,,,,In vitro inhibition of [3H]NE re-uptake into synaptosome,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL331799,PORDAYLSLHLTRQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,KI,=,266,NM,,"","","","","","",,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1479,POZRVZJJTULAOH-LHZXLZLDSA-N,DANAZOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,5698,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1479,POZRVZJJTULAOH-LHZXLZLDSA-N,DANAZOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,5651,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1818218,PPANZCQXFYBGHN-UHFFFAOYSA-N,PF-4840154,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21741838,INHIBITION,<,10,%,,"","","","","","",,,,,,,,Inhibition of noradrenaline transporter at 2.8 uM,"Design and pharmacological evaluation of PF-4840154, a non-electrophilic reference agonist of the TrpA1 channel.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL408230,PPEMPAPSRLGSIO-RDJZCZTQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,17,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1076371,PPGSXHUOGGBHHP-YNBFDDPPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
,PPJRQXMDFSRWFH-UHFFFAOYSA-N,HYDROXYNEFAZODONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,664,NM,,"","","","","","",,,,,,,,,,,,
,PPJRQXMDFSRWFH-UHFFFAOYSA-N,HYDROXYNEFAZODONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,1053,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL572163,PPLVDBKGJPKXLH-HSZRJFAPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821575,IC50,=,16,NM,,"","","","","","",,,,,,,,Inhibition of NET,Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1762473,PPQGTHAGWWVLEX-XFULWGLBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21398123,IC50,=,15000,NM,,"","","","","","",,,,,,,,Inhibition of NET,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL40583,PPQNQXQZIWHJRB-UHFFFAOYSA-N,3-METHYLCHOLANTHRENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,29650,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL40583,PPQNQXQZIWHJRB-UHFFFAOYSA-N,3-METHYLCHOLANTHRENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,29405,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL582928,PPQUPQGZDGZYJI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,EC50,=,83,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL582928,PPQUPQGZDGZYJI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,168,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2206517,PPWGBAKMSRMGKP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,54,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL497679,PQCPVVBGHDVKFV-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,9,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL206153,PQGGSLAVULAHLP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,13.3,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2047569,PQGQRUUEBWORMY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,62,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL2021583,PQMJWYCYCSXLGZ-JJLQDPRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,25118.86,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2021582,PQMJWYCYCSXLGZ-JYAVWHMHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,12.59,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1808424,PQQHOBXFKJXQAU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21724392,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 0.5 uM,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL227233,PQQIGLGAWBKHRP-NQAVQENRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,620,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL227233,PQQIGLGAWBKHRP-NQAVQENRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,1270,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL609908,PQVFTFGHDAAJKQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20034793,IC50,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]nisoxetine from human NET transfected in human HEK293 cells,Synthesis and hSERT activity of homotryptamine analogs. Part 6: [3+2] dipolar cycloaddition of 3-vinylindoles.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3289656,PQVQCEDGSJVHMK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24800940,KI,=,2754.23,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by PDSP assay,Identification of a new selective dopamine D4 receptor ligand.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3289656,PQVQCEDGSJVHMK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24800940,KI,=,2773,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by PDSP assay,Identification of a new selective dopamine D4 receptor ligand.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL569465,PREYWAJYVTVVPE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,472,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL569465,PREYWAJYVTVVPE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,1171,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL569465,PREYWAJYVTVVPE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,370,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL3673170,PRHCBLDIFFVLSZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,133.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL1076381,PRJXZTZPPOXOHQ-BLPBYGFISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL2030632,PRKCBGIXZFUCEF-UHFFFAOYSA-N,N-(3-FLUOROBENZYL)PYRROLIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL193482,PROQIPRRNZUXQM-ZXXIGWHRSA-N,ESTRIOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL193482,PROQIPRRNZUXQM-ZXXIGWHRSA-N,ESTRIOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL202910,PRPQDTYJTKSLKO-SJCJKPOMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,20300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL260988,PRTQZTFEHWCKDF-BLLLJJGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,12,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205836,PSBBAGWMKGXQRW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,=,9905,NM,,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL717,PSGAAPLEWMOORI-PEINSRQWSA-N,MEDROXYPROGESTERONE ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL717,PSGAAPLEWMOORI-PEINSRQWSA-N,MEDROXYPROGESTERONE ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1076405,PSGQFYHSPPQQPO-HFKIQIMQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL191,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,LOSARTAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL191,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,LOSARTAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL213754,PSIGDYKJTYBHDY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,31,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL213754,PSIGDYKJTYBHDY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,31,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2407323,PSMAIUZEWLCYGR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,12,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL63703,PSNHNKLTGOOICN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,IC50,=,87,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL63703,PSNHNKLTGOOICN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,KI,=,180,NM,,"","","","","","",,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL387758,PSPJUVHWZINCFD-KOQKOIQBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,=,6100,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL387758,PSPJUVHWZINCFD-KOQKOIQBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,KI,=,3700,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL2096876,PSPJUVHWZINCFD-KWJLTHHISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,=,4700,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL2096876,PSPJUVHWZINCFD-KWJLTHHISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,KI,=,2800,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL1807053,PSUFQBRCUSJTDO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21618986,INHIBITION,>,16,%,,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter at 4 uM,Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist.,J. Med. Chem.,PUBLICATION,
CHEMBL1649,PTJADDMMFYXMMG-UHFFFAOYSA-N,DEMETHYL-CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,1820,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1649,PTJADDMMFYXMMG-UHFFFAOYSA-N,DEMETHYL-CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,0.77,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL2326686,PTKQUPHPZRJQRH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,130,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL1909078,PTLRDCMBXHILCL-UHFFFAOYSA-M,SODIUM ARSENITE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909078,PTLRDCMBXHILCL-UHFFFAOYSA-M,SODIUM ARSENITE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1619,PTOAARAWEBMLNO-KVQBGUIXSA-N,CLADRIBINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1619,PTOAARAWEBMLNO-KVQBGUIXSA-N,CLADRIBINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL574428,PTVWULKTBHSTNS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,170,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2206522,PUACBDCIAIMRLD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,806,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1124,PUAQLLVFLMYYJJ-UHFFFAOYSA-N,DEALKYLATED DIETHYLPROPION,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12954796,KI,=,12.4,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1683891,PUCWXLYHLYMUCG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,61,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2380975,PUIPTRFLVUMEKQ-JSGCOSHPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23578689,IC50,=,3700,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2380975,PUIPTRFLVUMEKQ-JSGCOSHPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23578689,INHIBITION,=,16,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes at 1 uM,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2380972,PUIPTRFLVUMEKQ-OCCSQVGLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23578689,IC50,=,510,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2380972,PUIPTRFLVUMEKQ-OCCSQVGLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23578689,INHIBITION,=,78,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes at 1 uM,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL255449,PUKHAHUSCTVYAW-SWLSCSKDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,8.7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL381056,PUKYDIKEMQFSPQ-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,150,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL563852,PUMRLCALOZDUIE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,45,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL559490,PUQYZIQIINNNTQ-RTWAWAEBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,66.7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL3673174,PUYNZNIAZURARP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,344.6,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL2206519,PUZGOXIAHPOFIX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,115,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310624,PVENMTZFPWNCAA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,67,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310624,PVENMTZFPWNCAA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310624,PVENMTZFPWNCAA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL475534,PVHUJELLJLJGLN-UHFFFAOYSA-N,NITRENDIPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL475534,PVHUJELLJLJGLN-UHFFFAOYSA-N,NITRENDIPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL408868,PVISFTMIHRDVDS-QZTJIDSGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,420,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL260259,PVISFTMIHRDVDS-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,8,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL261076,PVISFTMIHRDVDS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,36,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL261076,PVISFTMIHRDVDS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,320,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL573,PVNIIMVLHYAWGP-UHFFFAOYSA-N,NIACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL573,PVNIIMVLHYAWGP-UHFFFAOYSA-N,NIACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3673131,PVPLKGUBRLAGAF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,273.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL2392692,PVTFEAGMCGMRRS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23664879,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter at 1 uM relative to control,"Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224303,PVTZQLSVJXEDHJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,IC50,=,234,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224303,PVTZQLSVJXEDHJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,37,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL238867,PWAQSKSFOYUNMV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18052090,KI,=,7.5,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,PUBLICATION,
CHEMBL562691,PWCRFPCCCWITCB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,35,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3577955,PWDBREUBRYUEGC-BTJKTKAUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25893048,ACTIVITY,,,,Not Active,"","","","","","",,,,,,,,Binding affinity to human NET at 1 uM,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3612828,PWJHFYJVKXVMET-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,IC50,=,4750,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3612828,PWJHFYJVKXVMET-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.8,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1173533,PWRNDGOMCQHVRL-HUUCEWRRSA-N,"6-(3,4-DICHLOROPHENYL)-1-[(ETHYLOXY)METHYL]-3-AZABICYCLO[4.1.0]-HEPTANE (ENANTIOMERIC MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,7.94,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173533,PWRNDGOMCQHVRL-HUUCEWRRSA-N,"6-(3,4-DICHLOROPHENYL)-1-[(ETHYLOXY)METHYL]-3-AZABICYCLO[4.1.0]-HEPTANE (ENANTIOMERIC MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,10,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173533,PWRNDGOMCQHVRL-HUUCEWRRSA-N,"6-(3,4-DICHLOROPHENYL)-1-[(ETHYLOXY)METHYL]-3-AZABICYCLO[4.1.0]-HEPTANE (ENANTIOMERIC MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,100,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL498367,PWVMDDIYWPUTLR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18793858,KI,>,1000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,"Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL643,PWWVAXIEGOYWEE-UHFFFAOYSA-N,PROMETHAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,4238,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL643,PWWVAXIEGOYWEE-UHFFFAOYSA-N,PROMETHAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,4203,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL345251,PWZMTBUSUJELNZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,1400,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL206649,PXASTWDWEDJFAW-SJCJKPOMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,680,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2030636,PXBKRGXXBYALIH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL249807,PXCLIXMWUZNIDA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,410000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL523574,PXFCLZUOFIJVNC-KBXCAEBGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,430,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL450435,PXHGECKMKPJNDM-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,74,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL469475,PXVMYRXIGXGAFB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,92,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL469475,PXVMYRXIGXGAFB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,61,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2407330,PXYULNPULNZYHU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,130,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL513360,PXZVEYWSVBEKRN-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,64,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL506397,PYEILVKGQDUINV-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,772,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL469551,PYEILVKGQDUINV-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL597000,PYIBCEOJEPANCH-MKBNYLNASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,IC50,=,0.251,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]noradrenalin reuptake at human NET expressed in LLCPK cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL597000,PYIBCEOJEPANCH-MKBNYLNASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,0.126,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL597000,PYIBCEOJEPANCH-MKBNYLNASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,0.316,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL603480,PYIBCEOJEPANCH-XHBSWPGZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,79.43,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL599376,PYPVCBLWSWFYNN-MOSHPQCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20020710,ACTIVITY,=,14,%,,"","","","","","",,,,,,,,Binding affinity to NET at 10 uM by displacement assay,Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain.,J. Med. Chem.,PUBLICATION,
CHEMBL196258,PYUBHJHQYILWFE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16250647,INHIBITION,<,10,%,,"","","","","","",,,,,,,,Percent inhibition against Norepinephrine transporter at 1 uM nonselective,"2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.",J. Med. Chem.,PUBLICATION,
CHEMBL741,PYZRQGJRPPTADH-UHFFFAOYSA-N,LAMOTRIGINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL741,PYZRQGJRPPTADH-UHFFFAOYSA-N,LAMOTRIGINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL436132,PZHJZKURLFYNOX-GNXKAVGDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,3240,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL436132,PZHJZKURLFYNOX-GNXKAVGDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,2210,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL189,PZRHRDRVRGEVNW-UHFFFAOYSA-N,MILRINONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL189,PZRHRDRVRGEVNW-UHFFFAOYSA-N,MILRINONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL180672,PZUJQWHTIRWCID-HXUWFJFHSA-N,SB-262470,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821575,IC50,=,0.2,NM,,"","","","","","",,,,,,,,Inhibition of NET,Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,PUBLICATION,
CHEMBL272285,PZVMCTLCQFNWSD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,130,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171211,QADQXQPJDYRHHG-UHFFFAOYSA-N,3-(ETHOXY(PHENYL)METHYL)AZETIDINE HCL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,4.5,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL584,QAGYKUNXZHXKMR-HKWSIXNMSA-N,NELFINAVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,8852,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL584,QAGYKUNXZHXKMR-HKWSIXNMSA-N,NELFINAVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,8779,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1224467,QANXQNKYGWZPJQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,84,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173355,QAPDCFXYLMIQOK-IINYFYTJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,>,100000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL16068,QARVLSVVCXYDNA-UHFFFAOYSA-N,BROMOBENZENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL16068,QARVLSVVCXYDNA-UHFFFAOYSA-N,BROMOBENZENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL469812,QBEXADKSFJNYHO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL381046,QBMUMECEHYHKPP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16202585,IC50,=,6430,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL492842,QBOITYXCKDGUNE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,1300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1779059,QCBXRMVDVAHCPR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL574427,QCGAHDLRCVBZHH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,1,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL430840,QDDIKUPXWGQLSU-SIUPQYRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10698458,IC50,=,620,NM,,"",cell_based,"","","","",,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL249329,QDLBXJOPGVUQLI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,IC50,=,39000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL249329,QDLBXJOPGVUQLI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,INHIBITION,=,25,%,,"","","","","","",,,,,,,,Inhibition of NET at 1 uM,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL101250,QDNMERQLRWGGDY-AXRJEEMOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10698458,IC50,=,296,NM,,"",cell_based,"","","","",,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310492,QDXMLWBTDCCUTJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,22,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL391864,QDZIBQWKRRRXAL-OSRDXIQISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446069,KI,=,1.78,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"Synthesis and biological evaluation of 2beta,3alpha-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1812750,QDZIBQWKRRRXAL-VIRABCJISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21058665,IC50,=,0.5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,PUBLICATION,
CHEMBL255768,QEDLIMYVQKJVCR-MJGOQNOKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL507723,QEHHRDFKZARORR-IBGZPJMESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,25,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL377552,QEKVURATSAPTGE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,INHIBITION,=,-23,%,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET at 1 uM,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL290916,QELUYTUMUWHWMC-UHFFFAOYSA-N,EDARAVONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL290916,QELUYTUMUWHWMC-UHFFFAOYSA-N,EDARAVONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL393625,QEMMIBZQGYYMNU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18052090,KI,=,12,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,PUBLICATION,
CHEMBL3673163,QEQQILAAIUZZEV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,79.2,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL1076402,QESSYWKKODTFHV-DNUYABSHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL772,QEVHRUUCFGRFIF-MDEJGZGSSA-N,RESERPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL772,QEVHRUUCFGRFIF-MDEJGZGSSA-N,RESERPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL413,QFJCIRLUMZQUOT-HPLJOQBZSA-N,SIROLIMUS,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL413,QFJCIRLUMZQUOT-HPLJOQBZSA-N,SIROLIMUS,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2205834,QFMGHZDEZHDVJJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2338034,QFQJPPPPEDIVLD-GUYCJALGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,10,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL396082,QGGSNXQBFWAFCC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,26000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL396082,QGGSNXQBFWAFCC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,39000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1812748,QGJBJCQWBZDANK-WGWURMLHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21058665,IC50,=,14,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,PUBLICATION,
CHEMBL87285,QGXBDMJGAMFCBF-HLUDHZFRSA-N,ANDROSTERONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL87285,QGXBDMJGAMFCBF-HLUDHZFRSA-N,ANDROSTERONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL575290,QHHWSRAVBLCPAI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,EC50,=,49,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL575290,QHHWSRAVBLCPAI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,13,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL445800,QHIKEMVZWMXQMI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,1499,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL445800,QHIKEMVZWMXQMI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,1034,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL3613157,QHJHMCYAXBKCKE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.97,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3321792,QHLAPIQLWATZKM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25070422,KI,=,462,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL111639,QHLGXPUIUKSADT-UHFFFAOYSA-N,FLUOROCARAZOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11512051,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL347199,QHMFRKMGCLKZRZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,670,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL1645601,QHOAGSGZOCDBGO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,EC50,=,239,NM,,"",cell_based,"","","","",HEK293,,,,,,,Agonist activity at human cloned NET expressed in HEK293 cells by FLIPR assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1645601,QHOAGSGZOCDBGO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,116,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432057,QHQJBDOHEUWLBB-CAUKCHDASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3334796,QHRPNPFRUGWUJT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,IC50,=,249.9,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL562444,QHSQRSCEVZFFIU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,4850,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL523652,QHSXELZOXIQJEU-UHFFFAOYSA-N,KF-A4,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17846138,IC50,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,PUBLICATION,
CHEMBL257808,QIEUXXFCMLEYMI-SJCJKPOMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,170,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3334775,QIIDHPUHHXZNJR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,4.9,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1086399,QIQQZHLHCWKLNI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,630,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL518748,QIVITPMRYRPJPE-HOCLYGCPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,6,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1681810,QIYANFXIRPCCFR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,529,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL269732,QJJXYPPXXYFBGM-LFZNUXCKSA-N,TACROLIMUS,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL269732,QJJXYPPXXYFBGM-LFZNUXCKSA-N,TACROLIMUS,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL213632,QJMPSMDQYHMYSR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,270,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL573531,QJRQNVRAJVCSDH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,162,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL277100,QKDHBVNJCZBTMR-UHFFFAOYSA-N,TEMAFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL277100,QKDHBVNJCZBTMR-UHFFFAOYSA-N,TEMAFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL454675,QKJSLGBMXQASRH-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,17,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL209707,QKYQOSPSZVKFEL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2338053,QLILSXLCYHMHMR-BDJLRTHQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,1.58,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2338052,QLILSXLCYHMHMR-ZBEGNZNMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,0.794,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL239302,QLIVPGJLVJVMJT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18052090,KI,>,1000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,PUBLICATION,
CHEMBL379333,QLJHRHJFUIHEAT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,IC50,=,1400,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL379333,QLJHRHJFUIHEAT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,KI,=,710,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL575546,QLJOCRJOIIVENA-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,20,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL9419,QLNWXBAGRTUKKI-UHFFFAOYSA-N,METACETAMOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL9419,QLNWXBAGRTUKKI-UHFFFAOYSA-N,METACETAMOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL385359,QLPRIWAESOJKJS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,IC50,=,3040,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL385359,QLPRIWAESOJKJS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,KI,=,1520,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL3323181,QLQQUDCJVQOCBW-OAQYLSRUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,8.3,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3323182,QLQQUDCJVQOCBW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,93,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3323182,QLQQUDCJVQOCBW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,7.1,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323182,QLQQUDCJVQOCBW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,7.6,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323182,QLQQUDCJVQOCBW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,53.4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323182,QLQQUDCJVQOCBW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,7.6,NM,314421,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL2321994,QLSUBNPMUSWHLS-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,430,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2321993,QLSUBNPMUSWHLS-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL511163,QLXIMJBRAWACSR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,3420,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL511163,QLXIMJBRAWACSR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL110691,QMBJSIBWORFWQT-DFXBJWIESA-N,CHLORMADINONE ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL110691,QMBJSIBWORFWQT-DFXBJWIESA-N,CHLORMADINONE ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL227934,QMGVPVSNSZLJIA-FVWCLLPLSA-N,STRYCHNINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL227934,QMGVPVSNSZLJIA-FVWCLLPLSA-N,STRYCHNINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL157548,QMLVECGLEOSESV-RYUDHWBXSA-N,DANOFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL157548,QMLVECGLEOSESV-RYUDHWBXSA-N,DANOFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL264174,QMMAMXVYCMLPGH-OALUTQOASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,84,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3663914,QMOZFCXYKWWVFV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3.3,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663914,QMOZFCXYKWWVFV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,12.6,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663914,QMOZFCXYKWWVFV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,35.4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663914,QMOZFCXYKWWVFV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,12.6,NM,314417,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL403363,QMRGFFVBWTXOKS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,13,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL489773,QNAJOTQQZIEJJF-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,4,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL599371,QNOVJSGRCXZVAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,921,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL408016,QNPLPYOQHFFYGC-HNAYVOBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,7.1,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2144958,QNRODODTMXCRKU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22172704,INHIBITION,=,67,%,,"","","","","","",,,,,,,,Inhibition of human NET at 10 uM by radioligand displacement assay,Discovery of a new molecular probe ML228: an activator of the hypoxia inducible factor (HIF) pathway.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171409,QNUHQFJRHPIXTE-UHFFFAOYSA-N,3-(PHENOXY(PHENYL)METHYL)AZETIDINE HCL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,18,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2206521,QNWBLRHWGDFQHE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,1020,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3321791,QOECKZUXJGSVMP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25070422,KI,=,510,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL596175,QOGSMHDQGODXBS-BEJSXWRTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740668,IC50,=,2097,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]NE reuptake at human NET expressed in HEK cells,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL596175,QOGSMHDQGODXBS-BEJSXWRTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740668,KI,=,3236,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL596185,QOGSMHDQGODXBS-HHMOXRITSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740668,IC50,=,2190,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]NE reuptake at human NET expressed in HEK cells,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL596185,QOGSMHDQGODXBS-HHMOXRITSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740668,KI,>,100000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3613149,QOGZMINVAKYXMT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.92,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1644610,QOSPLNXOHCYGSB-BJWYYQGGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,13,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430701,QOTGNPSPQIIZKE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,1376,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430701,QOTGNPSPQIIZKE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,27.4,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430701,QOTGNPSPQIIZKE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,89,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL378377,QPAFLDILQMKTGS-RBUKOAKNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16413778,KI,=,160.8,NM,,"","","","","","",,,,,,,,Binding affinity to NET,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL438,QPPBRPIAZZHUNT-UHFFFAOYSA-N,SULFAMERAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL438,QPPBRPIAZZHUNT-UHFFFAOYSA-N,SULFAMERAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL583332,QPPDVPUFQFPJKK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,3,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL483749,QPUXUSUONDVIKY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19338356,ACTIVITY,<,50,%,Active,"","","","","","",,,,,,,,Binding affinity to NET,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,PUBLICATION,
CHEMBL272986,QPWPMQLSJRESDN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL264173,QQHREAWMTUYOBO-OALUTQOASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,180,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683878,QQKNLGCYRCQFQP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,114,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2338055,QQMFCCASOIUAMW-KKSFZXQISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,2.51,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL515914,QQOBRRFOVWGIMD-OJAKKHQRSA-N,AZARIBINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL515914,QQOBRRFOVWGIMD-OJAKKHQRSA-N,AZARIBINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2432054,QQUOSDRKLSIRED-DKSPCFMDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,KI,=,8533,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL216015,QRBFMQFAEQGJIW-ZROIWOOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16784855,KI,=,25.5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET transfected in HEK293 cells,Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257390,QRBKUYBUQLQJEH-DZGCQCFKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,64,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2206511,QREUWDKINMWLMS-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,35,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1262,QRJJEGAJXVEBNE-HKOYGPOVSA-N,OXICONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1910.3,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1262,QRJJEGAJXVEBNE-HKOYGPOVSA-N,OXICONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1894.5,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL514424,QRNLLMHKIXCFGM-IYIFBUTFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,1850,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL14305,QRRDJSMVPRYYBA-KTKRTIGZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14971892,KI,=,111,NM,,"","","","","","",,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [125I]-RTI-55 radioligand,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL1644604,QRRQVHBNSBQIBJ-OPVJXMOQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,148,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL64,QRXWMOHMRWLFEY-UHFFFAOYSA-N,ISONIAZID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL64,QRXWMOHMRWLFEY-UHFFFAOYSA-N,ISONIAZID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL413965,QRZAKQDHEVVFRX-UHFFFAOYSA-N,FELBINAC,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL413965,QRZAKQDHEVVFRX-UHFFFAOYSA-N,FELBINAC,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL256667,QSCRGZVJRUUPPV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,8.4,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1170795,QSIIURGKHNVJBN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,>,5011.87,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL21731,QSLMDECMDJKHMQ-UHFFFAOYSA-N,MAPROTILINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,11.1,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL21731,QSLMDECMDJKHMQ-UHFFFAOYSA-N,MAPROTILINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,12,NM,,"","","","","","",,,,,,,,Inhibition of norepinephrine reuptake at NET,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL21731,QSLMDECMDJKHMQ-UHFFFAOYSA-N,MAPROTILINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,30,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL21731,QSLMDECMDJKHMQ-UHFFFAOYSA-N,MAPROTILINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,30,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1813485,QSOVYEIFTQKDEW-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,190.55,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813483,QSOVYEIFTQKDEW-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,208.93,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813483,QSOVYEIFTQKDEW-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,467.74,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL30713,QSQQQURBVYWZKJ-UHFFFAOYSA-N,ALPHA-METHYLTRYPTAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,IC50,=,3715.35,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL30713,QSQQQURBVYWZKJ-UHFFFAOYSA-N,ALPHA-METHYLTRYPTAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,KI,=,642,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL30713,QSQQQURBVYWZKJ-UHFFFAOYSA-N,ALPHA-METHYLTRYPTAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]Nisoxetine from human recombinant norepinephrine transporter expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting analysis,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL255246,QSSYRFOLGZMPLN-MAUKXSAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,20,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1200748,QTAOMKOIBXZKND-PPHPATTJSA-N,CARBIDOPA,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200748,QTAOMKOIBXZKND-PPHPATTJSA-N,CARBIDOPA,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL174304,QTGSINBFNYAXSI-HYRLGQOJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15012999,INHIBITION,=,21,%,,"","","","","","",,,,,,,,Inhibitory activity against human adrenergic norepinephrine transporter at 10 uM,Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL434063,QTQMRBZOBKYXCG-MHZLTWQESA-N,GW1929,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,40308,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL434063,QTQMRBZOBKYXCG-MHZLTWQESA-N,GW1929,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,39975,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL498564,QTWYMQIZRRTWFB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18461921,KI,>,100000,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,PUBLICATION,
CHEMBL1173753,QUJMNYWULZSJDX-HZPDHXFCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,501.19,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL404027,QUKVPZYBMYBTQO-FUHWJXTLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,8.3,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205828,QUMVESOWCHBEEV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2096857,QUSLQENMLDRCTO-HXSCFSKGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,7200,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL2096857,QUSLQENMLDRCTO-HXSCFSKGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,4340,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL222705,QUSLQENMLDRCTO-SHWKFHJASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,1200,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL222705,QUSLQENMLDRCTO-SHWKFHJASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,741,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL2079586,QUSLQENMLDRCTO-TUVASFSCSA-N,WIN-35428,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9804682,IC50,=,834,NM,,"","","","","","",,,,,,,,The compound was tested in vitro for binding affinity for the norepinephrine transporter (NET) using competitive binding assay.,TROTEC-1: a new high-affinity ligand for labeling of the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL2079586,QUSLQENMLDRCTO-TUVASFSCSA-N,WIN-35428,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,835,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL2079586,QUSLQENMLDRCTO-TUVASFSCSA-N,WIN-35428,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,503,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL2079586,QUSLQENMLDRCTO-TUVASFSCSA-N,WIN-35428,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20597489,KI,,,,Not Determined,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL2079586,QUSLQENMLDRCTO-TUVASFSCSA-N,WIN-35428,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21458259,KI,=,635,NM,,"",cell_based,"","","","",LLC-PK1,,,,,,,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL219281,QUVNADBNAUIISW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,610,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219281,QUVNADBNAUIISW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,680,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219281,QUVNADBNAUIISW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,1800,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219281,QUVNADBNAUIISW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,2400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL272699,QUZXTJYADOYRDB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18060777,KI,=,420,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL157902,QVETYJWSBDNUGB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,>,30000,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL1830878,QVFGNQQNMCPCBY-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,9,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830878,QVFGNQQNMCPCBY-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,13,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830879,QVFGNQQNMCPCBY-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,5,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830879,QVFGNQQNMCPCBY-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,11,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830877,QVFGNQQNMCPCBY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,7,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830877,QVFGNQQNMCPCBY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,18,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL2046455,QVIAHGYFYZASCH-GAJHUEQPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,34,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL2047576,QVIAHGYFYZASCH-UZUQRXQVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,78,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL3350391,QVIXLSYROOSFHA-ACDBMABISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16213721,KI,=,1810,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3085019,QVIXLSYROOSFHA-OWZKRDHZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16213721,KI,=,152000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683905,QVLGCILLMAUJBI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,9987,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3084641,QVLWORPSNMYKIE-QYESKELBSA-M,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9435902,INHIBITION,=,38,%,,"","","","","","",,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL214004,QVONDVLKKQSPCH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1097147,QVVYUPDVPHVIPQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1097147,QVVYUPDVPHVIPQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,INH,=,50800.0,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL900,QVYRGXJJSLMXQH-UHFFFAOYSA-N,ORPHENADRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2666,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL900,QVYRGXJJSLMXQH-UHFFFAOYSA-N,ORPHENADRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2643,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL114,QWAXKHKRTORLEM-UGJKXSETSA-N,SAQUINAVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL114,QWAXKHKRTORLEM-UGJKXSETSA-N,SAQUINAVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1109,QWCJHSGMANYXCW-UHFFFAOYSA-N,SULFAPHENAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1109,QWCJHSGMANYXCW-UHFFFAOYSA-N,SULFAPHENAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL49,QWCRAEMEVRGPNT-UHFFFAOYSA-N,BUSPIRONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL49,QWCRAEMEVRGPNT-UHFFFAOYSA-N,BUSPIRONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL564786,QWDPOYBOJIBHAD-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,18.6,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL1085830,QWFUAOOOLIDWBY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,94,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1085830,QWFUAOOOLIDWBY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,238,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1113,QWGDMFLQWFTERH-UHFFFAOYSA-N,AMOXAPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,16,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1113,QWGDMFLQWFTERH-UHFFFAOYSA-N,AMOXAPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,13,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1113,QWGDMFLQWFTERH-UHFFFAOYSA-N,AMOXAPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,13,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1914699,QWGVIOYTQRTWPO-UMQBVGHOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21458259,KI,=,66.2,NM,,"",cell_based,"","","","",LLC-PK1,,,,,,,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3622360,QWHKGOUNYNQXJA-FEHRVWHQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25801931,INHIBITION,=,6,%,,"","","","","","",,,,,,,,Inhibition of human NET at 10 uM relative to control,Pseudosaccharin amines as potent and selective KV1.5 blockers.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1170210,QWWBXRLAEPLMHV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,12.59,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1365675,QXAITBQSYVNQDR-ZIOPAAQOSA-N,AMITRAZ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1365675,QXAITBQSYVNQDR-ZIOPAAQOSA-N,AMITRAZ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL202479,QXBWECFEEZMKTN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,46.5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL202479,QXBWECFEEZMKTN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,310,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2047570,QXCOEFGWAUGVTR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,IC50,=,385,NM,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL214395,QXDADQKWVQYGSQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,22,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL499461,QXJNTMSGRQZRFO-DQZOQLMQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19014888,IC50,=,6811,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL499461,QXJNTMSGRQZRFO-DQZOQLMQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19014888,KI,=,6567,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL454507,QXJNTMSGRQZRFO-PDZHLSQESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19014888,IC50,=,6553,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL454507,QXJNTMSGRQZRFO-PDZHLSQESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19014888,KI,=,4600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,METHOXSALEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL416,QXKHYNVANLEOEG-UHFFFAOYSA-N,METHOXSALEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL199598,QXKRLFHQZJJIMH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16202585,IC50,=,62600,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3613150,QXORAPZZHCKPIB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,IC50,=,472,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3613150,QXORAPZZHCKPIB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.49,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL395649,QXYYDFAFOMWDHD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,499000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL395649,QXYYDFAFOMWDHD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,675000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1818460,QYAZFPSPLQVWMZ-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,25.12,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL443797,QYIDZGIRYRGUNF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,IC50,=,180,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL443797,QYIDZGIRYRGUNF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,KI,=,42,NM,,"","","","","","",,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL566001,QYLKSFXBRALDIS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566001,QYLKSFXBRALDIS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566001,QYLKSFXBRALDIS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,2540,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL3612693,QYOJMNDDVVEPFN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26372073,INHIBITION,,,,Active,"","","","","","",,,,,,,,Displacement of [3H]-nisoxetine from norepinephrine transporter (unknown origin) at 1 to 10 mM,Reengineered tricyclic anti-cancer agents.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL214259,QYPSCQLKEMPYGY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,82,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201066,QYRYFNHXARDNFZ-UHFFFAOYSA-N,VENLAFAXINE HYDROCHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,IC50,=,2553,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1201066,QYRYFNHXARDNFZ-UHFFFAOYSA-N,VENLAFAXINE HYDROCHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,IC50,=,2550,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL527,QYSPLQLAKJAUJT-UHFFFAOYSA-N,PIROXICAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL527,QYSPLQLAKJAUJT-UHFFFAOYSA-N,PIROXICAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1042,QYSXJUFSXHHAJI-YRZJJWOYSA-N,CHOLECALCIFEROL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1042,QYSXJUFSXHHAJI-YRZJJWOYSA-N,CHOLECALCIFEROL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL197315,QZFLFWOTDWFGFO-GXSJLCMTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL198019,QZFLFWOTDWFGFO-KOLCDFICSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL383347,QZFLFWOTDWFGFO-MWLCHTKSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter; nt is not tested,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL196513,QZFLFWOTDWFGFO-ONGXEEELSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1470,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1458,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL598614,QZVQFWATMTZJGK-URBRKQAFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,1.4,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL598614,QZVQFWATMTZJGK-URBRKQAFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,5.5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL132614,QZZUDVMQVVGVGN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14592523,KI,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL404247,RAEJZLUTUUNZSA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18060777,KI,=,1300,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL202420,RAHKQMUBMIJUFG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,83,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL202420,RAHKQMUBMIJUFG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,386,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1086273,RANMCMHHAKTCAZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,84,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323183,RAPYOTFVDQSFNZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,23,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL85,RAPZEAPATHNIPO-UHFFFAOYSA-N,RISPERIDONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL85,RAPZEAPATHNIPO-UHFFFAOYSA-N,RISPERIDONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL26320,RAQPOZGWANIDQT-UHFFFAOYSA-N,GBR-12935,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871666,IC50,=,1261,NM,,"","","","","","",,,,,,,,Compound was tested for its ability to inhibit the uptake of Norepinephrine in Norepinephrine transporter system,Design and synthesis of a biotinylated dopamine transporter ligand for the purification and labeling of dopaminergic neurons.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL26320,RAQPOZGWANIDQT-UHFFFAOYSA-N,GBR-12935,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,IC50,=,165,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL26320,RAQPOZGWANIDQT-UHFFFAOYSA-N,GBR-12935,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,KI,=,630,NM,,"","","","","","",,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL1641622,RAQYAPJFZWPJNL-NSHDSACASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21095126,IC50,=,1849,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant norepinephrine transporter,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643515,RAQYAPJFZWPJNL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21095126,IC50,=,2597,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant norepinephrine transporter,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1076383,RAVKGPRQAKJYQC-CISKXPIPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1909048,RBCUCXILXJXLTB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909048,RBCUCXILXJXLTB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL272074,RBGQVIWIAYEYFG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1630578,RBKASMJPSJDQKY-RBFSKHHSSA-N,TIRILIZAD,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1630578,RBKASMJPSJDQKY-RBFSKHHSSA-N,TIRILIZAD,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL403616,RBKMRYYKCJETLF-DZGCQCFKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,20,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL154541,RBKZPZVPVZNIMS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,250,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL488422,RBLJKXZFEKSSRK-AEPIDVSQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,1300,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL513258,RBNFIIOAQFISLC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,7,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL382241,RBZDTFXHCQBMRR-OAUVRVJYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,1800,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL172806,RCAXDUZVJIMXJF-UFZHQWOOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15012999,INHIBITION,=,3,%,,"","","","","","",,,,,,,,Inhibitory activity against human adrenergic norepinephrine transporter at 10 uM,Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL311350,RCIMBBZXSXFZBV-UHFFFAOYSA-N,PIROMIDIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL311350,RCIMBBZXSXFZBV-UHFFFAOYSA-N,PIROMIDIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL428647,RCINICONZNJXQF-MZXODVADSA-N,PACLITAXEL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL428647,RCINICONZNJXQF-MZXODVADSA-N,PACLITAXEL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1813484,RCJIOMDJRBCHJE-RISCZKNCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,22.39,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813478,RCJIOMDJRBCHJE-SMDDNHRTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,23.99,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813478,RCJIOMDJRBCHJE-SMDDNHRTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,95.5,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL576036,RCMGBZYHSPTETA-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,224,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL450813,RCMVHXAYSDWNBI-GFCCVEGCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,37,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL476954,RCMVHXAYSDWNBI-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,IC50,=,23,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL476954,RCMVHXAYSDWNBI-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,23,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL476954,RCMVHXAYSDWNBI-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,52,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1172929,RCOBKSKAZMVBHT-RNCFNFMXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,241,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1172929,RCOBKSKAZMVBHT-RNCFNFMXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21319801,IC50,=,1200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,PUBLICATION,
CHEMBL1172928,RCOBKSKAZMVBHT-TVQRCGJNSA-N,RADAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,9900,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1172928,RCOBKSKAZMVBHT-TVQRCGJNSA-N,RADAFAXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21319801,IC50,=,100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,PUBLICATION,
CHEMBL1297,RDJGLLICXDHJDY-UHFFFAOYSA-N,FENOPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1297,RDJGLLICXDHJDY-UHFFFAOYSA-N,FENOPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL476941,RDLDWTPNWMTWKO-FQEVSTJZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,30,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL379181,RDLXBTKNMZJTIX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,KI,>,2000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL841,RDOIQAHITMMDAJ-UHFFFAOYSA-N,LOPERAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL841,RDOIQAHITMMDAJ-UHFFFAOYSA-N,LOPERAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1083430,RDRQTGHODUVHMX-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,277,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1083430,RDRQTGHODUVHMX-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,394,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1082611,RDRQTGHODUVHMX-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,36,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1082611,RDRQTGHODUVHMX-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,43,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1076376,RDWNVUCLDHTWPI-MLSOLMIFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1200993,REEUVFCVXKWOFE-UHFFFAOYSA-K,GALLAMINE TRIETHIODIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200993,REEUVFCVXKWOFE-UHFFFAOYSA-K,GALLAMINE TRIETHIODIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3323178,REFDLFNZTJITBX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,2.9,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL50,REFJWTPEDVJJIY-UHFFFAOYSA-N,QUERCETIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12110997,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL640,REQCZEXYDRLIBE-UHFFFAOYSA-N,PROCAINAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL640,REQCZEXYDRLIBE-UHFFFAOYSA-N,PROCAINAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL28079,REZGGXNDEMKIQB-UHFFFAOYSA-N,ZAPRINAST,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL28079,REZGGXNDEMKIQB-UHFFFAOYSA-N,ZAPRINAST,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL393701,RFECIGQVKKOIMS-CHWSQXEVSA-N,METHYL 2-(3-(TRIFLUOROMETHYL)PHENYL)CYCLOHEXANECARBOXYLATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,991000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL246388,RFEHSKWKBMZDQP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19926484,KI,=,1245,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,Synthesis and in vitro evaluation of fluorinated diphenyloxide derivatives and sulfur analogs as serotonin transporter ligands.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL106,RFHAOTPXVQNOHP-UHFFFAOYSA-N,FLUCONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL106,RFHAOTPXVQNOHP-UHFFFAOYSA-N,FLUCONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL258062,RFJRYJRDVNGNCX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,33,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL564100,RFKSUPOWTRFCKG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,30,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL447598,RFOPOIPYLVKPSZ-AEFFLSMTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,520,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173752,RFTBXAYWUQYHOQ-CHWSQXEVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,794.33,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1201216,RFWZESUMWJKKRN-UHFFFAOYSA-N,DAPIPRAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201216,RFWZESUMWJKKRN-UHFFFAOYSA-N,DAPIPRAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL503609,RFZOKJQQTZLOBO-BJUDXGSMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18487050,KI,=,2770,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1644606,RGCRPWWXLBCYBL-OPVJXMOQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,60,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL567,RGCVKNLCSQQDEP-UHFFFAOYSA-N,PERPHENAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL567,RGCVKNLCSQQDEP-UHFFFAOYSA-N,PERPHENAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL411,RGLYKWWBQGJZGM-ISLYRVAYSA-N,DIETHYLSTILBESTROL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,3670,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL411,RGLYKWWBQGJZGM-ISLYRVAYSA-N,DIETHYLSTILBESTROL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3640,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL257348,RGPDAGIHVSVOQP-BDBMTWCYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,37,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL411655,RGXBRYANHNSPHQ-VBKZILBWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,5.8,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL498510,RHFJKUASNIKDKP-SJKOYZFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,145,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL410062,RHHBTYFKWRRJPP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3291023,RHOHKPLNPSKULL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24814532,DRUG UPTAKE,,,,Active,"",cell_based,"","","","",,,,,,,,Cellular uptake in human SK-N-SH cells assessed as noradrenaline transporter-mediated uptake at 1 x 10'-4 M after 15 mins by [3H]-noradrenaline uptake assay,Synthesis and biological effects of new hybrid compounds composed of benzylguanidines and the alkylating group of busulfan on neuroblastoma cells.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3703732,RHVRAPZNMRRCCU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,97,NM,302096,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL574546,RHZULZDFMYQLIX-UHDQLFAASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,=,118,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1308,RIKMMFOAQPJVMX-UHFFFAOYSA-N,FOMEPIZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1308,RIKMMFOAQPJVMX-UHFFFAOYSA-N,FOMEPIZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL563030,RILKVQPDTVTHBN-CWQZNGJJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,3,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL563030,RILKVQPDTVTHBN-CWQZNGJJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,13,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL549825,RILKVQPDTVTHBN-FWJOYPJLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL549825,RILKVQPDTVTHBN-FWJOYPJLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,35,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL394373,RILPYESNVZTTIN-CHWSQXEVSA-N,METHYL 2-(4-(TRIFLUOROMETHYL)PHENYL)CYCLOHEXANECARBOXYLATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,439000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL550932,RIMYGAIUGCFOTN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,199.53,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL444412,RINBNPPEMJIWTC-UHFFFAOYSA-N,KF-A2,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17846138,IC50,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,PUBLICATION,
CHEMBL203453,RISBSIZJBWBMEB-UGSOOPFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,4200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL103,RJKFOVLPORLFTN-LEKSSAKUSA-N,PROGESTERONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL103,RJKFOVLPORLFTN-LEKSSAKUSA-N,PROGESTERONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL491810,RJOGBLCDKSENEL-WCQYABFASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,9,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1554,RJURFGZVJUQBHK-IIXSONLDSA-N,DACTINOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1554,RJURFGZVJUQBHK-IIXSONLDSA-N,DACTINOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL172090,RJVRDLDDCGQDGE-GTRCSXEUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15012999,INHIBITION,=,15,%,,"","","","","","",,,,,,,,Inhibitory activity against human adrenergic norepinephrine transporter at 10 uM,Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 3: SAR studies on the benzylpyrazole segment.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL132676,RKCUTIXVCFBEGE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213054,KI,=,11,NM,,"","","","","","",,,,,,,,Inhibition of [125I]- RTI -55 binding at the Norepinephrine transporter sites on HEK-hNET cells,Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL217987,RKHFLVYZXJYWKW-RDPSFJRHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,95,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL426743,RKSAEPSMCMRCOK-ROUUACIJSA-N,LY-2152041,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17123820,KI,=,10.8,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL517712,RKUNBYITZUJHSG-SPUOUPEWSA-N,ATROPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL517712,RKUNBYITZUJHSG-SPUOUPEWSA-N,ATROPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL498,RKWGIWYCVPQPMF-UHFFFAOYSA-N,CHLORPROPAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL498,RKWGIWYCVPQPMF-UHFFFAOYSA-N,CHLORPROPAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1237,RLAWWYSOJDYHDC-BZSNNMDCSA-N,LISINOPRIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1237,RLAWWYSOJDYHDC-BZSNNMDCSA-N,LISINOPRIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3673179,RLLIIRDYLONSJW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,55.8,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL402999,RLOLTHVCQCDNSF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,180,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323099,RLPCKFFTXOAFOK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,52,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3317697,RLSDCBVRAGSYCJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25017029,IC50,=,660,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL607548,RLTILGBQVNXKRQ-DDZGMJBXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,1200,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL506874,RLUHSIYRINOGAT-RTWAWAEBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,120,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173277,RLZACOPBIXSOEX-SMDDNHRTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,1130,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL249215,RLZDYYKLMOPCMU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,170000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1108,RMEDXOLNCUSCGS-UHFFFAOYSA-N,DROPERIDOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1108,RMEDXOLNCUSCGS-UHFFFAOYSA-N,DROPERIDOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL599638,RMFDASBXQBLDIL-BREBYQMCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,223.87,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL603540,RMFDASBXQBLDIL-OPQQBVKSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,1288.25,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL596809,RMFDASBXQBLDIL-OUJBWJOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,1.74,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL596809,RMFDASBXQBLDIL-OUJBWJOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,3.16,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL596809,RMFDASBXQBLDIL-OUJBWJOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,4.57,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in LLCPK cells by liquid scintillation counting,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL481696,RMKQQVTXLRWNDV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,2900,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1089,RMUCZJUITONUFY-UHFFFAOYSA-N,PHENELZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1089,RMUCZJUITONUFY-UHFFFAOYSA-N,PHENELZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1089,RMUCZJUITONUFY-UHFFFAOYSA-N,PHENELZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL551646,RMVVWYWHBYZSBH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL504892,RNEOSZBYBZJIGX-CVEARBPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,68,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL556714,RNLDMCBNMHSZQI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,199.53,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL12856,RNLQIBCLLYYYFJ-UHFFFAOYSA-N,INAMRINONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL12856,RNLQIBCLLYYYFJ-UHFFFAOYSA-N,INAMRINONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL504033,RNMJRHMRVJNPGK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,2.96,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL524153,RNPCOHCWKNMBRI-QHCPKHFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18799310,ACTIVITY,=,1790,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,"Identification and SAR around N-{2-[4-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-[1,4]diazepan-1-yl]-ethyl}-2-phenoxy-nicotinamide, a selective alpha2C adrenergic receptor antagonist.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173519,RNWPCCAJXHTPIS-BFHYXJOUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,100,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173520,RNWPCCAJXHTPIS-MGPQQGTHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,50.12,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL597135,RNYJGXWCOXRLAG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,181,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL190703,ROARIPXQVCVHPS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15974579,KI,=,269,NM,,"",cell_based,"","","","",,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,PUBLICATION,
CHEMBL488,ROBVIMPUHSLWNV-UHFFFAOYSA-N,AMINOGLUTETHIMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL488,ROBVIMPUHSLWNV-UHFFFAOYSA-N,AMINOGLUTETHIMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL184238,ROFVXGGUISEHAM-UHFFFAOYSA-N,URB597,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16352709,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL654,RONZAEMNMFQXRA-UHFFFAOYSA-N,MIRTAZAPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,2900,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL654,RONZAEMNMFQXRA-UHFFFAOYSA-N,MIRTAZAPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,4600,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL654,RONZAEMNMFQXRA-UHFFFAOYSA-N,MIRTAZAPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL505592,ROTDEDNYANYXDF-PMACEKPBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19067522,KI,=,3.68,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET receptor expressed in HEK293 cells,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL510484,ROTSFLNCGRVNJJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18782666,IC50,=,13,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. Part 3: Site-directed metabolism as a strategy to avoid active circulating metabolites: structure-activity relationships of (thioalkyl)phenoxy benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL377510,ROXOOMBIDGERBZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL573971,ROZQUSZIXUCKCC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,20,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL198038,RPAXLFKEFIYMPQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,150,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310477,RPBPOTIIGUEQSZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,56,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310477,RPBPOTIIGUEQSZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310477,RPBPOTIIGUEQSZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL322348,RPEDEMBGNMELBV-YHZLUUAOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,IC50,,,,Not Determined,"","","","","","",,,,,,,,In vitro ability of compound to inhibit NE re-uptake of radiolabeled [3H]-tritium transmitter into synaptosome; ND=not determined,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL322348,RPEDEMBGNMELBV-YHZLUUAOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,KI,=,120,NM,,"","","","","","",,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL566618,RPHSTODYKZLNFU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,221,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566618,RPHSTODYKZLNFU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,5700,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566618,RPHSTODYKZLNFU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,>,100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL514937,RPJFGKOZZHLXFS-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673139,RPNWMLLBQPFWML-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,691,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL276832,RPTUSVTUFVMDQK-UHFFFAOYSA-N,HYDRALAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL276832,RPTUSVTUFVMDQK-UHFFFAOYSA-N,HYDRALAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2407321,RPURJJSUIZKBOK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,200,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1794855,RPZYOWNZYQHSLJ-SPIKMXEPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15203136,ACTIVITY,,,,Not Active,"","","","","","",,,,,,,,Binding towards norepinephrine transporter; NA= Not active,"(+/-)8-Amino-5,6,7,8-tetrahydroisoquinolines as novel antinociceptive agents.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3104092,RQBRUGMHSQYCNU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24365159,KI,=,1348.96,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3104092,RQBRUGMHSQYCNU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24365159,KI,=,1349,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL380559,RQBVJCCLVRZSFV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,ACTIVITY,=,39,%,,"","","","","","",,,,,,,,Percentage displacement of [3H]nisoxetine radioligand from norepinephrine transporter at concentration of 1000 nM,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL380559,RQBVJCCLVRZSFV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,>,200,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL549510,RQCXDPJNIVTCJD-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL481941,RQDOQYXVLGVVBA-UHFFFAOYSA-N,4-(2-((DIMETHYLAMINO)METHYL)PHENOXY)BENZONITRILE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323176,RQGSUGDPXICJIV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,41,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3310035,RQPAEAIGXOANQF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from NET (unknown origin) expressed in HEK cells at 10 uM after 90 mins by microbeta counting analysis,,J. Nat. Prod.,PUBLICATION,
CHEMBL567944,RQQIFQXOKVSJMS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,8900,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL498509,RQRGTZIPGLRQOJ-CXAGYDPISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,46,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL498509,RQRGTZIPGLRQOJ-CXAGYDPISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,35,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL510352,RQRGTZIPGLRQOJ-GUYCJALGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,3100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL304656,RQTWPNKOATVIPT-CFXFOKGESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10821718,KI,=,640,NM,,"",cell_based,"","","","",,,,,,,,Compound was evaluated for inhibition of [3H]NE uptake in HEK-hNET cells expressing Human norepinephrine transporter,Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL304656,RQTWPNKOATVIPT-CFXFOKGESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10821718,KI,=,3770,NM,,"",cell_based,"","","","",,,,,,,,Compound was evaluated for binding affinity using [125I]RTI-55 as a radioligand in HEK-hNET cells expressing human norepinephrine transporter,Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL1201139,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,MEGESTROL ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201139,RQZAXGRLVPAYTJ-GQFGMJRRSA-N,MEGESTROL ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL42710,RRAFCDWBNXTKKO-UHFFFAOYSA-N,EUGENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL42710,RRAFCDWBNXTKKO-UHFFFAOYSA-N,EUGENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2205831,RRBNCHNWWUXYEM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding affinity to NET at 10 uM,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205831,RRBNCHNWWUXYEM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2113217,RRFLDGUEDAERPR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,350,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2113217,RRFLDGUEDAERPR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,4100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2337601,RRGCJEHCXSKPFY-RHSMWYFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,0.501,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL799,RRGUKTPIGVIEKM-UHFFFAOYSA-N,CILOSTAZOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL799,RRGUKTPIGVIEKM-UHFFFAOYSA-N,CILOSTAZOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1643519,RRPWTJMHWMGFPI-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21095126,IC50,=,3091,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant norepinephrine transporter,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643516,RRPWTJMHWMGFPI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21095126,IC50,=,1857,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant norepinephrine transporter,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1076367,RRVNDCQJFDMBLZ-ZIZRRBHYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL2338032,RSAGNBIVUSOUTP-BBRMVZONSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,0.794,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL234706,RSNYUBDIPFPZKJ-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17391962,IC50,=,390,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]Nisoxetine from human NET expressed in HEK293 cells,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL234706,RSNYUBDIPFPZKJ-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560923,IC50,=,390,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]nisoxetine from human NET expressed in HEK293 cells,Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL234706,RSNYUBDIPFPZKJ-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20034793,IC50,=,390,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]nisoxetine from human NET transfected in human HEK293 cells,Synthesis and hSERT activity of homotryptamine analogs. Part 6: [3+2] dipolar cycloaddition of 3-vinylindoles.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL234705,RSNYUBDIPFPZKJ-CQSZACIVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17391962,IC50,=,37,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]Nisoxetine from human NET expressed in HEK293 cells,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL390432,RSNYUBDIPFPZKJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17391962,IC50,=,57,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]Nisoxetine from human NET expressed in HEK293 cells,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL390432,RSNYUBDIPFPZKJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17391962,INHIBITION,=,90,%,,"","","","","","",,,,,,,,Inhibition of human NET at 1 uM,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1909076,RSTSYGXUDMJEFP-SECBINFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909076,RSTSYGXUDMJEFP-SECBINFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL608380,RSVUNKKDIROCQS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,IC50,=,960,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL608380,RSVUNKKDIROCQS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,792,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL404145,RSWULBWZZJNURY-SWLSCSKDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,73,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3094316,RSZFCDGHJLBYEB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24238903,INHIBITION,=,63.6,%,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1456,RTGDFNSFWBGLEC-SYZQJQIISA-N,MYCOPHENOLATE MOFETIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1456,RTGDFNSFWBGLEC-SYZQJQIISA-N,MYCOPHENOLATE MOFETIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1169388,RTHCYVBBDHJXIQ-INIZCTEOSA-N,(S)-FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12232544,KI,=,410,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1169388,RTHCYVBBDHJXIQ-INIZCTEOSA-N,(S)-FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12232544,KI,=,686,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8496700,INHIBITION,>,50,%,,"","","","","","",,,,,,,,Inhibition of norepinephrine reuptake site of norepinephrine transporter at 100 nM,The role of receptor binding in drug discovery.,J. Nat. Prod.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,777,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,2186,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,240,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,240,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12232544,KI,=,574,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12232544,KI,=,599,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12431845,KI,=,1022,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,KI,=,440,NM,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16220969,KI,=,2000,NM,,"","","","","","",,,,,,,,Inhibition constant against norepinephrine transporter,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,5200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,5200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,1,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,2000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,2000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,=,563,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19014888,IC50,=,1020,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19014888,KI,=,1560,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,IC50,=,1020,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,KI,=,1560,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,563,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,IC50,,,,Not Determined,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,IC50,=,6309.57,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,KI,=,1394,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,56,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,4410,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,5,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,8,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,56,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1303,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL41,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,FLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1292,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3334800,RTJQGAYVHIKRGT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,IC50,=,205.7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL564229,RTKAHBPTWDBIEJ-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,6.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL564229,RTKAHBPTWDBIEJ-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,7.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL1173412,RTLOWGFIODTOMO-ZIAGYGMSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,199.53,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL257549,RTMQOOCMZQWPBD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673157,RTZINNBUTTZVCY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,54.8,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL2206528,RUBLHLUAVCRNAN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,37,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL513313,RUCURZAOXQKURR-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,70,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL201666,RUCXEVOCSDADAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,22.8,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL201666,RUCXEVOCSDADAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,1140,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL443922,RUEHEMMKOYGDGT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,290,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL356531,RUFGGNDBOBTWQC-LPHOPBHVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,2200,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL356531,RUFGGNDBOBTWQC-LPHOPBHVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL148104,RUFGGNDBOBTWQC-QFBILLFUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,440,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL148104,RUFGGNDBOBTWQC-QFBILLFUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,1000,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL1257975,RUQIIZGSRSUFTC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20801651,INHIBITION,,,,Active,"","","","","","",,,,,,,,Inhibition of NET,Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL227180,RUZFACWXYQTPTF-HIUFNZKISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,912,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL227180,RUZFACWXYQTPTF-HIUFNZKISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,2700,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL707,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,DOXAZOSIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL707,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,DOXAZOSIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL246519,RVDUVVPILREHEK-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,40,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL561878,RVLRGNBXYBRGGM-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,13,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1170793,RVOPEWUULYWWBF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,15.85,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173530,RVRYTWVPEPGNKI-CHWSQXEVSA-N,"RAC-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[4.1.0]HEPTAN-6-YL)METHANOL (STRUCTURAL MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,100,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173530,RVRYTWVPEPGNKI-CHWSQXEVSA-N,"RAC-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[4.1.0]HEPTAN-6-YL)METHANOL (STRUCTURAL MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,158.49,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173530,RVRYTWVPEPGNKI-CHWSQXEVSA-N,"RAC-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[4.1.0]HEPTAN-6-YL)METHANOL (STRUCTURAL MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,398.11,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL491268,RVVDMQMBQDIWKD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,1300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL462402,RWLJNOQFNVGFMO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,10,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673171,RWPUMYBDIXPXIA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,450.7,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL1256017,RWTGFMPOODRXIM-UHFFFAOYSA-N,ARCAINE SULFATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1256017,RWTGFMPOODRXIM-UHFFFAOYSA-N,ARCAINE SULFATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL914,RWTNPBWLLIMQHL-UHFFFAOYSA-N,FEXOFENADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL914,RWTNPBWLLIMQHL-UHFFFAOYSA-N,FEXOFENADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909065,RWVUEZAROXKXRT-VQLSFVLHSA-N,LYSERGOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909065,RWVUEZAROXKXRT-VQLSFVLHSA-N,LYSERGOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL230000,RXBAZUHMGOEBGO-CLFYSBASSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17705359,KI,=,28,NM,,"",cell_based,"","","","",HEK293,,,,,,,Binding affinity to human NET expressed in HEK293 cells,Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent.,J. Med. Chem.,PUBLICATION,
CHEMBL395998,RXBAZUHMGOEBGO-LIOZXAKYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053782,KI,=,28,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET transfected in human HEK293 cells,"Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL552167,RXJIAQGHWRMBEZ-KGLIPLIRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560923,IC50,=,7900,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]nisoxetine from human NET expressed in HEK293 cells,Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL552167,RXJIAQGHWRMBEZ-KGLIPLIRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20034793,IC50,=,7900,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]nisoxetine from human NET transfected in human HEK293 cells,Synthesis and hSERT activity of homotryptamine analogs. Part 6: [3+2] dipolar cycloaddition of 3-vinylindoles.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL610220,RXLIIMKHNRHPBV-IWIIMEHWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,25.12,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL469912,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,PUROMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL469912,RXWNCPJZOCPEPQ-NVWDDTSBSA-N,PUROMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1214185,RXZBMPWDPOLZGW-XMRMVWPWSA-N,ROXITHROMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1214185,RXZBMPWDPOLZGW-XMRMVWPWSA-N,ROXITHROMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1173754,RYHCLMRIRKKHKV-ZIAGYGMSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,15.85,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1643513,RYIJMRFACOYPNH-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21095126,IC50,=,601,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant norepinephrine transporter,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643511,RYIJMRFACOYPNH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21095126,IC50,=,934,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant norepinephrine transporter,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL498566,RYMGUUFPMNAKMP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18461921,KI,>,100000,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,PUBLICATION,
CHEMBL1064,RYMZZMVNJRMUDD-HGQWONQESA-N,SIMVASTATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1064,RYMZZMVNJRMUDD-HGQWONQESA-N,SIMVASTATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL225235,RYRHNOGQFYLMHQ-KOQKOIQBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,=,132,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL225235,RYRHNOGQFYLMHQ-KOQKOIQBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,KI,=,61,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL453493,RYTIZBPXUHTIDS-UHFFFAOYSA-N,"(3,4-DICHLOROPHENYL)(2-((DIMETHYLAMINO)METHYL)PHENYL)METHANONE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,8600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL207886,RYUCCDFXIDUVPN-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,15,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1947088,RYXJNKOIIVLWKR-ANDHVUINSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22300887,KI,=,188,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET receptor expressed in HEK293 cells,QSAR study and synthesis of new phenyltropanes as ligands of the dopamine transporter (DAT).,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL113,RYYVLZVUVIJVGH-UHFFFAOYSA-N,CAFFEINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL113,RYYVLZVUVIJVGH-UHFFFAOYSA-N,CAFFEINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL550696,RYZMJJMMTKGIGG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,23,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1076370,RZCFFRMJSWPPMC-WBFXVXKESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1914696,RZDYKEZBUSRGJW-UMQBVGHOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21458259,KI,=,29.1,NM,,"",cell_based,"","","","",LLC-PK1,,,,,,,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CELECOXIB,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,7308,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CELECOXIB,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,7247,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL45245,RZFVLEJOHSLEFR-UHFFFAOYSA-N,PHENANTHRIDIN-6(5H)-ONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL45245,RZFVLEJOHSLEFR-UHFFFAOYSA-N,PHENANTHRIDIN-6(5H)-ONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL122,RZJQGNCSTQAWON-UHFFFAOYSA-N,ROFECOXIB,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL122,RZJQGNCSTQAWON-UHFFFAOYSA-N,ROFECOXIB,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL467323,RZKZTKPGTZKVOQ-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,12,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL467323,RZKZTKPGTZKVOQ-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,12,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1076386,RZMZSLGBWMSARY-CAKWXZNXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1076388,RZMZSLGBWMSARY-GFFHZWSNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1076387,RZMZSLGBWMSARY-HBHWHIAESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1076390,RZMZSLGBWMSARY-NILNYKIASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1076391,RZMZSLGBWMSARY-NJPHSXLDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1076406,RZMZSLGBWMSARY-OECJZXFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1076385,RZMZSLGBWMSARY-VBIRFCDQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1076360,RZMZSLGBWMSARY-ZWRUYHAFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in COS7 cells assessed as inhibition of [3H]norepinephrine uptake at 1 uM,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1076360,RZMZSLGBWMSARY-ZWRUYHAFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,IC50,=,181.97,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1076360,RZMZSLGBWMSARY-ZWRUYHAFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,LOGEC50,=,-6.74,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in COS7 cells assessed as inhibition of [3H]norepinephrine uptake,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL2326694,RZPGXWQFZWSYES-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,15,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL1480,RZTAMFZIAATZDJ-UHFFFAOYSA-N,FELODIPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1480,RZTAMFZIAATZDJ-UHFFFAOYSA-N,FELODIPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL112,RZVAJINKPMORJF-UHFFFAOYSA-N,ACETAMINOPHEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL112,RZVAJINKPMORJF-UHFFFAOYSA-N,ACETAMINOPHEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL595539,RZXLCNVGLULZII-FLNOXTKTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,4900,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL487873,RZZJNEKORGOFAD-XDGABKOJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,770,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1683900,SAARGPSTPXUSIL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,232,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL232674,SADMOVBJKBFJNN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,247000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL232674,SADMOVBJKBFJNN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,1318000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL381079,SAEFVYOQTPRNBW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,15.9,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL451264,SAGAKZDNFJIHDD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18793858,KI,>,2500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,"Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1173413,SAIAWHLAJVOTCR-ZIAGYGMSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,316.23,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL87708,SAPNXPWPAUFAJU-UHFFFAOYSA-N,LOFEPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,5.4,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1831166,SAUWBVJOXSKPQX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21899931,KI,=,1350,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Synthesis and pharmacological evaluation of indole-based sigma receptor ligands.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL486041,SAYSUZYFOLMWGB-FOYRJYEQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,454,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL402644,SBAQYPMYNRQKBF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18060777,KI,=,3200,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL509,SBDNJUWAMKYJOX-UHFFFAOYSA-N,MECLOFENAMIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL509,SBDNJUWAMKYJOX-UHFFFAOYSA-N,MECLOFENAMIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1084971,SBKGLFTUHHUCII-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,58,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3704750,SBTIZQKJKFHNPY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,1,NM,317704,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL3704750,SBTIZQKJKFHNPY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,13.4,NM,317692,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL1384,SBUJHOSQTJFQJX-NOAMYHISSA-N,KANAMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1384,SBUJHOSQTJFQJX-NOAMYHISSA-N,KANAMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL104700,SCDKHPSUXHBJDJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1644609,SCEZKNSHVTVFNV-MUJYYYPQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,9,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL6310,SCIRNASYBOGBOO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643338,KI,,10000,NM,Not Determined,"","","","","","",,,,,,,,Binding affinity towards NET; No data,Binding of beta-carbolines at 5-HT(2) serotonin receptors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1413,SCKYRAXSEDYPSA-UHFFFAOYSA-N,CICLOPIROX,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1413,SCKYRAXSEDYPSA-UHFFFAOYSA-N,CICLOPIROX,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3323094,SCNQXZMXILXZRI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,69,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3323094,SCNQXZMXILXZRI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323094,SCNQXZMXILXZRI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,4.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323094,SCNQXZMXILXZRI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,19.2,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323094,SCNQXZMXILXZRI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,2,NM,314407,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL357553,SDCIJOLMGUGDKZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,>,20000,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL396754,SDIRDYYWJCYZFU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,10000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL213287,SDLVJPBOBLQFEW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,22,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL213287,SDLVJPBOBLQFEW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,22,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,GEMCITABINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL888,SDUQYLNIPVEERB-QPPQHZFASA-N,GEMCITABINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL208444,SDXZUZKWTPTGAT-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,43,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL401070,SEBXOWVFQDITBN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,5800,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL441358,SECNEKAFHNWBBW-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,1.8,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL439,SEEPANYCNGTZFQ-UHFFFAOYSA-N,SULFADIAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL439,SEEPANYCNGTZFQ-UHFFFAOYSA-N,SULFADIAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1477,SEERZIQQUAZTOL-ANMDKAQQSA-N,CERIVASTATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1477,SEERZIQQUAZTOL-ANMDKAQQSA-N,CERIVASTATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL165790,SFBODOKJTYAUCM-UHFFFAOYSA-N,IPRIFLAVONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2512.5,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL165790,SFBODOKJTYAUCM-UHFFFAOYSA-N,IPRIFLAVONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2491.7,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL403759,SFBSHUOIEODSEA-DZGCQCFKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL543925,SFESMQNHNIKYIQ-CJRXIRLBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,29.9,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2311152,SFLSHLFXELFNJZ-CMIMLBRMSA-N,[3H]NOREPINEPHRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17428804,KM,=,690,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity to human wild type NET expressed in african green monkey COS1 cells,chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.,J. Biol. Chem.,PUBLICATION,
CHEMBL2311152,SFLSHLFXELFNJZ-CMIMLBRMSA-N,[3H]NOREPINEPHRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17428804,VMAX,=,1.78,PMOL/MIN,,"",cell_based,"","","","",,,,,,,,Activity at human wild type NET expressed in african green monkey COS1 cells assessed per mg protein,chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.,J. Biol. Chem.,PUBLICATION,
CHEMBL1437,SFLSHLFXELFNJZ-QMMMGPOBSA-N,NOREPINEPHRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19962901,ACTIVITY,>,10000,%,,"","","","","","",,,,,,,,Inhibition of NET PDSP analysis,"Synthesis, pharmacological studies and molecular modeling of some tetracyclic 1,3-diazepinium chlorides.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL378536,SFVKEKBNXMUWFU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16784855,KI,=,4.84,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET transfected in HEK293 cells,Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1214005,SGCXLJVGGMOGGK-PMWAWBRWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20597489,KI,=,2607,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL852,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,MELPHALAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL852,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,MELPHALAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2432052,SGFPDDMJMPKKTB-RAOGCBAWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1094208,SGKVPHOMCZNDPT-UHFFFAOYSA-N,"1-(2,3-DICHLOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (ENANTIOMERIC MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20427184,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter at 1 uM,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL282468,SGMZJAMFUVOLNK-UHFFFAOYSA-M,CHOLINE CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL282468,SGMZJAMFUVOLNK-UHFFFAOYSA-M,CHOLINE CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL6966,SGTNSNPWRIOYBX-UHFFFAOYSA-N,VERAPAMIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL6966,SGTNSNPWRIOYBX-UHFFFAOYSA-N,VERAPAMIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL429,SGUAFYQXFOLMHL-UHFFFAOYSA-N,LABETALOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,3354,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL429,SGUAFYQXFOLMHL-UHFFFAOYSA-N,LABETALOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3326,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL566957,SGVYOOIAHHLONY-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,117,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL264159,SGXWOKUJCWMPJE-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL653,SGXXNSQHWDMGGP-IZZDOVSWSA-N,NIZATIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL653,SGXXNSQHWDMGGP-IZZDOVSWSA-N,NIZATIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL221067,SHAKAEUQTANHLB-NVQXNPDNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,4168,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL599798,SHDFZRRKZIILLR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,663,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL547,SHGAZHPCJJPHSC-XFYACQKRSA-N,ISOTRETINOIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL547,SHGAZHPCJJPHSC-XFYACQKRSA-N,ISOTRETINOIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL38,SHGAZHPCJJPHSC-YCNIQYBTSA-N,TRETINOIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL38,SHGAZHPCJJPHSC-YCNIQYBTSA-N,TRETINOIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL469552,SHJHTXWKDLOBQS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,1900,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257336,SHSUQLQDTJDCTQ-IFXJQAMLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,4.4,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673167,SHTPCUCEADJDFW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,35.1,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL43048,SHXWCVYOXRDMCX-UHFFFAOYSA-N,METHYLENEDIOXYMETHAMPHETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12761331,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL43048,SHXWCVYOXRDMCX-UHFFFAOYSA-N,METHYLENEDIOXYMETHAMPHETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19717215,IC50,=,405,NM,,"","","","","","",,,,,,,,Inhibition of human noradrenaline transporter,Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL43048,SHXWCVYOXRDMCX-UHFFFAOYSA-N,METHYLENEDIOXYMETHAMPHETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20466553,IC50,=,405,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,"Synthesis and in vitro toxicity of 4-MTA, its characteristic clandestine synthesis byproducts and related sulfur substituted alpha-alkylthioamphetamines.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL43048,SHXWCVYOXRDMCX-UHFFFAOYSA-N,METHYLENEDIOXYMETHAMPHETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,IC50,=,1995.26,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL43048,SHXWCVYOXRDMCX-UHFFFAOYSA-N,METHYLENEDIOXYMETHAMPHETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,KI,=,398,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL43048,SHXWCVYOXRDMCX-UHFFFAOYSA-N,METHYLENEDIOXYMETHAMPHETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26233799,EC50,=,1000,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity to human NET expressed in HEK293 cells assessed as induction of [3H]MPP+ release by liquid scintillation counting method,"Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1200396,SIEYLFHKZGLBNX-UHFFFAOYSA-N,BUPIVACAINE HYDROCHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200396,SIEYLFHKZGLBNX-UHFFFAOYSA-N,BUPIVACAINE HYDROCHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL202348,SIFVHGKZPNIKBO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,24.9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL202348,SIFVHGKZPNIKBO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,509,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2096860,SIIICDNNMDMWCI-HXSCFSKGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,760,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL2096860,SIIICDNNMDMWCI-HXSCFSKGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,458,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL610766,SIIICDNNMDMWCI-JYVUQVBGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,19,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL242338,SIIICDNNMDMWCI-KBXIAJHMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,10,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL242338,SIIICDNNMDMWCI-KBXIAJHMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,34,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL375889,SIIICDNNMDMWCI-SHWKFHJASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,52.4,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL375889,SIIICDNNMDMWCI-SHWKFHJASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,32,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL311347,SIIICDNNMDMWCI-VOFREWHGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12620070,KI,=,1.4,NM,,"",cell_based,"","","","",,,,,,,,In vitro competitive binding versus [3H]- nisoxatine in murine kidney cells transfected with cDNA for human norepinephrine transporter (NET),Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.,J. Med. Chem.,PUBLICATION,
CHEMBL311347,SIIICDNNMDMWCI-VOFREWHGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12620070,RATIO,=,1.4,,,"","","","","","",,,,,,,,Ratio of binding affinity between human norepinephrine transporter (NET) and human serotonin transporter (SERT),Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.,J. Med. Chem.,PUBLICATION,
CHEMBL311347,SIIICDNNMDMWCI-VOFREWHGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14971892,KI,=,36,NM,,"","","","","","",,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [3H]-nisoxatine radioligand,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL311347,SIIICDNNMDMWCI-VOFREWHGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15080991,KI,=,11.2,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity to norepinephrine (NE) transporter in membranes of cells selectively expressing the human genes for NET,Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL311347,SIIICDNNMDMWCI-VOFREWHGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,36,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL311347,SIIICDNNMDMWCI-VOFREWHGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,22,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL215376,SIIICDNNMDMWCI-YJNKXOJESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24262882,KI,=,32.77,NM,,"","","","","","",,,,,,,,Binding affinity to NET (unknown origin),"Synthesis, radiosynthesis and first in vitro evaluation of novel PET-tracers for the dopamine transporter: [(11)C]IPCIT and [(18)F]FE@IPCIT.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL611959,SIPPOOBBYQOQKQ-UYLXQDHASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,810,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL208993,SJKATDZDYZMMAP-VQTJNVASSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16413778,KI,=,5.2,NM,,"","","","","","",,,,,,,,Binding affinity to NET,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL291338,SJQBHPJLLIJASD-UHFFFAOYSA-N,"3,3',4',5-TETRACHLOROSALICYLANILIDE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL291338,SJQBHPJLLIJASD-UHFFFAOYSA-N,"3,3',4',5-TETRACHLOROSALICYLANILIDE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2432050,SJWCMFMHVZULSJ-DKSPCFMDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL554336,SKAPWNQXRANDFK-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,61,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL270240,SKEKTDQXWYTVGO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1914695,SKIKZARVXIZUJL-DXCLHELWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21458259,KI,=,16877,NM,,"",cell_based,"","","","",LLC-PK1,,,,,,,Displacement of [125I]-INXT from NET transfected in pig LLC-PK1 cells by radioligand competition binding assay,Synthesis and evaluation of novel N-fluoropyridyl derivatives of tropane as potential PET imaging agents for the dopamine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL575133,SKJWCGCNEAHUQZ-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,52,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1171424,SKNMQBHFOCWPIZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,1584.89,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1172524,SKRQWFVNZMYZQL-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,158.49,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1170374,SKRQWFVNZMYZQL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,39.81,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1169912,SKRQWFVNZMYZQL-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,31.62,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL103936,SKSUKRWKVAZHJI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,46700,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL103936,SKSUKRWKVAZHJI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL115280,SKVXOYIMICHFPV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11585444,IC50,=,2810,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine transporter,From hit to lead. Analyzing structure-profile relationships.,J. Med. Chem.,PUBLICATION,
CHEMBL27577,SKZKKFZAGNVIMN-UHFFFAOYSA-N,SALICYLAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL27577,SKZKKFZAGNVIMN-UHFFFAOYSA-N,SALICYLAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL412873,SLRCCWJSBJZJBV-TUVASFSCSA-N,SPARTEINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL412873,SLRCCWJSBJZJBV-TUVASFSCSA-N,SPARTEINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1224384,SLSGGVPSCGVWNP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,39,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL218174,SLSRYMJCMOWUIE-RDPSFJRHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,257,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1046,SLXKOJJOQWFEFD-UHFFFAOYSA-N,AMINOCAPROIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1046,SLXKOJJOQWFEFD-UHFFFAOYSA-N,AMINOCAPROIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL30008,SMANXXCATUTDDT-QPJJXVBHSA-N,FLUNARIZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1339,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL30008,SMANXXCATUTDDT-QPJJXVBHSA-N,FLUNARIZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1328,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201195,SNBUBQHDYVFSQF-HIFRSBDPSA-N,CEFMETAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201195,SNBUBQHDYVFSQF-HIFRSBDPSA-N,CEFMETAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1642913,SNDGNPRZZZPUAX-BLLLJJGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,158,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642912,SNDGNPRZZZPUAX-WBMJQRKESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,26,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3,SNICXCGAKADSCV-JTQLQIEISA-N,NICOTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3,SNICXCGAKADSCV-JTQLQIEISA-N,NICOTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2386164,SNNRWIBSGBMYRF-DZGCQCFKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,30,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2386165,SNNRWIBSGBMYRF-HIFRSBDPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,438,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2386166,SNNRWIBSGBMYRF-UKRRQHHQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,177,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2386162,SNNRWIBSGBMYRF-ZFWWWQNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,6.9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2386162,SNNRWIBSGBMYRF-ZFWWWQNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,INHIBITION,,,,Active,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET transfected in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake incubated 30 mins prior to substrate addition measured after 1 minute 50 secs,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL577504,SNORKSVJXFFHHB-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,IC50,=,321,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1371937,SNPLKNRPJHDVJA-UHFFFAOYSA-N,PANTHENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1371937,SNPLKNRPJHDVJA-UHFFFAOYSA-N,PANTHENOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL894,SNPPWIUOZRMYNY-UHFFFAOYSA-N,BUPROPION,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL894,SNPPWIUOZRMYNY-UHFFFAOYSA-N,BUPROPION,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12431845,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL894,SNPPWIUOZRMYNY-UHFFFAOYSA-N,BUPROPION,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12723940,IC50,=,1450,NM,,"","","","","","",,,,,,,,Inhibition of Norepinephrine (NA) reuptake using cloned human transporter was determined,2002 Medicinal Chemistry Division Award address: monoamine transporters and opioid receptors. Targets for addiction therapy.,J. Med. Chem.,PUBLICATION,
CHEMBL894,SNPPWIUOZRMYNY-UHFFFAOYSA-N,BUPROPION,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,443,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL894,SNPPWIUOZRMYNY-UHFFFAOYSA-N,BUPROPION,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,6970,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL894,SNPPWIUOZRMYNY-UHFFFAOYSA-N,BUPROPION,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,1850,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL894,SNPPWIUOZRMYNY-UHFFFAOYSA-N,BUPROPION,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,1850,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL894,SNPPWIUOZRMYNY-UHFFFAOYSA-N,BUPROPION,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21058665,IC50,=,1850,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,PUBLICATION,
CHEMBL894,SNPPWIUOZRMYNY-UHFFFAOYSA-N,BUPROPION,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL894,SNPPWIUOZRMYNY-UHFFFAOYSA-N,BUPROPION,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL384649,SOCOFADTVIPCCY-CUNXSJBXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,9261,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL373773,SOCRIYWOGGANHT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,2900,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL373773,SOCRIYWOGGANHT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,>,8800,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL373773,SOCRIYWOGGANHT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,2900,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL373773,SOCRIYWOGGANHT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,4000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL1818466,SOSAAAUSVCKKRE-QRWMCTBCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,39.81,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1201353,SOYKEARSMXGVTM-HNNXBMFYSA-N,DEXCHLORPHENIRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,4966,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201353,SOYKEARSMXGVTM-HNNXBMFYSA-N,DEXCHLORPHENIRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,4925,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200633,SPBDXSGPUHCETR-JFUDTMANSA-N,IVERMECTIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,3947.5,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200633,SPBDXSGPUHCETR-JFUDTMANSA-N,IVERMECTIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3914.9,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL576145,SPBUAQRRWQFNRI-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL15511,SPFYMRJSYKOXGV-UHFFFAOYSA-N,ENROFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL15511,SPFYMRJSYKOXGV-UHFFFAOYSA-N,ENROFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL154297,SPGFFOXASUPGGC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,3600,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL1085197,SPHAUOPMTCENAZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,55,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1493,SPIUTQOUKAMGCX-UHFFFAOYSA-N,FLAVOXATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1493,SPIUTQOUKAMGCX-UHFFFAOYSA-N,FLAVOXATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL525952,SPQWIGAZLYFACO-SREVYHEPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053782,KI,=,101.3,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET transfected in human HEK293 cells,"Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL2206524,SPUPMMOBNUTZEB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,12.3,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL209821,SPWZXWDPAWDKQE-UHFFFAOYSA-N,NALUZOTAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16722631,KI,>,2000,NM,,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter by radioligand binding assay,"An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression.",J. Med. Chem.,PUBLICATION,
CHEMBL1255837,SPXACGZWWVIDGR-SPZWACKZSA-N,DIHYDROERGOCRISTINE MESYLATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1255837,SPXACGZWWVIDGR-SPZWACKZSA-N,DIHYDROERGOCRISTINE MESYLATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL509007,SQCPLVXIAQOQFF-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,>,3000,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL513912,SQCPLVXIAQOQFF-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,=,7,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL444742,SQKSQRKXCFBFLF-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,8,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL444742,SQKSQRKXCFBFLF-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,3,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2047584,SQNUVGLAMLMYCU-HRAATJIYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,57,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL2047583,SQNUVGLAMLMYCU-IIBYNOLFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,83,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL584152,SQRPNDYXHFVWJL-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,64,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1084033,SQSFWPVYWBTHEX-UHFFFAOYSA-N,1-(1-(4-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,30,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1084033,SQSFWPVYWBTHEX-UHFFFAOYSA-N,1-(1-(4-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,51,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1084033,SQSFWPVYWBTHEX-UHFFFAOYSA-N,1-(1-(4-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1902981,SQUNAWUMZGQQJD-UHFFFAOYSA-N,EPERISONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1902981,SQUNAWUMZGQQJD-UHFFFAOYSA-N,EPERISONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL478877,SRCJGUQGCJJPSA-PKOBYXMFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,27,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1095525,SRKHUCZOFIQCSE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,=,100,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1095525,SRKHUCZOFIQCSE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,INH,=,86000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL40733,SRPXSILJHWNFMK-ZBEGNZNMSA-N,DESMETHYLSERTRALINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,811,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL40733,SRPXSILJHWNFMK-ZBEGNZNMSA-N,DESMETHYLSERTRALINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,2365,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL40733,SRPXSILJHWNFMK-ZBEGNZNMSA-N,DESMETHYLSERTRALINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,390,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL2030629,SRRZEMVAQOSBLB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2047562,SSEWYSOPUMSOTB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,61,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL338790,SSMIFVHARFVINF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL338790,SSMIFVHARFVINF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1902627,SSMSBSWKLKKXGG-UHFFFAOYSA-N,CLORPRENALINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1902627,SSMSBSWKLKKXGG-UHFFFAOYSA-N,CLORPRENALINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2432062,SSQDVMAIIMMISV-SEDVZXITSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL218848,SSUIQPFKMQJHGV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,51,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218848,SSUIQPFKMQJHGV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,810,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218848,SSUIQPFKMQJHGV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,>,10000000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL575206,SSYVIQKCLJMLJB-IOXAMRCBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,>,2000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL610514,STELSYDZPWCAMN-URBRKQAFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,4.6,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL49080,STJMRWALKKWQGH-UHFFFAOYSA-N,CLENBUTEROL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL49080,STJMRWALKKWQGH-UHFFFAOYSA-N,CLENBUTEROL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL178,STQGQHZAVUOBTE-VGBVRHCVSA-N,DAUNORUBICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL178,STQGQHZAVUOBTE-VGBVRHCVSA-N,DAUNORUBICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL467335,STZYVQIHBQCDSY-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,INHIBITION,=,32,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1 uM,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL451652,SUAFTJAVJHXARK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,92,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL451652,SUAFTJAVJHXARK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,2013,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1503,SUBDBMMJDZJVOS-UHFFFAOYSA-N,OMEPRAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1503,SUBDBMMJDZJVOS-UHFFFAOYSA-N,OMEPRAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL417049,SUFVPROIOBRYEK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,IC50,=,200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL417049,SUFVPROIOBRYEK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,KI,=,29,NM,,"","","","","","",,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL605119,SUHBXDPETHQPJC-RLFYNMQTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,2,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1567463,SUHOQUVVVLNYQR-MRVPVSSYSA-N,CHOLINE ALFOSCERATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1567463,SUHOQUVVVLNYQR-MRVPVSSYSA-N,CHOLINE ALFOSCERATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL205866,SUXMSNIBAHOLFO-RBUKOAKNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16413778,INHIBITION,=,25.2,%,,"","","","","","",,,,,,,,Binding affinity to NET at 100 nM,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2206512,SUYOCKAQLJWIGF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,100,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224316,SVDKSLGSXDLGEV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,10,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL146332,SVFXPTLYMIXFRX-BBRMVZONSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,130,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL146332,SVFXPTLYMIXFRX-BBRMVZONSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,600,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL296602,SVFXPTLYMIXFRX-UHFFFAOYSA-N,INDATRALINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,1.58,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL341898,SVFXPTLYMIXFRX-XJKSGUPXSA-N,"(R,S)-INDATRALINE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,15,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL341898,SVFXPTLYMIXFRX-XJKSGUPXSA-N,"(R,S)-INDATRALINE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,22,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL3309706,SVQJWGJWTNGCQH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,50,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309706,SVQJWGJWTNGCQH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309706,SVQJWGJWTNGCQH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL194574,SVXFDINGBNILGI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,79,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL563384,SWADTMSKMJUFBO-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,1120,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL552338,SWADTMSKMJUFBO-ZDUSSCGKSA-N,PF-3409409,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,6,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683902,SWBCLQGKCJMOJJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,7,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3334795,SWBSCJHQPHFHOQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,IC50,=,2541.5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL3334799,SWFPZMNSOVHJBG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,IC50,=,427.6,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL319244,SWUARLUWKZWEBQ-VQHVLOKHSA-N,CAFFEIC ACID PHENETHYL ESTER,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,3787,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL319244,SWUARLUWKZWEBQ-VQHVLOKHSA-N,CAFFEIC ACID PHENETHYL ESTER,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3756,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL372312,SWUVZKWCOBGPTH-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,11.3,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL372312,SWUVZKWCOBGPTH-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,109,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL380699,SWUVZKWCOBGPTH-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL201960,SWUVZKWCOBGPTH-UHFFFAOYSA-N,PYROVALERONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,28.3,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL201960,SWUVZKWCOBGPTH-UHFFFAOYSA-N,PYROVALERONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,195,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL403071,SXCVOEWVYRDQSX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,22,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173353,SXEGCINDYXTNFI-TVQRCGJNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,3800,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL599240,SXVNDMHECZDJQS-RLFYNMQTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,39.81,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL566534,SXYIRMFQILZOAM-HVNFFKDJSA-N,ARTEMETHER,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL566534,SXYIRMFQILZOAM-HVNFFKDJSA-N,ARTEMETHER,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL467736,SYDKDXKLTMXNAA-JXLXBRSFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19284718,KI,=,3404,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.,J. Med. Chem.,PUBLICATION,
CHEMBL492916,SYDKDXKLTMXNAA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19284718,KI,=,2733,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.,J. Med. Chem.,PUBLICATION,
CHEMBL1683896,SYDXJSKTVHXBGQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,28,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL470079,SYEDLPTWFRUJMC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,673,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL470079,SYEDLPTWFRUJMC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,368,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL155211,SYFFAEMYTWTOCA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,570,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL574348,SYLMRMITUMFBTA-UHFFFAOYSA-N,4-(2-(PHENOXYMETHYL)PHENYL)PIPERIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,1710,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL567481,SYMAJWVHHBJSJV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL567481,SYMAJWVHHBJSJV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL567481,SYMAJWVHHBJSJV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,>,100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1644472,SYNKGZURWSKSDC-DABQJJPHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,86,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL563,SYTBZMRGLBWNTM-UHFFFAOYSA-N,FLURBIPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL563,SYTBZMRGLBWNTM-UHFFFAOYSA-N,FLURBIPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201010,SYWHXTATXSMDSB-GSLJADNHSA-N,FLUDROCORTISONE ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201010,SYWHXTATXSMDSB-GSLJADNHSA-N,FLUDROCORTISONE ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL250008,SZBJSPPPDLPVBD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,210000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL241648,SZDGGXPDQJKRHQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18052090,KI,=,14,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,PUBLICATION,
CHEMBL3703742,SZGCLROZELTVOC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,9.8,NM,302106,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL253184,SZIXMPCDFZGATL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18085744,KI,=,725,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET t expressed in HEK293 cells,"Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.",J. Med. Chem.,PUBLICATION,
CHEMBL1076397,SZRIYBBJSDFTBY-LJJGSBRBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL295416,SZRPDCCEHVWOJX-UHFFFAOYSA-N,PIRINIXIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL295416,SZRPDCCEHVWOJX-UHFFFAOYSA-N,PIRINIXIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL270569,SZXFAVGUAGOGII-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,2600,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL86,TTWJBBZEZQICBI-UHFFFAOYSA-N,METOCLOPRAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL86,TTWJBBZEZQICBI-UHFFFAOYSA-N,METOCLOPRAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL206404,TUDVVMCZTNBXMS-SJCJKPOMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,1500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL572951,TUHQZGVWJDBKNN-AEFFLSMTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,21,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL497845,TUPKUZCHBMCYHC-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,11,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL457968,TUZLHPUVXHTPCQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,374,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL457968,TUZLHPUVXHTPCQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,882,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1144,TUZYXOIXSAXUGO-PZAWKZKUSA-N,PRAVASTATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1144,TUZYXOIXSAXUGO-PZAWKZKUSA-N,PRAVASTATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL457416,TVDANBVAWXCYSJ-MKRRPMGHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,>,5000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL2205826,TVDFWGUKMIRJAD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683901,TVDNUGUVGACHFB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,295,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683901,TVDNUGUVGACHFB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,295,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1095524,TVEJRNDJZBJGNP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,=,720,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1095524,TVEJRNDJZBJGNP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,INH,=,55000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL139168,TVGWXQAGBGCBIQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,KI,=,160,NM,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL379021,TVYLLZQTGLZFBW-OUONYHMNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16257206,IC50,=,2000,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of Norepinephrine,Derivatives of tramadol for increased duration of effect.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL201531,TVYLLZQTGLZFBW-TUYUVJPESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16257206,IC50,=,3600,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of Norepinephrine,Derivatives of tramadol for increased duration of effect.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1237044,TVYLLZQTGLZFBW-UHFFFAOYSA-N,TRAMADOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16257206,IC50,=,790,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of Norepinephrine,Derivatives of tramadol for increased duration of effect.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1237044,TVYLLZQTGLZFBW-UHFFFAOYSA-N,TRAMADOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,3861,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1237044,TVYLLZQTGLZFBW-UHFFFAOYSA-N,TRAMADOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1237044,TVYLLZQTGLZFBW-UHFFFAOYSA-N,TRAMADOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL438627,TVYLLZQTGLZFBW-ZEYWGEJISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16257206,IC50,=,3200,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of Norepinephrine,Derivatives of tramadol for increased duration of effect.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL493057,TVYXGLWTICSLOM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,2000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL376180,TVZGACDUOSZQKY-LBPRGKRZSA-N,AMINOPTERIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL376180,TVZGACDUOSZQKY-LBPRGKRZSA-N,AMINOPTERIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2206508,TWJQHLGFNXDIDH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,5.8,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3663916,TWKWOGUGCQDBEG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,12.9,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663916,TWKWOGUGCQDBEG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,58.2,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663916,TWKWOGUGCQDBEG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,>,1000,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663916,TWKWOGUGCQDBEG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,58.2,NM,314419,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL2205812,TWMXGXSGGIIQDM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1204410,TWOLHZITFDHKDN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,12,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3334771,TWOMIKAXPRBJNB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,79.1,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL256293,TWSKMFBDRRENNV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,22,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256293,TWSKMFBDRRENNV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,30,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2030626,TWUZJTIHFYRNSV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL683,TXCGAZHTZHNUAI-UHFFFAOYSA-N,CLOFIBRIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL683,TXCGAZHTZHNUAI-UHFFFAOYSA-N,CLOFIBRIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL419385,TXMJJPVQXBIOQV-YHZLUUAOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,IC50,,,,Not Determined,"","","","","","",,,,,,,,In vitro ability of compound to inhibit NE re-uptake of radiolabeled [3H]-tritium transmitter into synaptosome; ND=not determined,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL419385,TXMJJPVQXBIOQV-YHZLUUAOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,KI,=,50,NM,,"","","","","","",,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1196025,TXPPKWZEHFNZOE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24187998,KI,=,128900,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-dopamine from human NET expressed in African green monkey COS7 cells after 10 mins,"Design, synthesis, and biological evaluation of Erythrina alkaloid analogues as neuronal nicotinic acetylcholine receptor antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1371125,TXVHTIQJNYSSKO-UHFFFAOYSA-N,BENZO[E]PYRENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1371125,TXVHTIQJNYSSKO-UHFFFAOYSA-N,BENZO[E]PYRENE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL208191,TYAWVYXKOKCMIW-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,4.1,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2087421,TYDKAHFZLFMNQX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22369198,INHIBITION,=,2,%,,"",cell_based,"","","","",,,,,,,,Inhibition of human NE transporter at 5 uM by cell based assay,From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL394158,TYFSSZYOVLRLQK-QXSJWSMHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446069,KI,=,1.86,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"Synthesis and biological evaluation of 2beta,3alpha-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL401976,TYJYIHODVVLAMM-FZMZJTMJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,1500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2220427,TYQXKHPOXXXCTP-CSLYCKPJSA-N,ERYTHROMYCIN ESTOLATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2220427,TYQXKHPOXXXCTP-CSLYCKPJSA-N,ERYTHROMYCIN ESTOLATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1173594,TYRLWIIURFREJC-ZIAGYGMSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,79.43,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL493040,TYVFKNAUSZXXJC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL44,TZBJGXHYKVUXJN-UHFFFAOYSA-N,GENISTEIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL44,TZBJGXHYKVUXJN-UHFFFAOYSA-N,GENISTEIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1371,TZFWDZFKRBELIQ-UHFFFAOYSA-N,CHLORZOXAZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1371,TZFWDZFKRBELIQ-UHFFFAOYSA-N,CHLORZOXAZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL195585,TZHJRGABGIEARJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15801845,KI,=,4332,NM,,"",cell_based,"","","","",HEK293,,,,,,,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,PUBLICATION,
CHEMBL3310622,TZJCUYLPPDCFHU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,25,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310622,TZJCUYLPPDCFHU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,96,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310622,TZJCUYLPPDCFHU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL380523,TZMGQAAZTGUQJN-LIRRHRJNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,270,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL381315,TZMILLWOFHAFNQ-GTNSWQLSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,9100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL578815,TZRAZPTWNAPWGU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,4603,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL578815,TZRAZPTWNAPWGU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,4476,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL70927,TZXKOCQBRNJULO-UHFFFAOYSA-N,DEFERIPRONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL70927,TZXKOCQBRNJULO-UHFFFAOYSA-N,DEFERIPRONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL566193,UAAZALAKZAQQRJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566193,UAAZALAKZAQQRJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL22183,UABIXNSHHIMZEP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15801845,KI,=,320.4,NM,,"",cell_based,"","","","",HEK293,,,,,,,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,PUBLICATION,
CHEMBL22183,UABIXNSHHIMZEP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15974579,KI,=,61,NM,,"",cell_based,"","","","",,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,PUBLICATION,
CHEMBL22183,UABIXNSHHIMZEP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16337793,IC50,>,100,NM,,"","","","","","",,,,,,,,Inhibitory activity against NET,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL22183,UABIXNSHHIMZEP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18793858,KI,=,325,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,"Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2338033,UAGADFQXODVTNQ-CXAGYDPISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,3.98,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673146,UAJXVGMIEPUGSN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1545,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL1077647,UAOCSOBBQYATOV-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,198,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL471029,UAUSBXOENIHVFX-IBGZPJMESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,80,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1086398,UBBWGPMMVOSPDJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,130,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL959,UBCHPRBFMUDMNC-UHFFFAOYSA-N,RIMANTADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL959,UBCHPRBFMUDMNC-UHFFFAOYSA-N,RIMANTADINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3673132,UBFYHGZTRDBAOO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,274.8,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3673132,UBFYHGZTRDBAOO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,1166,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
,UBIQMAFTTDZGEX-UHFFFAOYSA-N,S33005,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11454918,KI,=,1510,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL3290152,UBNJOSSBOHRSMZ-SOFGYWHQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24918261,INHIBITION,>,50,%,,"","","","","","",,,,,,,,Displacement of antagonist radioligand from human NET at 10 uM,Cinnamic anilides as new mitochondrial permeability transition pore inhibitors endowed with ischemia-reperfusion injury protective effect in vivo.,J. Med. Chem.,PUBLICATION,
CHEMBL43882,UBOXGVDOUJQMTN-UHFFFAOYSA-N,TRICHLOROETHANE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL43882,UBOXGVDOUJQMTN-UHFFFAOYSA-N,TRICHLOROETHANE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3663918,UBPCUEVRWJIHLS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2.4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663918,UBPCUEVRWJIHLS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,4.1,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663918,UBPCUEVRWJIHLS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,41.3,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663918,UBPCUEVRWJIHLS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,2.4,NM,314423,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL234927,UBQCLKWUZCABQJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17391962,INHIBITION,=,35,%,,"","","","","","",,,,,,,,Inhibition of human NET at 1 uM,Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310480,UBQLLVMEOGBWCI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,32,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310480,UBQLLVMEOGBWCI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310480,UBQLLVMEOGBWCI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1835609,UBQRACCCHXXOJB-ZOWNYOTGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21905669,INHIBITION,=,14.2,%,,"","","","","","",,,,,,,,Binding affinity to NET at 10 uM by radioligand displacement assay,Discovery of Isoxazole Analogues of Sazetidine-A as Selective a4ß2-Nicotinic Acetylcholine Receptor Partial Agonists for the Treatment of Depression.,J. Med. Chem.,PUBLICATION,
CHEMBL3334782,UBTISEJLHYNQTI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,49.5,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL388605,UBUINJQFQXKDNL-JHDZUBBNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,=,10000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL388605,UBUINJQFQXKDNL-JHDZUBBNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,KI,=,6000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL388825,UBUINJQFQXKDNL-XKXWHVAQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,=,78000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL388825,UBUINJQFQXKDNL-XKXWHVAQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,KI,=,46000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL84,UCFGDBYHRUNTLO-QHCPKHFHSA-N,TOPOTECAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL84,UCFGDBYHRUNTLO-QHCPKHFHSA-N,TOPOTECAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1204415,UCFNHHVPDLJJEJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,27,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430696,UCFURURGGMKGCC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430696,UCFURURGGMKGCC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,79.9,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL787,UCHDWCPVSPXUMX-TZIWLTJVSA-N,MONTELUKAST,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2689,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL787,UCHDWCPVSPXUMX-TZIWLTJVSA-N,MONTELUKAST,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2667,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1950351,UCMNIYFDRVBMFV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22284817,ACTIVITY,<,50,%,,"","","","","","",,,,,,,,Activity at human NET receptor at 10 uM,¿-Carbolines: a novel class of cannabinoid agonists with high aqueous solubility and restricted CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL372795,UCSJYZPVAKXKNQ-HZYVHMACSA-N,STREPTOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL372795,UCSJYZPVAKXKNQ-HZYVHMACSA-N,STREPTOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1740,UCTWMZQNUQWSLP-UHFFFAOYSA-N,RACEPINEPHRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10411589,KI,=,3680,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL679,UCTWMZQNUQWSLP-VIFPVBQESA-N,EPINEPHRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL679,UCTWMZQNUQWSLP-VIFPVBQESA-N,EPINEPHRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL220819,UCYBGEFJKJSJQI-HOFKKMOUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,3449,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL343211,UDCVQVNMMCKETF-NZQKXSOJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,1600,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL343211,UDCVQVNMMCKETF-NZQKXSOJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,2800,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL497664,UDDSGRJSILNSQD-KBXCAEBGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,4500,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL599028,UDGISDAHRCDXMV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,135,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL584042,UEDLLBHXEVXPDP-ZEQRLZLVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,INHIBITION,=,26,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL482292,UEHLVCUNIAJBCM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,1050,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL558551,UEJJHQNACJXSKW-SECBINFHSA-N,(R)-THALIDOMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL558551,UEJJHQNACJXSKW-SECBINFHSA-N,(R)-THALIDOMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,THALIDOMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL468,UEJJHQNACJXSKW-UHFFFAOYSA-N,THALIDOMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL426123,UEJJHQNACJXSKW-VIFPVBQESA-N,(-)-THALIDOMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL426123,UEJJHQNACJXSKW-VIFPVBQESA-N,(-)-THALIDOMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL542501,UEKLEFLNJKLESJ-LMRHVHIWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,3430,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643514,UEPBVWIBDNMJPA-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21095126,IC50,=,1184,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant norepinephrine transporter,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643510,UEPBVWIBDNMJPA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21095126,IC50,=,7141,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant norepinephrine transporter,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL252719,UEQUQVLFIPOEMF-GOSISDBHSA-N,(S)-MIANSERIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,71,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL6437,UEQUQVLFIPOEMF-UHFFFAOYSA-N,MIANSERIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,163,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL6437,UEQUQVLFIPOEMF-UHFFFAOYSA-N,MIANSERIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,161,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL257905,UETBCRHGQLBFHE-JWQCQUIFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18243691,INHIBITION,=,24,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,"Potent, selective MCH-1 receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL403730,UEXMLAHFKICZJK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18243691,INHIBITION,=,57,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,"Potent, selective MCH-1 receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL438059,UEYARIMIGYJNDI-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,3.3,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL361949,UFBLPBWRPPLNJN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1683884,UFFRBOMGNQGCAY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,51,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL940,UGJMXCAKCUNAIE-UHFFFAOYSA-N,GABAPENTIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL940,UGJMXCAKCUNAIE-UHFFFAOYSA-N,GABAPENTIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3317700,UGMVHZUXVSBGFN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25017029,IC50,=,8,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1171392,UGNWXJYZJYLNRT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,398.11,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL803,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,CYTARABINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL803,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,CYTARABINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL218262,UHVITKONHRHSFJ-FIPFOOKPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,876,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL203266,UHWVSEOVJBQKBE-UHFFFAOYSA-N,TRIMETAZIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL203266,UHWVSEOVJBQKBE-UHFFFAOYSA-N,TRIMETAZIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL449145,UHXIHVPCQYVYLG-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,92,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1428,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,NIMODIPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1428,UIAGMCDKSXEBJQ-UHFFFAOYSA-N,NIMODIPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL34431,UIAYVIIHMORPSJ-UHFFFAOYSA-N,CILOSTAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL34431,UIAYVIIHMORPSJ-UHFFFAOYSA-N,CILOSTAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1813473,UIBIRCANCAKLIN-BXUZGUMPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,2137.96,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813473,UIBIRCANCAKLIN-BXUZGUMPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,6025.6,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813472,UIBIRCANCAKLIN-RISCZKNCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,204.17,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813471,UIBIRCANCAKLIN-SMDDNHRTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,112.2,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813471,UIBIRCANCAKLIN-SMDDNHRTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,177.83,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL380890,UIEMDECNRHYLAZ-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,3.2,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL211501,UIFFUZWRFRDZJC-SBOOETFBSA-N,ANTIMYCIN A,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL211501,UIFFUZWRFRDZJC-SBOOETFBSA-N,ANTIMYCIN A,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL575535,UIJBKUNWEPERDV-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,16,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1830885,UIKJCHWTULEUKX-CQSZACIVSA-N,WYE-114152,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,5,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830885,UIKJCHWTULEUKX-CQSZACIVSA-N,WYE-114152,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,15,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL3334788,UIOBXKSDWRXQBR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,77.4,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1099134,UIOCALWWKYWNPJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1099134,UIOCALWWKYWNPJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,INH,=,32000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2206523,UIVAIANIXTWVHO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,28,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2206523,UIVAIANIXTWVHO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,630,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1084313,UJEHPOIYQOLYRD-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,10,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1084313,UJEHPOIYQOLYRD-CYBMUJFWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,34,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1083118,UJEHPOIYQOLYRD-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,2,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1083118,UJEHPOIYQOLYRD-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1762471,UJFDPLITEKQPEB-WMQZXYHMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21398123,IC50,=,0,NM,,"","","","","","",,,,,,,,Inhibition of NET,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL599242,UJQCJTWDIZLQBH-BREBYQMCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,316.23,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL599241,UJQCJTWDIZLQBH-OUJBWJOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,1.58,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL599241,UJQCJTWDIZLQBH-OUJBWJOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,5.01,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL3310640,UJWNMDBIDDUPKQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,83,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL404364,UJXZJZLGZRRPNH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,41,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1385840,UJYGDMFEEDNVBF-OGGGUQDZSA-N,ERGOCORNINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1385840,UJYGDMFEEDNVBF-OGGGUQDZSA-N,ERGOCORNINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL522483,UKCDLIWPLWMDCP-GJZGRUSLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,20,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL523636,UKCDLIWPLWMDCP-LSDHHAIUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,2570,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL122859,UKJAARKQBNAPHJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,IC50,>,10,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL122859,UKJAARKQBNAPHJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,KI,=,7050,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL337798,UKLJVQPVIADCAE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,KI,=,67,NM,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684049,UKMRWNNKRBSVIH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,4000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1170794,UKQYNWZANZHZLT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,50.12,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL497512,ULFUJAQEYUFVSH-HOTGVXAUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL497512,ULFUJAQEYUFVSH-HOTGVXAUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,4,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL532,ULGZDMOVFRHVEP-RWJQBGPGSA-N,ERYTHROMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL532,ULGZDMOVFRHVEP-RWJQBGPGSA-N,ERYTHROMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2171214,ULHAPYHRFNPZCO-UHFFFAOYSA-N,"3-((3,4-DICHLOROPHENYL)(METHOXY)METHYL)AZETIDINE HCL",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,47,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL3323185,ULLMROULDBOCOZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,110,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL201976,ULUHBYVKNOUSDX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,93,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL201976,ULUHBYVKNOUSDX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,95,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL213785,ULVITMXAXCXEQQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,94,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL270786,UMFDUXSRXIHGAG-AEFFLSMTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,6248,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2407335,UMJOPAHCVSNVNC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,110,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL207713,UMMWKVQAQBVCAO-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16413778,KI,=,30,NM,,"","","","","","",,,,,,,,Binding affinity to NET,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL183470,UMYMNRFUWNCPOG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15456270,KI,=,20,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity for Norepinephrine transporter (NET) expressed in LCK PK1 cells,2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.,J. Med. Chem.,PUBLICATION,
CHEMBL3317701,UMZZJUZWLRKJTC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25017029,IC50,=,7.7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1419,UNAANXDKBXWMLN-UHFFFAOYSA-N,SIBUTRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,5665,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1419,UNAANXDKBXWMLN-UHFFFAOYSA-N,SIBUTRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,5619,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201356,UNBRKDKAWYKMIV-QWQRMKEZSA-N,METHYLERGONOVINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201356,UNBRKDKAWYKMIV-QWQRMKEZSA-N,METHYLERGONOVINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL356750,UNCBFTIAWJTNTF-WMLDXEAASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,21,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL356750,UNCBFTIAWJTNTF-WMLDXEAASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,52,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL356750,UNCBFTIAWJTNTF-WMLDXEAASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,130,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL356750,UNCBFTIAWJTNTF-WMLDXEAASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,130,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL147950,UNCBFTIAWJTNTF-YOEHRIQHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,86,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL147950,UNCBFTIAWJTNTF-YOEHRIQHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,150,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL1224469,UNCNBGAOAXFUFU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,55,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1167,UNFWWIHTNXNPBV-WXKVUWSESA-N,SPECTINOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1167,UNFWWIHTNXNPBV-WXKVUWSESA-N,SPECTINOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL450987,UNRUJFXXAULDMY-NWDGAFQWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,3392,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL450987,UNRUJFXXAULDMY-NWDGAFQWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,9085,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL456221,UNRUJFXXAULDMY-VXGBXAGGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,7983,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL456221,UNRUJFXXAULDMY-VXGBXAGGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,24120,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL481527,UNSWDCIYZPOJLJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673176,UNUKMFOSTQWWQA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,175.2,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3673176,UNUKMFOSTQWWQA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,955.6,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL1645613,UNWRSVCWVWOSPV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,192,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224383,UOGHZTJKVOOTDF-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,IC50,=,14.7,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224383,UOGHZTJKVOOTDF-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,76,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL558525,UOLFASMVWNZYMB-AEFICSSHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19791802,KI,=,27.8,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.",J. Med. Chem.,PUBLICATION,
CHEMBL553224,UOLFASMVWNZYMB-GIDGLZBFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19791802,KI,=,1.19,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.",J. Med. Chem.,PUBLICATION,
CHEMBL553224,UOLFASMVWNZYMB-GIDGLZBFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19791802,KI,=,4.16,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.",J. Med. Chem.,PUBLICATION,
CHEMBL558065,UOLFASMVWNZYMB-WRRDZZDISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19791802,KI,=,153,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.",J. Med. Chem.,PUBLICATION,
CHEMBL558329,UOLFASMVWNZYMB-WSCVZUBPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19791802,KI,=,75.7,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.",J. Med. Chem.,PUBLICATION,
CHEMBL558329,UOLFASMVWNZYMB-WSCVZUBPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19791802,KI,=,330,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.",J. Med. Chem.,PUBLICATION,
CHEMBL402057,UOPYFDKQWMFBDI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,11,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1169916,UOSHXPJHXMVWLW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,251.19,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL401347,UOTMBQUAJZORIE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,IC50,=,19000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL401347,UOTMBQUAJZORIE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17766113,INHIBITION,=,20,%,,"","","","","","",,,,,,,,Inhibition of NET at 1 uM,Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1076404,UOTRVSJUPBLQSJ-ZWRUYHAFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1172760,UOWSMEUBNCLAHO-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,5011.87,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL564631,UPHOWEAWENOKEG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,5850,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1080155,UPQNBHKMICCAIA-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20137933,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1020,UPSPUYADGBWSHF-UHFFFAOYSA-N,TOLMETIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1020,UPSPUYADGBWSHF-UHFFFAOYSA-N,TOLMETIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL378804,UPTXQSAYNARODX-UGSOOPFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,9600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL488222,UPUKKBZBVUXCSQ-CVEARBPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,4000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3334776,UPVLRNUPSLZGHM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,IC50,=,68.9,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1489254,URAYPUMNDPQOKB-UHFFFAOYSA-N,TRIACETIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1489254,URAYPUMNDPQOKB-UHFFFAOYSA-N,TRIACETIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL384467,UREBDLICKHMUKA-CXSFZGCWSA-N,DEXAMETHASONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL384467,UREBDLICKHMUKA-CXSFZGCWSA-N,DEXAMETHASONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL632,UREBDLICKHMUKA-DVTGEIKXSA-N,BETAMETHASONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL632,UREBDLICKHMUKA-DVTGEIKXSA-N,BETAMETHASONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL221753,UREZNYTWGJKWBI-UHFFFAOYSA-M,BENZETHONIUM CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,907,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL221753,UREZNYTWGJKWBI-UHFFFAOYSA-M,BENZETHONIUM CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,900,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL716,URKOMYMAXPYINW-UHFFFAOYSA-N,QUETIAPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL716,URKOMYMAXPYINW-UHFFFAOYSA-N,QUETIAPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL522721,URMSDCFJUVHWMC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,43.8,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL2030628,URNOPSHFIGOPOJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337605,URVPSAOJVKMKND-BBRMVZONSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,0.398,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337606,URVPSAOJVKMKND-CZUORRHYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,2,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL221886,URWAJWIAIPFPJE-YFMIWBNJSA-N,SISOMICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL221886,URWAJWIAIPFPJE-YFMIWBNJSA-N,SISOMICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1172902,URWDPKNAGFZFDK-ZIAGYGMSSA-N,"3-(3,4-DICHLORO-PHENYL)-6-AZA-TRICYCLO[4.2.1.0*1,3*]NONANE (STRUCTURAL MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,63.1,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1172902,URWDPKNAGFZFDK-ZIAGYGMSSA-N,"3-(3,4-DICHLORO-PHENYL)-6-AZA-TRICYCLO[4.2.1.0*1,3*]NONANE (STRUCTURAL MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,794.33,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL388850,URXGPOFPBIBVGT-NBDWZHNGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,=,920,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL388850,URXGPOFPBIBVGT-NBDWZHNGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,KI,=,550,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL2096874,URXGPOFPBIBVGT-ZUPWUQBJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,=,1040,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL2096874,URXGPOFPBIBVGT-ZUPWUQBJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,KI,=,626,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL481697,USDWPOAZUSPDGS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,5600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2037528,USGLWFZAXHASGB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22520153,KI,>,10000,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET by liquid scintillation assay,Benzothiazoles as probes for the 5HT(1A) receptor and the serotonin transporter (SERT): A search for new dual-acting agents as potential antidepressants.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL219649,USGRALLMTYXJMV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,8.1,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219649,USGRALLMTYXJMV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,47,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219649,USGRALLMTYXJMV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,3.9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219649,USGRALLMTYXJMV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,30,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL157455,USKJECUROJSHQU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL157455,USKJECUROJSHQU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL190700,USOGSVQPPWDNQD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15974579,KI,=,4.95,NM,,"",cell_based,"","","","",,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,PUBLICATION,
CHEMBL210126,USQDYFAONFKQLW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,72,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1784694,USRJTKDRTOTPRU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21570838,INHIBITION,<,50,%,Active,"","","","","","",,,,,,,,Inhibition of human recombinant NET at 10 uM by radioligand binding assay,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL502896,USROQQUKEBHOFF-SKKCDYJJSA-N,CETRAXATE HYDROCHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL502896,USROQQUKEBHOFF-SKKCDYJJSA-N,CETRAXATE HYDROCHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL476116,USUPIRYFHGUVOR-IBGZPJMESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,6,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL476116,USUPIRYFHGUVOR-IBGZPJMESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,14,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL476116,USUPIRYFHGUVOR-IBGZPJMESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,6,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673159,USYVVKCTZJJTBD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,119,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL502620,USZYSDMBJDPRIF-SVEJIMAYSA-N,ACLARUBICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL502620,USZYSDMBJDPRIF-SVEJIMAYSA-N,ACLARUBICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1333512,UTGQNNCQYDRXCH-UHFFFAOYSA-N,"N,N'-DIPHENYL-P-PHENYLENEDIAMINE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,786,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1333512,UTGQNNCQYDRXCH-UHFFFAOYSA-N,"N,N'-DIPHENYL-P-PHENYLENEDIAMINE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,780,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL377574,UTKRCKRKACMWMX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,9.6,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL562115,UTLIGDFWNZZYCH-MANSERQUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22082561,IC50,=,22.48,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,Characterisation of [¹¹C]PR04.MZ in Papio anubis baboon: a selective high-affinity radioligand for quantitative imaging of the dopamine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL562115,UTLIGDFWNZZYCH-MANSERQUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22082561,IC50,=,31.04,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]NE from human NET expressed in HEK293 cells,Characterisation of [¹¹C]PR04.MZ in Papio anubis baboon: a selective high-affinity radioligand for quantitative imaging of the dopamine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1762481,UTNAGBHMGVWHTR-SBSPUUFOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21398123,IC50,>,100000,NM,,"","","","","","",,,,,,,,Inhibition of NET,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL569270,UTPGRZGMQVAYAA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24147864,KI,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity to human NET by PDSP assay,Synthesis and evaluation in monkey of [(18)F]4-fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([(18)F]FIMX): a promising radioligand for PET imaging of brain metabotropic glutamate receptor 1 (mGluR1).,J. Med. Chem.,PUBLICATION,
CHEMBL1683899,UTQLEVQLADDVHS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,20,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2036266,UTTUELHWYPRNHJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22420844,IC50,=,280,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in CHO cells after 120 mins by scintillation counting,"First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL13378,UUDAMDVQRQNNHZ-UHFFFAOYSA-N,"(R,S)-AMPA",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL13378,UUDAMDVQRQNNHZ-UHFFFAOYSA-N,"(R,S)-AMPA",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3673143,UUEYKVGDKFNPHW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2305,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL2430687,UUNYJDCLTZOEDK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,2521,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430687,UUNYJDCLTZOEDK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,24.2,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430687,UUNYJDCLTZOEDK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,90,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL357995,UUOJIACWOAYWEZ-UHFFFAOYSA-N,BOPINDOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL357995,UUOJIACWOAYWEZ-UHFFFAOYSA-N,BOPINDOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL24441,UUQMNUMQCIQDMZ-UHFFFAOYSA-N,BETAHISTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL24441,UUQMNUMQCIQDMZ-UHFFFAOYSA-N,BETAHISTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2337595,UUSPTDRDECONSP-RHSMWYFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,0.501,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337594,UUSPTDRDECONSP-YOEHRIQHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,2,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2431797,UUUXPUGZNDRYSV-ZQIYAJFXSA-N,(-)-O-METHYLCUBEBIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24112084,INHIBITION,,,,Not Active,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK cells using [3H]-norepinephrine as substrate at 200 uM after 10 mins by scintillation counting,The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities.,J. Nat. Prod.,PUBLICATION,
CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,ALTRETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,ALTRETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL577825,UUZFTXGGHPBIFW-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,49,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL479044,UVCDBPBNDXOVKD-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,124,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL605502,UVFXBMLDXDSRJM-SLEUVZQESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,15.85,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL255839,UVKUMJGXPDEXSQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL648,UVKZSORBKUEBAZ-UHFFFAOYSA-N,CYCLIZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL648,UVKZSORBKUEBAZ-UHFFFAOYSA-N,CYCLIZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL573844,UVNCBAMPWZRVGM-CPWXKJDLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,=,1900,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL408867,UVSWWUWQVAQPJR-UHFFFAOYSA-N,[11C]SA4503,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,INHIBITION,>,90,%,,"","","","","","",,,,,,,,Binding affinity to NE transporter (unknown origin) at 10 uM by displacement assay relative to control,,MedChemComm,PUBLICATION,
CHEMBL1173416,UVVKDTGZBLYAEF-COLVAYQJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,50.12,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL106939,UVWLEPXXYOYDGR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10956218,KI,=,1350,NM,,"","","","","","",,,,,,,,In vitro binding affinity on cloned Norepinephrine transporter,"Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines.",J. Med. Chem.,PUBLICATION,
CHEMBL106939,UVWLEPXXYOYDGR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15456270,KI,>,1000,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity for Norepinephrine transporter (NET) expressed in LCK PK1 cells,2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.,J. Med. Chem.,PUBLICATION,
CHEMBL106939,UVWLEPXXYOYDGR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15801845,KI,=,5127,NM,,"",cell_based,"","","","",HEK293,,,,,,,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,PUBLICATION,
CHEMBL404811,UVYVLBIGDKGWPX-YCCXZQINSA-N,DIGITONIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL404811,UVYVLBIGDKGWPX-YCCXZQINSA-N,DIGITONIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL139835,UWFYSQMTEOIJJG-FDTZYFLXSA-N,CYPROTERONE ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL139835,UWFYSQMTEOIJJG-FDTZYFLXSA-N,CYPROTERONE ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL220247,UWHKVOABKKOHHU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,120,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL220247,UWHKVOABKKOHHU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,750,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL220247,UWHKVOABKKOHHU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,840,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL220247,UWHKVOABKKOHHU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,4500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL201556,UWJUQVWARXYRCG-BMJHUOGNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16257206,IC50,=,6700,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of Norepinephrine,Derivatives of tramadol for increased duration of effect.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1400,UWJUQVWARXYRCG-HIFRSBDPSA-N,O-DESMETHYL TRAMADOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16257206,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of Norepinephrine,Derivatives of tramadol for increased duration of effect.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1400,UWJUQVWARXYRCG-HIFRSBDPSA-N,O-DESMETHYL TRAMADOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL525371,UWKDYASULVDCRI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18793858,KI,>,5200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET expressed in HEK293 cells,"Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL481,UWKQSNNFCGGAFS-XIFFEERXSA-N,IRINOTECAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL481,UWKQSNNFCGGAFS-XIFFEERXSA-N,IRINOTECAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL204702,UWLGSNCXKLOAAD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16337793,IC50,>,100,NM,,"","","","","","",,,,,,,,Inhibitory activity against NET,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1078073,UWLXWGKTAMTBSF-NSHDSACASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,139,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL458072,UWVXBFZXNOPEDU-CHKHYCHESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,270,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL594388,UWXLPDJHYFZQEG-ZEUZZLKZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,5000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2430697,UXGIXJLEBICYQD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,26,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430697,UXGIXJLEBICYQD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,64.8,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL523916,UXQWVKZZHZNXRM-SLWGAWGTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18434164,KI,=,2560,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL86754,UXZFQZANDVDGMM-UHFFFAOYSA-N,IODOQUINOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL86754,UXZFQZANDVDGMM-UHFFFAOYSA-N,IODOQUINOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL226984,UYCWPYLNAMMOLO-NQAVQENRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,2040,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL226984,UYCWPYLNAMMOLO-NQAVQENRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,990,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL555121,UYHGUPUXXZHREH-NSHDSACASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,172,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL282575,UYIFTLBWAOGQBI-BZDYCCQFSA-N,ESTRADIOL BENZOATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,17229,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL282575,UYIFTLBWAOGQBI-BZDYCCQFSA-N,ESTRADIOL BENZOATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,17087,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL208252,UYKZMZQXFWTAIG-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,3.4,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL203236,UYRXAUJWAVZHMT-LIRRHRJNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,2700,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL476320,UYSHSCPIMATHOZ-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,23,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL566830,UYZAXUWVJGHEFL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,1260,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566830,UYZAXUWVJGHEFL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,3090,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566830,UYZAXUWVJGHEFL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,1520,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL207374,UZGZHONLKDCUMO-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,4.8,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL80,UZHSEJADLWPNLE-GRGSLBFTSA-N,NALOXONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL80,UZHSEJADLWPNLE-GRGSLBFTSA-N,NALOXONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3586032,UZJCBPUZLIMFRR-VJGNERBWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25981690,INHIBITION,=,0,%,,"","","","","","",,,,,,,,Inhibition of radioligand binding at human NET at 10 uM,2-Aminoalkyl nicotinamide derivatives as pure inverse agonists of the ghrelin receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL487355,UZKWACFLBGIUSH-UHFFFAOYSA-N,5-(3-BENZYLPYRROLIDIN-3-YL)-1H-INDOLE (STRUCTURAL MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,1,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL487355,UZKWACFLBGIUSH-UHFFFAOYSA-N,5-(3-BENZYLPYRROLIDIN-3-YL)-1H-INDOLE (STRUCTURAL MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,17,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL487355,UZKWACFLBGIUSH-UHFFFAOYSA-N,5-(3-BENZYLPYRROLIDIN-3-YL)-1H-INDOLE (STRUCTURAL MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,1,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3094320,UZVSKGBBGCJIRV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24238903,INHIBITION,=,83.9,%,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL260335,UZYRBFYXTKDZOC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,6400,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1191,VACCAVUAMIDAGB-UHFFFAOYSA-N,SULFAMETHIZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1191,VACCAVUAMIDAGB-UHFFFAOYSA-N,SULFAMETHIZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL542933,VAHMWGICKYTGSY-UHFFFAOYSA-N,GBR-12909,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24315194,KI,=,48.5,NM,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin),"Flexible and biomimetic analogs of triple uptake inhibitor 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Synthesis, biological characterization, and development of a pharmacophore model.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL257704,VAIOZOCLKVMIMN-PRJWTAEASA-N,EPLIVANSERIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15999145,KI,=,739.5,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL272002,VANVVYOTKNTIED-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17983754,KI,=,1.32,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL137,VAOCPAMSLUNLGC-UHFFFAOYSA-N,METRONIDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL137,VAOCPAMSLUNLGC-UHFFFAOYSA-N,METRONIDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL567292,VARGWBUXBMFVJN-UHFFFAOYSA-N,GSK554418A,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19743867,ACTIVITY,=,15,%,,"","","","","","",,,,,,,,Binding affinity to NET at 1 uM,"Discovery of 1-[4-(3-chlorophenylamino)-1-methyl-1H-pyrrolo[3,2-c]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a brain penetrant 5-azaindole CB2 agonist for the treatment of chronic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL461241,VAVYBCGVZAGHSF-ZNAMSDCWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,>,3000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL1683873,VAXCWNURWRJNKL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,36,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL573532,VAXHGPCUAFNAQS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,554,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL524624,VBCNPTPFVJBMLY-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,480,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1170209,VBDVAWKLCDBKGM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,50.12,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323177,VBHKUWHGDVHSSQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,180,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2030637,VBKWQJLSFFFYLC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1645598,VBNJXEPLSRKHGO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,507,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
,VBOQYPQEPHKASR-GSVOUGTGSA-N,D-HOMOCYSTEIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12649361,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
,VBOQYPQEPHKASR-UHFFFAOYSA-N,DL-HOMOCYSTEIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12649361,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL230951,VBOQYPQEPHKASR-VKHMYHEASA-N,L-HOMOCYSTEATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12649361,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL514193,VBPKFUYKYAIDNV-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,627,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL461323,VBPKFUYKYAIDNV-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,32,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL566050,VBQDZZHUUPHQGQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,43,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566050,VBQDZZHUUPHQGQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,520,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566050,VBQDZZHUUPHQGQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,180,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL364050,VCCPIFXWHLLCQB-KOLCDFICSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2171413,VCDSAMDGVWEPBI-UHFFFAOYSA-N,3-((BENZYLOXY)(4-CHLOROPHENYL)METHYL)AZETIDINE HCL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,16,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL3094317,VCEAPZBMHGKMHI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24238903,INHIBITION,=,61.3,%,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1765684,VCKIDQVWSDVZCZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21428406,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding affinity to NET at 10 uM by radioligand binding assay,"N-(4-Cyanotetrahydro-2H-pyran-4-yl) and N-(1-Cyanocyclohexyl) Derivatives of 1,5-Diarylpyrazole-3-carboxamides Showing High Affinity for 18 kDa Translocator Protein and/or Cannabinoid Receptors.",J. Med. Chem.,PUBLICATION,
CHEMBL611,VCKUSRYTPJJLNI-UHFFFAOYSA-N,TERAZOSIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL611,VCKUSRYTPJJLNI-UHFFFAOYSA-N,TERAZOSIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1083708,VCVDPONUNCPTCQ-UHFFFAOYSA-N,1-(2-(2-(DIFLUOROMETHOXY)PHENYL)-1-PHENYLETHYL)PIPERAZINE (ENANTIOMERIC MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,28,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1083708,VCVDPONUNCPTCQ-UHFFFAOYSA-N,1-(2-(2-(DIFLUOROMETHOXY)PHENYL)-1-PHENYLETHYL)PIPERAZINE (ENANTIOMERIC MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,30,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1083708,VCVDPONUNCPTCQ-UHFFFAOYSA-N,1-(2-(2-(DIFLUOROMETHOXY)PHENYL)-1-PHENYLETHYL)PIPERAZINE (ENANTIOMERIC MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,180,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL220713,VCYYAUWOLSKMPO-CUNXSJBXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,317,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3085024,VCZAQTQIUKEOCH-ACDBMABISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16213721,KI,=,7580,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL573667,VDFAJYFMKVKZLC-GOSISDBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,34,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL453838,VDFAJYFMKVKZLC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,=,47,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL453838,VDFAJYFMKVKZLC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,47,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3099899,VDWKDBPHAPPUBO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24215892,INHIBITION,=,-17,%,,"","","","","","",,,,,,,,Inhibition of human NET at 10 uM relative to control,"Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL567479,VEOJUGKGLUEXTM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL567479,VEOJUGKGLUEXTM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,3800,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL119385,VEPKQEUBKLEPRA-UHFFFAOYSA-N,VX-745,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,20404,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL119385,VEPKQEUBKLEPRA-UHFFFAOYSA-N,VX-745,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,20236,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200629,VEPSYABRBFXYIB-PWXDFCLTSA-M,VECURONIUM BROMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200629,VEPSYABRBFXYIB-PWXDFCLTSA-M,VECURONIUM BROMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL277474,VEQOALNAAJBPNY-UHFFFAOYSA-N,ANTIPYRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL277474,VEQOALNAAJBPNY-UHFFFAOYSA-N,ANTIPYRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL345607,VFLCTSVVOXXGMD-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,1400,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL283196,VFMMPHCGEFXGIP-UHFFFAOYSA-N,ALPHA-NAPHTHOFLAVONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL283196,VFMMPHCGEFXGIP-UHFFFAOYSA-N,ALPHA-NAPHTHOFLAVONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3323180,VGAJKWKQOHMKHS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,INHIBITION,=,99,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells at 100 nM after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL29292,VGGGPCQERPFHOB-RDBSUJKOSA-N,UBENIMEX,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL29292,VGGGPCQERPFHOB-RDBSUJKOSA-N,UBENIMEX,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL207712,VGJFVJKZCAUGKE-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16413778,KI,=,148,NM,,"","","","","","",,,,,,,,Binding affinity to NET,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL809,VGKDLMBJGBXTGI-SJCJKPOMSA-N,SERTRALINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,420,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL809,VGKDLMBJGBXTGI-SJCJKPOMSA-N,SERTRALINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,825,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL809,VGKDLMBJGBXTGI-SJCJKPOMSA-N,SERTRALINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,825,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL809,VGKDLMBJGBXTGI-SJCJKPOMSA-N,SERTRALINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,984.8,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL809,VGKDLMBJGBXTGI-SJCJKPOMSA-N,SERTRALINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,976.6,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL190573,VGKDLMBJGBXTGI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14573386,KI,=,715,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL284994,VGKDLMBJGBXTGI-YVEFUNNKSA-N,"(1R,4S)-TRANS-SERTRALINE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,817,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL284994,VGKDLMBJGBXTGI-YVEFUNNKSA-N,"(1R,4S)-TRANS-SERTRALINE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,1716,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL284994,VGKDLMBJGBXTGI-YVEFUNNKSA-N,"(1R,4S)-TRANS-SERTRALINE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,420,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL284994,VGKDLMBJGBXTGI-YVEFUNNKSA-N,"(1R,4S)-TRANS-SERTRALINE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12232544,KI,=,714,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL284994,VGKDLMBJGBXTGI-YVEFUNNKSA-N,"(1R,4S)-TRANS-SERTRALINE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12232544,KI,=,925,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1084015,VGSAURUBNJSRDU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,196,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL477580,VGSCEHIVOAIVKK-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,29,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL555146,VGSYEFOBFMUWGO-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22313227,KI,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity to human recombinant NET,Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.,J. Med. Chem.,PUBLICATION,
CHEMBL401819,VGUGGBCMZNBMLT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,46,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL239079,VGVAYDIHTPWEKS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18052090,KI,=,97,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,PUBLICATION,
CHEMBL2429890,VGYQUDBPYFLBLJ-PTCVETCVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,KI,=,7352,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1258843,VHENJOBTWCOIPN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20727749,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of norepinephrine receptor at 10 uM,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL478,VHFVKMTVMIZMIK-UHFFFAOYSA-N,CHLOROPHENYLPIPERAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,1940,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL478,VHFVKMTVMIZMIK-UHFFFAOYSA-N,CHLOROPHENYLPIPERAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,4360,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL641,VHGCDTVCOLNTBX-QGZVFWFLSA-N,ATOMOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,2.03,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL641,VHGCDTVCOLNTBX-QGZVFWFLSA-N,ATOMOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,5.1,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL641,VHGCDTVCOLNTBX-QGZVFWFLSA-N,ATOMOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,5.1,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL641,VHGCDTVCOLNTBX-QGZVFWFLSA-N,ATOMOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL641,VHGCDTVCOLNTBX-QGZVFWFLSA-N,ATOMOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL641,VHGCDTVCOLNTBX-QGZVFWFLSA-N,ATOMOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL641,VHGCDTVCOLNTBX-QGZVFWFLSA-N,ATOMOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,=,3,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL641,VHGCDTVCOLNTBX-QGZVFWFLSA-N,ATOMOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL641,VHGCDTVCOLNTBX-QGZVFWFLSA-N,ATOMOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954038,IC50,=,5.1,NM,,"",cell_based,"","","","",HEK293,,,,,,,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter","Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL641,VHGCDTVCOLNTBX-QGZVFWFLSA-N,ATOMOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL641,VHGCDTVCOLNTBX-QGZVFWFLSA-N,ATOMOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL641,VHGCDTVCOLNTBX-QGZVFWFLSA-N,ATOMOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,3.1,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL641,VHGCDTVCOLNTBX-QGZVFWFLSA-N,ATOMOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL299052,VHGCDTVCOLNTBX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,2.03,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL299052,VHGCDTVCOLNTBX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12431845,KI,=,5,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1645604,VHKIHYNCEPOAKX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,433,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL270299,VHKZGNPOHPFPER-ONNFQVAWSA-N,BAY-11-7085,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL270299,VHKZGNPOHPFPER-ONNFQVAWSA-N,BAY-11-7085,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1829485,VHKZHZYOGPESQF-JKSUJKDBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21782432,INHIBITION,=,19,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,"Identification of pyridazin-3-one derivatives as potent, selective histamine H3 receptor inverse agonists with robust wake activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL960,VHOGYURTWQBHIL-UHFFFAOYSA-N,LEFLUNOMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,4630,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL960,VHOGYURTWQBHIL-UHFFFAOYSA-N,LEFLUNOMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,4591,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL459165,VHOZFHYPZOTVKS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,1,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL459165,VHOZFHYPZOTVKS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,78,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL650,VHRSUDSXCMQTMA-PJHHCJLFSA-N,METHYLPREDNISOLONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL650,VHRSUDSXCMQTMA-PJHHCJLFSA-N,METHYLPREDNISOLONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL22587,VHVPQPYKVGDNFY-ZPGVKDDISA-N,ITRACONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL22587,VHVPQPYKVGDNFY-ZPGVKDDISA-N,ITRACONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL469150,VIHUCKRDYCSWQL-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,217,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL469150,VIHUCKRDYCSWQL-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,217,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1162,VIKNJXKGJWUCNN-XGXHKTLJSA-N,NORETHINDRONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1162,VIKNJXKGJWUCNN-XGXHKTLJSA-N,NORETHINDRONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL377882,VILBBVHEBGZUJO-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,6,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL267894,VIROVYVQCGLCII-UHFFFAOYSA-N,AMOBARBITAL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL267894,VIROVYVQCGLCII-UHFFFAOYSA-N,AMOBARBITAL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL550469,VITWCGUBRNYQIV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,6.31,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL580143,VIWKHXNVEIOPSC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,718,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1078162,VJADHLVJCCCGKY-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,29,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL559137,VJAXFVGMNNFSQS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,1258.93,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,ETOPOSIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,ETOPOSIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL540978,VKEVCZGXCJOVET-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL605990,VKFRVICFXISTJZ-BHDTVMLSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,21,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1276308,VKHAHZOOUSRJNA-GCNJZUOMSA-N,MIFEPRISTONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1276308,VKHAHZOOUSRJNA-GCNJZUOMSA-N,MIFEPRISTONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL12089,VKJGBAJNNALVAV-UHFFFAOYSA-M,BERBERINE CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL12089,VKJGBAJNNALVAV-UHFFFAOYSA-M,BERBERINE CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3310638,VKOHWMDCIHAUTC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,43,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1726,VKQFCGNPDRICFG-UHFFFAOYSA-N,NISOLDIPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1726,VKQFCGNPDRICFG-UHFFFAOYSA-N,NISOLDIPINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL462585,VKZWZSZGPDLBNV-FPLPWBNLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053782,KI,=,30.2,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET transfected in human HEK293 cells,"Synthesis, radiosynthesis, and biological evaluation of fluorine-18-labeled 2beta-carbo(fluoroalkoxy)-3beta-(3'-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL564288,VLCJRBGIGILJAS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,50.12,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL541196,VLCYASXBDSCXJI-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,16,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL514354,VLIFAHMVTGLJCP-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,=,19,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL574921,VLLHQEDHCOUXKK-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,15,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL592854,VLLKJTHFWNJPCE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,8700,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL558,VLPIATFUUWWMKC-UHFFFAOYSA-N,MEXILETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL558,VLPIATFUUWWMKC-UHFFFAOYSA-N,MEXILETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL321067,VMBSZAVHWRUISI-KRCSLNALSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10698458,IC50,=,11,NM,,"",cell_based,"","","","",,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL589494,VMEDIUSDIYRUSA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,577,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL512435,VMHPHANZAYAVEB-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,73,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL50858,VMITZEMDDZVHBZ-KCNJBTMXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12723940,IC50,=,0.8,NM,,"","","","","","",,,,,,,,Inhibition of Norepinephrine (NA) reuptake using cloned human Norepinephrine transporter was determined,2002 Medicinal Chemistry Division Award address: monoamine transporters and opioid receptors. Targets for addiction therapy.,J. Med. Chem.,PUBLICATION,
CHEMBL1812749,VMITZEMDDZVHBZ-UGQVUOCMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21058665,IC50,=,6.5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,PUBLICATION,
CHEMBL1812745,VMITZEMDDZVHBZ-XNISGKROSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21058665,IC50,=,1.1,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,PUBLICATION,
CHEMBL1612004,VMPITZXILSNTON-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1612004,VMPITZXILSNTON-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL386493,VMQXOMTZSIHVEX-LVXARBLLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,1052,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL207807,VMRYJLGXIPJJKQ-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,20,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1790041,VMXUWOKSQNHOCA-UHFFFAOYSA-N,RANITIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1790041,VMXUWOKSQNHOCA-UHFFFAOYSA-N,RANITIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL104,VNFPBHJOKIVQEB-UHFFFAOYSA-N,CLOTRIMAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,7936,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL104,VNFPBHJOKIVQEB-UHFFFAOYSA-N,CLOTRIMAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,7870,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2432055,VNGQWOKKSKAESQ-RAOGCBAWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL611379,VNJFIBFHISUZRV-YESZJQIVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,1,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL611379,VNJFIBFHISUZRV-YESZJQIVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,316.23,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL598215,VNJFIBFHISUZRV-ZACQAIPSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,0.631,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1765599,VNRFZHXTMQEXQW-XHDPSFHLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21319801,IC50,=,24,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,PUBLICATION,
CHEMBL1643518,VNSMQTHLCZBNAH-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21095126,IC50,=,1246,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant norepinephrine transporter,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1643517,VNSMQTHLCZBNAH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21095126,IC50,=,1005,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant norepinephrine transporter,"Discovery of 1-(3,4-dichlorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydroquinolin-4-amine, a dual serotonin and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1830890,VOAKSCZKUWRXKS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,8,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830890,VOAKSCZKUWRXKS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,14,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL401651,VOSGCNSEIZQWJC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,82,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1370,VOVIALXJUBGFJZ-KWVAZRHASA-N,BUDESONIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1370,VOVIALXJUBGFJZ-KWVAZRHASA-N,BUDESONIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL135,VOXZDWNPVJITMN-ZBRFXRBCSA-N,ESTRADIOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL135,VOXZDWNPVJITMN-ZBRFXRBCSA-N,ESTRADIOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2407319,VPFSCTXNTBOTFE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,9.3,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL272531,VPKOLELPULBVMY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,6100,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL210026,VPNYIGJUQBPBMU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,14,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL526306,VPTOWUWJWIVXIJ-DYESRHJHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,400,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL524271,VPTOWUWJWIVXIJ-LAUBAEHRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,30,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1909073,VPUGSHLBERYQGC-UHFFFAOYSA-M,PIPERILATE ETHOBROMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909073,VPUGSHLBERYQGC-UHFFFAOYSA-M,PIPERILATE ETHOBROMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3613147,VPUIRNPMXUBXBD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.49,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL213496,VPVFIULLMFQQSH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,21,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3334790,VQCUPTYEZOLTOL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,40.4,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL2165063,VQECILSOQQFMKP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25155913,INHIBITION,=,61,%,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) at 30 uM,Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1818458,VQEHAMZDBNCIFO-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,31.62,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3673154,VQELKPWZCFCRFB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,123.6,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL498904,VQGISMYTICCORC-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257335,VQHFZGHDNLRMRZ-SUMWQHHRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,8.1,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL563897,VQHNOBXUTWSPMZ-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,16.8,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL563897,VQHNOBXUTWSPMZ-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,17.5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL2171212,VQJDDPXSICHYDO-UHFFFAOYSA-N,3-((4-CHLOROPHENYL)(METHOXY)METHYL)AZETIDINE HCL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,7.7,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL486043,VQMGCAXPAOTPQE-HOCLYGCPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,840,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201207,VQODGRNSFPNSQE-DVTGEIKXSA-N,BETAMETHASONE PHOSPHORIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201207,VQODGRNSFPNSQE-DVTGEIKXSA-N,BETAMETHASONE PHOSPHORIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL229383,VQOXZBDYSJBXMA-VHFLTRTASA-N,NYSTATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL229383,VQOXZBDYSJBXMA-VHFLTRTASA-N,NYSTATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL486236,VQTWAJKQIHYINF-QUCCMNQESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,2000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL454674,VQXFWDGKPFYMCF-DLBZAZTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,11,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL564021,VQXNEYZVHJNUFJ-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,19,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1818457,VQZCUVHOYIJXAO-HZPDHXFCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,158.49,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL623,VRBKIVRKKCLPHA-UHFFFAOYSA-N,NEFAZODONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,618,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL623,VRBKIVRKKCLPHA-UHFFFAOYSA-N,NEFAZODONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,713,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL623,VRBKIVRKKCLPHA-UHFFFAOYSA-N,NEFAZODONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,360,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL623,VRBKIVRKKCLPHA-UHFFFAOYSA-N,NEFAZODONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,360,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL661,VREFGVBLTWBCJP-UHFFFAOYSA-N,ALPRAZOLAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL661,VREFGVBLTWBCJP-UHFFFAOYSA-N,ALPRAZOLAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL194310,VROMWSWPRNOJJN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,38,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL194310,VROMWSWPRNOJJN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,54,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684051,VRVDHYBVMARMIQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,3200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL382955,VRVNOJASIHQHAC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16202585,IC50,=,158000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1400945,VSBHRRMYCDQLJF-ZDNYCOCVSA-N,PREGNENOLONE CARBONITRILE ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1400945,VSBHRRMYCDQLJF-ZDNYCOCVSA-N,PREGNENOLONE CARBONITRILE ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL7318,VSGPGYWZVPDDSK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10715164,KI,>,10000,NM,,"","","","","","",,,,,,,,Compound was evaluated for its binding affinity towards human NET(norepinephrine) transporter,2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.,J. Med. Chem.,PUBLICATION,
CHEMBL65,VSJKWCGYPAHWDS-FQEVSTJZSA-N,CAMPTOTHECIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL65,VSJKWCGYPAHWDS-FQEVSTJZSA-N,CAMPTOTHECIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL489774,VSMRJAFWIRCVKM-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,16,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,HYDROXYUREA,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL467,VSNHCAURESNICA-UHFFFAOYSA-N,HYDROXYUREA,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1224471,VSRNUBMEUKSAAJ-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,79,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224298,VSRNUBMEUKSAAJ-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,37,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL386978,VSVUJKJXMNJRFE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,KI,>,2000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL3323110,VSXRMFADTFRTBM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,INHIBITION,=,15,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells at 100 nM after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL488423,VSZILPWZKJQRHV-LIAHKDQHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,435,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL483316,VTAMJLRZTZEHBO-BJUDXGSMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18487050,KI,=,6600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,Carbon-11 labeled indolylpropylamine analog as a new potential PET agent for imaging of the serotonin transporter.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL597190,VTIJRYTVJGTTAJ-BREBYQMCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,1.58,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL598202,VTIJRYTVJGTTAJ-OUJBWJOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,3.98,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL598202,VTIJRYTVJGTTAJ-OUJBWJOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,346.74,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL76904,VTJXFTPMFYAJJU-UHFFFAOYSA-N,TYRPHOSTIN 23,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL76904,VTJXFTPMFYAJJU-UHFFFAOYSA-N,TYRPHOSTIN 23,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2205818,VTLZIWJSKWWYHL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1084829,VUEFLJKLCMGDEG-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,51,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1084829,VUEFLJKLCMGDEG-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,146,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1084828,VUEFLJKLCMGDEG-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,244,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1084828,VUEFLJKLCMGDEG-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,328,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1818451,VUEZBOYAXGKAME-ZYMOGRSISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,3.16,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1818451,VUEZBOYAXGKAME-ZYMOGRSISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,1000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1098855,VUNYCPOWVGTRIS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1098855,VUNYCPOWVGTRIS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,INH,=,21000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells at 1 uM,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL479411,VUQUGOYPDVYZTL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,2000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL133868,VVHJUSGIUWQPIT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12954071,KI,>,30000,NM,,"","","","","","",,,,,,,,Inhibitory constant against norepinephrine transporter receptor using [3H]radioligand,"A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.",J. Med. Chem.,PUBLICATION,
CHEMBL133455,VVHJUSGIUWQPIT-VIFPVBQESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12954071,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibitory constant against norepinephrine transporter receptor using [3H]radioligand,"A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.",J. Med. Chem.,PUBLICATION,
CHEMBL1679,VVIAGPKUTFNRDU-ABLWVSNPSA-N,LEUCOVORIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1679,VVIAGPKUTFNRDU-ABLWVSNPSA-N,LEUCOVORIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL203403,VVIVTDYOMWHKAE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,19.7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL203403,VVIVTDYOMWHKAE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,425,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1430,VVNCNSJFMMFHPL-VKHMYHEASA-N,PENICILLAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1430,VVNCNSJFMMFHPL-VKHMYHEASA-N,PENICILLAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL525238,VVQIWKYSMSGPNS-DNVCBOLYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL498481,VVQIWKYSMSGPNS-KXBFYZLASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,690,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL486537,VVROCSNBKQTQEO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,3,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL245492,VWGQRLFYWPDXNG-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,13,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL181188,VWKLNUPRXXIKKE-WMZOPIPTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17983754,KI,=,0.76,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1645603,VWOHPBLHZAONKH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,164,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1645611,VWOHRXMXNABMIC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,1350,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL212878,VWOWSEBOGHLBFX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL649,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,NADOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL649,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,NADOLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL497550,VWPPLGQILGHEGL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18461921,KI,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,PUBLICATION,
CHEMBL1766,VWVSBHGCDBMOOT-IIEHVVJPSA-N,DESOXIMETASONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1766,VWVSBHGCDBMOOT-IIEHVVJPSA-N,DESOXIMETASONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL573972,VWVYZCFGGWGOMP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,1710,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL572917,VWWGPYFAWGEBAY-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,60,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL272533,VWXSFQRIRPPNDO-WBVHZDCISA-N,O-METHYL TRAMADOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,161,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL477571,VXAFVYYBYDYSHN-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,30,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL600645,VXAKZDFZAIJNGP-MJVIPROJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,2,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL471002,VXBRIAOTINONRK-FZMZJTMJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954038,IC50,=,15,NM,,"",cell_based,"","","","",HEK293,,,,,,,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter","Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL1085906,VXBYAINQGAYGQT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,140,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL611961,VXFJRJWYWCHNJF-SESHTJHWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,100,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3703746,VXVOMCCQHIVMJK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,26,NM,302110,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL401877,VXYNDBOWMKXSIO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,62,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL59,VYFYYTLLBUKUHU-UHFFFAOYSA-N,DOPAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10411589,KI,=,323,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL59,VYFYYTLLBUKUHU-UHFFFAOYSA-N,DOPAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14592523,IC50,=,6.63,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake in HEK cells expressing human NET,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL59,VYFYYTLLBUKUHU-UHFFFAOYSA-N,DOPAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14592523,KI,>,28000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL101,VYMDGNCVAMGZFE-UHFFFAOYSA-N,PHENYLBUTAZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL101,VYMDGNCVAMGZFE-UHFFFAOYSA-N,PHENYLBUTAZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1388,VYQNWZOUAUKGHI-UHFFFAOYSA-N,MONOBENZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,3886,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1388,VYQNWZOUAUKGHI-UHFFFAOYSA-N,MONOBENZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3854,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1230333,VYTXLSQVYGNWLV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1230333,VYTXLSQVYGNWLV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL595751,VZAQFIJMTJXBKF-VGYQQOEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,1500,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3593401,VZFSSAZWIAREQM-YLCXCWDSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,5.8,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL44814,VZGDMQKNWNREIO-UHFFFAOYSA-N,CARBON TETRACHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL44814,VZGDMQKNWNREIO-UHFFFAOYSA-N,CARBON TETRACHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL494814,WAIMVSIHYKGAQF-GAPKJMMISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18434164,KI,=,14,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3310493,WALNRLHGEDDGRH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,10,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2032049,WAOZNBXSEVIAGX-MBOZVWFJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22542010,KI,>,2000,NM,,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter,Discovery of a novel melanin concentrating hormone receptor 1 (MCHR1) antagonist with reduced hERG inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1083426,WARUECLCXNMKJR-UHFFFAOYSA-N,1-(1-(2-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,17,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1083426,WARUECLCXNMKJR-UHFFFAOYSA-N,1-(1-(2-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,46,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1083426,WARUECLCXNMKJR-UHFFFAOYSA-N,1-(1-(2-FLUOROPHENYL)-2-(2-(TRIFLUOROMETHOXY)PHENYL)ETHYL)PIPERAZINE (ENANTIOMERIC MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,116,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1170017,WBGRUPCVVLWKNH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,501.19,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2206534,WBMAKFNAAWXWBA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,13,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL164290,WBNQDOYYEUMPFS-UHFFFAOYSA-N,N-NITROSODIETHYLAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL164290,WBNQDOYYEUMPFS-UHFFFAOYSA-N,N-NITROSODIETHYLAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL381792,WBQILMOPSULAPL-UGSOOPFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,60,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL600220,WBTKYJAWLLWAMV-VOMIJIAVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,5.7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL434959,WBUKLOIGDUMVEL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,68000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL434959,WBUKLOIGDUMVEL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL492014,WBUMYVRFZVRYPV-PMACEKPBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,457,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL371300,WBYHTZYHAFNBKW-ZETCQYMHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16392816,INHIBITION,=,-11.2,%,,"","","","","","",,,,,,,,Inhibition of NET at 1 nM,1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity.,J. Med. Chem.,PUBLICATION,
CHEMBL371300,WBYHTZYHAFNBKW-ZETCQYMHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16392816,INHIBITION,=,3.93,%,,"","","","","","",,,,,,,,Inhibition of NET at 100 nM,1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity.,J. Med. Chem.,PUBLICATION,
CHEMBL371300,WBYHTZYHAFNBKW-ZETCQYMHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16392816,INHIBITION,=,42.59,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity.,J. Med. Chem.,PUBLICATION,
CHEMBL371300,WBYHTZYHAFNBKW-ZETCQYMHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16392816,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibitory activity against NET,1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity.,J. Med. Chem.,PUBLICATION,
CHEMBL381045,WCMJUQVXFGLIRF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16202585,IC50,=,3360,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL512202,WCTHXORWWZOJGX-HHZCPPTISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,1110,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL512130,WDAYPJKNBZKLPA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,1500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337587,WDFMVSDPRALOJK-CRAIPNDOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,2,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337588,WDFMVSDPRALOJK-MAUKXSAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,5.01,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337589,WDFMVSDPRALOJK-QAPCUYQASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,3.16,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337586,WDFMVSDPRALOJK-YJBOKZPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,0.398,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257389,WDJLGAAWPRVZRR-DZGCQCFKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,3.9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL254219,WDJUZGPOPHTGOT-XUDUSOBPSA-N,DIGITOXIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL254219,WDJUZGPOPHTGOT-XUDUSOBPSA-N,DIGITOXIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3310629,WDKXWEBKYOHYSC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,8,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256447,WDLBUKLHPSKQTF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,3700,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1818542,WDNOUFVJCUYSDQ-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,39.81,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1818543,WDNOUFVJCUYSDQ-ZYMOGRSISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,25.12,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1818543,WDNOUFVJCUYSDQ-ZYMOGRSISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,1584.89,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3593395,WDNXRQXGZIPADY-CSDGMEMJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,2,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3593394,WDNXRQXGZIPADY-KATIXKQHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,6,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3593393,WDNXRQXGZIPADY-PKKHVXKMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,8.5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3593396,WDNXRQXGZIPADY-WYUVZMMLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,5.8,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL417249,WDOKGNOTOAMJEX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9435902,KI,=,5920,NM,,"","","","","","",,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL523489,WDSNWUWPKXWDIQ-WMZOPIPTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,13,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL567725,WDVSSBLBRVMZEM-LLVKDONJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,5700,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL370158,WDYVPLUNLVBVMN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16202585,IC50,=,2020,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1660,WDZCUPBHRAEYDL-GZAUEHORSA-N,RIFAPENTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1660,WDZCUPBHRAEYDL-GZAUEHORSA-N,RIFAPENTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL114275,WDZSPNFWRVITEJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9986702,KI,=,234,NM,,"",cell_based,"","","","",,,,,,,,In vitro binding affinity against monoamine transporter NET (norepinephrine transporter) in LLC-PK1 cell membranes.,"A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol.",J. Med. Chem.,PUBLICATION,
CHEMBL114275,WDZSPNFWRVITEJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15456270,KI,=,234,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity for Norepinephrine transporter (NET) expressed in LCK PK1 cells,2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.,J. Med. Chem.,PUBLICATION,
CHEMBL420,WDZVGELJXXEGPV-YIXHJXPBSA-N,GUANABENZ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL420,WDZVGELJXXEGPV-YIXHJXPBSA-N,GUANABENZ,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL575930,WEBWNOZIRPUGTR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL485259,WEEGYLXZBRQIMU-UHFFFAOYSA-N,EUCALYPTOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL485259,WEEGYLXZBRQIMU-UHFFFAOYSA-N,EUCALYPTOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL565594,WEKVVEUCXILQOT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,360,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL565594,WEKVVEUCXILQOT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,2300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL227179,WEUZYHQNGQDGAB-HIUFNZKISA-N,RTI-219,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,750,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL227179,WEUZYHQNGQDGAB-HIUFNZKISA-N,RTI-219,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,1840,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL561140,WFCCOUNTGTUDOI-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,257,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL456017,WFCMRRKVDOAHNR-MFKMUULPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL456017,WFCMRRKVDOAHNR-MFKMUULPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,48870,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL512736,WFCMRRKVDOAHNR-ZWNOBZJWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL512736,WFCMRRKVDOAHNR-ZWNOBZJWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,27500,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL207854,WFIWNBXHHPXBTA-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,3.6,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL405017,WFOBTVZPUZNUSA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,58,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1278088,WFQOETMVYMINSA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20931963,IC50,>,1000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,PUBLICATION,
CHEMBL197966,WFSQIXHBUDPSMK-YPMHNXCESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL20883,WFWLQNSHRPWKFK-UHFFFAOYSA-N,TEGAFUR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL20883,WFWLQNSHRPWKFK-UHFFFAOYSA-N,TEGAFUR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL204574,WGCRPMFFZVDRHS-BJKOFHAPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16413778,KI,=,3.7,NM,,"","","","","","",,,,,,,,Binding affinity to NET,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1079079,WGIPGQAPFNVWIX-XXFZXMJFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19767206,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from NET at 10 uM by scintillation counting,Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL123252,WGJCAKQLYZFCSH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,IC50,=,143,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL123252,WGJCAKQLYZFCSH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,KI,=,30,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL460295,WGJPAKIMPPHUPQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,2800,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL467513,WGKLCHBGQMKIIW-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,99,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1172850,WGLPIGWBBSYDNT-KBPBESRZSA-N,"RAC-1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-2-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERS)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,100,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1172850,WGLPIGWBBSYDNT-KBPBESRZSA-N,"RAC-1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-2-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERS)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,199.53,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1172850,WGLPIGWBBSYDNT-KBPBESRZSA-N,"RAC-1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-2-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERS)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,1000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1683887,WGNABQIMYMHUQC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,269,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1081212,WGTCBXOFOSMWEQ-IBGZPJMESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20137933,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL137936,WGXGFDYUAPSJDQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,INHIBITION,=,55,%,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323096,WHFIZFJGGYNLFH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,10,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL415690,WHGYBXFWUBPSRW-FOUAGVGXSA-N,BETADEX,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL415690,WHGYBXFWUBPSRW-FOUAGVGXSA-N,BETADEX,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1085321,WHMNJJQFCNBWSW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,30,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224224,WHNHYVQHXLVZHR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,IC50,=,264,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224224,WHNHYVQHXLVZHR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,30,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL565397,WHPARCHZPIKXEX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL565397,WHPARCHZPIKXEX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL388590,WHQCHUCQKNIQEC-UHFFFAOYSA-N,BENZBROMARONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL388590,WHQCHUCQKNIQEC-UHFFFAOYSA-N,BENZBROMARONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1481,WIGIZIANZCJQQY-RUCARUNLSA-N,GLIMEPIRIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1481,WIGIZIANZCJQQY-RUCARUNLSA-N,GLIMEPIRIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL130,WIIZWVCIJKGZOK-RKDXNWHRSA-N,CHLORAMPHENICOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL130,WIIZWVCIJKGZOK-RKDXNWHRSA-N,CHLORAMPHENICOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL728,WIKYUJGCLQQFNW-UHFFFAOYSA-N,PROCHLORPERAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,400,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL728,WIKYUJGCLQQFNW-UHFFFAOYSA-N,PROCHLORPERAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,396,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL525717,WINONEAFBRSOAL-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,370,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL448375,WINONEAFBRSOAL-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,17,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL448375,WINONEAFBRSOAL-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18672364,IC50,=,8,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL496284,WINONEAFBRSOAL-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,140,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL335165,WIQKRMGNDCWEGO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14592523,KI,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL465123,WIQRCHMSJFFONW-HNNXBMFYSA-N,SEPROXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,3050,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL465123,WIQRCHMSJFFONW-HNNXBMFYSA-N,SEPROXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,3947,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL465123,WIQRCHMSJFFONW-HNNXBMFYSA-N,SEPROXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,1426,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL465123,WIQRCHMSJFFONW-HNNXBMFYSA-N,SEPROXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19014888,IC50,=,2806,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL465123,WIQRCHMSJFFONW-HNNXBMFYSA-N,SEPROXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19014888,KI,=,6186,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL446084,WIQRCHMSJFFONW-OAHLLOKOSA-N,(R)-NORFLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19014888,IC50,=,1995,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL446084,WIQRCHMSJFFONW-OAHLLOKOSA-N,(R)-NORFLUOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19014888,KI,=,7490,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1684056,WISXSHNMYCUZHH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,23,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684056,WISXSHNMYCUZHH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,180,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL625,WJCNZQLZVWNLKY-UHFFFAOYSA-N,THIABENDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL625,WJCNZQLZVWNLKY-UHFFFAOYSA-N,THIABENDAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL828,WJFKNYWRSNBZNX-UHFFFAOYSA-N,PHENOTHIAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,461,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL828,WJFKNYWRSNBZNX-UHFFFAOYSA-N,PHENOTHIAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,457,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL382741,WJNQZXPCJCLCNG-JOCHJYFZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821575,IC50,=,0.003,NM,,"","","","","","",,,,,,,,Inhibition of NET,Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1501,WJOHZNCJWYWUJD-IUGZLZTKSA-N,FLUOCINONIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1501,WJOHZNCJWYWUJD-IUGZLZTKSA-N,FLUOCINONIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL86760,WJPJNUGOFZCYAX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18847250,KI,=,845,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxitine from NET,"Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.",J. Med. Chem.,PUBLICATION,
CHEMBL3291022,WKRFGCNWUFZBLO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24814532,DRUG UPTAKE,,,,Active,"",cell_based,"","","","",,,,,,,,Cellular uptake in human SK-N-SH cells assessed as noradrenaline transporter-mediated uptake at 1 x 10'-4 M after 15 mins by [3H]-noradrenaline uptake assay,Synthesis and biological effects of new hybrid compounds composed of benzylguanidines and the alkylating group of busulfan on neuroblastoma cells.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1258223,WKWADEWWLCVVLF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20812727,KI,=,3226,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL1258671,WLHFUBIRAHRPHA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20812727,KI,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL269798,WLIAMZZYIMPMEA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL574127,WLIGTTARDYGFBV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,183,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL576170,WLILWEIYLCPPKG-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,11,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL583752,WLJMFBUPVRQPDQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,EC50,=,21,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL583752,WLJMFBUPVRQPDQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,11,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL595252,WLLDZAMGIXUOIX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,IC50,=,47,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL595252,WLLDZAMGIXUOIX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,27,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL599760,WLMBSKSEPQCRJV-OAHLLOKOSA-N,RO-85,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20045645,ACTIVITY,>,50,%,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in CHO cells at 10 uM after 120 mins by scintillation counting,"Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL232671,WLWFROPHDLATTA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,285000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL232671,WLWFROPHDLATTA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,470000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1224094,WMONHIUXMOXBDS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,7.94,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL243204,WMVXAQQBRYETCJ-CHWSQXEVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,35200,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL388255,WMVXAQQBRYETCJ-QWHCGFSZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,36300,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL397392,WMWARSGGACJLII-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3612830,WMWWIRQFIVCLLM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.37,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3085031,WMXMBHFOTXTZMK-LGKQTMLJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16213721,KI,=,2470,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3703747,WNADNMZKSSOJHJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,70.4,NM,302111,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL567656,WNNACCODSWYYDZ-VXKWHMMOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,INHIBITION,=,5,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL611617,WNOWEUDDCASDAD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,INHIBITION,<,10,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1000 nM after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL402088,WNRLDTKTSLUNNC-GXTWGEPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,1500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL445185,WNSBUBHOLORHPN-CVEARBPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,2000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL449015,WNTGIUMXZUDPIG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,530,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673165,WOGNFHHHGZELSI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,373,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL557119,WOINXFXWLFAPBG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,12.59,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3686863,WOJKYHBOHSQZDW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27020304,Inhibition,=,7,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,Identification and biological activity of 6-alkyl-substituted 3-methyl-pyridine-2-carbonyl amino dimethyl-benzoic acid EP4 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673172,WOOPIGBZZPHOGG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,231.3,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL383071,WOORERZMTSEMTL-BQAIUKQQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,40,NM,,"","","","","","",,,,,,,,Inhibition of [3H]NE uptake,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL383071,WOORERZMTSEMTL-BQAIUKQQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,340,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL424682,WOORERZMTSEMTL-GNAFDRTKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,560,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL3703737,WOWZZXDFWZHBKO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,282.9,NM,302101,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL2371923,WOXOMROGQFUOGC-PYZAKKTJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16821765,IC50,=,25000,NM,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of rat NET-mediated norepinephrine uptake in CHO cells,Development of peptidic dopamine transporter inhibitors via aromatic modification-mediated conformational restriction.,J. Med. Chem.,PUBLICATION,
CHEMBL66112,WPCCYICQOQQNOQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,IC50,=,200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL66112,WPCCYICQOQQNOQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,KI,=,150,NM,,"","","","","","",,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL206697,WPEZYNICVOURFR-UGSOOPFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,980,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL451120,WPGUQXCZGQYNLZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,7900,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL486044,WPKZZLMFEYGCJR-RDJZCZTQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,72,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL446570,WPKZZLMFEYGCJR-WBVHZDCISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,660,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224034,WPNGDOZEXVRNMZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20692833,INHIBITION,=,34.1,%,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET at 10 uM,N-tetrahydrothiochromenoisoxazole-1-carboxamides as selective antagonists of cloned human 5-HT2B.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224034,WPNGDOZEXVRNMZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20692833,KI,>,10000,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET,N-tetrahydrothiochromenoisoxazole-1-carboxamides as selective antagonists of cloned human 5-HT2B.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL19236,WPNJAUFVNXKLIM-UHFFFAOYSA-N,MOXONIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL19236,WPNJAUFVNXKLIM-UHFFFAOYSA-N,MOXONIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL541,WPYMKLBDIGXBTP-UHFFFAOYSA-N,BENZOIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL541,WPYMKLBDIGXBTP-UHFFFAOYSA-N,BENZOIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL574231,WPYMMOOTBZOFOZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,97,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL558853,WQAXZHUMPQMMEW-GOSISDBHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,38,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL549584,WQAXZHUMPQMMEW-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683898,WQBHQWJJWWMKPS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,3177,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2105807,WQGJEAMPBSZCIF-HKSLRPGUSA-N,MADURAMICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2105807,WQGJEAMPBSZCIF-HKSLRPGUSA-N,MADURAMICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL307145,WQGWDDDVZFFDIG-UHFFFAOYSA-N,PYROGALLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL307145,WQGWDDDVZFFDIG-UHFFFAOYSA-N,PYROGALLOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL510915,WQHNJPRNTDZGGW-RRPNLBNLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1644480,WQUWMFJMVPTZHQ-DDFAGTSDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,91,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL442924,WQZFFUKLKSSLDH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,151,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173600,WROCJHDKYNTMKL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,7950,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL410622,WRXKFTMLELOBNB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,12,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL556025,WSDLKTZBSNTKJA-QJHJCNPRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,2250,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1508,WSEQXVZVJXJVFP-FQEVSTJZSA-N,ESCITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24944746,INHIBITION,,,,Not Active,"",cell_based,"","","","",,,,,,,,"Inhibition of 2,5,6-[3H]-dopamine uptake at human NET expressed in African green monkey COS7 cells at 10 uM incubated for 10 mins prior to radioligand addition measured after 5 mins by scintillation counting analysis",Novel and high affinity fluorescent ligands for the serotonin transporter based on (s)-citalopram.,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL399730,WSEQXVZVJXJVFP-HXUWFJFHSA-N,(R)-CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12232544,KI,=,6243,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL399730,WSEQXVZVJXJVFP-HXUWFJFHSA-N,(R)-CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12232544,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,7865,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,4070,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11454918,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12232544,KI,=,5029,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12232544,KI,=,6190,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12232544,KI,=,6514,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12232544,KI,=,7841,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14744476,KI,=,4870,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14744476,KI,=,8690,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14971892,KI,=,6190,NM,,"","","","","","",,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [3H]-nisoxatine radioligand,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18429609,INHIBITION,=,0.24,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23168018,KI,>,1000000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine uptake at human NET expressed in COS7 cells after 5 mins by beta-counting,A rhodamine-labeled citalopram analogue as a high-affinity fluorescent probe for the serotonin transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2196,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL549,WSEQXVZVJXJVFP-UHFFFAOYSA-N,CITALOPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2178,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL422290,WSLCFIYYDJNWLK-KAXARAQCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9804682,IC50,=,16.3,NM,,"","","","","","",,,,,,,,The compound was tested in vitro for binding affinity for the norepinephrine transporter (NET) using competitive binding assay.,TROTEC-1: a new high-affinity ligand for labeling of the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL576622,WSLDIWPVDFGUNH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL576622,WSLDIWPVDFGUNH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,3190,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL514232,WSUKOKAEFHVCAH-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,8,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL467094,WSVWKHTVFGTTKJ-UHFFFAOYSA-N,NANTENINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19963380,KI,>,10000,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET,Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL443979,WSZDFPKNUKEBNH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19445453,KI,>,6000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK293 cells,Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL443979,WSZDFPKNUKEBNH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19445453,KI,>,6000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL1224165,WTCFDFPSNBMAOR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,2,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1009,WTDRDQBEARUVNC-LURJTMIESA-N,LEVODOPA,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1009,WTDRDQBEARUVNC-LURJTMIESA-N,LEVODOPA,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3310495,WTHYQJZGHQZHTL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,37,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL363396,WTJNBQYUXJFISF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15801845,KI,=,505,NM,,"",cell_based,"","","","",HEK293,,,,,,,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,PUBLICATION,
CHEMBL363396,WTJNBQYUXJFISF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15974579,KI,=,219,NM,,"",cell_based,"","","","",,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,PUBLICATION,
CHEMBL229429,WTLBLIGPXACYET-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17571866,KI,>,10000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxitine from NET,Synthesis and simple 18F-labeling of 3-fluoro-5-(2-(2-(fluoromethyl)thiazol-4-yl)ethynyl)benzonitrile as a high affinity radioligand for imaging monkey brain metabotropic glutamate subtype-5 receptors with positron emission tomography.,J. Med. Chem.,PUBLICATION,
CHEMBL2171412,WTTOEXNCJGXGDZ-UHFFFAOYSA-N,3-((BENZYLOXY)(PHENYL)METHYL)AZETIDINE HCL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,9.4,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL241228,WTZRMYOBIYKNQJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18052090,KI,=,33,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,PUBLICATION,
CHEMBL1169,WUBBRNOQWQTFEX-UHFFFAOYSA-N,AMINOSALICYLIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1169,WUBBRNOQWQTFEX-UHFFFAOYSA-N,AMINOSALICYLIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL388760,WUFOGTRCLDMXRM-RYTRXMBJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,650,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL388760,WUFOGTRCLDMXRM-RYTRXMBJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,2510,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL1598608,WUKZPHOXUVCQOR-UHFFFAOYSA-N,AZASETRON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1598608,WUKZPHOXUVCQOR-UHFFFAOYSA-N,AZASETRON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2385464,WUMCAEVLFYSGKO-UTKFAANNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,INHIBITION,<,70,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter at 10 uM relative to control,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2206536,WUPUWAHXLJUMFK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,14,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1642910,WUSGTAILSJGBRD-DYVFJYSZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,565,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642911,WUSGTAILSJGBRD-GUYCJALGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,309,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1078169,WUTRVCAUFFQVGX-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,65,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL273348,WUWFMDMBOJLQIV-UHFFFAOYSA-N,TOSUFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL273348,WUWFMDMBOJLQIV-UHFFFAOYSA-N,TOSUFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL720,WVDDGKGOMKODPV-UHFFFAOYSA-N,BENZYL ALCOHOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL720,WVDDGKGOMKODPV-UHFFFAOYSA-N,BENZYL ALCOHOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL469889,WVFLQQCCAZKCGK-LIAHKDQHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,519,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL428,WVPSKSLAZQPAKQ-CDMJZVDBSA-N,TROVAFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL428,WVPSKSLAZQPAKQ-CDMJZVDBSA-N,TROVAFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL119443,WVVSZNPYNCNODU-XTQGRXLLSA-N,ERGONOVINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL119443,WVVSZNPYNCNODU-XTQGRXLLSA-N,ERGONOVINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL154111,WVYADZUPLLSGPU-UHFFFAOYSA-N,SALSALATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL154111,WVYADZUPLLSGPU-UHFFFAOYSA-N,SALSALATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1224089,WVZMHYCNWMCWBJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,7.94,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3334769,WWEXFJSAHWQFBA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,IC50,=,157.3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL583751,WWIFVPBPYYVHTD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,EC50,=,358,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL583751,WWIFVPBPYYVHTD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,1370,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL601879,WWIVDDWMWBWRJK-KGQXAQPSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,15,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL358967,WWPITPSIWMXDPE-UHFFFAOYSA-N,PARA-CHLOROAMPHETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19717215,IC50,=,207,NM,,"","","","","","",,,,,,,,Inhibition of human noradrenaline transporter,Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1645597,WWTGDTLFSFRIFW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,528,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683886,WWUXHADAODEZLF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,9990,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2205823,WWXCWTRLUXMAHX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding affinity to NET at 10 uM,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2107797,WWYNJERNGUHSAO-CULCCENASA-N,NORGESTREL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2107797,WWYNJERNGUHSAO-CULCCENASA-N,NORGESTREL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL564934,WXFURHRZZPXAMP-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,24,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323109,WXJVSDNWZOTTOK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,1000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL197960,WXJZYVUSQHOXID-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,10,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL493369,WXNMBSMVRGWTNC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18461921,KI,>,100000,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,PUBLICATION,
CHEMBL556539,WXQUVTDLXMNHNT-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,6,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL502129,WXULFWHQRUUESN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,510,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1076366,WXWLWERTZPQZCF-HRIPAEOASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL208067,WXXAHIZLARZXBW-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,3.3,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL405613,WYBWTBVGJJOVDM-KBXCAEBGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,5.2,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257423,WYCWVUGQDBCHEF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,256,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257423,WYCWVUGQDBCHEF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,180,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL219048,WYKUNXLKNJTHND-UGKGYDQZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,233,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2336611,WYURUVQXJTWRLS-NUSMLGSUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23168018,KI,=,194,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine uptake at human NET expressed in COS7 cells after 5 mins by beta-counting,A rhodamine-labeled citalopram analogue as a high-affinity fluorescent probe for the serotonin transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL196760,WYURUVQXJTWRLS-QEJKBDCMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16302792,KI,=,194,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]dopamine from human NET expressed in COS7 cells,"Rhodamine-labeled 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)tropane analogues as high-affinity fluorescent probes for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL196760,WYURUVQXJTWRLS-QEJKBDCMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24944746,KI,=,91,NM,,"",cell_based,"","","","",,,,,,,,"Inhibition of 2,5,6-[3H]-dopamine uptake at human NET expressed in African green monkey COS7 cells incubated for 10 mins prior to radioligand addition measured after 5 mins by scintillation counting analysis",Novel and high affinity fluorescent ligands for the serotonin transporter based on (s)-citalopram.,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,THIOGUANINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL727,WYWHKKSPHMUBEB-UHFFFAOYSA-N,THIOGUANINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL762,WYWIFABBXFUGLM-UHFFFAOYSA-N,OXYMETAZOLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL762,WYWIFABBXFUGLM-UHFFFAOYSA-N,OXYMETAZOLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL564201,WYXSYVWAUAUWLD-SHUUEZRQSA-N,6-AZAURIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL564201,WYXSYVWAUAUWLD-SHUUEZRQSA-N,6-AZAURIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1645605,WYYIFGYFQYWQOA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,374,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2103774,WZDGZWOAQTVYBX-XOINTXKNSA-N,TIBOLONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2103774,WZDGZWOAQTVYBX-XOINTXKNSA-N,TIBOLONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1480987,WZHCOOQXZCIUNC-UHFFFAOYSA-N,CYCLANDELATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1480987,WZHCOOQXZCIUNC-UHFFFAOYSA-N,CYCLANDELATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL19215,WZHJKEUHNJHDLS-QTGUNEKASA-N,METERGOLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20451398,ACTIVITY,=,1132,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human cloned NET,Evaluation of [(11)C]metergoline as a PET radiotracer for 5HTR in nonhuman primates.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL19215,WZHJKEUHNJHDLS-QTGUNEKASA-N,METERGOLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,366,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL19215,WZHJKEUHNJHDLS-QTGUNEKASA-N,METERGOLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,363,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL257940,WZHXVKWOVBWNIB-RHDGDCLCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18160282,INHIBITION,<,10,%,,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter at 10 uM,Discovery of novel orally active ureido NPY Y5 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL245416,WZNJWVWKTVETCG-YFKPBYRVSA-N,L-MIMOSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL245416,WZNJWVWKTVETCG-YFKPBYRVSA-N,L-MIMOSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL158,WZPBZJONDBGPKJ-VEHQQRBSSA-N,AZTREONAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL158,WZPBZJONDBGPKJ-VEHQQRBSSA-N,AZTREONAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL513204,WZTBYHQYXSTVTK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,240,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL513204,WZTBYHQYXSTVTK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,364,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL453321,WZVJYHZPOKMITP-NVXWUHKLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,950,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL453061,WZVJYHZPOKMITP-WBVHZDCISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,630,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL602323,WZYMYZUFIBBREW-OKCYCAHKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,7.94,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL404197,XACDGGGJRPPGDU-QUCCMNQESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,3776,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1696,XAEWZDYWZHIUCT-UHFFFAOYSA-N,DESIPRAMINE HYDROCHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20597489,KI,=,0.8,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL256039,XAFDYZFDMXIOPG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,360,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1818449,XAKHVFLBNVAXLY-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,31.62,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL373710,XANSRGJYZPYJFY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,210,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL373710,XANSRGJYZPYJFY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,3000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL373710,XANSRGJYZPYJFY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,830,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL373710,XANSRGJYZPYJFY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,12000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL1684042,XAXLSVQFDZVYNG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,170,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684042,XAXLSVQFDZVYNG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,320,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684042,XAXLSVQFDZVYNG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,1000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL113136,XAYGSYISSLIYTN-CXMPNGEBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,IC50,=,44,NM,,"","","","","","",,,,,,,,In vitro inhibition of [3H]NE re-uptake into synaptosome,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL113136,XAYGSYISSLIYTN-CXMPNGEBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12951108,KI,=,51,NM,,"","","","","","",,,,,,,,Displacement of [3H]-Nisoxetine from norepinephrine transporter,Bicyclo[2.2.1]heptanes as novel triple re-uptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL365183,XAYGSYISSLIYTN-YAAHMLIESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16220969,IC50,=,22,NM,,"","","","","","",,,,,,,,Inhibition constant against norepinephrine transporter,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL3673177,XBECXOYAIBURBV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,78.6,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3673177,XBECXOYAIBURBV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,798.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL37858,XBHBWNFJWIASRO-UHFFFAOYSA-N,SARAFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL37858,XBHBWNFJWIASRO-UHFFFAOYSA-N,SARAFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL383464,XBIRPUDVQBQYMW-JMAPEOGHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,736,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL202860,XBIRPUDVQBQYMW-XXIQNXCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,79,NM,,"","","","","","",,,,,,,,Inhibition of [3H]NE uptake,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL202860,XBIRPUDVQBQYMW-XXIQNXCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,460,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL6273,XBJBPGROQZJDOJ-UHFFFAOYSA-N,FLEROXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL6273,XBJBPGROQZJDOJ-UHFFFAOYSA-N,FLEROXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3613154,XBKFHSYCRYCLCK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,0.1,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL261465,XBLJZKGUMJUESI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,366,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL513577,XBSXEAMPHZZPKZ-LJQANCHMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,201,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL463387,XBZYPUYXVGRGJR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,10,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3704748,XCAMEKYVLTTXGP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,10.6,NM,317702,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL3704748,XCAMEKYVLTTXGP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,38.2,NM,317690,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL1076389,XCAPQYWGCHEMFA-JXJOGBRVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL3545252,XCDIRYDKECHIPE-QHEQPUDQSA-N,DOCETAXEL HYDRATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3545252,XCDIRYDKECHIPE-QHEQPUDQSA-N,DOCETAXEL HYDRATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL442,XCGSFFUVFURLIX-VFGNJEKYSA-N,ERGOTAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL442,XCGSFFUVFURLIX-VFGNJEKYSA-N,ERGOTAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL203563,XCHIECWEKDGHNL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,86.7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL203563,XCHIECWEKDGHNL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,1290,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL512851,XCOOHOIRZJLJRQ-WFASDCNBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954038,IC50,=,2.3,NM,,"",cell_based,"","","","",HEK293,,,,,,,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter","Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL3310634,XCSFWQOZLCRJAK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,6,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257388,XCUFOYFDVQBJRW-DZGCQCFKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,8.2,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL606174,XCXKFSMMFREDTK-SRJVRDNSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,23,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL470313,XCYJTWMYHQVABH-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,1053,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL516965,XCYJTWMYHQVABH-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,IC50,=,30,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL595677,XDCKKLJZZNMBOS-CHPDAQJUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,26,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL95764,XDDAORKBJWWYJS-UHFFFAOYSA-N,GLYPHOSATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL95764,XDDAORKBJWWYJS-UHFFFAOYSA-N,GLYPHOSATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2171410,XDHXBWIHBPXIJQ-UHFFFAOYSA-N,3-((4-CHLOROPHENYL)(PHENOXY)METHYL)AZETIDINE HCL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,68,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL507422,XDILVFHJKVYNDZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,1400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL55,XDRYMKDFEDOLFX-UHFFFAOYSA-N,PENTAMIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2214,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL55,XDRYMKDFEDOLFX-UHFFFAOYSA-N,PENTAMIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2196,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1117,XDXDZDZNSLXDNA-TZNDIEGXSA-N,IDARUBICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1117,XDXDZDZNSLXDNA-TZNDIEGXSA-N,IDARUBICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL249214,XEKOGGCKFOLDIR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,9000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224381,XENSJUHNMOKFGM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,IC50,=,69,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224381,XENSJUHNMOKFGM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,56,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3612827,XEQQTZYAFZACLX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,IC50,=,621,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3612827,XEQQTZYAFZACLX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.54,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 3 uM after 15 mins by liquid scintillation counting relative to venlafaxine HCl,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL377189,XEWUKTSZOJWBEW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,120,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL365812,XEZCTGHRWRPHGS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15801845,KI,=,3823,NM,,"",cell_based,"","","","",HEK293,,,,,,,In vitro displacement of [3H]nisoxetine from human norepinephrine transporter expressed in HEK293 cells,"Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.",J. Med. Chem.,PUBLICATION,
CHEMBL1754,XFDJYSQDBULQSI-UHFFFAOYSA-N,DOXAPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1754,XFDJYSQDBULQSI-UHFFFAOYSA-N,DOXAPRAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1645607,XFIFFAHPFWAWSS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,489,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL238868,XFIVQANHMYEPDG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18052090,KI,=,37,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,PUBLICATION,
CHEMBL1762472,XFORHSSANNSJHD-PKLMIRHRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21398123,IC50,=,500,NM,,"","","","","","",,,,,,,,Inhibition of NET,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL476942,XFORZXNXAQQOKS-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,70,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL522699,XFRJSOUJVWXXAT-GAPKJMMISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18434164,KI,=,230,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2103747,XFSBVAOIAHNAPC-FKHWODAVSA-N,ACONITINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2103747,XFSBVAOIAHNAPC-FKHWODAVSA-N,ACONITINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3612833,XFUBYPOXEIGKQC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,IC50,=,342,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET after 15 mins by liquid scintillation counting,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3612833,XFUBYPOXEIGKQC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26337019,RATIO,=,1.03,,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as reduction of serotonin reuptake using [3H]-NET at 1 uM after 15 mins by liquid scintillation counting relative to GBR-12909,Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL514208,XGCHOCPXNPEOLZ-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,7,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673162,XGJMFUFVUDLHTF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,147.9,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL607547,XHEKSGUJENDBTI-SCCDFBDJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,1300,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL505902,XHOQDMBOUAKHDY-QFBILLFUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18667309,IC50,=,5000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL575648,XIHXZWUTKBABCV-IOXAMRCBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,>,2000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL404258,XIINYKRQARUYJK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,14,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1231,XIQVNETUBQGFHX-UHFFFAOYSA-N,OXYBUTYNIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2595.1,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1231,XIQVNETUBQGFHX-UHFFFAOYSA-N,OXYBUTYNIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2573.7,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL189375,XIVFNOGFYONSDE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15974579,KI,=,445.36,NM,,"",cell_based,"","","","",,,,,,,,In vitro inhibition of [3H]nisoxetine binding to norepinephrine transporter expressed in human kidney cells,"Synthesis, in vitro characterization, and radiolabeling of N,N-dimethyl-2-(2'-amino-4'-substituted-phenylthio)benzylamines: potential candidates as selective serotonin transporter radioligands.",J. Med. Chem.,PUBLICATION,
CHEMBL3334778,XIYLELDHKGRFPU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,19,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1909070,XJGBDJOMWKAZJS-UHFFFAOYSA-N,NAFENOPIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909070,XJGBDJOMWKAZJS-UHFFFAOYSA-N,NAFENOPIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL573769,XJJHPGZYVOFINN-UHFFFAOYSA-N,4-(2-(BENZYLOXY)PHENYL)PIPERIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,76,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3085018,XJLOQWKHCAZUQM-LGKQTMLJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16213721,KI,=,8250,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL593527,XJPCNUDKTWEBSY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,IC50,=,353,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL593527,XJPCNUDKTWEBSY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,306,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3317702,XJTZQDVYMGLFOP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25017029,IC50,=,14,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3317705,XJTZQDVYMGLFOP-UTONKHPSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25017029,IC50,=,570,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3317704,XJTZQDVYMGLFOP-YDALLXLXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25017029,IC50,=,3.8,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in CHO cells after 45 mins by scintillation counting,"Design, synthesis, and biological activities of 1-aryl-1,4-diazepan-2-one derivatives as novel triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL479999,XKDQGWQMRLNJCO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,430,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1762475,XKEZEUVEUQSKDY-PKLMIRHRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21398123,IC50,=,28000,NM,,"","","","","","",,,,,,,,Inhibition of NET,"The discovery of novel, potent and highly selective inhibitors of inducible nitric oxide synthase (iNOS).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL59986,XKFMBGWHHBCWCD-QMMMGPOBSA-N,A-85380,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8887981,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL404730,XKGBYDWMVKBQIC-OXJNMPFZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,3.9,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3104093,XKGPHJMKJBEURD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24365159,KI,=,1949.84,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3104093,XKGPHJMKJBEURD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24365159,KI,=,1955,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL258713,XKQXMBVWEDMNAK-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,12,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171418,XKYAZKCRLILWNB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,IC50,=,16,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2171418,XKYAZKCRLILWNB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,79,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL563987,XLDPRVVEMAUFLK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,24,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224226,XLHBGLMPNFVKBD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,10,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL101055,XLJMMCKWKGQCNY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,208,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL101055,XLJMMCKWKGQCNY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,316,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL295698,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,KETOCONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,24203,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL295698,XMAYWYJOQHXEEK-ZEQKJWHPSA-N,KETOCONAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,24003,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3323108,XMNGPUYPQMMGIP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,22,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL410054,XMOVWPQOTYUSTK-FXAWDEMLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,40,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL575899,XMQIWPUGABPALG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,526,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1321154,XMVJITFPVVRMHC-UHFFFAOYSA-N,ROXARSONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1321154,XMVJITFPVVRMHC-UHFFFAOYSA-N,ROXARSONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL14376,XMXHEBAFVSFQEX-UHFFFAOYSA-N,ILOPERIDONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11750183,KI,=,1479,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL3663910,XNBOTHGRHLGURP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,470,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663910,XNBOTHGRHLGURP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1375,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663910,XNBOTHGRHLGURP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2787,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663910,XNBOTHGRHLGURP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,1375,NM,314403,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL991,XNKLLVCARDGLGL-JGVFFNPUSA-N,STAVUDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL991,XNKLLVCARDGLGL-JGVFFNPUSA-N,STAVUDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1765600,XNZHLLAIQAZMMY-BLLLJJGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21319801,IC50,=,13,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,PUBLICATION,
CHEMBL1947087,XOBBOJHELMBHFC-JVEPLPTMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22300887,KI,=,426,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET receptor expressed in HEK293 cells,QSAR study and synthesis of new phenyltropanes as ligands of the dopamine transporter (DAT).,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL635,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,PREDNISONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL635,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,PREDNISONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL975,XOGTZOOQQBDUSI-UHFFFAOYSA-M,MESNA,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL975,XOGTZOOQQBDUSI-UHFFFAOYSA-M,MESNA,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2430692,XOMFYIZXAHTPCL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,384.2,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430692,XOMFYIZXAHTPCL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,90.5,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430692,XOMFYIZXAHTPCL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,93,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL197354,XOQCOACREKNTCH-YPMHNXCESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16162005,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding inhibition towards human norepinephrine transporter at 1 uM,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL208533,XOXGVFCUPFEFPL-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,420,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL838,XPCFTKFZXHTYIP-PMACEKPBSA-N,BENAZEPRIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL838,XPCFTKFZXHTYIP-PMACEKPBSA-N,BENAZEPRIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1830886,XPDPSRJQWMZUMS-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,89,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1830886,XPDPSRJQWMZUMS-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21916421,IC50,=,99,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,PUBLICATION,
CHEMBL1173086,XPEGTFDNPKUQMC-RBSFLKMASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,1584.89,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173085,XPEGTFDNPKUQMC-RRFJBIMHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,1258.93,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL918,XPFRXWCVYUEORT-UHFFFAOYSA-N,PHENACEMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL918,XPFRXWCVYUEORT-UHFFFAOYSA-N,PHENACEMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2385460,XPLWBHWPOUEOSJ-GSZYCOFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,INHIBITION,<,70,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter at 10 uM relative to control,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL455221,XPMTXFPUXPYNCB-LSDHHAIUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,7124,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL455221,XPMTXFPUXPYNCB-LSDHHAIUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,2222,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL204586,XPPDUQXXSFOWGY-JCOPYZAKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,485,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL382783,XPPDUQXXSFOWGY-LNLSOMNWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,785,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL154735,XPRQYNYHTBQVGX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,2600,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL210028,XPYLNZBNFQMTKZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,90,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL788,XQFRJNBWHJMXHO-RRKCRQDMSA-N,IDOXURIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL788,XQFRJNBWHJMXHO-RRKCRQDMSA-N,IDOXURIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL575132,XQGCYOUBZLLPMY-AEFFLSMTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL571536,XQHYQPRYOHIDGH-SNVBAGLBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,17400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2047582,XQLBAPHRSPLANO-HTAPYJJXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,55,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL2047581,XQLBAPHRSPLANO-VGOFRKELSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22608762,INHIBITION,=,62,%,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells at 10 uM after 10 mins by scintillation counting,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL470481,XQNGYGNOPUIZQG-RMRYJAPISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,1290,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL470481,XQNGYGNOPUIZQG-RMRYJAPISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,544,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL469476,XQNGYGNOPUIZQG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,284,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL469476,XQNGYGNOPUIZQG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,140,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL470482,XQNGYGNOPUIZQG-ZEECNFPPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,140,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL470482,XQNGYGNOPUIZQG-ZEECNFPPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,117,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL204814,XQOCAAJLFFVLEP-QDSLRZTOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,402,NM,,"","","","","","",,,,,,,,Inhibition of [3H]NE uptake,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL204814,XQOCAAJLFFVLEP-QDSLRZTOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,941,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL381842,XQOCAAJLFFVLEP-ZXVJYWQYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,338,NM,,"","","","","","",,,,,,,,Inhibition of [3H]NE uptake,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL381842,XQOCAAJLFFVLEP-ZXVJYWQYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16509591,KI,=,851,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity.,J. Med. Chem.,PUBLICATION,
CHEMBL403148,XQRFKDJVDZKQDO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18060777,KI,=,730,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683895,XQUUVZDIAMCEHA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,346,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL19224,XQYZDYMELSJDRZ-UHFFFAOYSA-N,PAPAVERINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL19224,XQYZDYMELSJDRZ-UHFFFAOYSA-N,PAPAVERINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL712,XRCFXMGQEVUZFC-UHFFFAOYSA-N,ANISINDIONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL712,XRCFXMGQEVUZFC-UHFFFAOYSA-N,ANISINDIONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2179222,XRDVQWJPAZZLKN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23006002,KI,=,2129,NM,,"","","","","","",,,,,,,,Binding affinity to NOR transporter,"Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT(6) Receptor Antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL1463,XRECTZIEBJDKEO-UHFFFAOYSA-N,FLUCYTOSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1463,XRECTZIEBJDKEO-UHFFFAOYSA-N,FLUCYTOSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL397490,XRGOEISCAQSORF-GHMZBOCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,3910,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL397490,XRGOEISCAQSORF-GHMZBOCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,41600,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1171425,XRHNNEJZJBTDKD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,316.23,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL503378,XROTXTXRLBZJNT-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,49,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683892,XRXPUZOKWCSSLL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,2188,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL945,XSDQTOBWRPYKKA-UHFFFAOYSA-N,AMILORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL945,XSDQTOBWRPYKKA-UHFFFAOYSA-N,AMILORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1512,XSFJVAJPIHIPKU-XWCQMRHXSA-N,FLUNISOLIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1512,XSFJVAJPIHIPKU-XWCQMRHXSA-N,FLUNISOLIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL259765,XSZZVXRYXJUWCA-QZTJIDSGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,610,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL260258,XSZZVXRYXJUWCA-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,6,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL603430,XTGQHXCVZRGUAO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,IC50,=,49,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL603430,XTGQHXCVZRGUAO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,28,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL255448,XTOFIVJPRPHPAF-WCQYABFASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,1100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL522482,XTOPLFVJQKWOCT-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,3,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL492214,XTOPLFVJQKWOCT-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,17,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL360328,XTTZERNUQAFMOF-QMMMGPOBSA-N,LORCASERIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19284718,KI,>,10000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.,J. Med. Chem.,PUBLICATION,
CHEMBL294105,XTYJQBUILMRWGE-GZAGPRJLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10821718,KI,=,68,NM,,"",cell_based,"","","","",,,,,,,,Compound was evaluated for inhibition of [3H]NE uptake in HEK-hNET cells expressing Human norepinephrine transporter,Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL294105,XTYJQBUILMRWGE-GZAGPRJLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10821718,KI,=,1040,NM,,"",cell_based,"","","","",,,,,,,,Compound was evaluated for binding affinity using [125I]RTI-55 as a radioligand in HEK-hNET cells expressing human norepinephrine transporter,Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL31,XUBOMFCQGDBHNK-UHFFFAOYSA-N,GATIFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL31,XUBOMFCQGDBHNK-UHFFFAOYSA-N,GATIFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL67387,XUBVUMLIQBPHGD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15080991,KI,=,1039,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity to norepinephrine (NE) transporter in membranes of cells selectively expressing the human genes for NET,Synthesis and monoamine transporter affinity of 3'-analogs of 2-beta-carbomethoxy-3-beta-(4'-iodophenyl)tropane (beta-CIT).,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL461727,XUCIJNAGGSZNQT-JHSLDZJXSA-N,AMYGDALIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL461727,XUCIJNAGGSZNQT-JHSLDZJXSA-N,AMYGDALIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL902,XUFQPHANEAPEMJ-UHFFFAOYSA-N,FAMOTIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL902,XUFQPHANEAPEMJ-UHFFFAOYSA-N,FAMOTIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1566,XUFXOAAUWZOOIT-SXARVLRPSA-N,ACARBOSE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1566,XUFXOAAUWZOOIT-SXARVLRPSA-N,ACARBOSE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL54943,XUJNEKJLAYXESH-UHFFFAOYSA-N,CYSTEINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12649361,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1829335,XUKROCVZGZNGSI-CQSZACIVSA-N,IRDABISANT,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21634396,IC50,=,17500,NM,,"","","","","","",,,,,,,,Inhibition of recombinant human norepinephrine transporter,"Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonist.",J. Med. Chem.,PUBLICATION,
CHEMBL1829335,XUKROCVZGZNGSI-CQSZACIVSA-N,IRDABISANT,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21634396,KI,=,10000,NM,,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter ,"Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonist.",J. Med. Chem.,PUBLICATION,
CHEMBL1487,XUKUURHRXDUEBC-KAYWLYCHSA-N,ATORVASTATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1487,XUKUURHRXDUEBC-KAYWLYCHSA-N,ATORVASTATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL214121,XURYNEATXQVNNR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,25,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL572350,XUWDFILRONYSDW-PMACEKPBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,IC50,=,1100,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL489977,XVDZZRJNPDNTBI-UHFFFAOYSA-N,2-((3-FLUOROPHENOXY)(PHENYL)METHYL)MORPHOLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,11,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL149878,XVELJKVGYZEBLI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12565962,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE uptake evaluated at the monoamine transporter (NET),Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL488424,XVISEQWOYJEMBG-CABCVRRESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18550369,IC50,=,4000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3094313,XVKBXJCHXRLYAQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24238903,INHIBITION,=,58.5,%,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1171434,XVOYSCVBGLVSOL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12649361,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL69380,XVRWPBKYLFMIHN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,IC50,=,350,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL69380,XVRWPBKYLFMIHN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,KI,=,110,NM,,"","","","","","",,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL1173598,XVUDIIQDUSBBTF-IINYFYTJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,527,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL3334503,XWALEBCOFGKXBG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,73.5,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1644478,XWDJHMXLIXWQGQ-PTEHBNRSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21112782,IC50,=,67,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]noradrenalin reuptake at NET expressed in MDCK cells scintillation counting,"The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL551474,XWEOTQVRTMMRCV-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,4.1,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL551474,XWEOTQVRTMMRCV-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,6.9,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL411262,XWFSWRARAVLBFN-ICSRJNTNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17983754,KI,=,1.21,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL256135,XWGDWRZGNMYDDL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,85,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683897,XWHBDOLRNWCIGO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,5761,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1235242,XWHHYOYVRVGJJY-QMMMGPOBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1235242,XWHHYOYVRVGJJY-QMMMGPOBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2430676,XWQSXOFSOWLMBI-DJIMGWMZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,10,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1760,XWTYSIMOBUGWOL-UHFFFAOYSA-N,TERBUTALINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1760,XWTYSIMOBUGWOL-UHFFFAOYSA-N,TERBUTALINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL194907,XWULIDJGQOXILD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,92,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL397520,XWZLDADSUCQSKI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,2540000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL397520,XWZLDADSUCQSKI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL457966,XXFWDPHWYVNJQG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,2126,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL457966,XXFWDPHWYVNJQG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,5947,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL549761,XXHZUORXKGMGAL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,13,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL51697,XXPANQJNYNUNES-AWEZNQCLSA-N,(S)-NOMIFENSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,21.5,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL51697,XXPANQJNYNUNES-AWEZNQCLSA-N,(S)-NOMIFENSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL400964,XXPANQJNYNUNES-CQSZACIVSA-N,(R)-NOMIFENSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,6450,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL400964,XXPANQJNYNUNES-CQSZACIVSA-N,(R)-NOMIFENSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,1200,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL273575,XXPANQJNYNUNES-UHFFFAOYSA-N,NOMIFENSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,15.6,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL273575,XXPANQJNYNUNES-UHFFFAOYSA-N,NOMIFENSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12431845,KI,=,29,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL273575,XXPANQJNYNUNES-UHFFFAOYSA-N,NOMIFENSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,23,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL273575,XXPANQJNYNUNES-UHFFFAOYSA-N,NOMIFENSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,IC50,=,630.96,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL273575,XXPANQJNYNUNES-UHFFFAOYSA-N,NOMIFENSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,KI,=,83,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL273575,XXPANQJNYNUNES-UHFFFAOYSA-N,NOMIFENSINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL234926,XXROGKLTLUQVRX-UHFFFAOYSA-N,ALLYL ALCOHOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL234926,XXROGKLTLUQVRX-UHFFFAOYSA-N,ALLYL ALCOHOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1535,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,HYDROXYCHLOROQUINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1535,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,HYDROXYCHLOROQUINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2321990,XXTLAOZBJDRYIU-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,49,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2326695,XXTLAOZBJDRYIU-CQSZACIVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,5.1,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL485549,XXUXXCZCUGIGPP-WLRTZDKTSA-N,NIFURSOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL485549,XXUXXCZCUGIGPP-WLRTZDKTSA-N,NIFURSOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL255112,XXWKAPSDJYNICL-SVBPBHIXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18243691,INHIBITION,=,61,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,"Potent, selective MCH-1 receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL844,XYLJNLCSTIOKRM-UHFFFAOYSA-N,BRIMONIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL844,XYLJNLCSTIOKRM-UHFFFAOYSA-N,BRIMONIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL401621,XYNHEKMBRVZVQR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,8100,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL388257,XYPXWICAIAFXBP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,268,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3608450,XYYAWEJOUNEPTR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26227772,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding affinity to NET (unknown origin) at 10 uM,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL246955,XYYGFCDTBHAUSN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17127059,KI,=,106,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]nisoxetine uptake in human NET expressed in MDCK cells,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2171417,XZKCSWMXTDEREX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,IC50,=,3.1,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2171417,XZKCSWMXTDEREX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,90,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1169524,XZQBKIYIWLHZIO-WMLDXEAASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,700,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310498,XZQIYFJCZFNASH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,79,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310498,XZQIYFJCZFNASH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310498,XZQIYFJCZFNASH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1214060,XZWRXMFAFBSAJC-OWANBTPYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20597489,KI,=,265,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL1214060,XZWRXMFAFBSAJC-OWANBTPYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21146989,IC50,>,1000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,METFORMIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,METFORMIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1788140,YABYABUWFUDQKN-GUUGRXDUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,34,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL1788140,YABYABUWFUDQKN-GUUGRXDUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,95,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL2029055,YAGXEFDTWYZUEO-PHHSGPBWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15177457,KI,>,10000000,NM,,"","","","","","",,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1214059,YANGDSFZAMQEBP-PMWAWBRWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20597489,KI,=,145,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis, fluorine-18 radiolabeling, and biological evaluation of N-((E)-4-fluorobut-2-en-1-yl)-2beta-carbomethoxy-3beta-(4'-halophenyl)nortropanes: candidate radioligands for in vivo imaging of the brain dopamine transporter with positron emission tomography.",J. Med. Chem.,PUBLICATION,
CHEMBL459644,YAOMVDAPALQFPR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,INHIBITION,=,29,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells at 1000 nM,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL459644,YAOMVDAPALQFPR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,717,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL121,YASAKCUCGLMORW-UHFFFAOYSA-N,ROSIGLITAZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL121,YASAKCUCGLMORW-UHFFFAOYSA-N,ROSIGLITAZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,ANASTROZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,ANASTROZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL411693,YBLHYQJAYABBGT-SJCJKPOMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,2900,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL574317,YBLWMYFOFQPXMI-UEXOWVPHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,=,515,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL448689,YBOXDTVMHIUYEG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,4900,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL85728,YBRVSVVVWCFQMG-UHFFFAOYSA-N,"4,4'-METHYLENEDIANILINE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL85728,YBRVSVVVWCFQMG-UHFFFAOYSA-N,"4,4'-METHYLENEDIANILINE",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL357312,YBUFEUDZXKMCFS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12565962,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE uptake evaluated at the monoamine transporter (NET),Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1812746,YBVYVIFNGYOFSX-MXYBEHONSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21058665,IC50,=,0.9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,PUBLICATION,
CHEMBL1818459,YBZZUBMYXLOQMZ-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,25.12,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3673178,YCAOLYRUUFDEGF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,438.2,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL280998,YCIMNLLNPGFGHC-UHFFFAOYSA-N,CATECHOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL280998,YCIMNLLNPGFGHC-UHFFFAOYSA-N,CATECHOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL495778,YCOFRPYSZKIPBQ-UHFFFAOYSA-N,PENICILLIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL495778,YCOFRPYSZKIPBQ-UHFFFAOYSA-N,PENICILLIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2336610,YCPGWXQYWPBVKD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23168018,KI,=,11800,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]dopamine uptake at human NET expressed in COS7 cells after 5 mins by beta-counting,A rhodamine-labeled citalopram analogue as a high-affinity fluorescent probe for the serotonin transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL491754,YCWGZWYJTIJTHX-UHFFFAOYSA-N,KF-A5,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17846138,IC50,=,9100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,PUBLICATION,
CHEMBL466500,YDGFCJZXRYFURC-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,20,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL566832,YDGOUEKZXBLUDG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566832,YDGOUEKZXBLUDG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL566832,YDGOUEKZXBLUDG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,6200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL205082,YDIIDRWHPFMLGR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,56,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL205082,YDIIDRWHPFMLGR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,199,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1076407,YDKFYCWSHGTMTO-SQKGNGEWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL574544,YDNOASAJYGOBQG-CPWXKJDLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,=,21,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1403281,YDOTUXAWKBPQJW-NSLWYYNWSA-N,ERGOCRYPTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1403281,YDOTUXAWKBPQJW-NSLWYYNWSA-N,ERGOCRYPTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL432727,YDRFQAANTRDVRU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,IC50,=,1846,NM,,"","","","","","",,,,,,,,Compound was tested for inhibition of [3H]NE binding to norepinephrine transporter HEK cells,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL432727,YDRFQAANTRDVRU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,KI,=,330,NM,,"","","","","","",,,,,,,,Compound was tested for inhibition of [125I]-RTI-55 binding to norepinephrine transporter HEK cells,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL432727,YDRFQAANTRDVRU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,RATIO,=,5.59,,,"","","","","","",,,,,,,,Ratio of uptake inhibition to binding affinity to human NET (IC50/Ki),Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL432727,YDRFQAANTRDVRU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,RATIO,=,8.3,,,"","","","","","",,,,,,,,Selectivity ratio determined of Ki human Norepinephrine transporter to Ki human Serotonin transporter,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL12375,YDSZXMRCXLHXST-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9435902,KI,=,2080,NM,,"","","","","","",,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET) using [3H]desmethylimipramine as radioligand,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL1818461,YEAGKKNHGFQLKI-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,10,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL511,YECBIJXISLIIDS-UHFFFAOYSA-N,PYRILAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL603,YEEZWCHGZNKEEK-UHFFFAOYSA-N,ZAFIRLUKAST,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL603,YEEZWCHGZNKEEK-UHFFFAOYSA-N,ZAFIRLUKAST,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL531,YEHCICAEULNIGD-MZMPZRCHSA-N,PERGOLIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL531,YEHCICAEULNIGD-MZMPZRCHSA-N,PERGOLIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL257592,YEIRDCHLYKWPAP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,86,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683893,YEMZPAKBIRTBDG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,146,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL544370,YEPHLOVPJHBBRN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,IC50,=,0.62,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL544370,YEPHLOVPJHBBRN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,KI,=,8.8,NM,,"","","","","","",,,,,,,,Ability to displace [125I]- RTI-55 binding at the Norepinephrine transporter site on HEK cells expressing cDNA for the human transporter (hNET),Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL148489,YFCWBKBNFCDPDF-UHFFFAOYSA-N,N-(3-PYRIDYLMETHYL)PYRROLIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22607684,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310483,YFFZLXAPKOKACC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,30,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310483,YFFZLXAPKOKACC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310483,YFFZLXAPKOKACC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310483,YFFZLXAPKOKACC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310483,YFFZLXAPKOKACC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,RATIO IC50,>,7,,,"",cell_based,"","","","",,,,,,,,Ratio of duloxetine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3310483,YFFZLXAPKOKACC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,RATIO IC50,>,7,,,"",cell_based,"","","","",,,,,,,,Ratio of venlafaxine IC50 to compound IC50 for norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1373,YFGHCGITMMYXAQ-UHFFFAOYSA-N,MODAFINIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1373,YFGHCGITMMYXAQ-UHFFFAOYSA-N,MODAFINIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2171419,YFIDHTXSPXGKFL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,IC50,=,21,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake after 30 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2171419,YFIDHTXSPXGKFL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22938049,INHIBITION,=,76,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of noradrenaline reuptake at 0.1 uM after 15 mins by fluorescence assay,Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL562569,YFOORSARAMYVQM-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,18,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173771,YFWBKVXUOIZZMD-QMHKHESXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,1570,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1085831,YFXILLLEWBTOSN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,1.1,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL1085831,YFXILLLEWBTOSN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,4.5,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL154488,YFXZWVUZIPQSKX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,2500,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL424,YGSDEFSMJLZEOE-UHFFFAOYSA-N,SALICYLIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL424,YGSDEFSMJLZEOE-UHFFFAOYSA-N,SALICYLIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2430678,YGVBSRWLELWASD-KZNAEPCWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,10,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL377714,YGVNVXMPAVCLBG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16337793,IC50,>,100,NM,,"","","","","","",,,,,,,,Inhibitory activity against NET,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3085029,YGVRYGYKGFIQTL-NUNAXRQHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16213721,KI,=,2920,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430699,YHCGXHXZKOJYFY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,IC50,=,482.9,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430699,YHCGXHXZKOJYFY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,11.7,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430699,YHCGXHXZKOJYFY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,94,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337591,YHCLEHAMAKETBI-SJLPKXTDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,0.794,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2337590,YHCLEHAMAKETBI-WMZOPIPTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,7.94,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL489775,YHKBQPFPSDCUBA-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,21,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL567933,YHNAHEPHKZYDTN-SECBINFHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL594519,YHPHFVMVXIQRCD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,IC50,=,12,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells after 10 mins by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL594519,YHPHFVMVXIQRCD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19836247,KI,=,13,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells after 2 hrs by scintillation counting,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL86304,YHXISWVBGDMDLQ-UHFFFAOYSA-N,MOCLOBEMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL86304,YHXISWVBGDMDLQ-UHFFFAOYSA-N,MOCLOBEMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL491889,YHXSELHUXJAOLR-UHFFFAOYSA-N,KF-A6,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17846138,IC50,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,PUBLICATION,
CHEMBL462401,YIEXSVBTWQZEGZ-MSOLQXFVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,770,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL455448,YIEXSVBTWQZEGZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,30,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL507359,YIEXSVBTWQZEGZ-ZWKOTPCHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954981,IC50,=,3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET transfected in HEK cells,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with improved pharmaceutical characteristics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1645609,YIGLINOPTZCHQC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,323,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL534723,YIQFFQJVNKNCNB-FSRHSHDFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,16,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL540107,YIQFFQJVNKNCNB-FYZYNONXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,19,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL273157,YIRWGCANORBOOM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18060777,KI,=,470,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430690,YIXJHLSDNZJSDC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,41,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2430690,YIXJHLSDNZJSDC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,68.9,%,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL61,YJGVMLPVUAXIQN-XVVDYKMHSA-N,PODOFILOX,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL61,YJGVMLPVUAXIQN-XVVDYKMHSA-N,PODOFILOX,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL402345,YJNSSHGTSILZGM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,32,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL402345,YJNSSHGTSILZGM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,32,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673155,YJSPAIGIXYSMEQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,910.4,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL2430679,YJTXADGPCUCDFY-KZNAEPCWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24012181,INHIBITION,=,10,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells at 10 uM,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL224771,YJWQTICONBXOHT-KOQKOIQBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,=,480,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL224771,YJWQTICONBXOHT-KOQKOIQBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,KI,=,280,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL2096875,YJWQTICONBXOHT-KWJLTHHISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,=,4850,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL2096875,YJWQTICONBXOHT-KWJLTHHISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,KI,=,2920,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL3673141,YJYMMJSBCVZBHP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,383.8,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL391074,YKCOYIKIANOWTN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17616397,KI,=,96,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL570317,YKDPKVFUKKJFFE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,10,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL177756,YKGGGCXBWXHKIZ-UHFFFAOYSA-N,FLUORESCEIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL177756,YKGGGCXBWXHKIZ-UHFFFAOYSA-N,FLUORESCEIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL423192,YKJYKKNCCRKFSL-RDBSUJKOSA-N,ANISOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL423192,YKJYKKNCCRKFSL-RDBSUJKOSA-N,ANISOMYCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL569700,YKOZIWZLLJVPPD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,2150,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL569700,YKOZIWZLLJVPPD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,4000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL294199,YKPUWZUDDOIDPM-SOFGYWHQSA-N,CAPSAICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL294199,YKPUWZUDDOIDPM-SOFGYWHQSA-N,CAPSAICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL407135,YKQOSKADJPQZHB-YNWHQGOSSA-N,COLISTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL407135,YKQOSKADJPQZHB-YNWHQGOSSA-N,COLISTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL382034,YKRZGFVSJMTZLF-LEWJYISDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16413778,KI,=,7.7,NM,,"","","","","","",,,,,,,,Binding affinity to NET,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL555565,YKTFTKYTVUHUCP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,794.33,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1812739,YKXMGNSTADTLNN-MLHJIOFPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21058665,IC50,=,52,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,PUBLICATION,
CHEMBL258450,YKZNMHWYVVPEPW-WMLDXEAASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,47,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2407320,YLCDOWWZEWUKRA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,8.7,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL95,YLJREFDVOIBQDA-UHFFFAOYSA-N,TACRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,11000,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL95,YLJREFDVOIBQDA-UHFFFAOYSA-N,TACRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,517,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL95,YLJREFDVOIBQDA-UHFFFAOYSA-N,TACRINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,513,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL256019,YLMUIVZGFNCEHD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,2300,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3085028,YLOMMHJWKYDOFW-KOUNCHBCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16213721,KI,=,5580,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL179249,YLQFFYJKBKUKLF-WMZOPIPTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19067522,KI,=,0.3,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET receptor expressed in HEK293 cells,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL570867,YLSKCQOVDOZHTQ-VWLOTQADSA-N,BMS-344577,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19896847,ACTIVITY,,,,Not Active,"","","","","","",,,,,,,,Inhibition of human NE transporter at 10 uM,Aroylguanidine-based factor Xa inhibitors: the discovery of BMS-344577.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2432059,YLVXPEMITKSDOS-RAOGCBAWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL579244,YLXJJHBNSKFHOT-AEFFLSMTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19713106,IC50,=,21,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL347933,YLXLGAOEMZMTCN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,12000,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL116,YMARZQAQMVYCKC-OEMFJLHTSA-N,AMPRENAVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL116,YMARZQAQMVYCKC-OEMFJLHTSA-N,AMPRENAVIR,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL19299,YMBXTVYHTMGZDW-UHFFFAOYSA-N,LOXOPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL19299,YMBXTVYHTMGZDW-UHFFFAOYSA-N,LOXOPROFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL260037,YMESBXUQEPAMAY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,394,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309703,YMKIEQRAGKLOPM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,50,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309703,YMKIEQRAGKLOPM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309703,YMKIEQRAGKLOPM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL608430,YMQUDJCSTPMZTF-HEHGZKQESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,1.26,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL596784,YMQUDJCSTPMZTF-IOASZLSFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,158.49,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL3703727,YMSGTOASAZCQKN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,63.1,NM,302091,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL672,YMTINGFKWWXKFG-UHFFFAOYSA-N,FENOFIBRATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,21408,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL672,YMTINGFKWWXKFG-UHFFFAOYSA-N,FENOFIBRATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,21231,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1504,YNDXUCZADRHECN-JNQJZLCISA-N,TRIAMCINOLONE ACETONIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1504,YNDXUCZADRHECN-JNQJZLCISA-N,TRIAMCINOLONE ACETONIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1834184,YNFDIGJKJPNFFD-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21873051,INHIBITION,=,9,%,,"","","","","","",,,,,,,,Binding affinity to human NET at 10 uM by radioligand binding assay,"Discovery of BI 99179, a potent and selective inhibitor of type I fatty acid synthase with central exposure.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL14053,YNJBWRMUSHSURL-UHFFFAOYSA-N,TRICHLOROACETIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL14053,YNJBWRMUSHSURL-UHFFFAOYSA-N,TRICHLOROACETIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1081648,YNLYAYGRKYOTBJ-IBGZPJMESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20137933,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1081649,YNLYAYGRKYOTBJ-LJQANCHMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20137933,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1626,YNNUSGIPVFPVBX-NHCUHLMSSA-N,CLEMASTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,3086,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1626,YNNUSGIPVFPVBX-NHCUHLMSSA-N,CLEMASTINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3060,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL256397,YNXFZOVYRWOMIR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,2800,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL567248,YNZNOMFLFOSBEA-OALUTQOASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,INHIBITION,=,45,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL463388,YOAPWCHKPSMTER-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954985,KI,=,288,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL983,YOEWQQVKRJEPAE-UHFFFAOYSA-L,SUCCINYLCHOLINE CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL983,YOEWQQVKRJEPAE-UHFFFAOYSA-L,SUCCINYLCHOLINE CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1513,YOSHYTLCDANDAN-UHFFFAOYSA-N,IRBESARTAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1513,YOSHYTLCDANDAN-UHFFFAOYSA-N,IRBESARTAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1683879,YOVGBLUPSNTJCU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,790,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL199116,YPBIYYFCLCGRRL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,11,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL60889,YPELFRMCRYSPKZ-UHFFFAOYSA-N,MOSAPRIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL60889,YPELFRMCRYSPKZ-UHFFFAOYSA-N,MOSAPRIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL123292,YPHMISFOHDHNIV-FSZOTQKASA-N,CYCLOHEXIMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL123292,YPHMISFOHDHNIV-FSZOTQKASA-N,CYCLOHEXIMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1818469,YPIFSSZDJKDNEK-HUUCEWRRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,100,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL132954,YPRKQXGDPALXAP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,IC50,=,1.73,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL132954,YPRKQXGDPALXAP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,KI,=,23.1,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL1668584,YPVOSIDECMYMTD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21333408,ACTIVITY,,,,Not Active,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter at 10 uM by radioligand binding assay,"2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonists.",Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1372,YPZRWBKMTBYPTK-BJDJZHNGSA-N,OXIGLUTATIONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1372,YPZRWBKMTBYPTK-BJDJZHNGSA-N,OXIGLUTATIONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL575699,YQANZQCQGNYBAC-MOSHPQCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,650,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL742,YQEZLKZALYSWHR-UHFFFAOYSA-N,KETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL742,YQEZLKZALYSWHR-UHFFFAOYSA-N,KETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL198275,YQMJGYZSSOOMCO-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,62,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL568095,YQOJGBMYXRTDBS-OALUTQOASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19632110,INHIBITION,=,11,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells at 1000 nM,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL403080,YQRYFSQPEXVGIK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,26,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3593403,YQVZJLGBHWQCGT-UOUQJYNVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,13,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL513139,YRBVTLBLPHIXQP-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,28,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1219,YREYEVIYCVEVJK-UHFFFAOYSA-N,RABEPRAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1219,YREYEVIYCVEVJK-UHFFFAOYSA-N,RABEPRAZOLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL518580,YRGCYAJUEHMWAR-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,98,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2407325,YROYMUJBXFJCBF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,44,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1189234,YSEXVIPNIGQQMN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1189234,YSEXVIPNIGQQMN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL2322002,YSGVIJFMBOEZJZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,83,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human recombinant NET expressed in HEK cells,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL1566956,YSIITVVESCNIPR-UHFFFAOYSA-N,TROXIPIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1566956,YSIITVVESCNIPR-UHFFFAOYSA-N,TROXIPIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3673160,YSRPCSSZNWLITA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,451.1,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL346142,YSSNAKHTYQUUHB-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,1400,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL3323089,YSXLAKJPPGTIOK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,2.6,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3323089,YSXLAKJPPGTIOK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323089,YSXLAKJPPGTIOK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,4.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323089,YSXLAKJPPGTIOK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,19.2,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3323089,YSXLAKJPPGTIOK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,2,NM,314410,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL511603,YSZKSMMSKUUKKE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19445453,KI,>,6000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK293 cells,Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL511603,YSZKSMMSKUUKKE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19445453,KI,>,6000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL214003,YTAOQYQJPVKYAI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,8.8,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1642917,YTBOYUYWXPLZQM-DLBZAZTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,7262,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642916,YTBOYUYWXPLZQM-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,1642,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642914,YTBOYUYWXPLZQM-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,766,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1642915,YTBOYUYWXPLZQM-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21093273,IC50,=,112,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in MDCK cells by scintillation counting,"Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL227232,YTNASRCFNXLDGR-HIUFNZKISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,582,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL227232,YTNASRCFNXLDGR-HIUFNZKISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,2270,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL611677,YTQLIVFAWSALJC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,1810,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL372378,YTXXRXPLJHCYAH-NUUPQPAYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16302792,KI,=,177,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]dopamine from human NET expressed in COS7 cells,"Rhodamine-labeled 2beta-carbomethoxy-3beta-(3,4-dichlorophenyl)tropane analogues as high-affinity fluorescent probes for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL3663908,YTYBDRIOUDWUGR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,488,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663908,YTYBDRIOUDWUGR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2250,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663908,YTYBDRIOUDWUGR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3170,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663908,YTYBDRIOUDWUGR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,488,NM,314401,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL497338,YUFDTETVOKSVLR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18461921,KI,>,100000,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,PUBLICATION,
CHEMBL38737,YUKQRDCYNOVPGJ-UHFFFAOYSA-N,THIOACETAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL38737,YUKQRDCYNOVPGJ-UHFFFAOYSA-N,THIOACETAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL235569,YUMUSCBAOZYAIX-BARDWOONSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446069,KI,=,4.88,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"Synthesis and biological evaluation of 2beta,3alpha-(substituted phenyl)nortropanes as potential norepinephrine transporter imaging agents.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2021577,YUSAYELUMYRKMP-CIUDSAMLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,199.53,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL63354,YUSWMAULDXZHPY-UHFFFAOYSA-N,AMENTOFLAVONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12110997,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL99653,YUTGLCAFRPAGFA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,32,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL99653,YUTGLCAFRPAGFA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,21,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2337599,YVEIFDFSCWTJRT-SJLPKXTDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,50.12,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL471898,YVGUKIACEDKFHT-LIAHKDQHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,=,349,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL361259,YVKDUIAAPBKHMJ-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9986702,KI,=,1.82,NM,,"","","","","","",,,,,,,,Compound was tested for inhibiting reuptake of [3H]- NE by norepinephrine transporter,"A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol.",J. Med. Chem.,PUBLICATION,
CHEMBL361259,YVKDUIAAPBKHMJ-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9986702,KI,=,11.3,NM,,"",cell_based,"","","","",,,,,,,,In vitro binding affinity against monoamine transporter NET (norepinephrine transporter) in LLC-PK1 cell membranes.,"A new single-photon emission computed tomography imaging agent for serotonin transporters: [123I]IDAM, 5-iodo-2-((2-((dimethylamino)methyl)phenyl)thio)benzyl alcohol.",J. Med. Chem.,PUBLICATION,
CHEMBL361259,YVKDUIAAPBKHMJ-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15456270,KI,=,11.3,NM,,"",cell_based,"","","","",,,,,,,,Binding affinity for Norepinephrine transporter (NET) expressed in LCK PK1 cells,2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent.,J. Med. Chem.,PUBLICATION,
CHEMBL3334777,YVOMATWVFCSQME-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,35.3,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1738699,YVPGZQLRPAGKLA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21570838,INHIBITION,<,50,%,Not Active,"","","","","","",,,,,,,,Inhibition of human recombinant NET at 10 uM by radioligand binding assay,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1201220,YVPYQUNUQOZFHG-UHFFFAOYSA-N,DIATRIZOIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201220,YVPYQUNUQOZFHG-UHFFFAOYSA-N,DIATRIZOIC ACID,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1829477,YVXDOSIKSIZMGR-CQSZACIVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21782432,INHIBITION,=,70,%,,"","","","","","",,,,,,,,Inhibition of NET at 10 uM,"Identification of pyridazin-3-one derivatives as potent, selective histamine H3 receptor inverse agonists with robust wake activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL575077,YWIYMDPWBAXEKQ-UHFFFAOYSA-N,4-(2-PHENOXYPHENYL)PIPERIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,416,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1683877,YWOVEHIRDVATGZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,232,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL306700,YWPHCCPCQOJSGZ-UHFFFAOYSA-N,VILOXAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,155,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL306700,YWPHCCPCQOJSGZ-UHFFFAOYSA-N,VILOXAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9871604,KD,=,155,NM,,"","","","","","",,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL571893,YXAAWHCXAGWLQX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,39.81,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL564094,YXBAJJFUPMTDTL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,12.59,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1614664,YXBUQQDFTYOHQI-UHFFFAOYSA-N,PSEUDOHYPERICIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12110997,KI,=,10000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1170212,YXKXFXIRENCHSD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,251.19,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL538876,YYCOWMQMXNLRHZ-DXWKFQSLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22300887,KI,>,500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human cloned NET receptor expressed in HEK293 cells,QSAR study and synthesis of new phenyltropanes as ligands of the dopamine transporter (DAT).,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL538876,YYCOWMQMXNLRHZ-DXWKFQSLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24262882,KI,>,1000,NM,,"","","","","","",,,,,,,,Binding affinity to NET (unknown origin),"Synthesis, radiosynthesis and first in vitro evaluation of novel PET-tracers for the dopamine transporter: [(11)C]IPCIT and [(18)F]FE@IPCIT.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1643897,YYCOWMQMXNLRHZ-GOOGKZTPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21146989,KI,>,1000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL605213,YYHJBTRUWUYGMM-MAOIFBLLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,72,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL518195,YYJIBHFMUZUGND-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,575,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL518195,YYJIBHFMUZUGND-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,417,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL3593402,YYOKDTWKQIVDFK-XCBLFTOQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26051602,IC50,=,2.3,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET expressed in CHOK1 cells incubated for 45 mins by [3H]-norepinephrine uptake assay,"Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3593402,YYOKDTWKQIVDFK-XCBLFTOQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27325446,IC50,=,2.3,NM,,"","","","","","",,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3094319,YYONFKYBFNEIKC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24238903,INHIBITION,=,59.9,%,,"","","","","","",,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3673166,YYPCUZDBNVUASA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,160.7,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL411941,YYQUWEHEBOMRPH-NYUBLWNDSA-N,CYCLORGDFV,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16722631,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter by radioligand binding assay,"An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression.",J. Med. Chem.,PUBLICATION,
CHEMBL1645610,YYTDEVINWTYBOD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,1950,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL448900,YYVFHUIYCOUOCD-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,=,62,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2407334,YYWIEWLZZQPVRT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23769168,IC50,=,25,NM,,"",cell_based,"","","","",CHO,,,,,,,Displacement of [3H]-norepinephrine from human NET expressed in CHO cells by TopCounting analysis,"Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL265951,YYYWQSQFBVNAPA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18313294,KI,=,296,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]Nisoxetine uptake in human noradrenaline transporter transfected HEK293 cells,[4-(Phenoxy)pyridin-3-yl]methylamines: a new class of selective noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1645606,YZDRSNBYBMAHDD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,1000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL481353,YZFBWQVFTDRJGQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,6700,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL7002,YZFWTZACSRHJQD-UHFFFAOYSA-N,CIGLITAZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,2220,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL7002,YZFWTZACSRHJQD-UHFFFAOYSA-N,CIGLITAZONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,2201,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL426316,YZGSHBDJMLWEBX-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,8.3,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL438889,YZHPFFVLNPTVQU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,17,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL591928,YZJOPQCWTRXOHP-URBRKQAFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,1.6,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL591928,YZJOPQCWTRXOHP-URBRKQAFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20131864,IC50,=,2.7,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL564071,YZKDZSSMZPGBAY-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19616432,KI,=,294,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL403469,YZLURQAUJPJHIZ-QFBILLFUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,=,21,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL442234,YZQHGCDBPHKCKB-CHWSQXEVSA-N,METHYL 2-(4-(TRIFLUOROMETHOXY)PHENYL)CYCLOHEXANECARBOXYLATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,719000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL474922,YZSUSCODCJEDGG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,680,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3673136,YZTRIEWOXRNWOV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,73.7,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3673136,YZTRIEWOXRNWOV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,242.3,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL438321,YZXXWGROTHDVOH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,2020000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL438321,YZXXWGROTHDVOH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1727,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,CEPHALEXIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1727,ZAIPMKNFIOOWCQ-UEKVPHQBSA-N,CEPHALEXIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL257550,ZAKNFBUXJCNYEX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18445525,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of human NET,"Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2380983,ZALXONRNDYIIGY-AAEUAGOBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23578689,IC50,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2380983,ZALXONRNDYIIGY-AAEUAGOBSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23578689,INHIBITION,=,55,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cell membranes at 1 uM,Conformationally restricted homotryptamines. Part 6: Indole-5-cycloalkyl methylamines as selective serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1081254,ZALZZXXESRJJEH-IBGZPJMESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20137933,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL212877,ZASFISMVWZDDES-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,76,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3105242,ZASUYZQUSFFDOQ-AACQVBLVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24262882,KI,=,785,NM,,"","","","","","",,,,,,,,Displacement of [3H]Imipramin from human NET after 2 hrs by liquid scintillation counting analysis,"Synthesis, radiosynthesis and first in vitro evaluation of novel PET-tracers for the dopamine transporter: [(11)C]IPCIT and [(18)F]FE@IPCIT.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL469460,ZASZYPPXOGNZRV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,870,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL469460,ZASZYPPXOGNZRV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,745,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL217975,ZBCBLJHLBKPDBD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,330,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL217975,ZBCBLJHLBKPDBD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,1400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL217975,ZBCBLJHLBKPDBD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,3800,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL217975,ZBCBLJHLBKPDBD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,12000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL477586,ZBFNMJAOUOICQA-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL609624,ZBHICRAJUNKGFK-QNGOZBTKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20020710,ACTIVITY,=,34,%,,"","","","","","",,,,,,,,Binding affinity to NET at 10 uM by displacement assay,Novel KCNQ2/Q3 agonists as potential therapeutics for epilepsy and neuropathic pain.,J. Med. Chem.,PUBLICATION,
CHEMBL2206520,ZBINDVNASLJSJF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,116,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL11776,ZBKITZYQNFJNIF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9435902,KI,>,8000,NM,,"","","","","","",,,,,,,,Compound was evaluated for binding to Norepinephrine Transporter (NET).,Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL471,ZBMZVLHSJCTVON-UHFFFAOYSA-N,SOTALOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL471,ZBMZVLHSJCTVON-UHFFFAOYSA-N,SOTALOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2338039,ZBOZPXXCXYETEE-YJBOKZPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,3.98,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1077,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,BROMFENAC,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1077,ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,BROMFENAC,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL498565,ZCFQGAKEQPCWDE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18461921,KI,>,100000,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,PUBLICATION,
CHEMBL2096878,ZCJYSKHDYKCJTO-CFBBYLOMSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,,,,Not Determined,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL224062,ZCJYSKHDYKCJTO-MOUZIVPDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,=,282,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL224062,ZCJYSKHDYKCJTO-MOUZIVPDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,KI,=,191,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL264160,ZCLPMZOFUORDSQ-ROUUACIJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,28,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL207804,ZCPBUGPJVONOEH-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,INHIBITION,=,-67,%,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET at 1 uM,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL554800,ZCSHCEYGULDLOB-SCGPDRHWSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16413778,KI,=,3.2,NM,,"","","","","","",,,,,,,,Binding affinity to NET,Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL466501,ZCUPCXFJNBQNMK-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,23,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL469606,ZCVDRKAWDMMKKP-AWEZNQCLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL469605,ZCVDRKAWDMMKKP-CQSZACIVSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,3000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL534,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,KETOTIFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL534,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,KETOTIFEN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL207634,ZDCUVFAPACGOSD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,6.2,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3703739,ZDIVPUUGCMEOOI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,23.3,NM,302103,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL377900,ZDQCOGINXTZCCG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,120,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL466293,ZDXWQKDOOAYJBD-SJORKVTESA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,62,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3323175,ZDZGDSLKDOSHHZ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,5.5,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL2112075,ZEBNDUQLNGYBNL-VEIFNGETSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19492813,IC50,=,200,NM,,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter,Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues.,J. Med. Chem.,PUBLICATION,
CHEMBL270570,ZEDCZVINJCBZGE-MJGOQNOKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3704757,ZEFQZGJPKZZHJW-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,2.79,NM,317712,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL3704757,ZEFQZGJPKZZHJW-KRWDZBQOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,6515,NM,317700,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL3704758,ZEFQZGJPKZZHJW-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,328.9,NM,317713,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL3704758,ZEFQZGJPKZZHJW-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,1086,NM,317701,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL3704756,ZEFQZGJPKZZHJW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,5.49,NM,317711,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL3704756,ZEFQZGJPKZZHJW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,>,10000,NM,317699,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL260038,ZEFZLXPQUSMAFT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18417343,IC50,=,257,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human recombinant NA transporter expressed in HEK293 cells,Pyridyl-phenyl ether monoamine reuptake inhibitors: Impact of lipophilicity on dual SNRI pharmacology and off-target promiscuity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL561,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,LOMEFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL561,ZEKZLJVOYLTDKK-UHFFFAOYSA-N,LOMEFLOXACIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3309705,ZEMHRXZHHOGKCW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,70,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309705,ZEMHRXZHHOGKCW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3309705,ZEMHRXZHHOGKCW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,INHIBITION,=,100,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL374712,ZEOHVQFWFVMPGM-FGDMXMHKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,559,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL374712,ZEOHVQFWFVMPGM-FGDMXMHKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,280,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL2096858,ZEOHVQFWFVMPGM-HXSCFSKGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,444,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL2096858,ZEOHVQFWFVMPGM-HXSCFSKGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,222,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL608703,ZEOHVQFWFVMPGM-JYVUQVBGSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,39,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL610897,ZEOHVQFWFVMPGM-LMRVLLHPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,37,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL610897,ZEOHVQFWFVMPGM-LMRVLLHPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,22,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL375888,ZEOHVQFWFVMPGM-SHWKFHJASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,5.14,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL375888,ZEOHVQFWFVMPGM-SHWKFHJASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,3.1,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL306208,ZEOHVQFWFVMPGM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,IC50,=,8.2,NM,,"","","","","","",,,,,,,,Compound was tested for inhibition of [3H]NE binding to norepinephrine transporter HEK cells,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL306208,ZEOHVQFWFVMPGM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,KI,=,37,NM,,"","","","","","",,,,,,,,Compound was tested for inhibition of [125I]-RTI-55 binding to norepinephrine transporter HEK cells,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL306208,ZEOHVQFWFVMPGM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,RATIO,=,0.22,,,"","","","","","",,,,,,,,Ratio of uptake inhibition to binding affinity to human NET (IC50/Ki),Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL611963,ZERAVOYPKCPVKA-VQTBRTBSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,2700,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11750180,KI,=,7.5,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,KI,=,7.5,NM,,"","","","","","",,,,,,,,Ability to inhibit the reuptake of NE at human norepinephrine transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15177457,KI,=,7450,NM,,"","","","","","",,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16220969,KI,=,16,NM,,"","","","","","",,,,,,,,Inhibition constant against norepinephrine transporter,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750359,IC50,=,19,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16750363,IC50,=,19,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17267217,IC50,=,19,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA from human NET expressed in HEK293 cells,N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,=,8.9,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,45,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18771916,IC50,=,4,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18954038,IC50,=,8.9,NM,,"",cell_based,"","","","",HEK293,,,,,,,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from human cloned NET expressed in HEK293 cells by microplate scintillation counter","Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic pain.",J. Med. Chem.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19329313,IC50,=,4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19359175,IC50,=,5,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19592243,KI,=,7.94,NM,,"","","","","","",,,,,,,,Inhibition of NET,"Novel, achiral aminoheterocycles as selective monoamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,45,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20378347,IC50,=,4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20471260,KI,=,45,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,5.97,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23347683,IC50,=,1.58,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,24974340,IC50,=,515,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,29,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL1175,ZEUITGRIYCTCEM-KRWDZBQOSA-N,DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,6.7,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]Nisoxetine from human NET transfected in HEK293 cells after 3 hrs by Wallac counting analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL336920,ZEUITGRIYCTCEM-QGZVFWFLSA-N,(R)-DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740668,IC50,=,13.2,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]NE reuptake at human NET expressed in HEK cells,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL336920,ZEUITGRIYCTCEM-QGZVFWFLSA-N,(R)-DULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740668,KI,=,61.3,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL424660,ZEUITGRIYCTCEM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14573386,KI,=,7.5,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL424660,ZEUITGRIYCTCEM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,KI,=,20,NM,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine (NE) transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL424660,ZEUITGRIYCTCEM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14744476,KI,=,1.17,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL424660,ZEUITGRIYCTCEM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14744476,KI,=,20,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL422,ZEWQUBUPAILYHI-UHFFFAOYSA-N,TRIFLUOPERAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL422,ZEWQUBUPAILYHI-UHFFFAOYSA-N,TRIFLUOPERAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL267615,ZEYRDXUWJDGTLD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10715164,KI,>,10000,NM,,"","","","","","",,,,,,,,Compound was evaluated for its binding affinity towards human NET(norepinephrine) transporter,2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.,J. Med. Chem.,PUBLICATION,
CHEMBL477584,ZFAZBQUXCIBGID-ZDUSSCGKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18625557,IC50,>,400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells by scintillation counting,N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1085904,ZFGMAUXPSXKTKJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20153188,IC50,=,790,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL595767,ZFJXYVKPCIOHJP-DDZGMJBXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19560930,KI,=,620,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]methyl 3-(4-iodophenyl)-8-methyl-8-aza-bicyclo[3.2.1]octane-2-carboxylate from human recombinant NET expressed in african green monkey COS1 cells by liquid scintillation counting,An extended study of dimeric phenyl tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL464099,ZFLRVRLYWHNAEC-AWEZNQCLSA-N,N-METHYLLAUROTETANINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25695425,KI,>,950,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK cell membranes by radioligand binding assay,Semisynthetic Studies on and Biological Evaluation of N-Methyllaurotetanine Analogues as Ligands for 5-HT Receptors.,J. Nat. Prod.,PUBLICATION,
CHEMBL802,ZFMITUMMTDLWHR-UHFFFAOYSA-N,MINOXIDIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL802,ZFMITUMMTDLWHR-UHFFFAOYSA-N,MINOXIDIL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL249854,ZFRLEPMXXGKKBN-WPFOTENUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17418570,KI,=,7700,NM,,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter,CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL403388,ZFUPFIUXGORYPF-AEFFLSMTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,1010,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL190,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,THEOPHYLLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL190,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,THEOPHYLLINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL128593,ZFZUYTCCHMWWTD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11082457,KI,=,1000,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL2432061,ZFZXJOHWFSRUAO-LLOIJXFCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3334791,ZGHQVNYQNYKDCM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,52.5,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL347914,ZGKKKWMQYVOFGE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,8558529,IC50,=,2600,NM,,"","","","","","",,,,,,,,Inhibitory activity against norepinephrine (NE) uptake in rat whole brain synaptosome preparation,Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
CHEMBL130477,ZGLAJTSGABGHND-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,IC50,=,4.9,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL130477,ZGLAJTSGABGHND-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,KI,=,18,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL130477,ZGLAJTSGABGHND-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213054,KI,=,18.2,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL239297,ZGPGDMLZVXIWAH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18052090,KI,=,114,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,PUBLICATION,
CHEMBL606120,ZGPLGLWQWPXKAN-HOTUBEGUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,28.84,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL592375,ZGPLGLWQWPXKAN-YGOYTEALSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,181.97,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL564,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,PROMAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,13,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL564,ZGUGWUXLJSTTMA-UHFFFAOYSA-N,PROMAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,13,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL403570,ZGYZPKKUJVRLKR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,33000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173279,ZHBAFJPTWCEURK-IINYFYTJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,3000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1824777,ZHHLHBNBIKLLJG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21788137,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Inhibition of NET transporter at 10 uM by NIMH PDSP,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL497549,ZHLYFJIHCTWRCA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18461921,KI,>,10000,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.,J. Med. Chem.,PUBLICATION,
CHEMBL375118,ZHNMSSREJSABQA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,44,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL375118,ZHNMSSREJSABQA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,1000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL375118,ZHNMSSREJSABQA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,380,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL375118,ZHNMSSREJSABQA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,3300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL260823,ZHYJMAJSBAQRIU-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,830,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL407732,ZHYJMAJSBAQRIU-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18387300,KI,=,12,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells,Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1824785,ZILQWXOKQUVSTI-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21788137,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET transporter by NIMH PDSP,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL444985,ZINGRQZUIVEPKX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19282174,IC50,=,4400,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL481863,ZIQGASWXUSSORV-UHFFFAOYSA-N,JNJ-10392980,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18588282,INHIBITION,<,10,%,,"","","","","","",,,,,,,,Inhibition of human NET at 1 uM,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,PUBLICATION,
CHEMBL666,ZJAOAACCNHFJAH-UHFFFAOYSA-N,FOSCARNET,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL666,ZJAOAACCNHFJAH-UHFFFAOYSA-N,FOSCARNET,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3323186,ZJEDITUWACTVKK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,INHIBITION,=,35,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]Nisoxetine from human NET expressed in HEK293E cells at 100 nM after 1 hr by liquid scintillation counting,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL3704752,ZJFMMMXNSXCMOB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,27.8,NM,317706,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL3704752,ZJFMMMXNSXCMOB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,77.7,NM,317694,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. The monoamine transporters inhibitory activities of selected compounds cycloalkylmethylamine derivatives comprising Formula (I) are reported herein. The compounds were evaluated using well established radioligand binding assays protocols (Galli, A. et al., J. Exp. Biol. 1995, 198, 2197-2212; Giros, B. et al., Trends Pharmcol. Sci. 1993, 14, 43-49; Gu, H. et al., J. Biol. Chem. 1994, 269(10), 7124-7130; Shearman, L. P. et al, Am. J. Physiol., 1998, 275(6 Pt 1), C1621-1629; Wolf, W. A. et al., J. Biol. Chem. 1992, 267(29), 20820-20825). The human recombinant transporter proteins dopamine (DAT), norepinephrine (NET) and serotonin (SERT) were selected for the in vitro assays. The radioligand binding assays were carried out at 11 different test concentrations 0.1 nm to 1 uM.",Methods of using cycloalkylmethylamine derivatives,,PATENT,
CHEMBL1170397,ZJJWZZFPUVRGQQ-INIZCTEOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,100,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1171007,ZJJWZZFPUVRGQQ-MRXNPFEDSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,316.23,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1170396,ZJJWZZFPUVRGQQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20570146,KI,=,316.23,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]-Nisoxetine from NET expressed in HEK293 cells by scintillation proximity assay,2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1073,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,GLIPIZIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1073,ZJJXGWJIGJFDTL-UHFFFAOYSA-N,GLIPIZIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1684045,ZJNJPYFFMXVAGY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,37,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684045,ZJNJPYFFMXVAGY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,57,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1684045,ZJNJPYFFMXVAGY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310612,IC50,=,440,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human recombinant NET expressed in HEK293 cells by scintillation counting,"Discovery of N-methyl-1-(1-phenylcyclohexyl)ethanamine, a novel triple serotonin, norepinephrine and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL401804,ZJRXMULNBNPBBB-SDBXPKJASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,560,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL245061,ZKDZVMXERDGTGV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,11000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL245061,ZKDZVMXERDGTGV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,28000,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL245061,ZKDZVMXERDGTGV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,11000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL578611,ZKFFJBXJJFDBJM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,,,,Not Determined,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL578611,ZKFFJBXJJFDBJM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL578611,ZKFFJBXJJFDBJM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,14000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL2205811,ZKOQRCXMSDAJIR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,=,3638,NM,,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1818453,ZKPUOIMTKQGENL-IAGOWNOFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21550808,KI,=,79.43,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET by scintillation proximity assay,"1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3334786,ZKYDECUCAZOZDB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25164761,INHIBITION,=,87.6,%,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells at 10 uM by scintillation counting,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL1084016,ZLLRZVQIIORCDV-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20462211,IC50,=,2255,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
CHEMBL511288,ZLNPNQNLLKIKSH-FOYRJYEQSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18556210,KI,>,2000,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL1224382,ZLRRLSAVNUFCQT-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,IC50,=,19.8,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224382,ZLRRLSAVNUFCQT-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20724153,INHIBITION,=,84,%,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells at 100 uM,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL343324,ZLTWNSXILLAQPT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14643350,INHIBITION,=,25,%,,"","","","","","",,,,,,,,Inhibition of [3H]nisoxetine binding to norepinephrine transporter,"Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1079973,ZLUFXVJXYLAVEN-AWDFDDCISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20138515,ACTIVITY,,,,Active,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter at 1 uM,Synthesis and in vitro evaluation of (18)F-labelled S-fluoroalkyl diarylguanidines: Novel high-affinity NMDA receptor antagonists for imaging with PET.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1079973,ZLUFXVJXYLAVEN-AWDFDDCISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20138515,ACTIVITY,,,,Not Active,"","","","","","",,,,,,,,Inhibition of norepinephrine transporter at 10 nM,Synthesis and in vitro evaluation of (18)F-labelled S-fluoroalkyl diarylguanidines: Novel high-affinity NMDA receptor antagonists for imaging with PET.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1080556,ZMAZHOAGBMLOSO-SFHVURJKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20137933,KI,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET,Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1078742,ZMEHJZMEBDWMRH-LBPRGKRZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19647430,KI,=,50,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]noradrenaline from human NET receptor expressed in HEK293 cells by scintillation counting,N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL383873,ZMKPUZMPYBNAFS-WQLSENKSSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16784855,KI,=,12.53,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET transfected in HEK293 cells,Synthesis and monoamine transporter affinity of front bridged tricyclic 3beta-(4'-halo or 4'-methyl)phenyltropanes bearing methylene or carbomethoxymethylene on the bridge to the 2beta-position.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL482293,ZMMDUENTAOWDLQ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18571404,IC50,=,3000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA reuptake in human noradrenaline transporter expressed in HEK293 cells,Designing rapid onset selective serotonin re-uptake inhibitors. 2: structure-activity relationships of substituted (aryl)benzylamines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1627,ZMOPTLXEYOVARP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18783208,ACTIVITY,<,50,%,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET at 10 uM,Synthesis and evaluation of [N-methyl-11C]N-desmethyl-loperamide as a new and improved PET radiotracer for imaging P-gp function.,J. Med. Chem.,PUBLICATION,
CHEMBL242273,ZMQAAUBTXCXRIC-UHFFFAOYSA-N,SAFROLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL242273,ZMQAAUBTXCXRIC-UHFFFAOYSA-N,SAFROLE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2349310,ZMQSLMZOWVGBSM-GXTWGEPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23516963,ACTIVITY,,,,Active,"","","","","","",,,,,,,,Binding affinity to norepinephrine transporter (unknown origin),"Substituted 7-amino-5-thio-thiazolo[4,5-d]pyrimidines as potent and selective antagonists of the fractalkine receptor (CX3CR1).",J. Med. Chem.,PUBLICATION,
CHEMBL589250,ZMRXSORFBXMBCB-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,8200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL268291,ZMXDDKWLCZADIW-UHFFFAOYSA-N,DIMETHYLFORMAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL268291,ZMXDDKWLCZADIW-UHFFFAOYSA-N,DIMETHYLFORMAMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL595063,ZMXLKLOJDLMZFC-INIZCTEOSA-N,(S)-NORDULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740668,IC50,=,445,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]NE reuptake at human NET expressed in HEK cells,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL595063,ZMXLKLOJDLMZFC-INIZCTEOSA-N,(S)-NORDULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740668,KI,=,2402,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL594585,ZMXLKLOJDLMZFC-MRXNPFEDSA-N,R-NORDULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740668,IC50,=,188,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]NE reuptake at human NET expressed in HEK cells,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL594585,ZMXLKLOJDLMZFC-MRXNPFEDSA-N,R-NORDULOXETINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740668,KI,=,953,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3703744,ZNELUNAFGGGGOF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,22.9,NM,302108,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL472,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,GLYBURIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL472,ZNNLBTZKUZBEKO-UHFFFAOYSA-N,GLYBURIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL56564,ZNRGQMMCGHDTEI-ITGUQSILSA-N,TROPISETRON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL56564,ZNRGQMMCGHDTEI-ITGUQSILSA-N,TROPISETRON,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2093958,ZNSNAOXTBUHNKX-IODNYQNNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15828826,IC50,=,290,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake in HEK293 cells expressing human norepinephrine transporter,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,PUBLICATION,
CHEMBL2093958,ZNSNAOXTBUHNKX-IODNYQNNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15828826,IC50,=,3700,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK293 cells,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,PUBLICATION,
CHEMBL2093958,ZNSNAOXTBUHNKX-IODNYQNNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15828826,IC50,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK293 cells,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,PUBLICATION,
CHEMBL2093958,ZNSNAOXTBUHNKX-IODNYQNNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15828826,IC50,>,10000,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake in HEK293 cells expressing human norepinephrine transporter,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,PUBLICATION,
CHEMBL534479,ZNSNAOXTBUHNKX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15828826,IC50,=,480,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake in HEK293 cells expressing human norepinephrine transporter,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,PUBLICATION,
CHEMBL534479,ZNSNAOXTBUHNKX-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15828826,IC50,>,7200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK293 cells,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,PUBLICATION,
CHEMBL1779060,ZOAKYUHDXICZSY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,KI,,,,Not Determined,"","","","","","",,,,,,,,Binding affinity to NET,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL517118,ZOJBCUHWLQNKOW-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18951020,INHIBITION,=,27,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells at 1 uM,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL371726,ZOMRBJBMKLVVRD-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16202585,IC50,=,3956,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1812744,ZONWPEAFLDQJPL-KKXYHZGYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21058665,IC50,=,19,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,PUBLICATION,
CHEMBL1224563,ZOOYCXCRVKSAIY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,7.94,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224563,ZOOYCXCRVKSAIY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,10,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1224563,ZOOYCXCRVKSAIY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20691589,KI,=,19.95,NM,,"","","","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,"Design, synthesis, and biological evaluation of new monoamine reuptake inhibitors with potential therapeutic utility in depression and pain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL557528,ZOPKRUALFVBFRZ-MOPGFXCFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19722525,IC50,=,39.4,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL1813474,ZOSQXAHBYHMVCA-GXFFZTMASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,208.93,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL1813475,ZOSQXAHBYHMVCA-MFKMUULPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,=,107.15,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL333667,ZOVQSSMFGDAFDJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,IC50,=,399,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL333667,ZOVQSSMFGDAFDJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,KI,=,604,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL390743,ZPAUAFZKIQYYOJ-HIUFNZKISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,IC50,=,690,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of human NET in HEK cells assessed as [3H]norepinephrine reuptake,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL390743,ZPAUAFZKIQYYOJ-HIUFNZKISA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17602602,KI,=,1700,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK cells after 90 mins,"Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL71,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,CHLORPROMAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,19,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL71,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,CHLORPROMAZINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,19,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL402851,ZPMMCRKQYUFTEM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18240382,IC50,=,15,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NA uptake at human NA transporter expressed in HEK293 cells,"1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173595,ZPPOFTVMEMXBDU-IAGOWNOFSA-N,"1-((CYCLOPROPYLMETHOXY)METHYL)-6-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,19.95,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173595,ZPPOFTVMEMXBDU-IAGOWNOFSA-N,"1-((CYCLOPROPYLMETHOXY)METHYL)-6-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,50.12,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL1173595,ZPPOFTVMEMXBDU-IAGOWNOFSA-N,"1-((CYCLOPROPYLMETHOXY)METHYL)-6-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20527970,KI,=,125.89,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [N-methyl-3H]nisoxetine from human recombinant NET expressed in pig LLCPK cells after 2 hrs by liquid scintillation counting,"6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.",J. Med. Chem.,PUBLICATION,
CHEMBL2179217,ZPUAIXYROPYWKA-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23006002,KI,=,2006,NM,,"","","","","","",,,,,,,,Binding affinity to NOR transporter,"Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT(6) Receptor Antagonists.",J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,IC50,=,230,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]- NE uptake in HEK cells expressing norepinephrine transporter,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10479296,KI,=,1770,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [125I]RTI-55 binding to norepinephrine transporter (NET) expressed in HEK cells,"Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.",J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,IC50,=,230,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE reuptake by human norepinephrine transporter expressed in HEK293 cells,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10649976,KI,=,1770,NM,,"","","","","","",,,,,,,,Binding affinity at the norepinephrine transporter was measured using [125I]RTI-55 as a radioligand,Novel 3-aminomethyl- and 4-aminopiperidine analogues of 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazines: synthesis and evaluation as dopamine transporter ligands.,J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10698458,IC50,=,186,NM,,"",cell_based,"","","","",,,,,,,,The compound was tested for inhibition of [3H]norepinephrine uptake in HEK cells by expressing cDNA for human norepinephrine transporter,"Design, synthesis and biological evaluation of 7-azatricyclodecanes: analogues of cocaine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10821718,KI,=,264,NM,,"",cell_based,"","","","",,,,,,,,Compound was evaluated for inhibition of [3H]NE uptake in HEK-hNET cells expressing Human norepinephrine transporter,Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10821718,KI,=,1740,NM,,"",cell_based,"","","","",,,,,,,,Compound was evaluated for binding affinity using [125I]RTI-55 as a radioligand in HEK-hNET cells expressing human norepinephrine transporter,Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,190,NM,,"","","","","","",,,,,,,,Inhibition of reuptake of [3H]-NE (20 nM) by norepinephrine transporter,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,11150168,KI,=,2700,NM,,"","","","","","",,,,,,,,Binding affinity against norepinephrine cloned human transporter using 40-80 pM [125I]RTI,"Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.",J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,IC50,=,233,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,KI,=,1940,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12565962,KI,=,108,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE uptake evaluated at the monoamine transporter (NET),Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,IC50,=,385,NM,,"","","","","","",,,,,,,,Compound was tested for inhibition of [3H]NE binding to norepinephrine transporter HEK cells,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,KI,=,830,NM,,"","","","","","",,,,,,,,Compound was tested for inhibition of [125I]-RTI-55 binding to norepinephrine transporter HEK cells,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,RATIO,=,0.46,,,"","","","","","",,,,,,,,Ratio of uptake inhibition to binding affinity to human Norepinephrine transporter (IC50/Ki),Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14592523,IC50,=,192,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine uptake in HEK cells expressing human NET,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14592523,KI,=,645,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RT155 binding in HEK cells expressing human NET,Synthesis and biological activity of 2-carbomethoxy-3-catechol-8-azabicyclo[3.2.1]octanes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,IC50,=,3300,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15566309,KI,=,1990,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.",J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15828826,IC50,=,462,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake in HEK293 cells expressing human norepinephrine transporter,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15828826,IC50,=,2990,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK293 cells,Synthesis and pharmacology of ethylphenidate enantiomers: the human transesterification metabolite of methylphenidate and ethanol.,J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,IC50,=,3300,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16279803,KI,=,1990,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.",J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,IC50,=,378,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H] norepinephrine uptake into human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16480278,KI,=,2150,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16821765,IC50,=,900,NM,,"",cell_based,"","","","",CHO,,,,,,,Inhibition of rat NET-mediated norepinephrine uptake in CHO cells,Development of peptidic dopamine transporter inhibitors via aromatic modification-mediated conformational restriction.,J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,IC50,=,3300,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,KI,=,1990,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,210,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,182,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]DA uptake in human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17446076,KI,=,887,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in COS1 cell membrane,"Synthesis, inhibition and binding of simple non-nitrogen inhibitors of monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17846138,IC50,=,1900,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18434164,KI,=,1990,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from norepinephrine transporter,"Synthesis and receptor binding properties of 2beta-alkynyl and 2beta-(1,2,3-triazol)substituted 3beta-(substituted phenyl)tropane derivatives.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19014888,IC50,=,835,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19014888,KI,=,1115,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,=,1281,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,=,1116,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,IC50,=,835,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19256502,KI,=,1115,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19523837,KI,=,1990,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,"Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740668,IC50,=,232,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]NE reuptake at human NET expressed in HEK cells,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740668,KI,=,2377,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,IC50,=,385,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19821577,KI,=,830,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addiction.,J. Med. Chem.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,IC50,=,6309.57,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL370805,ZPUCINDJVBIVPJ-LJISPDSOSA-N,COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23602445,KI,=,1257,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL32363,ZPUCINDJVBIVPJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15121762,KI,=,2420,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL781,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,MAZINDOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,0.46,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL781,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,MAZINDOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9400006,KI,=,1.93,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL781,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,MAZINDOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,IC50,=,4.9,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL781,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,MAZINDOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,KI,=,18,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL781,ZPXSCAKFGYXMGA-UHFFFAOYSA-N,MAZINDOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213054,KI,=,18,NM,,"","","","","","",,,,,,,,Inhibition of [125I]- RTI -55 binding at the Norepinephrine transporter sites on HEK-hNET cells,Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL1651219,ZQBPXBADOJMCRU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23009245,INHIBITION,=,-17,%,,"","","","","","",,,,,,,,Inhibition of radioligand binding to human NET at 10 uM,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,PUBLICATION,
CHEMBL565639,ZQHFQDYTXXQENI-QGZVFWFLSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19740658,IC50,=,7500,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline reuptake at human noradrenaline transporter expressed in HEK293 cells after 15 mins by scintillation counting,Design and optimisation of selective serotonin re-uptake inhibitors with high synthetic accessibility: part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256163,ZQJYAEVPJBDRFS-GOEBONIOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,898,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL257083,ZQJYAEVPJBDRFS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,=,3873,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL256371,ZQJYAEVPJBDRFS-ZBFHGGJFSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18242987,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of NET mediated norepinephrine uptake,In vitro and in vivo evaluation of O-alkyl derivatives of tramadol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL303266,ZQNWAFLIAPMFBG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,IC50,=,266,NM,,"","","","","","",,,,,,,,Compound was tested for inhibition of [3H]NE binding to norepinephrine transporter HEK cells,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL303266,ZQNWAFLIAPMFBG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,KI,=,2970,NM,,"","","","","","",,,,,,,,Compound was tested for inhibition of [125I]-RTI-55 binding to norepinephrine transporter HEK cells,Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL303266,ZQNWAFLIAPMFBG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12798324,RATIO,=,0.09,,,"","","","","","",,,,,,,,Ratio of uptake inhibition to binding affinity to human NET (IC50/Ki),Bivalent biogenic amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2111067,ZRGONKKAENTXKT-ZBOSIHDASA-N,OXAPROTILINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,4.9,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL336613,ZRGPKZSODCXXDH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,IC50,=,6.9,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of NE uptake in HEK cells expressing human noradrenaline transporter (hNET),Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL336613,ZRGPKZSODCXXDH-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12213053,KI,=,170,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI-55 from human Norepinephrine transporter expressed in HEK cells,Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL401683,ZRHGDWMRFCDZHY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18060777,KI,=,470,NM,,"","","","","","",,,,,,,,Binding affinity to human NET,Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1255901,ZRJBHWIHUMBLCN-HZRLMBICSA-N,HUPERZINE A,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1255901,ZRJBHWIHUMBLCN-HZRLMBICSA-N,HUPERZINE A,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL599,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,MELOXICAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL599,ZRVUJXDFFKFLMG-UHFFFAOYSA-N,MELOXICAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3323184,ZRXUBWRDOKMUIN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25050161,IC50,=,16,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]-RTI-55 from recombinant NET (unknown origin) expressed in HEK cells by saturation binding analysis,,ACS Med. Chem. Lett.,PUBLICATION,
CHEMBL644,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,TRIMIPRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9537821,KI,=,2450,NM,,"","","","","","",,,,,,,,,,,,
CHEMBL1812747,ZSEXNBSYJGXEIW-MGTHKWJCSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21058665,IC50,=,6.3,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake after 10 mins by scintillation counting,Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes.,J. Med. Chem.,PUBLICATION,
CHEMBL384199,ZSHFBVRJUAGORQ-FIPFOOKPSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,497,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL598346,ZSIHFDAUAFSTIM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,EC50,=,28,NM,,"","","","","","",,,,,,,,Agonist activity at NET,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL598346,ZSIHFDAUAFSTIM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,32,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL598346,ZSIHFDAUAFSTIM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,EC50,=,28,NM,,"",cell_based,"","","","",HEK293,,,,,,,Agonist activity at human cloned NET expressed in HEK293 cells by FLIPR assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL598346,ZSIHFDAUAFSTIM-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21185183,KI,=,32,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of azetedine and pyrrolidine derivatives as dual norepinephrine reuptake inhibitors and 5-HT(1A) partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1651906,ZSJLQEPLLKMAKR-YDEIVXIUSA-N,STREPTOZOTOCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1651906,ZSJLQEPLLKMAKR-YDEIVXIUSA-N,STREPTOZOTOCIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1076394,ZSLRJBTZLBKDHH-AEXJFDPHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL383427,ZSNSOTIXFBSXLU-LIRRHRJNSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16314097,IC50,=,760,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of noradrenaline re-uptake at human noradrenaline transporter expressed in HEK293 cells,"Designing rapid onset selective serotonin re-uptake inhibitors. Part 1: Structure-activity relationships of substituted (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthaleneamine.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL459333,ZSXFOCIJQHAVQI-JRTRGBLZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19053748,KI,=,2600,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,Development of 3-phenyltropane analogues with high affinity for the dopamine and serotonin transporters and low affinity for the norepinephrine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL1940402,ZTBBOIYRZHAFIN-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,25070422,KI,=,1225,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL573973,ZTEDPRVVBLHAKJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19854053,KI,=,1720,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL2391147,ZTGRWYMPQCQTHD-ONGXEEELSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23582449,INHIBITION,=,-17,%,,"","","","","","",,,,,,,,Binding affinity to human nonepinephrine transporter at 10 uM by radioligand displacement assay relative to control,Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL382001,ZTKREAOJYPYCOX-WLHGVMLRSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,190,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL382554,ZTLCDNXGGSLCCK-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16497500,KI,=,33,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from NET,N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptake.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL196110,ZTNSUUWAQMMYEF-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16137883,KI,=,8,NM,,"","","","","","",,,,,,,,Inhibition of monoamine reuptake at norepinephrine transporter,"1-Aryl-3,4-dihydro-1H-quinolin-2-one derivatives, novel and selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL219707,ZTZXXNVAKZPHBL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,940,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219707,ZTZXXNVAKZPHBL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,1700,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219707,ZTZXXNVAKZPHBL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,4200,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL219707,ZTZXXNVAKZPHBL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,4300,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL461095,ZUFCXVFSSJFSOT-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,46,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL461095,ZUFCXVFSSJFSOT-HNNXBMFYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,41,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL448953,ZUFCXVFSSJFSOT-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,303,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL448953,ZUFCXVFSSJFSOT-OAHLLOKOSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,339,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL101899,ZUFCXVFSSJFSOT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,IC50,=,121,NM,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL101899,ZUFCXVFSSJFSOT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,KI,=,149,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL2205832,ZUHLFYHHSNMSRE-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,22959245,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding affinity to NET at 10 uM,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL459390,ZUIXQIJYPVGBQL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,IC50,,,,Not Determined,"",cell_based,"","","","",,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL459390,ZUIXQIJYPVGBQL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19201198,KI,>,10000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET expressed in HEK cells,"2,5-Disubstituted tetrahydrofurans as selective serotonin re-uptake inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL253387,ZUJSUIUCXPKMMG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18085744,KI,=,467,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET t expressed in HEK293 cells,"Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.",J. Med. Chem.,PUBLICATION,
CHEMBL403760,ZUTOYMZNVAREQR-GXTWGEPZSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18468895,IC50,=,3700,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1813481,ZUYOKFFWVNAACC-DZGCQCFKSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21739935,IC50,>,10000,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of norepinephrine reuptake at NET expressed in MDCK cells,Synthesis and pharmacological characterization of bicyclic triple reuptake inhibitor 3-aryl octahydrocyclopenta[c]pyrrole analogues.,J. Med. Chem.,PUBLICATION,
CHEMBL3663919,ZUZFJRJMEROGCY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,12.7,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663919,ZUZFJRJMEROGCY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,22.5,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663919,ZUZFJRJMEROGCY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,105,NM,,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL3663919,ZUZFJRJMEROGCY-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,12.7,NM,314427,"","","","","","",,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
CHEMBL1076401,ZVAYAKGYURRAPZ-AEXJFDPHSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431,ACTIVITY,,,,Not Active,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
CHEMBL1765683,ZVRXOXFSMYJETP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21428406,INHIBITION,<,50,%,,"","","","","","",,,,,,,,Binding affinity to NET at 10 uM by radioligand binding assay,"N-(4-Cyanotetrahydro-2H-pyran-4-yl) and N-(1-Cyanocyclohexyl) Derivatives of 1,5-Diarylpyrazole-3-carboxamides Showing High Affinity for 18 kDa Translocator Protein and/or Cannabinoid Receptors.",J. Med. Chem.,PUBLICATION,
CHEMBL211372,ZVUBOJJCNXGQFS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,IC50,=,2800,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL211372,ZVUBOJJCNXGQFS-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16854064,KI,=,1400,NM,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human NET,"Synthesis and monoamine transporter binding properties of 2,3-cyclo analogues of 3beta-(4'-aminophenyl)-2beta-tropanemethanol.",J. Med. Chem.,PUBLICATION,
CHEMBL492013,ZVXWSRHRVJCNFV-IRXDYDNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18805691,ACTIVITY,=,66,NM,,"","","","","","",,,,,,,,Binding affinity at NET,Design and synthesis of reboxetine analogs morpholine derivatives as selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL598216,ZVZFXZCYKJIUGR-KWBADKCTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20170186,KI,=,7.94,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in BacMam virus-transduced cells by scintillation proximity assay,1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL3703733,ZWAMWGRVKGXYIC-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,86,NM,302097,"","","","","","",,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Compounds were dissolved in 100% DMSO at a concentration 100 times the desired highest assay concentration, serially diluted 1:3 in 100% DMSO, and 1.0 ul/well of each solution was dispensed to a Nunc polypropylene, round bottom, 384-well plate. 100% inhibition is defined with 1.0 ul/well of 10 mM desipramine dissolved in DMSO. 50 ul/well of a 2x membrane preparation (0.4 mg/ml in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) and 50 ul/well of a 2x radioligand solution (4 nM [3H]nisoxetine in 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl) were added to the well and the reaction incubated for 1 hour at room temperature. The contents of the assay plate were then transferred to a Millipore MultiscreenHTS GF/B filter plate which was pretreated with 0.5% PEI for at least one hour. The plate was vacuum filtered and washed with 7 washes of 100 ul/well 50 mM Tris-Cl, pH 7.5, 120 mM NaCl, 5 mM KCl chilled to 4 C.","Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof",,PATENT,
CHEMBL1130,ZWAOHEXOSAUJHY-ZIYNGMLESA-N,DOXIFLURIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1130,ZWAOHEXOSAUJHY-ZIYNGMLESA-N,DOXIFLURIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2432045,ZWCQZHOWEDKJBN-CAUKCHDASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23981939,INHIBITION,<,50,%,,"",cell_based,"","","","",,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL596715,ZWJLIFWNALUYLT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20031410,KI,=,140,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells by scintillation proximity assay,"Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL150045,ZWLWOTHDIGRTNE-UHFFFAOYSA-N,4-BENZHYDRYL-PYRIDINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,12565962,KI,=,3460,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE uptake evaluated at the monoamine transporter (NET),Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL1173597,ZWMHSADWUIOURG-ZFWWWQNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20509659,IC50,=,31,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine reuptake at human NET expressed in HEK293 cells after 90 mins by scintillation counting,Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1173597,ZWMHSADWUIOURG-ZFWWWQNUSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21319801,IC50,=,9,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of human NET in HEK293 cells assessed as inhibition of [3H]norepinephrine uptake,"Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.",J. Med. Chem.,PUBLICATION,
CHEMBL272003,ZWMWTNKSRCRPSI-WMZOPIPTSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17983754,KI,=,2.06,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK293 cells,"Synthesis, in vitro characterization, and radiolabeling of reboxetine analogs as potential PET radioligands for imaging the norepinephrine transporter.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL469666,ZWZSMMPAZKEDJW-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18557608,INHIBITION,=,34,%,,"",cell_based,"","","","",,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells at 1000 nM,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,PUBLICATION,
CHEMBL1683876,ZXAIYPYVRUXIRT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,6,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL501919,ZXJNEUYTPXBETE-NSHDSACASA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18621528,KI,=,86,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]nisoxetine reuptake at human NET expressed in HEK293 cells by SPA,Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL64894,ZXJXZNDDNMQXFV-UHFFFAOYSA-M,GENTIAN VIOLET,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL64894,ZXJXZNDDNMQXFV-UHFFFAOYSA-M,GENTIAN VIOLET,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL36994,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,ANIRACETAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL36994,ZXNRTKGTQJPIJK-UHFFFAOYSA-N,ANIRACETAM,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2206507,ZXQHLFVRUPRIEJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,23084899,KI,=,5,NM,,"","","","","","",,,,,,,,Inhibition of human NET,4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL204591,ZXSCHWNAHIGTOP-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16337793,IC50,>,100,NM,,"","","","","","",,,,,,,,Inhibitory activity against NET,Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL241647,ZXTNAQHXTXATFR-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18052090,KI,=,7,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]iodonisoxetine from NET expressed in LLCPK1 cells,2-(2'-((dimethylamino)methyl)-4'-(fluoroalkoxy)-phenylthio)benzenamine derivatives as serotonin transporter imaging agents.,J. Med. Chem.,PUBLICATION,
CHEMBL395368,ZYALYWXELCWDBL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17127059,KI,=,118,NM,,"",cell_based,"","","","",MDCK,,,,,,,Inhibition of [3H]nisoxetine uptake in human NET expressed in MDCK cells,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL6466,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,COUMARIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL6466,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,COUMARIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL218849,ZYPXTTXHMBCKFT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,26,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218849,ZYPXTTXHMBCKFT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,IC50,=,180,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]NE uptake into human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218849,ZYPXTTXHMBCKFT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,230,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL218849,ZYPXTTXHMBCKFT-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17228864,KI,=,1600,NM,,"",cell_based,"","","","",HEK293,,,,,,,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,"Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.",J. Med. Chem.,PUBLICATION,
CHEMBL450623,ZYQIUGBSDWKKMU-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,18207394,IC50,>,10000,NM,,"","","","","","",,,,,,,,Inhibition of human NET,Studies on the SAR and pharmacophore of milnacipran derivatives as monoamine transporter inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL420142,ZYSPQRLLQVFKDB-NTISSMGPSA-M,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,15177457,KI,>,10000000,NM,,"","","","","","",,,,,,,,Ability to inhibit [3H]nisoxetine binding to cloned human norepinephrine (NE) transporter,Synthesis and biological activity of some known and putative duloxetine metabolites.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL398559,ZYTLNNQUXXHCCG-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,17869101,KI,=,8000,NM,,"",cell_based,"","","","",,,,,,,,Displacement of [125I]RTI55 from human NET transfected in COS1 cells,High dopamine transporter selectivity can be displayed by remarkably simple non-nitrogen containing inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL383879,ZZJGNQRWIXQQDJ-CUNXSJBXSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,16931001,KI,=,1379,NM,,"","","","","","",,,,,,,,Inhibition of NET,"2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL62193,ZZORFUFYDOWNEF-UHFFFAOYSA-N,SULFADIMETHOXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL62193,ZZORFUFYDOWNEF-UHFFFAOYSA-N,SULFADIMETHOXINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1683875,ZZRHLICOWQQNJL-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,21310609,IC50,=,9,NM,,"","","","","","",,,,,,,,Inhibition of human recombinant Norepinephrine transporter,"Discovery of N-methyl-1-(1-phenylcyclohexyl)methanamine, a novel triple serotonin, norepinephrine, and dopamine reuptake inhibitor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL35,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,FUROSEMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL35,ZZUFCTLCJUWOSV-UHFFFAOYSA-N,FUROSEMIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL657,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,DIPHENHYDRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,3542,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL657,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,DIPHENHYDRAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,3513,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL599846,ZZWUEOYQVWAKCJ-UHFFFAOYSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,20158204,IC50,=,2530,NM,,"",cell_based,"","","","",HEK293,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation.,J. Med. Chem.,PUBLICATION,
CHEMBL1200431,,GADOPENTETATE DIMEGLUMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200431,,GADOPENTETATE DIMEGLUMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200528,,CHROMIC CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200528,,CHROMIC CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200693,,MANGANESE CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1200693,,MANGANESE CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201469,,GRAMICIDIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201469,,GRAMICIDIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201631,,INSULIN HUMAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1201631,,INSULIN HUMAN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1351,,CARBOPLATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1351,,CARBOPLATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL136478,,SODIUM NITROPRUSSIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL136478,,SODIUM NITROPRUSSIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1366,,AURANOFIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1366,,AURANOFIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1386,,TRANSPLATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1386,,TRANSPLATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1458880,,CADMIUM DICHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1458880,,CADMIUM DICHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1476898,,CADMIUM ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1476898,,CADMIUM ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909054,,CARBOXYMETHYLCELLULOSE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909054,,CARBOXYMETHYLCELLULOSE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909055,,COBALTOUS CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909055,,COBALTOUS CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909056,,COBALT(II) ACETYLACETONATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909056,,COBALT(II) ACETYLACETONATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909057,,COPPER(II) OXIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909057,,COPPER(II) OXIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909062,,LEAD (II) ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909062,,LEAD (II) ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909063,,LEAD(IV) ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909063,,LEAD(IV) ACETATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909064,,LIPOPOLYSACCHARIDE E. COLI O55:B5,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909064,,LIPOPOLYSACCHARIDE E. COLI O55:B5,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909067,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909067,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909068,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909068,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909069,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909069,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909071,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909071,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909074,,POLYVINYLPYRROLIDONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909074,,POLYVINYLPYRROLIDONE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909075,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909075,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909079,,STANNOUS FLUORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909079,,STANNOUS FLUORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909083,,ZIRCONIUM(IV) CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL1909083,,ZIRCONIUM(IV) CHLORIDE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2068237,,CISPLATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL2068237,,CISPLATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL306043,,GOLD SODIUM THIOMALATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL306043,,GOLD SODIUM THIOMALATE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL324631,,PIPERIDINE BASED ANALOGUE OF COCAINE (STRUCTURAL MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10576690,KI,=,392.6,NM,,"","","","","","",,,,,,,,Norepinephrine transporter activity was determined by inhibition of monoamine [3H]-NE reuptake,Synthesis and biological evaluation of two novel DAT-binding technetium complexes containing a piperidine based analogue of cocaine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL324631,,PIPERIDINE BASED ANALOGUE OF COCAINE (STRUCTURAL MIX),,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10576690,KI,=,2030,NM,,"","","","","","",,,,,,,,Norepinephrine transporter activity was determined by inhibition of monoamine [3H]-NE reuptake,Synthesis and biological evaluation of two novel DAT-binding technetium complexes containing a piperidine based analogue of cocaine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL343369,,RHENIUM COMPLEX,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,9804682,IC50,=,7.3,NM,,"","","","","","",,,,,,,,The compound was tested in vitro for binding affinity for the norepinephrine transporter (NET) using competitive binding assay.,TROTEC-1: a new high-affinity ligand for labeling of the dopamine transporter.,J. Med. Chem.,PUBLICATION,
CHEMBL3559671,,POLYVINYL ALCOHOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3559671,,POLYVINYL ALCOHOL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL3735756,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Ki,=,11,NM,,"","","","","","",,,,,,,,Displacement of [3H]Nisoxetine from human norepinephrine transporter stably expressed in HEK293 cells after 30 mins by neurotransmitter transporter uptake assay,Identification of tris-(phenylalkyl)amines as new selective h5-HT2Breceptor antagonists,MedChemComm,PUBLICATION,
CHEMBL3741992,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26460788,Inhibition,<,30,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,Novel Series of Dihydropyridinone P2X7 Receptor Antagonists.,J. Med. Chem.,PUBLICATION,
CHEMBL3752576,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26739781,Ki,=,1000,NM,,"","","","","","",,,,,,,,Binding affinity to NET (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3752900,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26739781,Ki,=,630.96,NM,,"","","","","","",,,,,,,,Binding affinity to NET (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3753318,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26739781,Ki,<,10000,NM,,"","","","","","",,,,,,,,Binding affinity to NET (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3754085,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26764191,Inhibition,=,-1,%,,"","","","","","",,,,,,,,Inhibition of human Noradrenaline transporter at 10 uM,"Discovery of potent aryl-substituted 3-[(3-methylpyridine-2-carbonyl) amino]-2,4-dimethyl-benzoic acid EP4 antagonists with improved pharmacokinetic profile.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3754166,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26739781,Ki,=,1000,NM,,"","","","","","",,,,,,,,Binding affinity to NET (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3754496,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26739781,Ki,=,1995.26,NM,,"","","","","","",,,,,,,,Binding affinity to NET (unknown origin) by competition binding assay,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3763166,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26653033,Inhibition,=,62,%,,"","","","","","",,,,,,,,Inhibition of Norepinephrine transporter (unknown origin) at 10 uM,"Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor Efficacy.",J. Med. Chem.,PUBLICATION,
CHEMBL3769872,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26935940,IC50,=,33,NM,,"","","","","","",,,,,,,,Inhibition of recombinant human norepinephrine transporter assessed as reduction in [3H]-NA reuptake,Emerging targets and new small molecule therapies in Parkinson's disease treatment.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3770651,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26935940,IC50,=,17,NM,,"","","","","","",,,,,,,,Inhibition of recombinant human norepinephrine transporter assessed as reduction in [3H]-NA reuptake,Emerging targets and new small molecule therapies in Parkinson's disease treatment.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3770663,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26935940,IC50,=,33,NM,,"","","","","","",,,,,,,,Inhibition of recombinant human norepinephrine transporter assessed as reduction in [3H]-NA reuptake,Emerging targets and new small molecule therapies in Parkinson's disease treatment.,Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3770836,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27072905,Inhibition,>=,70,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3774423,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.26,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3774516,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.34,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3774516,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,IC50,=,1170,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3774556,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.46,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3774556,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,IC50,=,530,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3774732,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.36,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3774732,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,IC50,=,890,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3774764,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.23,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3774784,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26774927,Activity,=,7,%,,"","","","","","",,,,,,,,Binding affinity to human norepinephrine transporter at 10 uM by radioligand binding assay,Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.,Eur. J. Med. Chem.,PUBLICATION,
CHEMBL3774952,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.26,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3774957,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.41,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3774957,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,IC50,=,380,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775008,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.29,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775008,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,IC50,=,2500,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775012,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.6,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775012,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,IC50,=,610,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775085,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.31,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775085,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,IC50,=,2100,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775140,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.63,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775140,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,IC50,=,560,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775177,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.51,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775177,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,IC50,=,600,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775266,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,0.08,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 1 uM by liquid scintillation counting method relative to GBR-12909,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775405,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.37,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775405,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,IC50,=,1070,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775429,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.18,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775436,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26988801,Inhibition,=,52.6,%,,"","","","","","",,,,,,,,Displacement of [3H]nisoxentine from human recombinant norepinephrine transporter expressed in CHO cells at 10'-5 M,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775450,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,0.2,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 1 uM by liquid scintillation counting method relative to GBR-12909,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775568,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.01,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775628,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,-0.05,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 1 uM by liquid scintillation counting method relative to GBR-12909,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775638,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.4,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775703,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.45,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775703,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,IC50,=,760,NM,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells by liquid scintillation counting method,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775769,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26988801,Inhibition,=,34.5,%,,"","","","","","",,,,,,,,Displacement of [3H]nisoxentine from human recombinant norepinephrine transporter expressed in CHO cells at 10'-5 M,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775835,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.29,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775920,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,0.41,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 1 uM by liquid scintillation counting method relative to GBR-12909,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775932,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3775944,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27041397,FC,=,1.16,,,"","","","","","",,,,,,,,Inhibition of [3H]-NE reuptake in human NET transfected into HEK293 cells at 10 uM by liquid scintillation counting method relative to venlafaxine HCl,"Design, synthesis, and biological evaluation of arylpiperazine-benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3785736,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26942860,Activity,>,77,%,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells assessed as remaining radioligand binding at 10 uM after 120 mins by scintillation counting method relative to control,Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity.,J. Med. Chem.,PUBLICATION,
CHEMBL3787247,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,26988308,Inhibition,=,65,%,,"","","","","","",,,,,,,,Inhibition of recombinant human norepinephrine transporter expressed in MDCK cells at 10 uM by radioligand binding assay,"N-Alkylpyrido[1',2':1,5]pyrazolo-[4,3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents.",Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3792888,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27072905,Inhibition,=,48,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3794389,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27072905,Inhibition,=,96,%,,"","","","","","",,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL3817915,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27325446,IC50,=,0.1,NM,,"","","","","","",,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818117,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27325446,IC50,=,0.08,NM,,"","","","","","",,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818345,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27325446,IC50,=,1,NM,,"","","","","","",,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818471,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27325446,IC50,=,0.64,NM,,"","","","","","",,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818596,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27325446,IC50,=,25,NM,,"","","","","","",,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818901,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27325446,IC50,=,0.21,NM,,"","","","","","",,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818946,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27325446,IC50,=,1.4,NM,,"","","","","","",,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3818953,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27325446,IC50,=,0.13,NM,,"","","","","","",,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819009,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27325446,IC50,=,1.9,NM,,"","","","","","",,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819201,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27325446,IC50,=,0.079,NM,,"","","","","","",,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819217,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27325446,IC50,=,100,NM,,"","","","","","",,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819243,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27325446,IC50,=,0.065,NM,,"","","","","","",,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3819441,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,27325446,IC50,=,1.1,NM,,"","","","","","",,,,,,,,Inhibition of human NET expressed in CHO cells assessed as [3H]-Norepinephrine reuptake incubated for 45 mins measured after 30 mins by topcount method,"Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors - Part 3.",Bioorg. Med. Chem.,PUBLICATION,
CHEMBL3823832,,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,Inhibition,=,51,%,,"","","","","","",,,,,,,,Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells at 10 uM after 120 mins by scintillation counting analysis,In vivo phenotypic drug discovery: applying a behavioral assay to the discovery and optimization of novel antipsychotic agents,MedChemComm,PUBLICATION,
CHEMBL414804,,OXALIPLATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL414804,,OXALIPLATIN,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL441075,,PIPERIDINE BASED ANALOGUE OF COCAINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,10576690,KI,=,231.1,NM,,"","","","","","",,,,,,,,Norepinephrine transporter activity was determined by inhibition of monoamine [3H]-NE reuptake,Synthesis and biological evaluation of two novel DAT-binding technetium complexes containing a piperidine based analogue of cocaine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
CHEMBL508338,,THIOMERSAL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,=,931,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
CHEMBL508338,,THIOMERSAL,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,=,923,NM,,"","","","","","",MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
